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Abstract 
Phosphate glass fibre polymer composites have the potential to be utilised as degradable 
orthopaedic implant devices with modifications to the glass fibre composition allowing for 
materials with tailorable mechanical properties and degradation rates. Accordingly such 
materials could be advantageous for the development of alternative cranioplasty implant 
devices. In collaboration with an industrial sponsor, a promising composition of phosphate 
glass was characterised to assess its potential as a composite reinforcing agent along with 
the applicability of different composite configurations as possible cranioplasty implants.   
The CorGlaes® Pure 107 phosphate glass was found to demonstrate suitable dissolution 
rates for cell culture whilst vibrational spectroscopy and analytical chemistry techniques 
confirmed its structural features and suitability for fibre manufacturing. The mechanical 
properties of its bulk and fibre formats were determined to be in line with alternate PG 
compositions but initial biocompatibility screenings of glass samples using human 
osteosarcoma cells found this composition to be cytotoxic. This was believed to be due to 
localised pH changes or from the release of Zn2+ ions towards cytotoxic levels. The 
absence of a carbonated hydroxyapatite layer formation when immersed in simulated body 
fluid also indicated that this glass composition possessed no in vitro bioactivity. 
Composite materials based on CorGlaes® Pure 107 fibres in a polylactic acid (PLA) matrix 
at a 0.2 fibre volume fraction (Vf) were found to exhibit mechanical properties within the 
same region as those reported for cranial bones. However rapid dissolution of the 
reinforcing fibres (due to autocatalysis) led to premature reductions in the composite 
mechanical properties and resulted in a cytotoxic response during in vitro cell culture. The 
introduction of a secondary hydroxyapatite filler phase into the CorGlaes® Pure 107 
composite to counteract the acidic pH led to changes in the samples mechanical properties 
and degradation media pH. However this failed to retard the fibre dissolution rate in 0.15Vf 
composites. At a 0.01Vf, the inclusion of HA produced biocompatible composites 
compared to the HA free equivalent and was attributed to the reduction of preferential Zn2+ 
ion release from the glass fibres due to the pH buffering at the fibre-matrix interface. 
However the low Vf required to achieve biocompatible composites made the CorGlaes® 
Pure 107 fibres unsuitable as a primary composite reinforcing agent. 
Consequently phosphate glass fibre composites may be suitable for cranioplasty 
applications with future hybrid composites allowing for the design of implant materials 
that are capable of eliciting an immediate in vivo response whilst retaining its long term 
mechanical properties. 
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Nomenclature 
 
A  Sample surface area 
Af  Fibre cross-sectional area 
b  Specimen width 
c  Average indent crack length 
cflaw  Flaw depth 
Cg  Atomic packing density 
d  Average indent diagonal length 
Dr  Dissolution rate 
E  Elastic modulus 
E1  Longitudinal (primary) elastic modulus 
Ecomp  Composite elastic modulus 
Ef  Fibre tensile modulus 
Em  Matrix modulus 
F  Maximum load 
Ff  Fibre maximum tensile force 
h  Specimen thickness 
H  Sample hardness 
HV   Vickers hardness 
i  ith tensile strength value 
IFFS  Interfacial shear stress 
k  System compliance factor 
KIC  Fracture toughness 
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ksp  Solubility product constant 
L  Specimen span 
Lf  Fibre gauge length 
m  Weibull modulus 
MFI  Melt flow index 
MO  Modifier oxide 
N  Total number of specimens tested 
n  An integer 
n0  Correction factor depending upon composite fibre orientation 
n1  Correction factor dependent upon fibre length 
OD570e  Mean optical density measured for each dissolution extract 
OD570b  Mean optical density value of the positive control media 
P  Indentation load 
PF  Probability of failure 
PG  Phosphate glass 
PGF  Phosphate glass fibre 
pm  Picometre 
PW  Processing window 
q  Weight loss 
Qi  Terminology used to describe phosphate structural groups 
R  Fibre radius 
RCM  Random continuous mat 
SA  Surface area 
s’  Beam mid-point deflection1 
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s’’  Beam mid-point deflection2 
t  Time 
Tg  Glass transition temperature 
Tlq  Liquidus temperature 
Tm  Melt temperature 
Toc  Crystallisation onset temperature 
Tp  Crystallisation peak temperature 
UD  Unidirectional 
Um  Total bonding energy 
V  Volume 
Vf  Composite fibre volume fraction 
VHA  Composite HA volume fraction 
VHA-m  Composite matrix sheet HA volume fraction 
VHA-pp  Composite fibre pre-preg HA volume fraction 
W  Wavenumber 
wa  Sample weight in air 
wc  Composite weight 
wf  Composite fibre weight 
Wf  Composite fibre weight fraction 
WHA  Composite HA weight fraction  
wHA  Composite HA weight 
Wm  Composite matrix weight fraction 
wm  Composite matrix weight 
wo  Initial sample weight 
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ws  Sample weight suspended in media 
wt  Sample weight at time tx 
Y(c, R) Crack geometry constant 
 
δ  Non-dimensional indenter geometry constant 
∆F  Differential between F’ and F’’ corresponding to s’ and s’’ 
∆FB  Difference in force corresponding to the selected strain limits 
∆LB  Difference in cross-head displacement corresponding to the strain limits 
∆s  Differential between deflections s’ and s’’ 
εf  Fibre strain at failure 
εf’  Flexural strain1 
εf''  Flexural strain2 
εm  Matrix strain at failure 
ρ  Sample density 
ρf  Fibre density 
ρHA  HA density 
ρL  Immersion media density 
ρm  Matrix density 
σ  Tensile strength 
σ0  Normalising stress 
σf  Fibre tensile strength 
σcomp  Composite flexural strength 
τb  Interfacial shear bond strength 
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1 Giltech Ltd 
Giltech Ltd are a Scottish company (based in Ayr) focused on the development of medical 
devices using their range of haemocompatible, biodegradable controlled release 
technologies for applications such as wound management, urology as well as vascular 
grafting. These include a range of soluble phosphate glasses, alginates and patented 
delivery methods that have been previously developed into products such as its alginate 
based Sorbsan® wound care management system and infection resistant Silverline® urinary 
catheters [1]. 
 
1.1 CorGlaes® Technology 
CorGlaes® is Giltech’s range of soluble phosphate based glasses that incorporate active 
metal ions into their composition to tailor the dissolution rates and ion release profiles. 
These glasses are typically manufactured according to application specific compositions 
and can be supplied in a range of material formats (e.g. powder, fibres). Furthermore, 
previous in vitro results using human and animal cell lines on different CorGlaes® 
compositions have also demonstrated the potential applicability of this technology platform 
as an orthopaedic biomaterial [1].  
 
1.1.1 CorGlaes® Pure 107 
CorGlaes® Pure 107 is a quinternary composition of ultraphosphate glass development by 
Giltech Ltd that substitutes specific concentrations (mol%) of magnesium (Mg) and zinc 
(Zn) into the initial phosphate (P), calcium (Ca) and sodium (Na) CorGlaes® system. This 
glass was selected for this project by Giltech Ltd with a view to its application as either a 
standalone biomedical implant or in its fibre form as a composite reinforcing agent.   
Due to the commercial confidentiality of the project, the precise composition of the 
CorGlaes® Pure 107 glass was not disclosed and consequently all conclusions based on the 
obtained results have been developed with this restriction in mind. However it was 
confirmed that the CorGlaes® Pure 107 composition contained 55 mol% P2O5 as well as 
low concentrations (mol%) of zinc and sodium. Additionally, the precursor compounds 
used in the manufacturing of the CorGlaes® Pure 107 glass are assumed to have been 
composed of those typically used in phosphate glass manufacturing (i.e. P2O5, CaO, Na2O, 
MgO and ZnO). 
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2 Introduction 
The reconstruction of cranial defects typically involves the use of auto- or allograft bone, 
titanium or PMMA based materials to improve neurological function, protect cerebral 
tissue and provide cosmetic restoration. However each material possesses specific 
disadvantages and the occurrence of post-operative infection at the treatment site is a major 
threat to the success of the implant [2, 3].  
Combined with their high radiolucency, specific moduli and impact strengths, pre-formed 
fibre reinforced composites are viewed as an attractive alternative to current cranioplasty 
plate materials. Accordingly, multi-structured dense-porous composite implant designs 
such as those using non-resorbable E-glass fibres, bioactive glass particles and a bisphol-a-
glycidyl methacrylate/triethyleneglycoldi-methacrylate (pBisGMA-pTEGDMA) matrix 
have been previously investigated by Aitasalo et al. (2014) for cranioplasty plate 
applications. This clinical study found that all patients treated with these composites 
displayed no inflammatory reactions or acute systematic toxicities with good functionality 
and aesthetic results [4, 5]. 
Given the issues with existing materials and emphasis on infectious prevention, bioactive 
phosphate glass fibre (PGF) reinforced composites could be advantageous for cranioplasty 
plate materials. The use of a degradable matrix material along with the antibacterial 
properties of specific phosphate glass compositions could subsequently allow for the 
manufacturing of degradable cranioplasty implant materials that facilitate the complete 
restoration of the skull defect with the host’s native bone tissue. Consequently the 
development of a dense PGF reinforced polymer composite with mechanical properties 
similar to those of the cranial bones was intended to provide an initial investigation into the 
suitability of these materials for cranioplasty plate applications. Such composites may be 
pre-formed to the defect contours and could be bonded to a porous composite foam system, 
mimicking the structure of cranial bone. This design would be similar to that tested by 
Aitasalo et al. (2014) with the porous foam scaffold allowing for bone tissue ingrowth 
whilst the dense PGF polymer composite exterior provided both fixation and mechanical 
protection (Figure 2.1.1) [4, 6].  
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Accordingly the development of a PGF composite as a potential cranioplasty plate 
component was conducted through a series of iterative steps intended to sequentially 
characterise the selected glass composition and then the properties of the resulting 
composite materials. 
Chapter 3 of this thesis presents a review of the literature concerning the general 
physiology, structure and mechanical properties of bone with additional information on the 
specific properties of the skull’s cranial bones. This continues with a breakdown of the 
biomaterials typically used in orthopaedic applications as well as an overview of the 
general principles behind composite materials. These concepts are carried forward as the 
current cranioplasty plate materials are reviewed before the fundamentals and 
compositional evolution of phosphate glasses (PGs) and PGF composites for hard tissue 
regeneration are examined. The basic mode of operation behind key analytical chemistry 
techniques related to this work is then reviewed in chapter 4. The subsequent development 
of the CorGlaes® Pure 107 composite is then broken down throughout chapters 5 to 8 that 
each contains their own materials and methods, results, discussion and conclusions.   
To expand on this, the structural characterisation along with the mechanical and in vitro 
properties of the CorGlaes® Pure 107 glass and applicability of its fibres as a composite 
reinforcing agent are investigated in chapters 5 and 6 respectively. This is carried into 
chapter 7 where the manufacture and testing of CorGlaes® Pure 107 composites through 
different interdisciplinary techniques is conducted to assess its initial and degenerative 
Figure 2.1.1. a) Illustration of potential CorGlaes® Pure 107 multi-component composite 
being applied as a cranioplasty implant material [Modified from Aitasalo et al. (2014)] and 
b) Magnified section showing the position of the implant in relation to the surrounding 
physiological tissue [Modified from Nganga et al. (2012)]. 
CorGlaes® Pure 107 fibre composite 
Porous inner layer 
Site of skull defect Porous inner layer 
Brain tissue 
Fixation screw 
a b 
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properties. Modification and optimisation of the initial composite configuration based on 
the previous data obtained from chapter 7 is reported in chapter 8 whilst an overall 
discussion and conclusion on the project work is found in chapters 9 and 10 respectively. 
Lastly the future direction of this work is outlined in chapter 11. 
 
2.1 Aims of Thesis 
The main aims of this thesis was to develop and investigate a degradable PGF reinforced 
composite as a potential cranioplasty plate implant component using the CorGlaes® Pure 
107 composition of phosphate based glass.  
Accordingly the aims of this project were: 
1. To investigate the suitability of the CorGlaes® Pure 107 phosphate glass composition 
as a biomaterial. 
2. To mechanically, chemically and biologically characterise the CorGlaes® Pure 107 
fibres and evaluate their potential as a composite reinforcing agent. 
3. To develop and examine different CorGlaes® Pure 107 fibre reinforced polymer 
composite configurations to assess their potential as a part of a degradable cranioplasty 
plate.  
 
It should also be noted that the characterisation and analysis performed here was composed 
of the general multidisciplinary techniques typically employed at the laboratory scale for 
the testing of glass and biomedical composites as discussed by Mustafa & Tanner (2011) 
and was not intended to reach in vivo testing during this project [7]. 
Furthermore as an initial design criterion, it was decided that the PGF composite plate 
must aim to retain at least 80% of its initial mechanical properties over a six week 
degradation period in order to satisfy the mechanical requirements of its intended 
application. However this may be later refined and extended given the reduced rate of 
skeletal regeneration in the skull compared to other anatomical sites [8-10]. 
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3 Literature Review 
3.1 Bone 
3.1.1 Definition and Function 
Composites are a group of materials composed of two or more components which have 
characteristics and properties derived from its constituent materials.  Bone tissue is an 
example of a bioceramic composite and is constructed of an organic matrix reinforced by 
an inorganic ceramic phase. This tissue is found in the vertebrate endoskeleton (Figure 
3.1.1) and enables various mechanical as well as physiological processes in the body. This 
includes crucial metabolic activities (such as the supply of red blood cells - 
haematopoiesis) and mineral homeostasis by acting as a reservoir for the body’s salts. 
Meanwhile the high mechanical properties of bone provide structural support, attachment 
sites for muscles (that permit skeletal locomotion) and grant protection to the body’s 
internal organs. Furthermore the dynamically responsive nature of bone allows its structure 
to be adapted according to the mechanical demands of its loading environment and 
continually repair itself through a naturally occurring remodelling process [11-13]. 
 
 
 
 
 
 
 
 
 
 
 
A complete human skeletal system is composed of over two hundred unique bones with a 
diverse range of geometrical and structural architectures. These are dependent upon 
Figure 3.1.1. Illustration of human skeleton with examples of different bone types (long, 
short, flat, irregular and sesamoid) [Modified from Hamill (2006) Biomechanical Basis of 
Human Movement]. 
Long bone (humerus) 
Short bone 
(carpals of wrist) 
Flat bone (illum) 
Irregular bone (vertebra)  
Sesamoid bone (patella)  
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various factors including its anatomical site (due to the associated mechanical loading), 
age, sex or required physiological function and are generally classified according to their 
type or location (Figure 3.1.1) [11-13]. 
 
3.1.2 Composition and Physiology 
3.1.2.1 Composition 
As mentioned in section 3.1.1, bone is often considered as a composite consisting of an 
organic matrix (composed mainly of collagen) reinforced by an inorganic ceramic phase of 
bone mineral. However despite the various structural organisations of this tissue 
throughout the body, its fundamental composition remains relatively constant.  
Orientated type I collagen fibrils account for ≈90% of bone’s organic matrix and provide 
flexibility to the tissue with the remaining matrix contents assigned to non-collagenous 
proteins such as fibronectin, osteopontin, osteocalcin and bone sialoproteins. Analysis of 
the mineral phase shows that it constitutes 60-70% of bone’s wet weight and is a reservoir 
for the human body’s calcium, phosphorous, sodium and magnesium content. These are 
stored as imperfect crystalline structures, mainly in the form of 20-80nm long, 2-5nm thick 
plate-like crystals of non-stoichiometric hydroxyapatite (Ca10(PO4)6(OH)2) (Table 3.1.1) 
and are responsible for providing the majority of bone’s stiffness, hardness and strength.  
Additionally, the inclusion of 5-8 % water in bone is considered to play a crucial role in its 
viscoelastic properties and facilitates nutrient transport throughout the tissue [12, 14, 15]. 
 
Table 3.1.1. Typical composition (wt.%) and Ca/P ratio of the hydroxyapatite mineral 
phase found in bone [Reproduced from Neira (2011) An efficient approach to the synthesis 
of a calcium phosphate bone cement and its reinforcement by hydroxyapatite crystals of 
various particle morphologies]. 
wt.% 
Ca2+ PO43- CO32- Na+ K+ Mg2+ Sr2+ Cl- F- P2O74- H2O Ca/P 
36.6 17.1 4.8 1.0 0.07 0.6 0.05 0.1 0.1 0.07 10 1.65 
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3.1.2.2 Bone Cells 
Despite only accounting for approximately 2% of its organic matrix the cells in bone are 
vital to its growth and repair. These consist of the four different cell types described below:  
 
Osteoprogenitor cells - Also known as osteogenic cells, these are mesenchymal stem cells 
(MSC’s) with the ability to differentiate into osteoblasts, chondroblasts, bone marrow 
stromal cells or fibroblasts (depending on the local stimuli). These cells are located within 
the periosteum as well as the endosteum membranes of the bone tissue and are capable of 
being reactivated during bone fracture repair [16, 17].  
Osteoblasts - Derived from osteoprogenitor cells, these large polygonal cells are critical to 
the growth and repair of bone. Osteoblast cells secrete type I collagen and the 
glycosaminoglycan’s necessary to form the organic matrix of bone as well as producing 
the previously mentioned non-collagenous proteins. These cells also facilitate the 
mineralisation process and are capable of producing receptors involved in the 
differentiation of osteoclasts [16, 17]. 
Osteocytes - These cells make up 90% of all cells in bone and are involved in the cell 
signalling processes that facilitate maintenance of the bone matrix and metabolic activities 
(through the bone remodelling process). Osteocytes are derived from mature osteoblasts 
that have become entrapped during bone deposition and enclosed in a calcified cavity of 
bone matrix during remodelling (known as a lucuna). These entrapped cells are unable to 
produce bone matrix and as a result differentiate into osteocytes [16-19].  
Osteoclasts - Large multinucleated cells responsible for the resorption of mineralised 
matrix through the release of bone-resorbing acids as well as enzymes for collagen 
resorption. Osteoclasts are derived from the fusion of multiple monocyte/macrophage cells 
into a single cell and are regulated by hormones such as calcitonin and growth factors 
including interleukin 6 (IL-6). These cells reside in resorption pits and facilitate the release 
of mineral salts from the calcified bone matrix to support mineral homeostasis [16-18]. 
 
3.1.2.3 Bone Remodelling 
The concept of modern bone remodelling is largely attributed to the work of Frost (1961) 
and is routinely described as a continually occurring physiological process where old bone 
is replaced with new tissue through a series of coordinated interactions between different 
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cells. This process maintains the mechanical strength of bone (through the repair of cracks) 
whilst allowing it to adapt its architecture, mass and density to meet the local mechanical 
loading regime (as described by Wolff’s Law). Bone remodelling also serves to control 
mineral homeostasis and is regulated from both systematic and local factors as well as 
mechanical stimuli. However the precise control mechanisms behind the remodelling of 
bone remain ambiguous [17, 20-22]. 
The remodelling of bone occurs across the skeleton at structures referred to as bone 
multicellular units (BMUs). These are primarily composed of osteoclasts and osteoblasts 
which facilitate the resorption and formation of bone respectively. In cortical bone these 
BMUs form a 150-200µm diameter cylindrical cutting cone (also known as a Howship’s 
lacunae) that burrow through the mineralised tissue at a rate of 20-40µm day-1. In 
cancellous bone the remodelling occurs through the formation of 40-60µm deep trenches 
as osteoclasts travel across individual trabeculae at rates of up to 25µm day-1. The 
remodelling process at these BMUs for cortical and cancellous bone can be summarised by 
the 3 phases described in Table 3.1.2  and is illustrated in Figure 3.1.2 [20, 22-25]. 
 
Table 3.1.2. Summary of the three stages encountered during bone remodelling for cortical 
and cancellous bone [Modified from Boccacini (2007)]. 
Phase Description 
Activation/
Resorption 
Initiates when partially differentiated pre-osteoclasts migrate to the bone 
surface and form multinucleated osteoclast cells that remove the 
mineralised component (i.e. hydroxyapatite). This phase can last for 
approximately two weeks. 
Reversal Mononuclear cells prepare the surface for new bone deposition by 
removing the resorption remnants and provide signals for the 
differentiation/migration of osteoblast cells. This phase can last four to five 
weeks. 
Formation Osteoblasts deposit new bone matrix in the region between old and new 
bone forming a cement line. This matrix material is then calcified at the 
mineralisation front until the resorbed area is completely replaced by new 
bone tissue. This phase can take up to four months to be completed.  
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In an adult skeleton the rate of bone resorption and formation are balanced in order to 
maintain a constant bone mass with studies estimating that the entire mass of an adult 
skeleton is replaced approximately every ten years. However irreversible reductions in a 
body’s total bone mass can occur from pathological conditions such as osteopenia or 
osteoporosis [20-22].  
 
3.1.3 Structure of Bone 
Bone is a hierarchically structured composite that displays various degrees of 
organisational architecture across the macro- to nanoscale. This is based on the mechanical 
and metabolic optimisation of the tissue that has been classically characterised over 
Figure 3.1.2. Illustration of a) Osteonal remodelling of cortical bone showing osteoclast 
resorption at the cone front along with the bone forming osteoblast cells. The blood supply 
(Bs) at the centre of the new Haversian canal and distance travelled are also shown over a 
56 day period and b) Remodelling of cancellous bone showing the trench formed across 
the trabeculae [Reproduced from Brickley (2010) The Bioarchaeology of Metabolic Bone 
Disease]. 
a 
b 
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different levels of hierarchy. However the number of levels defining this hierarchy has 
typically been user-defined with examples of four (Currey et al. 2012) and seven levels 
(Weiner & Wagner, 1998) commonly reported (Figure 3.1.3) [19, 26-28]. 
 
 
 
 
 
 
 
 
3.1.3.1 Macrostructure    
At the macroscopic scale the structure of mature bone tissue is considered to be composed 
of either a high density, high modulus tissue (cortical) or high porosity mechanically weak 
structure (cancellous) with the proportions of each distinct phase dependent upon the bones 
function.   
Cortical bone (also known as compact bone) is mainly found in the long bones (e.g. femur, 
tibia, radius, ulna) as well as the flat bones (e.g. ribs and skull) and is the primary source of 
mechanical support in the skeleton (Figure 3.1.4). Cortical bone makes up approximately 
80 wt.% of a human’s total skeletal mass and forms the bone’s outer shell with greater 
concentrations found at anatomical sites subjected to significant mechanical loading. This 
shell surrounds the bone marrow contained in the medullary canal of the diaphysis with 
variations in cortical bone concentrations across the epiphysis reflecting the distribution of 
mechanical loading throughout the long bone (Figure 3.1.5) [12, 29-32].  
 
Figure 3.1.3. Seven level hierarchy structure found in the diaphysis of the long bone across 
the macro- to nanometre scale showing the diversity in structural arrangement 
[Reproduced from Rho et al. (1998)]. 
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Cancellous bone (also known as trabecular or spongy bone) can be idealised as an 
organised open-cell lattice of short 200µm thick, 1000µm long tubular struts or plates of 
bone matrix called trabeculae that are adjacently spaced by 300-1500µm (apparent density 
≈0.3 g cm-3). This bone structure is primarily concentrated in the epiphyses and 
metaphyses of long bones as well as in flat and irregular shaped bones such as the 
vertebrae (Figure 3.1.1). The high porosity of trabecular bone (50-90 vol.%) subsequently 
provides a high surface contact area for bone marrow, blood vessels and connective tissues 
Figure 3.1.4. Illustration of a) Partial frontal section of tibia (long bone) with the different 
regions and structural components labelled and b) Sagittal section of the tibia (lateral view) 
showing distribution of cortical and cancellous bone throughout the tissue [Reproduced 
from Patton (2014) Survival Guide for Anatomy & Physiology]. 
Cancellous bone 
Cortical bone 
Figure 3.1.5. Sagittal section through a long bone showing the outer shell of cortical bone 
with concentrations of cancellous bone at the epiphyses [Reproduced from Khurana (2009) 
Bone Pathology]. 
a b 
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that facilitate its role in haematopoiesis and mineral homeostasis. However due to this 
porosity, cancellous bone possess a severely reduced compressive strength compared to 
cortical bone and is consequently found at anatomical sites generally free from any 
significant mechanical loading. Yet this internal structure does allow for the absorbance of 
compressive energies and subsequent distribution of stresses throughout the bone to occur 
such as at areas below the surface of joints [12, 29, 30].  
 
3.1.3.2 Microstructure  
At the microstructural level (i.e. 10-500µm) the exterior and interior surfaces of bone are 
covered by thin membranes involved in the vascularisation, growth and remodelling of 
bone (Figure 3.1.6) [32].  
 
 
 
 
 
 
 
 
The periosteum is a highly vascularised dense fibrous membrane of connective tissue that 
covers the exterior surfaces of bone (except at sites near joints) and acts as a transitional 
layer between the bone and overlying soft tissue/musculature (Figure 3.1.6). This layer 
contains blood vessels and nerves as well as the MSCs that are involved in bone growth 
whilst the interior surfaces are lined by a thin membrane called the endosteum that contains 
osteoprogenitor cells (section 3.1.2.2) [12].  
Figure 3.1.6. Internal microscopic structure of the diaphysis from a long bone showing the 
cortical and cancellous regions as well as the osteons found in the cortical bone tissue 
[Reproduced from Patton (2013) Survival Guide for Anatomy & Physiology]. 
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Microstructurally the basic repeating unit of cortical bone is a cylindrical element called an 
osteon or Haversian system (Figure 3.1.6) which is typically orientated along their long 
axis according to the principal stress direction. These structural units are composed of a 
20-100µm diameter central canal (known as a Haversian canal) that houses a blood vessel 
as well as nerve fibres. Each Haversian canal is successively surrounded by concentric 3-
7µm thick layers of mineralised bone matrix (called lamella) that are separated by 0.1µm 
thick sheets of interlamellar cement (Figure 3.1.7). These Haversian systems are 
consequently linked by a series of smaller blood vessels (called Volkmanns canals) that 
occur perpendicularly to the osteons and originate from either the periosteum or endosteum 
to create a network of blood vessels throughout the bone (Figure 3.1.6) [12, 14, 25].  
 
 
 
 
 
 
 
 
 
Alternatively the trabeculae of cancellous bone are composed of concentric lamellae that 
develop into disk shaped sections and form its branched open structural network. Similar to 
the osteons of cortical bone, these trabeculae can be preferentially oriented along the 
principal stress direction (in areas such as the vertebrae) or isotropically distributed 
depending on the mechanical loading regime. However these trabeculae structures do not 
display the same osteonal units or interstitial mechanisms (i.e. Haversian canals) as found 
in cortical bone (Figure 3.1.7). As a result, cancellous bone is typically vascularised 
directly from the surrounding haemopoietic tissue [12, 14, 25]. 
 
Figure 3.1.7. Illustration of a) Transverse section of an osteon in cortical bone and b) 
Individual trabeculae of cancellous bone at the microstructural level [Reproduced from 
Belinha (2014)]. 
a b 
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3.1.3.3 Sub-microstructure  
Each layer of osteonic lamellae surrounding the Haversian canal of cortical bone is 
considered to be composed of orientated arrays of mineralised collagen fibres. Yet 
concepts behind the precise arrangements and mechanisms that stimulate fibre orientation 
between lamella remain controversial with various models adopted based on the 
interpretation of experimental data (e.g. microscopically, X-ray diffraction) [11, 33].  
Based on early work using polarised light microscopy (Gebhardt, 1905; Ascenzi & 
Bonnucci, 1967) the variation in dark, bright and dark/bright fields was believed to 
represent the presence of three different types of osteons in cortical bone (Figure 3.1.8a). 
These were classified by the alignment of parallel arrays of collagen fibres in each lamella 
either longitudinally (dark), transversely (bright) or intermediately (dark/bright) to the long 
axis of the Haversian canal. This led to the concept of an orthogonal plywood model in the 
lamella with fibres limited to two orientations that alternated by 90° between each 
concentric lamella (i.e. longitudinal/transverse) or intermediately composed of both [11, 34, 
35]
.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.8. a) Depiction of three different osteonal types 1) Transversely 2) 
Longitudinally 3) Intermediately orientated as viewed by polarised light microscopy and 
the associated osteonal lamella arrays as described by the orthogonal plywood model 
[Reproduced from Giraud-Guille (1988)] b) Illustration of twisted plywood model showing 
alternation of fibre orientations between adjacently concentric lamellae. [Reproduced from 
Adler (2000) Bone Diseases: Macroscopic, Histological, and Radiological Diagnoses of 
Structural Changes in the Skeleton]. 
1 2 3 
a b 
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However the use of alternative techniques (e.g. scanning electron microscope) has led to 
other osteonal models being developed such as the twisted plywood model of collagen 
fibres as proposed by Giraud-Guille (1988) (Figure 3.1.8). This model depicts the fibres in 
each lamella as running in a continually spiralling manner around the Haversian canal that 
are rotated from plane to plane with fibre orientations alternated inversely between each 
concentric layer. Based on this concept, the three distinct birefringence patterns are 
attributed to the gradual change in orientation from two distinct structural arrangements as 
oppose to the three in the orthogonal plywood model. A random orientation of collagen 
fibres in each lamella has also been proposed with the variation in polarised light attributed 
to changes in the collagen fibre density instead of alternate orientations (Marotti & Muglia, 
1995). Under this model high density and low density fibre lamella were associated with 
dark and bright bands respectively [11, 34, 36].  
Although the specific mechanisms behind fibre orientation remain a subject of debate, the 
mechanical testing of cortical bones has found that sites typically loaded in vivo under 
tension or compression displayed responsive preferential collagen fibre orientations. As a 
result, discrete areas of longitudinal (tensile) and transverse (compressive) collagen fibre 
orientations were found in response to the respective loading regimes. This subsequently 
supports the theory that the mechanical stimulus plays a highly influential role in dictating 
the collagen fibre alignment throughout cortical bone (Ascenzi & Bonucci, 1967) [17, 26, 37]. 
 
3.1.3.4 Nanostructural and Sub-nanostructures 
The collagen fibres in the lamella of bone are composed of intimately arranged collagen 
fibril sub-units that are each constructed from the association of multiple 1.5nm diameter, 
300nm length tropocollagen molecules (Figure 3.1.9) [38, 39]. Tropocollagen is the basic 
structural unit of collagen and its molecules subsequently consist of three coiled 
polypeptide chains which, through hydrogen bonding, are structurally arranged as a right 
handed triple helix. Each tropocollagen molecule is self-assembled with neighbouring 
molecules into a staggered fibril arrangement with 40nm gaps between the head and tail of 
each tropocollagen molecule and a 67nm periodicity (due to the 40nm gap and 27nm 
overlap). These gaps then act as nucleation sites for the formation of ≈100x25x2nm 
platelets of hydroxyapatite (HA) that are orientated along the fibrils long axis (Figure 
3.1.10) [38-40]. 
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3.1.3.5 Lamellar and Woven Bone 
As previously discussed in section 3.1.3.3, the submicroscopic level of mature bone is 
composed of mineralised lamellar tissue with organised collagen fibres orientated relative 
to the stress state environment to provide the bone with optimised mechanical properties 
(i.e. anisotropic). This structure is contrasted by the disorganised irregular collagen fibre 
arrangement found in woven bone (also known as primary, fibre or reticular bone) that is 
encountered during embryonic development or during bone fracture repair. The rapid 
formation of this tissue (>4µm day-1) is believed to provide the body with a means of 
quickly reacting to alterations in the mechanical environment (such as those encountered 
Figure 3.1.10. Sub-nanostructural level of cortical bone showing the staggered 
arrangement of the tropocollagen molecules and hydroxyapatite crystals in a collagen fibre 
[Reproduced from Olszta et al. (2007)]. 
Figure 3.1.9. Nanostructural hierarchy of bone showing the collagen fibre bundles in the 
osteons of cortical bone to be composed of a single collagen fibre that consists of 
tropocollagen molecules and hydroxyapatite crystals [Reproduced from Roesler (2007)]. 
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during growth). However its disorganised structure and corresponding isotropic properties 
are unsuitable for efficiently providing long term stability. As a result woven bone is 
gradually replaced by lamellar bone (<1µm day-1) during childhood and is generally not 
found in the adult skeleton except during the early stages of fracture repair or from certain 
pathological conditions such as Paget’s disease [12, 17, 41].  
 
3.1.4 The Human Skull 
3.1.4.1 Anatomy 
The skull refers to the osseous framework of the head in the overall skeleton and is 
composed of 22 irregularly shaped flat bones that make up the facial (splanchnocranium), 
mandible and cranium sub-divisions of the skull (Figure 3.1.11) [42].  
 
 
 
 
 
 
 
 
 
 
The cranial base and vault designate further sub-groups of the cranium bones which when 
combined form the cranial vault that surrounds and protects the delicate brain tissue. Also 
known as the calvarium, it is composed of the frontal, occipital, sphenoid, ethmoid as well 
as two parietal and two temporal bones, which are fused together by morphologically 
jagged joints (referred to as sutures). In an adult skeleton these sutures are composed of 
Figure 3.1.11. Illustration of skull (lateral view) showing the bones that make up the 
cranium, facial and mandible bones [Reproduced from Martini (2007) Anatomy and 
Physiology]. 
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dense fibrous tissue with the sagittal, coronal, lambdoidal and squamosal sutures regarded 
as the major joints of the cranial vault [43-45]. 
 
3.1.4.2 Structure 
At the macroscopic scale, flat bones like the scapula, ribs and those composing the cranial 
vault are formed as a three layered composite sandwich structure. In the cranial bones this 
consists of a homogenously structured cancellous bone (known as a dipolë) that is situated 
between upper (ectocranial) and lower (endocranial) tables of dense cortical bone (Figure 
3.1.12). This structural organisation provides the high mechanical properties required to 
protect the brain tissue (from the tables of cortical bone) whilst the porous energy 
absorbing layer reduces the bone weight without compromising its strength [46-48]. 
 
 
 
 
 
 
 
 
 
 
 
Characterisation of the cranial bones has determined a general thickness >5mm with the 
endocranial layer of cortical bone typically possessing a lower thickness and bone density 
than the ectocranial bone. These properties are believed to stem from the localised stress 
microenvironments found in the ectocranial layer due to the presence of anchorage sites for 
masticatory and nuchal musculature. This subsequently imparts areas of highly localised 
orientations and distinct anisotropy due to the associated mechanco-stimulated effects 
Figure 3.1.12. a) Left lateral view of posterior half of skull showing radiographic features 
and tri-layered structure of the cranium [Modified from Gallucci (2007) Radiographic 
Atlas of Skull and Brain Anatomy] and b) Illustration of the basic architecture and 
sandwich structure of the flat bones (such as those in the cranium) [Reproduced from 
Orchard & Nation (2014) Cell Structure & Function]. 
b 
External occipital protubernace 
Outer table 
Dipolë 
Inner table 
Vasal imprints 
Lambdoid suture 
Posterior clinoid process 
a 
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especially in areas such as the parietal bone where significant muscle attachment sites 
exist. Such anchorage effects are not encountered at the endocranial layer and 
consequently imply that the influence of mechanical stimuli plays a significantly 
diminished role in the remodelling of cranial bones. Yet when considered as a whole 
element (i.e. as a three layered structure), cranial bone tissue is generally idealised as a 
linear elastic and isotropic material with acknowledgement of its minor degree of in-plane 
anisotropy on its outer table [46, 49-51]. 
 
3.1.5 Mechanical Properties of Bone 
3.1.5.1 Overview 
The mechanical properties of bone are attributed to its composition (section 3.1.2.1) which, 
similar to conventional engineering composites, generates its mechanical properties 
through the reinforcement of a ductile organic matrix with a high modulus ceramic 
reinforcing phase (Figure 3.1.13). However its mechanical properties are also a 
conglomerate of the bones microarchitecture, material properties (e.g. mineral density, 
apparent density) and testing method. Consequently it is general convention to consider the 
mechanical properties of cortical and cancellous bone as separate entities in order to 
effectively evaluate their mechanical properties with regards to the dominating factors 
described. Yet due to these influences it is also often acknowledged that no true value can 
be considered “correct” for the precise mechanical properties of an entire bone 
microstructure type and thus mechanical data is typically expressed as a set range of values 
[33, 49, 52]
.  
 
 
 
 
 
Figure 3.1.13. Contributions from the matrix (collagen) and reinforcing (hydroxyapatite) 
phases of bone showing the influence from each component on the mechanical properties 
of normal bone [Reproduced from Burr (2013) Basic and Applied Bone Biology]. 
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3.1.5.2 Cortical Bone 
When considering the diaphysis of a long bone (Figure 3.1.4), cortical bone can be 
considered as a transversely isotropic material that exhibits an increased elastic modulus 
when tested parallel to its longitudinal axis compared to the radial or circumferential 
directions. These heterogeneous properties are due to the structural orientations of the 
osteons and collagen fibres that generate anisotropic properties throughout cortical bone 
(section 3.1.3.2 and 3.1.3.3). As such, the elastic modulus of cortical bone can increase by 
up to ≈1.5 times in the longitudinal direction (Table 3.1.3). This variation is further 
demonstrated by the change in mechanical properties obtained under different testing 
techniques, anatomical locations or tissue age. Yet a consistent range of values for the 
mechanical properties of cortical bone have been reported despite these variations and 
influencing factors that approximate its tensile strength, elastic modulus and Poisson’s 
ratio as 100-130 MPa, 17-30 GPa and 0.3-0.4 respectively [11, 49, 52-54].  
 
Table 3.1.3. Anisotropic and asymmetric properties of human femoral cortical bone 
mechanically tested at different axis [Reproduced from Winkelstein (2012) Orthopaedic 
Biomaterials]. 
Mechanical Properties Longitudinal Transverse Shear 
Elastic modulus (GPa) 17.9 ± 3.9 10.1 ± 2.4 
 
Ultimate tensile stress (MPa) 135 ± 15.6 53 ± 10.7  
Ultimate compressive stress (MPa) 205 ± 17.3 131 ± 20.7  
Modulus (GPa)   3.3 ± 0.4 
Ultimate stress (MPa)   65 ± 4 
 
 
Due to its viscoelastic behaviour, cortical bone also shows increased strength and elastic 
modulus values with an increasing strain rate that is coupled with a ductile to brittle 
transition in its failure behaviour (Schaffler et al. 1989). Furthermore, daily activities have 
been estimated to place in vivo strain rates of 0.001-0.01 s-1 on cortical bone with the 
changes in its mechanical properties shown to follow a power law correlation according to 
the applied strain rate (Carter & Hayes, 1976) [12]. 
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3.1.5.3 Cancellous Bone 
As an interconnected lattice structure the mechanical testing of cancellous bone has 
showed that under compression its mechanical behaviour is likened to an open celled foam 
with the compressive stress-strain behaviour of this tissue demonstrating its considerable 
levels of energy absorption compared to cortical bone. This is evident by the large 
compressive strains observed post-yield given the relatively low mass of cancellous bones 
(Figure 3.1.14a). However cancellous bone also possesses varying degrees of isotropy 
depending on the anatomical site and associated mechanical loads. For isotopic cancellous 
bone (such as that in the proximal humerus) the elastic modulus can be related to the bones 
apparent density following the power-law relationship shown in Figure 3.1.14b [30, 55]. 
 
 
 
 
 
 
 
 
 
 
Yet in regions of anisotropic cancellous bone (e.g. vertebrae) where the trabeculae are 
generally aligned along the primary loading axis the same considerations must be 
accounted for as detailed in cortical bone (such as the testing method and direction of 
loading). Accordingly cancellous bone displays higher mechanical properties in 
compression compared to tension or shear when tested along its primary axis and is 
considered to possess extremely limited viscoelasticity that is only observed at relatively 
high strain rates (10 s-1). As a result cancellous bone is generally regarded as a non-linear 
viscoelastic material with generalised strength, modulus and Poisson ratio values 
frequently stated as ranging between 0.1-37 MPa, 0.01-3 GPa and 0.3-0.4 respectively 
(Table 3.1.4) [11, 54-57].  
Figure 3.1.14. a) Comparison of stress-strain curves between cortical and trabecular 
(cancellous) bone with the bending and compression of individual trabeculae represented 
by the linear elastic region and b) Power-law relation between the elastic modulus and 
apparent density for an isotropic section of cancellous bone [Reproduced from Narayan 
(2009) Biomedical Materials]. 
a b 
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Table 3.1.4. Comparison of mechanical properties collected from the compression testing 
of human cancellous bone obtained from different anatomical sites [Reproduced from 
Nahum (2002) Accidental Injury: Biomechanics and Prevention]. 
Author Anatomical site 
Ultimate Strength 
(MPa) 
Elastic Modulus 
(GPa) 
Schoenfeld et al. (1974) Proximal femur - 0.02-0.97 
Brown and Ferguson (1980) Proximal femur 2.1-16.2 0.05-2.25 
Ciarello et al. (1986,1991) Distal femur 18.6 0.007-0.8 
Pugh et al. (1973) Distal femur - 0.41-1.52 
Williams and Lewis (1982) Proximal tibia 1.5-6.7 0.01-0.5 
Hvid and Hansen (1985) Proximal tibia 13.8-116.4 0.004-0.430 
Lindahl (1976) Vertebrae 4.6 0.055 
McElhaney et al. (1970) Vertebrae 4.13 0.151 
Struhl et al. (1987) Vertebrae 0.06-15 0.01-0.43 
 
 
3.1.5.4 Cranial Bones 
Investigations into the behaviour of the skull bones have shown that its response to 
traumatic loading is intrinsically linked to its mechanical properties and anatomical 
features. As already discussed in section 3.1.4.2, the tri-layered structure of the calvarial 
bones provide a mechanically strong and light weight system due to the combination of a 
porous cancellous layer between sheets of high density cortical bone. This architecture is 
analogous to an engineering sandwich structure with the dipolë layer acting as an energy 
absorbing core that facilities increased bone thickness without significantly increasing its 
weight [46, 47]. 
For cranial bones a large variation in the mechanical properties of these tissues has been 
reported which has been primarily attributed to morphological influences such as the 
sample size and shape (Motherway et al. 2009). However further discrepancies have arisen 
from factors such as the tissue preservation methods as well as the testing technique and its 
specifications (e.g. test speed, quasi-static/dynamic loading). This consequently limits 
inter-study comparisons due to discrepancies and conflicting data (Evans & Lissner, 1956; 
Roberts & Melvin, 1968; McElhaney et al., 1970; Wood et al., 1971; Peterson et al., 2002; 
Motherway et al., 2009). Yet such studies have shown some degree of continuity by 
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primarily testing the frontal and parietal bones of the calvaria using compression, tensile or 
bending tests [46, 49, 50]. 
From this, the generally accepted mechanical properties of the adult cranial bones have 
averaged values for the flexural strength and elastic modulus as 80-140 MPa and 5-15 GPa 
respectively (McElhaney et al., 1970; Hubbard, 1971; Wood, 1971; Motherway et al., 
2009).  Furthermore, experimental data (Table 3.1.5) has shown these properties to be rate-
dependant [46, 50, 58]. 
 
Table 3.1.5. Strain rate dependence on the flexural strength and elastic modulus of the 
frontal and parietal bones of an adult skull [Data from Motherway et al. (2009)]. 
Bone Strain rate (s-1) Flexural Strength (MPa) Elastic Modulus (GPa) 
Parietal 
21.09 84.50 10.33 
30.83 82.98 9.44 
109.43 123.12 12.80 
Frontal 
21.77 90.80 4.35 
26.28 102.60 4.87 
103.98 126.91 16.34 
 
 
Additionally, impact investigations on cranial bones relating to those experienced during 
blunt trauma injuries have examined the tolerances of the calvaria bones using a 28mm 
indenter (Allsop et al. 1993). The data collected on the impact energies required to initiate 
fracture were observed to vary across the frontal (8700 kPa), parietal (7100 kPa) as well as 
the temporal bones (5700 kPa) and correlated with the reported alterations in thickness and 
density of the different calvaria bones [49]. 
 
3.1.6 Fracture of Bone 
3.1.6.1 Skull Fracture  
The fracture of bone tissue is highly site specific and is dependent on various factors 
including the magnitude, direction, loading rate and duration of applied force that can 
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ultimately lead to fracture when the maximum strain limits or applied forces to the bone 
are exceeded.  
A skull fracture typically refers to a localised injury sustained to one or multiple calvaria 
bones due to a direct impact with sufficient force as to cause the bone to fracture. 
Classification of these fractures has traditionally been based on the presence of a scalp 
laceration (i.e. open fracture) or its location (e.g. vault and basilar fractures). However due 
to their potentially complex and diverse nature the classification of skull fracture types is 
typically limited to the generalised definitions described below [8, 49, 59, 60]. 
 
Linear fracture - Accounts for 80% of all skull fractures and are most likely to occur in the 
frontal, parietal or occipital calvaria bones. These injuries involve a single fracture 
occurring across one or multiple bones that passes through its entire thickness and can be 
sub-categorised into fractures of relatively small size (hairline fractures) or linear 
separation fractures that are characterised by a separation distance of 3mm between the 
fractured segments. 
Complex fracture - Fracture of the skull bone containing multiple fracture lines that are 
interconnected and can be sub-divided into the various types including multiple-linear, 
stellate, comminuted and depressed fractures (Table 3.1.6). 
 
Table 3.1.6. Summary of different types of complex skull fracture encountered. 
Complex Fracture Description 
Multiple-linear Intersection of multiple linear fracture lines. 
Stellate Star shaped multiple fractures.  
Comminuted Fracture of skull into multiple fragments (Figure 3.1.15). 
Depressed Skull caves inwards towards the brain (Figure 3.1.15). 
 
 
Lastly a diastatic fracture is one that has occurred along a cranial suture and is considered 
rare compared to the other fracture types.  
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Furthermore it has been shown that the type of fracture encountered can be directly linked 
to the area over which the force has been applied during impact. In force trauma this 
corresponds to a greater probably of a linear fracture occurring at larger impact areas (e.g. 
>13 cm2) compared to the depressed fracture types commonly encountered at smaller, 
more focalised areas of impact (e.g. 5 cm2) [49].   
 
3.1.6.2 Fracture Repair  
Fracture repair is a complex auto-activated mechanism which attempts to restore damaged 
bone tissue to its original anatomical architecture and function. This can occur through 
either direct (primary) or secondary (indirect) healing processes with the method of 
fracture repair controlled by the biomechanical conditions at the fracture site. These factors 
include the degree of mechanical loading, fracture gap size and vascularisation with the 
presence of adverse conditions (e.g. excessive motion or poor vascularity) potentially 
leading to delayed or complete non-unions of the fractured bone ends [57, 61, 62]. 
Primary fracture healing can only occur in cases of extreme fracture stability that are free 
from any relative motion with a minimal fracture gap size. Under these conditions 
osteoclasts are able to tunnel across the fracture line to form a cutting cone at the site of 
damaged bone tissue. The subsequent deposition of bone matrix by osteoblasts during 
remodelling then restores the continuity of the Haversian systems and union of the bone 
fragments [61, 62].  
Alternatively at a fracture site where some degree of biomechanical motion is present a 
secondary healing process of fracture repair occurs and involves the formation of a callus 
followed by endochondral ossification as illustrated for a long bone in Figure 3.1.16 [57, 61, 
a b 
Figure 3.1.15. Examination of skull fractures showing a) Lateral radiograph of skull with 
comminuted fracture and b) CT scan of skull showing depressed fracture of the left parietal 
bone (large arrow) and epidural hematoma (small arrow) [Reproduced from Demetriades  
& Lewton, (2011)]. 
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62]
. In secondary healing, immediately after fracture the local environment consists of 
various damaged soft tissues (e.g. muscle, tendon and ligaments) and dead bone from the 
ruptured blood vessels that leads to the formation of a hematoma (i.e. blood clot) at the 
fracture site. This hematoma is typically formed within 48 hours of fracture and is shown 
by inflammation at the fracture site. After several days this hematoma is replaced with 
granulation tissue composed of fibroblasts, collagen, osteoblasts and osteoclasts (recruited 
from pluripotent MSCs). As the necrotic tissue is removed, capillaries are introduced with 
collagen fibres and cartilaginous tissue deposited by fibroblasts that form a reparative soft 
callus. This callus provides a degree of mechanical stability to the fracture site whilst 
preventing disruption of the newly forming blood vessels. The formation of a hard callus 
by endochondral ossification then converts the soft callus into woven bone with 
membranous bone formation restoring union to the bone fracture ends. Finally, tissue 
remodelling and restoration of the bones functionality occurs through the conversion of 
woven bone into lamellar bone (known as consolidation). This subsequently restores the 
medullary cavity as well as the bone architecture and can continue for months or even 
years after the fracture has been clinically classified as healed [57, 61, 63, 64]. 
 
 
 
 
 
 
 
 
 
 
Given that the majority of bone fractures are typically treated through methods that exhibit 
some degree of motion (e.g. sling or cast immobilisation as well as internal or external 
fixation) secondary bone healing is the most commonly encountered process. Yet 
consideration should also be taken regarding the allowable amplitude of motion (limited to 
Figure 3.1.16. Illustration of a) Restoration of fractured bone union through hematoma and 
subsequent hard callus formation via the deposition of woven bone and b) Conversion of 
woven bone to lamellar bone and restoration of the medullary cavity [Modified from Porth 
(2011) Essentials of Pathophysiology: Concepts of Altered Health States]. 
a b 
Proliferating 
osteogenic cells 
Conversion of 
woven bone to 
lamellar bone 
Conversion 
of callus to 
woven bone 
Osteoclasts 
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0.2–1mm at a fracture gap <2mm) due to the inhibition of osteoblastic behaviour observed 
at high strain values. In the case of a linear skull fracture, no treatment is required and bone 
repair follows the same principles as those previously described. However the restoration 
of skull bone tissue is considered to occur at a slower rate compared to that observed for 
long bones [8, 10, 62]. 
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3.2 Biomaterials for Bone Augmentation 
The damage and fracture of bone can occur from a variety of incidents that include events 
of high energy trauma or bone resection procedures (due to a tumour or infection). 
However studies have estimated that of the 7.9 million annual fractures occurring in the 
United States, ≈10% will be affected by delayed or non-unions of the fractured bone due to 
an impairment of the physiological bone repair process. This can stem from the 
misalignment and non-continuity of the fractured bones (e.g. comminuted fracture) or 
presence of a critical sized defect (CSD). These are believed to be dependent on the bone 
type with 30mm, 50mm, and 60mm gaps considered critical for the radius/ulna, femur/tibia 
and humerus in humans respectively. As a result, surgical intervention is often required 
through the use of fracture fixation devices and bone graft materials in order to stabilise the 
defect site and restore continuity to the fractured bones [65-67].  
Furthermore when considering a bone graft material it is necessary to consider the different 
material properties that can be advantageous to the in vivo bone forming response. This 
includes its potential to retain viable osteoprogenitor cells during transplantation 
(osteogenic), ability to stimulate MSCs from the surrounding host tissue into bone forming 
cell lineages (osteoinduction) and facilitate bone growth across its surface 
(osteoconduction) [68]. 
 
3.2.1 Natural Biomaterials for Bone Augmentation 
Natural biomaterials for bone augmentation typically involve the use of autogenous and/or 
allogeneic bone grafts that are intended to be used as bone defect fillers in order to bridge 
the CSD and restore bone union. 
 
3.2.1.1 Autografts  
Autogenous bone (collected from the patient’s own tissue) has established itself as the gold 
standard of bone grafting material for the treatment of bone tissue defects due to its 
osteoconductive, osteoinductive and osteogenic properties. These materials are typically 
extracted from the iliac crest, proximal tibia or distal femur and given that they are 
harvested from the patient’s own tissue any potential immunogenic response is eliminated. 
Depending on the application, autogenous bone can provide a supply of vascularised 
cortical or cancellous bone but is hampered by its limited supply especially in elderly and 
paediatric patients. The bone harvesting process can also significantly lengthen the surgical 
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procedure with post-operative complications associated with 8.5-20% of autologous bone 
grafts that are generally related to the patients donor site. Such complications can include 
nerve damage, sepsis, pelvic instability, hernia, chronic pain, iatrogenic fracturing as well 
as ureteral and arterial injuries [69-71]. 
 
3.2.1.2 Allografts 
As of 2005, allogeneic bone is estimated to account for 35% of all bone grafts performed 
in the United States and involves the harvesting and transplant of bone tissue from a 
separate individual to the intended patient (Figure 3.2.1) [71, 72].  
 
 
 
 
 
 
 
 
 
 
Allografts are intended to alleviate the issues identified with autologous bone (such as 
donor supply or increased surgical duration) and have also been used to develop 
commercially available allograft-based bone substitute materials. These products utilise 
demineralised bone matrix (DBM) which are made available from bone banking facilities 
in a variety of formats such as dowels, strips and chips to meet the surgical requirements. 
This subsequently allows the surgeon greater options and has led to allograft bone being 
the primary bone substitute in total hip arthroplasty (THA) procedures [70, 73, 74]. Once 
implanted, allogeneic bone follows the kinetics of physiological bone-tissue remodelling 
and is gradually replaced by newly formed bone as the fracture is repaired [71, 72]. 
Figure 3.2.1. Reconstruction of radial fracture containing a critical size defect (CSD) a) 
Resection of fibrous tissue b) Implantation of bone graft with locking compression plate as 
well as a haemostatic agent and c) Post-operative CT images of defect site after 9 months 
showing metallic plates and allograft bone [Reproduced from Calori et al. (2011)]. 
a 
b 
c 
Fixation devices 
Allograft bone 
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In order to avoid disease transmission between the donor and recipient, a strict screening 
process for diseases such as the human immunodeficiency virus (HIV) and Hepatitis C is 
required. This is coupled with regulated radiation, freezing or freeze drying pre-treatments 
to allografts in order to further alleviate the potential risk of disease transmission or 
immunogenic reactions. However these techniques have also been shown to induce 
changes to the graft material and its biological properties (e.g. mechanical properties, 
vascularisation) whilst also adversely affecting its osteoinductivity and osteoconductivity. 
These methods also destroy any viable cells within the allograft bone and thus eliminate 
any osteogenic potential. As a result the application of structural allografts is associated 
with a 15-20% failure rate due to the occurrence of fractures and non-unions [70, 71, 73, 74].  
This lack of osteoinductivity in allograft bone has been addressed by the development of 
allograft based composites via the inclusion of collagen, non-collagenous proteins and 
growth factors. These materials are typically combined with cancellous chips or ceramics 
to further improve their osteoconductivity with commercial DBM-based allograft products 
available as DBX® (Synthes, USA) and Orthoblast® (Citagenix, CAN) [70, 72-74]. 
 
3.2.2 Artificial Biomaterials for Bone Augmentation 
3.2.2.1 Tissue Response to Artificial Biomaterials 
A biocompatible material has been commonly defined as “one which possesses the ability 
to perform with an appropriate host response in a specific application” (Boutrand, 2012) 
[75]
. Furthermore, according to Hench (2013), no biomaterial can be considered as truly 
inert and upon implantation will inevitably elicit a response from the host tissue at the 
material interface. This type of reaction is dependent upon the implant’s material 
properties that include its composition, morphology, porosity, dimensions (relative to the 
defect size) and the mechanical loading conditions. However these host reactions are 
further complicated by tissue specific influences such as the anatomical site, patient health, 
age, vascularisation and damage incurred from the surgical procedure itself. Consequently 
the resulting tissue-implant interactions of a biomaterial can be summarised by four 
generalised reactions according to Hench (2013) [76]. These are cytotoxic, encapsulation, 
bonding to the surrounding tissue and resorption. 
To consider in greater detail, a cytotoxic response from an implanted material is clearly 
undesirable with the occurrence of localised cell death or migration of chemicals released 
by the foreign material potentially causing systematic damage to the patient.  
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The most commonly encountered response to an implanted material is its gradual 
encapsulation with fibrous tissue that isolates the foreign body from the host tissue as part 
of a protective mechanism. This type of response is typically elicited from the implantation 
of an inert metal or polymer based device as well as biologically inactive ceramics (the so 
called 1st generation biomaterials). Sufficient loading of these encapsulated implant 
devices and interfacial movement can then lead to an increased thickness of the fibrous 
capsule which eventually results in the loosening of the implant and its subsequent failure. 
To combat this, porous ceramic coatings are commonly applied to these inert materials in 
order provide a route for tissue ingrowth and biological fixation [76]. 
Alternatively implanted materials can form an interfacial bond with the surrounding host 
tissue. In the case of bone this is through the precipitation of a hydroxyl-carbonate apatite 
(HCA) layer across the materials surface after implantation (2nd generation biomaterials) 
which is analogous to the composition found in the mineral phase of bone (section 3.1.2.1). 
This can then act as a substrate for the proliferation and differentiation of osteoblasts that 
inhibit the materials fibrous encapsulation. Fusion between the implant surface and 
surrounding tissue is then achieved through the incorporation of collagen fibrils into the 
HCA layer. Materials displaying this type of tissue response are termed to be bioactive and 
are defined by Hench (2013) as “a material that elicits a specific biological response at the 
interface of the material which results in the formation of a bond between the tissue and 
material”. Investigations into this type of response have identified a variety of materials 
capable of displaying this bioactive behaviour that include synthetic calcium phosphates 
(e.g. HA, tri-calcium phosphate) as well as certain glass and glass-ceramic compositions. 
These bioactive materials have since been utilised as either standalone implants or used to 
improve the tissue response of inert materials through the development of bioactive 
composites and surface deposited bioactive coatings. Additional investigations have also 
shown how the bioactive fixation of these materials can display a diverse range of bonding 
mechanisms, bonding rates, interfacial layer thickness and bond strengths [76].  
The degree of a material’s bioactivity can be rated according to its bioactivity index (IB) 
which is defined as “the time required for more than 50% of the materials interface to bond 
with the native bone tissue” Hench (1991). This rate of bioactivity is influenced by the 
materials composition as well as its microstructure and has allowed for different classes of 
bioactivity to be categorised. This includes the class A bioactivity (IB >8) that is capable of 
bonding to both hard and soft tissues (e.g. Bioglass® 45S5) or class B (IB < 8) which is 
limited to only hard tissues (e.g. synthetic HA) [77].  
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Finally materials exhibiting a resorbable response are intended to gradually degrade over 
time and eventually be replaced by the host tissue. This concept is considered to be the 
optimal method of addressing interfacial stability with the intention that the damaged tissue 
will be regenerated instead of being replaced by the implant. Such degradable biomaterials 
can elicit inert or bioactive responses and include degradable devices manufactured from 
different polymers, ceramics and glasses. However the application of degradable 
biomaterials is coupled with the difficulty in synchronising their resorption rates with the 
rate of new tissue formation as well as maintaining suitable mechanical properties as they 
degrade [76].  
 
3.2.2.2 Metals  
Metallic biomaterials have the potential to be manufactured into a range of high strength 
implant devices of various architectures that exhibit reproducible and predictable long term 
material properties under in vivo load bearing conditions. For orthopaedic applications, 
implants based on 316L stainless steel, cobalt-chrome (Co-Cr) alloys as well as 
commercially pure titanium (CPTi) and its alloys are considered to be the most frequently 
used metals for osteosynthesis devices (i.e. bone fracture fixation). This is due to their high 
mechanical properties (Table 3.2.1) and good corrosion resistance [78-81]. 
However 316L stainless steel can be susceptible to localised corrosion at sites depleted of 
oxygen (such areas underneath the screws of fracture fixation plates) and as a result  
implants based on 316L stainless steel have generally been used for relatively short term 
implant devices where removal during secondary revision surgery is expected [78, 79]. More 
generally, metallic implants can induce stress shielding in the surrounding bone - a 
phenomena that arises due to the mismatch between the elastic modulus of the native bone 
and metal implant. The resulting absence of mechanical stimulus to the bone can then lead 
to osteopenia in the surrounding bone tissue (i.e. reduced bone density) which can 
ultimately cause bone weakening, localised bone atrophy and possible bone fracture after 
implant removal. The permanent nature of metallic orthopaedic biomaterials also makes 
them susceptible to long term complications such as wear, migration and late foreign body 
reactions as well obscuring radiographic and topographic techniques [79-82].  
 
 
72 
 
Table 3.2.1. Generalised mechanical properties of typical metal and metal alloys used in 
orthopaedic applications [Reproduced from Yaszemski (2003) and Mow (2005)]. 
 316L  
(ASTM F138) 
Co-Cr alloys 
(ASTM F75) 
CPTi 
(ASTM F67) 
Ti alloy 
(Ti-6Al-4V) 
Elastic Modulus (GPa) 190 210-253 110 116 
Yield Strength (MPa) 792 448-841 485 897-1034 
UTS (MPa) 930 655-1277 760 965-1103 
Fatigue Strength (MPa) 241-820 207-950 300 620-689 
Hardness (HV) 130-180 300-400 120-200 310 
Elongation at Fracture 
(%) 43-45 4-14 14-18 8 
Fatigue Limit (at 107 
Cycles, R= -1) (MPa) 241-276 
207-310 
*725-950 
300 620-689 
*Power metallurgy produced, hot-isostatically pressed. 
 
3.2.2.3 Degradable Polymers  
The use of degradable polymers for fracture fixation devices has been driven by the 
temporary nature of the fracture repair process and the long term complications observed 
with permanent implant devices. Degradable polymers are consequently considered 
advantageous for orthopaedic applications given their temporary nature (section 3.2.2.1), 
lower elastic modulus (reducing stress shielding) and compatibility with radiography. This 
is coupled with their ability to be easily manufactured into relatively complex shapes using 
conventional processing techniques. As a result, degradable polymers have been used to 
develop commercially available internal fracture fixation devices (e.g. plates, rods, pins 
and screws) which after implantation are intended to slowly transfer mechanical loading 
back to the regenerating bone as the device gradually degrades [78, 79, 83].  
Yet despite the wide range of degradable polymers from natural and synthetic origin, only 
the synthetic polyesters are considered practical for orthopaedic applications. This is due to 
their material properties and susceptibility to hydrolytic degradation processes that can 
provide suitable degradation rates with relatively non-toxic by-products. Of these the 
polylactictides (PLA) and polyglycolides (PGA) along with their subsequent copolymers 
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are regarded as the most widely used members of this polymer family. However alternative 
biopolymers such as polyhydroxybutyrate (PHB) and polyhydroxybutyrate-co-valerate 
(PHBV) as well as polycaprolcatone (PCL) have also received interest for bone 
engineering devices [78, 79].  
PLA and PGA are synthesised by ring opening polymerisation with the extra methyl group 
of the PLA structure making it more hydrophobic and less crystalline compared to PGA. 
The ester bond of PLA is also more resistant to hydrolytic degradation and due to the 
presence of an asymmetric α-carbon atom, three different PLA isomers can exist as L-
lactic acid, D-lactic or DL-lactic. Each can be used to form polymers of poly(L-lactic) acid 
(PLLA) or poly(D,L-lactic) acid (PDLA) along with the manufacturing of poly-L-lactide-
co-DL-lactide (PDLLA) or polyglycolide-co-polylactide (PGLA) copolymers (if combined 
with PGA) [84]. Consequently through the formation of different co-polymer variations, 
materials with different molecular compositions, molecular weights (Mw) and degree of 
crystallinity can be developed with tailorable material properties. With regards to this, it is 
generally accepted that high molecular weight polymers with high degrees of crystallinity 
will degrade more slowly than a completely amorphous, low molecular weight alternative 
[83, 85]
. 
Upon immersion, the degradation of the PLA or PGA occurs through a homogenous 
hydrolytic degradation process whereby water absorption results in cleavage and 
reductions to the polymer chain length. Through this process, the polymers molecular 
weight (Mw) is gradually reduced in what is described as the ‘quasi-stable’ stage of 
polymer degradation with the sample weight, shape and mechanical properties remaining 
unchanged. This stage continues until the ‘loss-of-strength’ phase where decreases in the 
polymers elastic modulus are observed despite no loss in sample weight. The final stage is 
characterised by significant reductions in the sample weight until it is completely 
disintegrated and is known as the ‘structure-disruption’ stage. For poly(α-hydroxyacid) 
materials (i.e. PLA or PGA), the hydrolysis of these ester bonds produces lactic acid or 
glycolic acid by-products (from PLA and PGA respectively) which are expelled from the 
body through catabolic pathways. However being acidic, these by-products can accelerate 
the polymer degradation rate through autocatalytic effects and can also accumulate at the 
centre of a polymer device. This can lead to a dramatic loss in the mechanical properties of 
the device as well as a delayed inflammatory response due to its internal degradation and 
sudden burst release of acidic by-products. Efforts to minimise these reactions have been 
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achieved through the inclusion of alkaline salts (e.g. calcium acetate) as filler materials or 
antibodies of anti-inflammatory mediators into the implant [85, 86]. 
Yet the implementation of polymer fracture fixation devices is limited at load bearing sites 
as a result of their relatively low mechanical properties (Table 3.2.2) as well as the 
accelerated polymer degradation rates that can occur from in vivo cyclic loading [85, 87, 88]. 
Accordingly, degradable polymer devices must be considerably thicker than their metallic 
equivalent in order to achieve properties suitable for fracture fixation (e.g. 2mm for PLLA 
compared to 1.5mm for metal). This added thickness may then make degradable polymer 
devices unsuitable for certain fractures such as those encountered in hand surgery [78, 79, 85]. 
 
 
 
 
 
 
 
 
 
 
  
 
Table 3.2.2. Comparison of material properties between different degradable polymers commonly used in orthopaedic applications [Reproduced from 
Sultana (2012) Biodegradable Polymer Based Scaffolds for Bone Tissue Engineering, Eglin (2008) Biodegradable Polymeric Materials For 
Osteosynthesis: Tutorial, and Dumitriu (2001) Polymer Biomaterials, Revised and Expanded]. 
Material Property PLLA PDLLA PGA PHB PHBV-10% PHBV-11% PHBV-20% PCL 
Density (g cm-3) 1.25–1.29 1.27 1.50–1.69     1.06–1.13 
*Structure SC Am C     SC 
Crystallinity (%) ≈40  >50 ≈80 ≈60  35  
Melt Temp. [Tm] (°C) 175 180 230 171 140 145 130 57 
Glass Transition Temp. [Tg] (°C) 53-64 50 - 57 36-45 1  2  -62 
Tensile strength (MPa) 50 29 - 36 25 20 20 16 
Elastic Modulus [E] (GPa) 2.7 1.9 7.0 3.5 1.2 1.1 0.8 0.4 
Elongation [εB] (%) 3.3 5.0 15-20 8 20 17 50 300-500 
Impact strength (J m-1)    60 110  350  
Degradation (months) >24  6-12     >24 
*C = Crystalline, SC = Semi-crystalline, Am = Amorphous 
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PHB is considered to be an advantageous alternative to current polymer biomaterials such 
as PLA, PGA or their copolymers as a result of its material properties. This includes its 
high biocompatibility as well as its 3-hydroxybutyrate acid degradation by-product that is 
found as a naturally occurring metabolite in human blood and consequently fails to illicit 
any form of inflammatory response. The piezoelectric nature of PHB is also an attractive 
option for developing so-called orthopaedic ‘smart materials’ that are capable of producing 
strain generated potentials at the tissue-implant interface. However the implementation of 
PHB is limited by its mechanically brittle nature and thermal instability [89-91]. 
Such issues have been alleviated by the inclusion of randomly distributed hydroxyvalerate 
(HV) monomer units (0-24 mol%) throughout the PHB polymer chain structure to produce 
copolymers with reduced crystallinity and increased ductility/thermal stability. The 
variation in HV concentration and associated changes to the polymers mechanical 
properties and degradation rates (due to the changes in its Mw and crystallinity) 
subsequently allow for the development of polyhydroxybutyrate-co-valerate (PHBV) 
polymer compositions with tailored properties specific to the implant application (Table 
3.2.2). Yet studies have shown that the in vivo hydrolysis reactions of PHB and PHBV can 
be catalysed by non-specific esterase and lysozyme enzymes secreted by the body’s 
immune system. This has led to accelerated rates of polymer degradation being observed in 
vivo compared to those measured in vitro. These materials are also significantly more 
expensive than conventional biopolymers and can exhibit variations in their material 
properties [92-94]. 
Lastly PCL is a semi-crystalline hydrophobic polymer generally used in pharmaceutical 
products or wound dressings and due to its low tensile strength, low elastic modulus as 
well as its high elongation (Table 3.2.2) is considered unsuitable for load bearing 
orthopaedic applications without a suitable reinforcing agent [83].  
 
3.2.2.4 Calcium Phosphate Ceramics  
Due to the limited supply, expense and potential dangers of natural bone graft materials 
(section 3.2.1) attention has focused on developing alternative “off the shelf” bone graft 
products. These would ideally be capable of providing surgeons with a readily available, 
easy-to-use graft material with reproducible results in an almost unlimited supply [69, 73, 74]. 
Synthetic calcium phosphate ceramics such as alpha- or beta-tricalcium phosphate (α-, β-
TCP, Ca3(PO4)2, Ca/P = 1.5) and HA (Ca10(PO4)6(OH)2, Ca/P = 1.67) have been clinically 
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used since the 1980s in orthopaedic and dentistry fields for applications including 
maxillofacial reconstruction and as a generalised bone defect filler. This appeal has been 
due to their compositional similarity to the apatite mineral phase of bone alongside their 
high biocompatibility, bioactivity and osteoconductivity. Due to their high density and 
crystallinity these materials possess high compressive strengths with slow degradation 
rates and over the last three decades have seen significant product differentiation. This 
diversification has been driven by the differences in physical properties that can be 
achieved from relatively small alterations to their chemical composition and crystalline 
structure. Consequently a range of commercially available synthetically manufactured HA, 
α-TCP, β-TCP and biphasic calcium phosphate (BCP) mixtures of HA/TCP (Ca/P = 1.5-
1.67) products have been introduced. These include ApaPore® (ApaTech, UK), Vitoss® 
(Orthovita, USA) as well as Ceraform® (Teknimed, France) and can be supplied as solid or 
porous preformed shapes, generalised wedges/blocks or in granule/paste formats. Further 
product optimisation has also been achieved through adequate control and tailoring of the 
porosity which has been shown to play a key role in influencing the rate of osteointegration 
as well as the materials inherent biocompatibility [69, 73, 74, 95-97]. 
The diverse performance of these calcium phosphate ceramics is apparent by the greater 
physiochemical resorption rates possessed by TCP (solubility, Ksp = 10-25.5 for α-TCP and 
10-28.9 for β-TCP at 25°C) which undergoes osteoclastic resorption in vivo. This is in 
contrast to HA (Ksp = 10-116.8 at 25°C) which is considered to have marginal degradation 
rates in its sintered form (e.g. multiple years) and consequently serves a more permanent 
nature. For BCP the rates are dependent upon the composition ratios and are intermediate 
between those displayed by TCP and HA [69, 72, 73, 98-100].  
As with their other material properties, the mechanical properties of calcium phosphates 
can vary significantly based upon their composition, architecture and crystallinity. 
However as bone graft materials, calcium phosphate ceramics suffer from low fracture 
toughness which confines their use to non-load bearing sites (Table 3.2.3). It also makes 
them difficult to shape or trim intraoperatively and can limit the quality of the implant 
interface which can inhibit bone formation [53, 76, 95, 101].  
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Table 3.2.3. Comparison of mechanical properties between calcium phosphate ceramic 
biomaterials and bone [Data from Kokubo et al. (2003), Domb (2011) Biodegradable 
polymers in clinical use and clinical development and Hench (2013) Introduction to 
bioceramics]. 
Material Property 
Ca-P ceramics 
(Generalised) 
Dense 
HA 
Porous 
HA 
Cortical 
bone 
Cancellous 
bone 
Compressive 
strength (MPa) 
30-900 
500-
1000 
0.21-0.41 100-230 2-12 
Flexural/Tensile 
Strength (MPa) 
30-200 115-200 - 50-150 10-20 
Strain to failure (%) 
 
- - - 1-3 5-7 
Elastic Modulus 
(GPa) 
30-103 80-110 0.001-0.83 7-30 0.05-0.5 
Fracture Toughness 
[KIC] (MPa m1/2) 
<1 ~1 - 2-12 - 
 
 
Natural derived HA (from bovine or coralline sources) presents another group of bioactive 
materials with an interconnected macroporous structure similar to that of cancellous bone 
(section 3.1.3.1). Such structures have traditionally been difficult to achieve in 
synthetically produced calcium phosphate ceramics and their natural source results in an 
impure form of HA containing trace elements of Mg, Sr, CO3, F, as well as Na. These 
impurities are considered to be advantageous for biological processes and may install a 
therapeutic effect into the graft material compared to synthetically pure HA. However in 
general, the performance of synthetic and naturally derived HA are considered to be 
similar with natural HA also possessing equally poor mechanical properties [69, 102, 103]. 
 
3.2.2.5 Bone Cements 
Initially developed for dental applications in the 1930s, these non-resorbable acrylic-based 
polymeric materials quickly became an attractive option as an implant material for 
orthopaedic surgery. Such materials have continued to be extensively applied in modern 
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orthopaedic procedures for filling osseous defects or as a grouting agent for the fixation of 
surgical prosthesis that includes hip or knee arthroplasties, vertebroplasty, kyphoplasty as 
well as in craniofacial or maxillofacial reconstruction. These two component solid-liquid 
phase systems are typically referred to as ‘bone cements’ and involve the bulk 
polymerisation of a liquid methyl methacrylate (MMA) monomer after it has been mixed 
with a poly(methyl methacrylate) (PMMA) powder [79, 104, 105].  
The use of bone cements are advantageous in orthopaedic surgery due to their low cost and 
suitable mechanical properties that, once hardened, allow immediate structural support 
(Table 3.2.4) [91]. Despite principally operating on the same composition for over fifty 
years, seventy different commercial bone cement products are now available. This 
diversification has been based on changes to the molecular weight of the PMMA as well as 
the inclusion of other components such as radiopacifiers, antibiotics and therapeutic 
elements [79, 106, 107]. 
 
Table 3.2.4. Typical physical and mechanical properties of bone cements [Reproduced 
from Yaszemski (2003)]. 
Material Property Value 
Density (g cm-3) 1.10-1.23 
Water sorption (%) 0.5 
Shrinkage after setting (%) 2.75-5.0 
Ultimate compressive strength (MPa) 72.6-114.3 
Compressive modulus (GPa) 1.94-3.18 
Compressive strain before fracture (%) 5.0-7.5 
Ultimate tensile strength (MPa) 23.6-49.2 
Tensile elastic modulus (GPa) 1.58-4.12 
Tensile strain before fracture (%) 0.86-2.49 
Shear strength (MPa) 42.7-50.2 
Fracture toughness [KIC] (MPa m1/2) 1.03-2.32 
 
 
However bone cements are typically not bioactive, relying on a mechanical interlock at the 
bone-cement interface in order to be fixated and lack any osteoinductive or 
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osteoconductive potential [106]. Another disadvantage of bone cement is its potential 
fragmentation and the corresponding foreign body reactions that can be elicited by the host 
tissue from the wear debris. This can ultimately lead to aseptic loosening of a prosthetic 
and the development of chromic complications. The polymerisation of MMA during its 
application also produces a significantly high exothermic response with peak temperatures 
reaching between 80-124°C which, without sufficient irrigation, can cause necrosis in the 
surrounding tissue [79, 104, 106].  
Alternatively calcium phosphate cements (CPC) are two or three component systems that 
function in a similar manner to PMMA and are used for filling small sized osseous defects. 
However in contrast to the polymerisation reactions of acrylic based cements, CPC 
function through a complex precipitation process of calcium phosphate crystals. The 
powder phases of these cements can consist of compounds such as dicalcium phosphate-
anhydrate (DCPA), tetra-calcium phosphate (TTCP), mono-calcium phosphate 
monohydrate (MCPM), calcium carbonate (CaCO3), amorphous calcium phosphate (ACP) 
or α-TCP. These are mixed with water and sodium phosphate (Na3PO4) to act as an 
accelerator [10, 69, 95].  
Given the composition of these calcium phosphates, the clinical advantages to using CPC 
cements lie in their excellent biocompatibility, bioactivity and osteoconductive properties 
as well as their ability to degrade by osteoclastic resorption and be gradually remodelled 
into new bone. This is further complimented by the low temperature precipitation reactions 
that occur during the hardening of these cements (<40°C). However CPCs are not suitable 
for load bearing applications (requiring osteosynthesis) and consequently have limited 
clinical applications [10, 69, 95].   
 
3.2.2.6 Glasses  
The idea of glass as a tissue regenerative material was first investigated over 100 years ago 
in Glasgow when Sir William Macewen implanted a glass tube into the medulla of a 
canine model after a 28.6mm resection of its radius bone. Retrieval of the tube after 
approximately nine weeks showed that a firm union in the radius had been re-established 
and that new osseous tissue had proceeded to grow into two-thirds of the glass tube (Figure 
3.2.2) [108].  
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Degradable bioactive glasses are an attractive option for bone tissue regenerative 
applications due to their ability to bond to hard tissue (as well as potentially soft tissues) 
and completely degrade in vivo at rates controlled by the glass’s composition. This is 
coupled with their ability to stimulate advantageous extracellular and intracellular 
responses from the release of its constituent ions that can potentially lead to an increased 
rate of bone formation (i.e. osteoinduction). Bioactive glasses can be based on a number of 
glass forming networks (e.g. silicate-, borate- or phosphate based) with the inclusion of 
additional components (such as zinc, copper, fluoride, strontium and boron) allowing for a 
wide range of potential glass compositions to be manufactured. Due to this compositional 
flexibility, a continued increase in the development and application of bioactive glasses has 
been observed worldwide (Figure 3.2.3) [109-111]. 
 
 
 
 
 
 
Figure 3.2.3. Number of papers published between 1990-2010 under the field of "bioactive 
glass" compiled from a search of Web of Science [Reproduced from Rahaman et al. 
(2011)]. 
Figure 3.2.2. Images of a-b) Canine radius with implanted glass tube after sixty one days of 
implantation performed by Sir William Macewan - stored at the Hunterian Museum in the 
University of Glasgow and c) Drawing of histological section after retrieval of glass tube 
from canine radius [Reproduced from Tanner & Dalby (2010) Guest Editorial]. 
a c b 
Radius 
Glass tube 
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However despite the wide range of available glass formulations, the silicate based 
Bioglass® 45S5 composition (Table 3.2.5) is considered to be the gold standard of 
bioactive glasses and has been the most widely researched glass for biomedical 
applications. This composition was discovered by Larry Hench over 40 years ago and was 
the first material found capable of bonding to bone through the formation of an HCA layer 
(which was later termed “bioactivity” – section 3.2.2.1) [109-111]. Consequently Bioglass® 
45S5 has been successfully exploited in its particulate form for clinically treating 
periodontal disease and as a bone filler material through the development of Perioglas™ 
and Novabone™ products respectively (Novabone Products LLC, USA). Similar 
particulate/granule systems have also been developed from alternate silicate based 
compositions and include the commercially available BonAlive® (Biomaterials Ltd, 
Finland) and StronBone™ (RepRegen Ltd, UK) [109, 111, 112].  
 
Table 3.2.5. Compositional comparison between commercially available Bioglass® 45S5, 
BonAlive™ and StronBone® products as well as the 13-93 glass composition [Data from 
Jones & Clare (2012) and Hench (2012)]. 
 
Composition (mol%) 
Material SiO2 Na2O CaO P2O5 SrO K2O MgO 
Bioglass® 45S5 [109] 46.13 24.35 26.91 2.60 -   
BonAlive™ (S53P4) [109] 53.80 22.70 21.80 1.70 -   
StronBone® [113] 44.47 27.26 21.47 4.42 2.39   
13-93 [109] 54.6 6 22.1 1.7 - 7.9 7.7 
 
 
As bulk monoliths, Bioglass® 45S5 has been successfully implanted in patients as a middle 
ear prosthesis in order to replace damaged ossicles and treat cases of conductive hearing 
loss.  However the commercial success of this product has been restricted by the poor 
intraoperative workability of the material. The mechanical properties of Bioglass® 45S5 
and other bioactive glass systems have also generally limited their clinical applications to 
anatomical sites free of any significant mechanical loading without additional metallic 
fixation devices (Table 3.2.6) [109, 110, 112].  
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Table 3.2.6. Material properties of Bioglass® 45S5 [Data from Jones & Clare (2012)]. 
Material Property Value 
Density 2.7 g cm-3 
Glass transition temperature [Tg]  538°C 
Glass crystallisation onset temperature [Toc]  677°C 
Glass Melt Temperature [Tm]  1224°C 
Thermal Expansion Coefficient 1.51x10-6°C-1 
Tensile Strength 42 MPa 
Youngs Modulus 35 GPa 
Fracture Toughness 0.6 MPa m1/2 
Vickers Hardness  5.75 GPa 
 
 
Furthermore the poor thermal workability of silicate based bioactive glasses can make 
them prone to crystallisation (which has a detrimental effect on a glass’s bioactivity). As a 
result, research has also examined the use of borosilicate, borate and phosphate based 
glasses. However investigations into other glass compositions have also been driven by the 
uncertainty over the long term effects of SiO2 in vivo [109, 114]. 
 
3.2.2.7 Glass-Ceramics 
Alternatively heat-treatments can be used to partially convert glass compositions from their 
completely amorphous structure into one that is primarily crystalline (commonly referred 
to as glass-ceramics). These can be manufactured to possess superior properties compared 
to the initial parent glass and can be machined into a variety of shapes (such as artificial 
vertebrae implants) whilst displaying a bioactive response similar to that observed from 
bioactive glasses [115, 116].  
Based on this ceramming process (i.e. conversion to crystalline phases) a variety of glass-
ceramics can be manufactured with different material properties through adequate control 
over the size and concentration of the developing crystalline phases (Table 3.2.7). The 
commercial development of glass-ceramic materials has resulted in several biomedical 
products being released such as Cerabone® A-W (Botiss Biomaterials, Germany) and 
Bioverit® (Vitron Spezialwerkstoffe GmbH, Germany). However despite their improved 
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mechanical properties (compared to bioactive glasses) they are still considered too brittle 
to be used at sites that experience sufficient mechanical loading [115-117].  
 
Table 3.2.7. Comparison of mechanical properties between commercially available glass-
ceramic materials [Data from Holand & Beall (2012)]. 
 Glass-Ceramic 
Material Property Cerabone® A-W Bioverit® I Bioverit® II 
Density (g cm-3) 3.07 2.8 2.5 
Flexural Strength (MPa) 215 140-180 90-140 
Compressive Strength (MPa) 1080 500 450 
Youngs Modulus (GPa) 118 70-88 70 
Vickers Hardness (GPa) 0.680 5 8 
Fracture Toughness (MPa m1/2) 2.0 1.2-2.1 1.2-1.8 
 
 
3.2.3 Composites 
3.2.3.1 Overview 
From a mechanical and biological perspective, a single material can often fail to meet the 
in vivo demands encountered within the human body.  
Composites are typically defined as a group of materials composed of at least two 
physically or chemically different constituent phases separated by a distinct interface 
(Thomas et al., 2012; Balasubramanian, 2013) [118, 119]. This commonly involves the 
homogenous distribution of a brittle, high modulus (Ef) reinforcing filler within a 
continuous ductile low modulus (Em) matrix phase. The incorporation of this filler phase 
typically leads to a general increase in the elastic modulus (Ecomp), strength (σcomp) and 
other mechanical properties but a reduction in the strain at failure compared to the matrix 
phase as the volume or weight content of filler is increased (i.e. volume or weight fraction - 
Vf, Wf respectively). This increase in mechanical properties is due to the transfer and 
distribution of externally applied stresses through the matrix to the high modulus 
reinforcing filler via the filler-matrix interface. Consequently due to their potentially high 
specific elastic modulus/strength (Figure 3.2.4), increased fatigue resistance, lower thermal 
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coefficient and high impact energies, composites are considered to be an advantageous 
alternative to traditional metal devices. However due to the breadth of available literature 
on composite materials, only a brief summary is presented here [96, 118, 120, 121]. 
 
 
 
 
 
 
 
Furthermore composites also offer the ability to tailor their mechanical properties to meet 
the demands of a specific application via alterations to different material parameters. These 
include the choice and associated mechanical properties of each constituent phase, filler 
form (Figure 3.2.5), the reinforcing phase distribution (i.e. geometrical orientations), filler 
concentration as well as the condition of the filler-matrix interface (e.g. coupling agents). 
As a result, a variety of composite configurations can be produced (Figure 3.2.6) with the 
classifications of these materials typically derived from the nature of their constituents 
(Table 3.2.8) [96, 118, 122, 123].  
 
 
 
 
Figure 3.2.5. Comparison of different filler types used in composite design [Reproduced 
from Mallick (1997)]. 
Figure 3.2.4. Comparison of the elastic modulus vs density (i.e. specific modulus) for 
different monolithic and fibre composite materials [Reproduced from Hull & Clyne (1996) 
An Introduction to Composite Materials]. 
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Table 3.2.8. Description of different composite designs [Data from Gurdal et al. (1999)]. 
*Composite Type Description 
Nano- Nano- fibres or particles embedded within the matrix.  
Particulate  Employs the random distribution of isometric particles (≥1µm).  
Flake  Uses the random distribution of thin, high aspect ratio 
flakes/platelets that can provide some degree anisotropy if properly 
aligned. 
Fibre-reinforced  Sub-categorized into continuous or discontinuous fibre reinforced 
composites that utilize long or short fibres respectively. 
Laminated  Combined stacks of aligned or randomly orientated composite 
fibre laminates. Laminate layers (also known as pre-pregs) are 
manufactured by impregnating fibres with a polymer resin.  
*Composites can be dense or of a porous foam like architecture depending on the manufacturing technique. 
 
Yet despite the different types of composite configurations, fibre reinforced composites are 
considered by Gurdal et al. (1999) to be the most predominantly used form due to the 
increase in mechanical properties that can be achieved (Figure 3.2.7). This is due to the 
higher aspect ratios encountered with fibres (i.e. larger surface areas per unit volume) and 
consequent increase in stress transfer compared to particles - where reinforcement of the 
sample occurs parallel to the fibres axis (x1/E1). Accordingly, fibres suitable for composite 
Figure 3.2.6. Comparison of different types of composite configurations using different 
fillers [Reproduced from Gurdal et al. (1999)]. 
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reinforcement should possess a uniform diameter along with a high elastic modulus, high 
ultimate tensile strength and suitable stability during handling [96, 123-125]. 
Fibre reinforced polymer composites (FRPC) can be manufactured from a variety of fibre 
types including continuous or discontinuous glass or carbon fibres through methods such 
as extrusion or injection moulding techniques. However the ability to also manufacture 
composites with anisotropic properties by aligning the reinforcing fibres is considered to 
be a major advantage compared to isotropic particulate composites or monolithic materials 
(Ratner et al. 2012) [96]. This is due to the ability to tailor the composite material properties 
(via the fibre orientation) in relation to the primary direction of the applied stresses. Yet 
when considering the illustration shown in Figure 3.2.7, the alignment of parallel 
reinforcing fibres in the x1 direction consequently offers lower reinforcement in the 
transverse direction (x2/E2). As such, laminated composite designs incorporating linear 
fibre pre-pregs of consecutively alternating orientations (e.g. 0°, 45°, 90°) have been used 
alongside various two dimensional and three-dimensional weave/woven designs to further 
modify and tailor the fibre composite material properties (Figure 3.2.8) [96, 121-123, 126].  
 
 
 
 
 
 
 
 
Figure 3.2.7. Illustration of FRPC showing a) Elastic modulus (E), shear modulus (G) and 
Poisson’s ratio (v) of the fibre (Ef, Gf, vf) and matrix (Em, Gm, vm) constituents in a 
unidirectional fibre reinforced composite and b) Elastic properties of composite with 
regards to global axis running parallel (x1) and transverse (x2) to the primary fibre axis 
with the elastic modulus (E1, E2) as well as the shear modulus (G12) and Poisson’s ratio 
(v12) labelled relative to the applied axis coordinates. [Reproduced from Gurdal et al. 
(1999)]. 
a b 
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In fibre-reinforced composites, the major stress field at the fibre-matrix interface is 
experienced as shear and as a result, the degree of reinforcement for a specific composite 
configuration is dependent upon the interfacial shear bond strength (τb) of the fibre-matrix 
interface. Consequently when mechanically loaded, the failure of fibre composite materials 
traditionally occurs through fibre fracture (for weaker fibres) or when the interfacial shear 
stresses (IFSS) exceed the interfacial bond strength (IFSS > τb). However the fibre-matrix 
interface is also influential to the fracture toughness of a composite specimen with 
interfacial debonding and fibre pull out regarded by Mallick (1997) as the primary energy 
absorbing mechanisms during composite failure. To expand on this, the interfacial 
debonding can disrupt the crack pathway and cause it to shift from its initial direction 
(through the fibre) to propagation along the fibre surface (Figure 3.2.9). Additionally if the 
reinforcing fibres fracture at locations away from the crack plane then the composite 
fracture toughness can increase due to the friction encountered during fibre pull-out [122, 
127]
.  
 
 
 
 
 
 
Figure 3.2.8. Comparison of different fibre architectures used in various composite 
laminate designs [Reproduced from Gurdal et al. (1999)]. 
Figure 3.2.9. Illustration of interfacial debonding, fibre fracture and fibre pull-out during 
composite fracture [Reproduced from Mallick (1997)]. 
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As previously discussed, the enhanced mechanical properties of fibre reinforced 
composites are related to the quality of the fibre-matrix interface which is dependent upon 
the ability to successfully infiltrate the fibres with polymer resin. In polymer reinforced 
laminate composites this can be expressed by a modified version of Darcy’s Law that 
describes the anisotropic viscous flow of the polymer phase during composite processing 
(Eqn 3.2.1). Based on Darcy’s law, improved polymer infiltration can be achieved when a 
lower viscosity resin (i.e. higher processing temperature) and increased pressure 
differential/gradient is applied for a set fibre construct of permeability [K] [122].  
 
  	  	
 
Eqn 3.2.1 
where [U] = superficial velocity, 	P = pressure gradient, µ= viscosity of the flowing resin 
and [K] is the permeability tensor of the fibre reinforcement. 
 
In addition to the previously discussed mechanisms of tailoring composite material 
properties, further modifications can also be achieved through the development of hybrid 
composite designs. These look to simultaneously incorporate different types of reinforcing 
phases due to the potential synergistic effects between the two different filler types. 
Examples of this include the production of composite materials with good fracture 
toughness (via fibre-pull out and crack deflection mechanisms), impact resistance, thermal 
shock and wear resistance from the combination of fibres and particles (Figure 3.2.10) [128].  
 
 
 
 
Figure 3.2.10. Illustration of a hybrid polymer composite that incorporates short fibres and 
particles into the matrix phase [Reproduced from Fu et al. (2009)]. 
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3.2.3.2 Composite Biomaterials 
Given the advantages and flexibility in composite mechanical properties, implant design 
has also looked to utilise such concepts for the application of polymer composite devices 
with mechanical properties targeted at a desired tissue or specific anatomical site. Such 
materials have been investigated for a range of tissue reconstructive applications using a 
variety of different matrix and filler materials including carbon, polymer (i.e. self-
reinforcing) or glass (Figure 3.2.11). This also includes architectural variations such as the 
use of dense or porous composite materials. However due to the breadth of the available 
literature surrounding the development and characterization of such composite 
biomaterials only dense glass/ceramic-polymer composites have been considered here [129]. 
In orthopaedic applications, the development of polymer composites using a brittle, high 
modulus bioactive ceramic or glass reinforcing filler phase alongside a synthetic or natural 
(e.g. collagen, chitosan etc.) polymer matrix has been investigated since the 1980s. This 
has been due to the natural ceramic-polymer composite composition of bone (section 
3.1.2.1) as well as the flexibility in material design and mechanical properties that can be 
achieved with composite materials. Consequently these materials have been investigated 
with the aim that the bioactive filler phase mechanically reinforces the low modulus ductile 
matrix as well as confer in vivo bioactivity to the inert polymer that would typically 
undergo fibrous encapsulation (Tanner, 2010). Similar to its mechanical properties, this 
degree of bioactivity can also be tailored via alterations to the bioactive filler 
concentration, morphology and its distribution (e.g. surface area-to-volume ratios and 
volume fraction) [86, 130, 131].  
One of the most successful biomedical composites based on this bioactive ceramic-
polymer composite concept has been through the reinforcement of a high-density 
polyethylene (HDPE) matrix with 40 vol% HA microparticles. Such composites possess an 
elastic modulus (4.4 ± 0.7 GPa) in the lower region of cortical bone whilst retaining a 
ductile failure mode. The development of this composite material has since led to its 
commercial success for orbital floor prosthesis, middle ear implants and maxiofacial 
surgery reconstructive applications under the tradename HAPEX™. However, HAPEX™ is 
non-resorbable and according to Tjong (2012) is unsuitable for major load bearing 
orthopaedic applications due to its low mechanical strength [132, 133].  
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The development and application of degradable composite materials has been viewed as an 
attractive alternative to traditional metallic orthopaedic implant devices (section 3.2.2.1). 
This is due to the time-dependent reduction in mechanical properties of such materials and 
their subsequent ability to gradually transfer mechanical loading to the regenerating tissue 
as the implant degrades. As discussed in section 3.2.2.3, this would help alleviate any 
stress-shielding problems (such as those encountered with metallic implant devices – 
section 3.2.2.2) whilst also eliminating any long term cytocompatibility issues or need for 
secondary removal surgery. Furthermore by altering the material configuration and 
precursor materials, composite biomaterials have the ability to be developed with tailored 
Figure 3.2.11. Overview of the different composite materials being developed for tissue 
reconstruction at different anatomical sites [Reproduced from Ramakrishna et al. (2001)]. 
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degradation rates aimed at matching specific tissue formation rates across different 
anatomical sites. Accordingly a variety of composite configurations using degradable 
materials have been investigated that have been primarily focused on applications such as 
fracture fixation plates, pins or screws (Table 3.2.9). In degradable materials the inclusion 
of basic calcium phosphate compounds has also been used in applications to mediate the 
acidic degradation of the polymer matrix and buffer any pH effects (such as the lactic acid 
and autocatalysis effects observed during PLA degradation – section 3.2.2.3) [7, 86, 131, 134].  
However the major challenge in the development of such materials is, according to Chen et 
al. (2012), achieving materials that are not only biodegradable but are also mechanically 
stable after implantation. This is due to the counterintuitive relationship between 
mechanical strength and material degradation. Consequently authors such as Pietrzak & 
Eppley (2000) have indicated that degradable orthopaedic devices should typically aim to 
retain at least 80% of their mechanical properties after six to eight weeks of degradation [9, 
86]
. 
 
Table 3.2.9. Examples of different composites from the literature and those commercially 
available for use as orthopaedic fracture fixation plates, pins and screws.  
Author/Product Matrix Filler Filler Conc. 
Doyle et al. (1991) [7] PHB HA Particles 40 vol.% 
Shikinami & Okuno (1999) [7] PLA HA Particles 50 wt.% 
Russias et al. (2006) [135] PLA HA Whiskers 70-85 wt.% 
Misra et al. (2007) [7] PHB Bioglass® 45S5 20 wt.% 
Zhou et al. (2009) [136]  PLLA Phosphate Glass Particles 10 wt.% 
Felfel et al. (2013) [137] PLA Phosphate Glass Fibres 30 vol.% 
Charles et al. (2013) [138] *Self-Reinforced PLLA-HA (15 wt.%) 
SmartPins (Bionx, USA) [139] *Self-Reinforced PLLA 
FIXSORB 30 (Takiron, Japan) [139] PLLA HA Particles 30 wt.% 
BioComposite (Arthrex, USA) [139] PLLA BCP Particles 30 wt.% 
*Self-reinforced (SR) composites incorporate matrix and reinforcing fibres of the same basic thermoplastic 
polymer family where the matrix has a significantly lower melt temperature compared to the polymer fibres. 
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3.3 Cranioplasty  
3.3.1 Overview 
Cranioplasty is a surgical procedure aimed at repairing a cranial vault defect such as those 
produced by incidents of neurosurgical trauma where sections of calvarial bone have been 
surgically removed (also known as a craniectomy). The subsequent closure of the defect 
site is then performed in order to physically protect the underlying brain, provide suitable 
cosmetic results and improve neurological symptoms. These defects typically range from 
12-178 cm2 and can be corrected through a range of different native or synthetic 
cranioplasty plate materials [140-142]. 
 
3.3.2 Cranioplasty Plate Materials 
3.3.2.1 Auto- and Allogenic Bone  
The use of autologous bone tissue in cranioplasty was introduced in the 1950s and corrects 
the defect using the section of bone (i.e. bone flap) previously removed during the earlier 
craniectomy surgery. This route is considered to be the simplest option given the 
advantages of autologous material (section 3.2.1.1) and likely correlation with the defect 
contours. However they can suffer from relatively high infection rates (≈33%) [2, 140, 142]. 
Alternatively cranioplasty procedures utilising allogeneic bone can be performed using a 
split-graft technique where the inner and outer tables of a donor’s calvarium are separated. 
The outer table is then used to correct the cranial defect whilst the inner table remains with 
the donor. This technique is considered to provide aesthetically pleasing results however it 
is unsuitable for large defects and suffers from the same allograft bone issues discussed in 
section 3.2.1.2 [2, 140]. 
 
3.3.2.2 Metals 
Since their initial use during the 1940s, titanium and its alloys have become the only 
metallic biomaterial currently used in cranioplasty and is considered to be the material of 
choice for the treatment of moderate to large sized craniectomy defects. This has been due 
to its good biocompatibility, high strength-to-weight ratio, malleability and comparatively 
low radiopacity at a reduced cost to alternate metals. Furthermore modern titanium 
implants can be pre-fabricated using 3D CAD/CAM technology to achieve customised 2-
4mm thick cranioplasty plates (Figure 3.3.1) that match the defect contours [2, 143].   
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Yet despite its higher radiolucency, titanium can continue to generate significant artefacts 
in both CT and MR imaging that can hinder the postoperative review of patients especially 
where large reconstructions have been performed. Its application is also associated with 
patient discomfort in extreme weather conditions due to its high thermal conductivity [2]. 
 
3.3.2.3 PMMA 
Polymethyl-methacrylate (PMMA) has become increasingly popular for cranioplasty due 
to its ease of handling and intraoperative flexibility that permits its application in 
technically challenging reconstructive craniectomy defects with cosmetically pleasing 
results. This is further complimented by the lightweight, non-magnetic and low thermal 
conduction of the resulting implant that can possess mechanical properties similar to bone 
for a comparatively lower cost than the titanium equivalent [2, 140, 143]. 
The application of PMMA during a cranioplasty procedure typically involves the manual 
moulding of the paste as it sets to fit the defect contours to produce 3-6mm thick plates. 
This plate is then secured using low profile titanium fixation devices (Figure 3.3.2) with 
large scale cranioplasty procedures commonly incorporating a titanium reinforcing mesh to 
combat the inherent brittleness of PMMA (Table 3.2.4) [2, 140, 143]. 
Figure 3.3.1. Manufacture and implantation of a titanium cranioplasty plate for frontal 
skull reconstruction showing a) Simulation of reconstruction using CAD/CAM software 
based on CT scan data b) Manufactured titanium plate and c) Surgical implantation and 
fixation of titanium plate for frontal basis reconstruction [Reproduced from Spetzger et al. 
(2010)]. 
a 
b 
c 
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Besides its brittle nature, the exothermic temperatures during the polymerisation of PMMA 
has been a major concern due to the risk of potentially damaging the surrounding tissue 
(i.e. dura mater, cerebral cortex etc.). Consequently the PMMA must be constantly 
irrigated with saline during polymerisation and contour shaped before being removed from 
the defect site whilst still in a deformable state [144-146]. Additionally PMMA implants are 
considered to have a high rate of extrusion and infection (reported to be ≈24%) with 
further concerns relating to its suitability in paediatric operations due to its inability to 
accommodate cranial growth [2, 143]. 
 
3.3.2.4 Polymers 
The development of porous polyethylene (PE) with Ø100-250µm pores offers an implant 
material that can be easily cut, shaped and sutured intraoperatively and is capable of tissue 
ingrowth from the surrounding skull bone tissue. Compared to PMMA, porous PE can 
reduce the overall duration of the surgical procedure at an equivalent cost and has been 
sold in different sizes as MEDPOR® or MEDPOR® Titan (Stryker®, USA) implant 
materials (Figure 3.3.3a,b). However due to its low mechanical properties (even with 
mechanical reinforcement) the use of porous PE has been limited to small cranial defects 
[143, 147].
  
Polyetheretherketone (PEEK) is a semi-crystalline, non-degradable thermoplastic polymer 
that has been widely used in spinal surgery since 1998 due to its inert nature, light weight, 
radiolucency and mechanical properties that approach those of cortical bone. Due to these 
features and previous clinical results, PEEK has now been suggested as a future 
cranioplasty plate material using 3D CT scanning data to create patient specific plates 
Figure 3.3.2. Navigation assisted reconstruction of a large skull defect using a PMMA 
cranioplasty plate fixed with titanium screws [Reproduced from Spetzger et al. (2010)]. 
96 
 
(Figure 3.3.3c). Initial publications on the performance of PEEK cranioplasty implants 
have reported promising results however no long term data is yet available [2, 143].  
 
 
 
 
 
 
 
 
 
 
3.3.2.5 Ceramics 
Calcium phosphate ceramics have held a particular interest as cranioplasty plate materials 
and are predicted to be important in developing future alloplastic cranioplasty implants [143, 
148]
. This has subsequently seen the development of preformed porous Ca-P implants with 
interconnected porosities such as the range of HA cranioplasty devices offered by Fin-
Ceramica® (Italy). However as discussed in section 3.3.2.4, the brittleness of calcium 
phosphates renders them highly susceptible to fracture especially during device fixation 
and is further compounded by their inability to be moulded intraoperatively [143, 149]. 
The development of HA based cements has allowed cranioplasties to be performed with 
ceramic materials that could be easily manipulated during surgery in a similar manner to 
PMMA. These products are supplied as BoneSource® (Stryker, USA) or Norian SRS® 
(DePuy Synthes, CH/USA) with titanium meshes commonly integrated into the cement 
during the reconstruction of large scale defects to improve their mechanical properties. Yet 
the application of these cements is limited by their relative expense and reported high rates 
of infection [2, 150, 151]. 
 
Figure 3.3.3. Polymer cranioplasty plates a) MEDPOR® Surgical implant [Reproduced 
from Liu et al. (2004)] b) MEDPOR® Titan cranial plate for temporal reconstruction with 
reinforcing titanium mesh visible [Reproduced from http://www.stryker.com (Accessed 
14/09/2014) and c) Patient specific customised pre-fabricated PEEK implant plate from 3D 
CT data [Reproduced Harris et al. (2014)].  
a b c 
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3.3.2.6 Composites 
The application of particulate or fibre reinforced composites as cranioplasty devices has 
been investigated with a range of material configurations. These have include use of HA 
reinforced HDPE as well as hydrolytically stable carbon, S-glass or E-glass fibres in 
different polymer resins (e.g. PEEK, bisphol-a-glycidyl methacrylate/triethyleneglycoldi-
methacrylate) [4-6, 152-155]. Due to the inert nature of these reinforcing fibres, these implant 
materials have also incorporated bioactive glass particles such as Bioglass® 45S5 or 
BonAlive™ into their composite structure (section 3.2.2.6). However unlike the dense 
composites intended for fracture fixation plates, cranioplasty composites have been 
developed with dense-porous sandwich like architectures in order for the material to 
possess suitable mechanical properties whilst allowing for cellular ingrowth (Figure 3.3.4) 
[5]
.  
 
 
 
 
 
 
 
 
 
Additional considerations in cranioplasty fibre composite design also related to the lack of 
a defined mechanical loading regime at anatomical sites across the calvarium. As a result, 
the use of continuous bi-directional or fibre weaves/fabrics are considered by Vallittu et al. 
(2015) to be the preferred option compared to the selective orientation and advantageous 
anisotropic properties found in fibre composite fracture fixation plates (section 3.2.3.1) [5].   
 
Figure 3.3.4. Illustration of a fibre reinforced cranioplasty plate design that combines high 
performance non-resorbable glass fibres with a porous layer containing bioactive glass 
(BG) particles [Reproduced from Vallittu et al. (2015)]  
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3.3.3 Cranioplasty Complications 
Despite being considered a physiologically and technically straightforward operation, high 
complication rates in cranioplasty procedures are common (≈30%) and can include patient 
symptoms such as infection, haematoma, headache and seizures. However these 
complication rates will vary and are dependent upon the patient’s radiography/surgical 
history, age, procedure duration and primary pathology as well as the cranioplasty site, size 
and implant material used [140, 141, 156]. 
Post-operative infection is the most common and significant complication in cranioplasty 
procedures due to its serious consequences and is regarded by Thavarajah et al. (2012) as 
one of the key drivers in the diversification and evolution of cranioplasty plate material 
technology. Retrospective studies on cranioplasty procedures have found these infection 
rates to range from 5-9% with Staphylococcus epidermidis, Staphylococcus aureus and 
Propionibacterium identified as the predominant infectious bacteria. These infections are 
believed to be caused by skin microbiota and their occurrence is influenced by disrupted 
wound healing, the duration between craniectomy and cranioplasty, prior procedures as 
well as inflammatory responses [3, 142, 156]. 
If an infected case is confirmed, the complete removal of the cranioplasty plate is required 
before a series of broad-spectrum and systemic antibiotic agents is conducted over six to 
eight weeks. A replacement cranioplasty procedure is then performed after 6-13 months. 
However the continued rise of antimicrobial resistant infections has placed greater 
emphasis on preventative measures rather than the current post-operative treatments with 
the financial implications of treating cranioplasty plate infections estimated to be £9,283 
per case to the National Health Service (NHS) according to O’Keeffe et al. (2012) [3, 141, 142, 
156]
. 
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3.4 Phosphate Glasses 
3.4.1 Definition and Theory of Glass Formation 
Given the range of manufacturing methods and materials capable of forming glasses, the 
definition of a glassy material has been typically based on its material characteristics. 
Accordingly glasses are defined by Shelby (2005) as “an amorphous solid completely 
lacking in long range, periodic atomic structure, and exhibiting a region of glass 
transformation behaviour” [157].   
The principles of glass formation can be explained when considering a heated melt of fixed 
volume that is subsequently cooled at a controlled rate to room temperature. As the 
temperature drops below the samples melt temperature (Tm) a crystalline state is typically 
formed that displays a short or long range periodic atomic arrangement. This transition is 
driven by the tendency of the thermodynamic system to fall to its lowest energy state and is 
signified by the sharp drop in enthalpy shown in Figure 3.4.1 [157].  
 
 
 
 
 
 
 
However, if a sample is cooled below its Tm without crystallisation then the materials 
structure continues to rearrange with decreasing temperature as kinetic factors (i.e. 
viscosity) overrule the thermodynamic system. Progressive cooling of the liquid and the 
corresponding increases in viscosity then lead to its structure becoming fixed without any 
atomic arrangement. This behaviour is represented by the gradual slope in Figure 3.4.1 as 
the enthalpy deviates from the equilibrium state (observed by the formation of a crystalline 
material) and is defined as the range of glass transition. The so-called ‘frozen liquid’ can 
Figure 3.4.1. Enthalpy-Temperature diagram showing formation of crystalline and glassy 
materials as well as the effect of cooling rate on glass formation [Reproduced from Shelby  
(2005) Introduction to Glass Science and Technology]. 
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now be considered as a glassy material. Additionally since deviation from the equilibrium 
state is dictated by kinetic factors, the rate at which the melt is cooled will ultimately 
control the temperature at which the sample enters this glass transition region. Thus if a 
material was to be cooled at a reduced rate then the glass transition temperature (Tg) would 
shift to lower values with the atomic arrangement of the resulting glass reflective of its 
arrangement prior to its deviation from the equilibrium state (Figure 3.4.1) [109, 157].  
Furthermore given the range of materials capable of forming a glass, the American Society 
for Testing and Materials (ASTM) has defined a glass as any material that has been 
“cooled from the melt without crystallising”. Accordingly the formation of glassy materials 
is dependent upon achieving cooling rates high enough for kinetic factors to dominate the 
thermodynamic system and prevent crystallisation. For a typical inorganic silicate melt 
(used in the manufacture of windows and drinking vessels) this corresponds to a relatively 
slow ≈20° min-1 whilst the generation of metallic glasses requires rapid cooling rates of 
≈2° sec-1 [109, 157]. 
 
3.4.2 Manufacturing of Phosphate Glasses 
Phosphate glasses (PGs) have conventionally been manufactured from a melt quenching 
technique that involves the mixing and heating of raw materials inside a platinum or 
ceramic crucible to form a homogenous melt. These temperatures typically range between 
800-1300°C with the selection and quantity of each precursor based on the calculated 
proportions of each glass component in order to achieve a specific glass composition 
(mol%). This melt is then rapidly cooled between two metal plates or poured into water 
with the production of bulk monoliths achieved using a preheated graphite or metal mould. 
Monolith samples are then typically subjected to an annealing cycle where they are slowly 
cooled from a predetermined value to room temperature at a controlled rate in order to 
alleviate any residual internal stresses in the glass that were generated as it was initially 
cast [109, 157].  
Other methods of PG production include relatively modern sol-gel techniques that allow 
glasses to be produced at comparatively lower temperatures from a polymer-type reaction 
of a compositionally specific solution. Due to the lower temperatures, sol-gel glasses can 
incorporate drugs and growth factors as well as allow for development of polymer-glass 
hybrid materials. However sol-gel PGs are reported to be especially fragile and possess 
dissolution rates unsuitable for most biomedical applications [109]. 
101 
 
3.4.3 Structure and Classification 
The theory of a glass’s structure includes the influential studies by Zachariasen (1932) who 
proposed the formation of a three dimensional structural network from silicates or 
phosphorus pentoxide (P2O5) glass forming compounds. Further studies by Hägg and Van 
Wazer challenged these concepts and proved that phosphate glasses could also be 
composed of large one dimensional molecular groups. This evidently led to glass structure 
models being described in terms of the short range bonding information and long range 
length scales throughout the materials overall structure [157, 158]. 
PGs are based on the P2O5 glass former with the orthophosphate P-tetrahedron (PO43-) the 
basic structural unit that is able to form covalent bonds with any surrounding P-
tetrahedrons via the molecule’s three free oxygen atoms. Due to their ability to bridge 
between P-tetrahedrons, these oxygen atoms are generally referred to as bridging oxygen’s 
(BOs) and allow for the formation of chains, rings or branching network structures of 
orthophosphate units to be generated (via the P-O-P bonds). This three dimensional 
random network of covalently bonded P-tetrahedrons (as described by Zachariasen, 1932) 
for a simple vitreous P2O5 glass (v-P2O5) is represented in Figure 3.4.2 [109, 158].   
 
 
 
 
 
 
 
 
 
 
The corresponding structure of a PG network is typically classified under the Qi 
terminology where i represents the number of available BOs per P-tetrahedron (Figure 
3.4.3). This classification is dictated by the PG composition and is influenced by the 
Figure 3.4.2. Random network structure of a vitreous phosphate glass generated by P-
tetrahedra linked by P-O-P covalent bonds [Modified from Jones & Clare (2012)]. 
P-O-P bonding via the bridging oxygen’s (BOs) 
Terminal double 
bonded oxygen 
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addition of alkali or alkaline earth metal ions into the PG structure. These ions are intended 
to modify the glass’s structure and have been typically used to improve the poor durability 
and hygroscopic nature of v-P2O5 glasses. These additional compounds are commonly 
referred to as network modifier oxides (MOs) and allow for the production of PGs with 
tailored material properties based on their specific composition [158]. 
 
 
 
 
 
These modifier oxides can include compounds such as magnesium oxide (MgO), calcium 
oxide (CaO) or titanium dioxide (TiO2) and their introduction cleaves the P-O-P bonds in 
the PG network. This subsequently generates ionically bonded crosslinks between the non-
bridging oxygens (NBOs) of different phosphate groups/chains which are often described 
as forming a chelate-like structure (Figure 3.4.4). This consequently disrupts the PG 
network and is known as network depolymerisation [109].  
 
 
 
 
 
 
Figure 3.4.3. Classification of PG networks based on Qi terminology showing decreasing 
BO’s as Qn decreases [Modified from Brow (2000)]. 
Figure 3.4.4. Change in P-O-P glass structure from the addition of MOs (CaO/Na2O) into 
the phosphate network and the formation of ionic bonds between the phosphate groups -
Note that due to the single positive charge of the Na+ ion, the PG network is depolymerised 
but no ionic bonding between chains occurs [Modified from Jones & Clare (2012)]. 
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As a result, the random three dimensional crosslinked P-tetrahedra network (Q3) in a v-
P2O5 glass can shift to one consisting of linear polymer-like phosphate chains of 
decreasing length (Q2/Q1) to a glass composed of isolated orthophosphate groups (Q0) as 
the concentration of MOs is increased (i.e. Q3 → Q2→ Q1→ Q0).  For a binary PG this shift 
in Qi classification can be described by the pseudo-reaction 2Qn + R2O → 2Qn-1 (where R 
is a metal atom and n refers to the Qi network classification) [158, 159].  
The resulting PG networks from MO addition typically consist of both covalent and ionic 
bonding and allows for a vast range of potential PG compositions with tailored properties 
to be achieved from the use of specific MOs and their relative concentrations (mol%). 
These include the glass’s thermal stability (i.e. its tendency towards crystallisation), 
mechanical properties and its dissolution rate (Dr) which can be altered by several orders of 
magnitude depending on the atomic radius and valence of the selected MO cations [109]. 
Some commonly utilised MOs along with their related properties are shown in Table 3.4.1. 
Additionally the increased PG network disruption caused by the number of different MOs 
can also influence the glass properties [109, 160, 161]. 
 
Table 3.4.1. Common modifier oxides (MOs) used in phosphate glass compositions 
showing their atomic weight, ionic radius and charge-to-size ratio (arranged by increasing 
ionic radius). 
MO/Cation Atomic weight of cation (amu) [146] 
Ionic radius of cation 
(pm) [146] Charge-to-size ratio 
B2O3/B3+ 10.810 41.0 0.0731 
Fe2O3/Fe3+ 55.845 75.0 0.0400 
MgO/Mg2+ 24.305 86.0 0.0232 
ZnO/Zn2+ 65.380 88.0 0.0227 
TiO2/Ti4+ 47.867 100.0 0.0400 
CaO/Ca2+ 40.078 114.0 0.0175 
Na2O/Na+ 22.989 116.0 0.0086 
La2O3/La3+ 138.905 117.2 0.0255 
Sr2O3/Sr2+ 87.620 132.0 0.0151 
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A summary of PG classification based on the glass former content (P2O5 mol%), Qi 
terminology and corresponding network structure is shown in Table 3.4.2. It should also be 
noted that due to the difficulty in achieving compositions with an exact stoichiometry of 50 
mol% P2O5, metaphosphate glasses are often considered as a long chained polyphosphate 
glass [109, 158]. Furthermore pyrophosphate glasses (also known as invert glasses) are formed 
by the interactions of cations and phosphate groups and not from a random network or 
entangled phosphate chains [109]. 
 
Table 3.4.2. Description of various phosphate glass structures and network characteristics 
showing the P2O5 content, Qi terminology and structure. 
Classification [109, 158] P2O5 (mol%) Q
i
 
[158]
 Structure [158] 
Vitreous P2O5 100 Q3 Cross-linked random network of Q
3 
tetrahedra 
Ultraphosphate >50 Q3/Q2 50-75 mol%: randomly linked Q
3/Q2 
>75-80 mol%: resembles v-P2O5 
Metaphosphate 50 Q2 Q
2
 phosphate polymeric chains of 
infinite length and ring type structures 
Polyphosphate <50 Q2/Q1 Q
2
 chains of various lengths 
terminated by Q1 P-tetrahedra 
Pyrophosphate <33.3 Q1 Phosphate dimers (P2O7
4-) with 
isolated phosphate tetrahedra (PO43-) 
Orthophosphate N/A Q0 (PO43-) phosphate tetrahedra 
 
Finally, intermediate oxides represent an additional glass component with the capability of 
functioning as either a MO or a network former. The introduction of these intermediate 
oxides can thus allow for the generation of hydration resistant covalent bonds to be 
introduced into the glass’s backbone (e.g. P-O-M-O-P, where M represents an intermediate 
metal atom). Examples of these intermediate oxides include those based on magnesium 
(Mg), iron (Fe), aluminium (Al) and zinc (Zn) [109].  
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3.4.4 Dissolution Mechanisms 
The dissolution rate (Dr) of a PG can vary over more than four orders of magnitude and is 
dictated by the glass composition/thermal history and immersion conditions (e.g. 
temperature, pH, static/dynamic media flow, media ionic concentration and surface area-
to-volume ratio). It is however generally accepted that PG dissolution is a two stage 
process and that it is consistent with a typical polymer hydration model where the initial 
diffusion of water into the glass surface leads to the release of phosphate chains through 
hydrolysis of the PG network (section 3.2.2.3). Furthermore PGs are considered to 
typically degrade congruently with the resulting dissolution products and changes to the 
ionic concentrations in the aqueous media reflective of the glass’s composition [111, 162, 163].  
Upon immersion in aqueous media, it is believed that water molecules penetrate into the 
surface of the phosphate glass leading to the formation of a smooth hydrated layer across 
the sample at the glass-water interface. The formation of this hydrated layer occurs in 
tandem with an immediate ion exchange reaction between the Na+ ions in the glass and the 
waters H+ ions at the phosphate chain ends (Figure 3.4.5) [163].  
 
 
 
 
Given that this ion exchange process occurs immediately, the formation of this hydrated 
layer is governed by the diffusion rate of water molecules into the bulk glass which is 
strongly affected by the composition of the PG. This is due to the resulting crosslinks/ 
chelated network structures formed from the introduction of suitable MOs and their ability 
to retard the diffusion of water molecules into the glass network which consequently 
improves the durability of the glass [163]. 
Once formed, this hydrated layer propagates inward into the glass and is followed by the 
hydration of entire P-O-P chains that are then disentangled and released into the aqueous 
environment (Figure 3.4.6). The liberation of these phosphate chains is coupled with the 
Figure 3.4.5. Hydration reaction that produces the formation of a hydrated surface layer 
across the glass surface due to the exchange of the sodium with hydrogen ions in water 
(Na-H) [Reproduced from Gao et al. (2004)]. 
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release of the glass’s modifier cations with the linear dissolution rate of a PG reflective of 
the release kinetics of its phosphate chains [109, 163].  
 
 
 
 
The dissolution process of PGs is consequently considered by Bunker et al. (1984) to 
follow two separate kinetic periods which are described by an initial decelerating 
dissolution period obeying q α t1/2 law (where q represents weight loss). This is then 
believed to be accompanied by a linear rate of time dependant dissolution (q α t). However 
these mechanisms are challenged by Delahaye et al. (1998) who attributes the initial 
decrease in PG Dr to the gradual increase in media ionic concentration as the glass begins 
to degrade. Accordingly Delahaye et al. (1998) believes that the dissolution kinetics of a 
PG should be considered as following a single linear time-dependant relationship (q α t) 
throughout the entire dissolution process [162, 164]. Furthermore it should be added that the 
dissolution rate of a PG must be considered with respect to its immersion conditions as 
accelerated dissolution rates will typically occur when samples are immersed low pH, 
elevated temperature environments and/or at high surface area-to-volume ratios.  
 
3.4.5 Bioactivity Mechanisms 
The mechanisms of bioactivity have been widely investigated for silica based glass 
compositions such as Bioglass® 45S5 and have been shown to be dependent upon a glass’s 
chemical reactivity in physiological media. Accordingly the stages of HCA surface layer 
formation in vivo have been well characterised by Hench to follow a sequence of initial 
surface reactions prior to a series of cellular events as described in Figure 3.4.7. However 
in contrast, very little has been reported on the bioactivity mechanisms of silica free 
phosphate glass compositions that fail to display any sort of silica rich surface layer 
formation which is considered vital for providing nucleation sites for the Ca2+ and (PO4)3- 
ions to accumulate and eventually crystallise/precipitate into HCA [76, 165-167]. 
Figure 3.4.6. Breakage of P-O-P bonds in a PG network from the attack of H2O water 
molecules after the initial surface hydration reaction [Reproduced from Gao et al. (2004)]. 
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However authors such as Kasuga et al. (2005) have discussed how in silica free glass 
compositions the nucleation of bone like apatite can be formed from alternate groups such 
as Ti-OH, Ta-OH, Zr-OH, Nb-OH, -COOH and PO4H2. Furthermore in comparison to the 
SiO2 rich gel layer found in silica based glasses, the formation of a calcium phosphate gel 
layer in PGs is also believed to play an important role in apatite layer formation [168]. Yet 
glasses possessing low dissolution rates (i.e. increased durability) are considered to exhibit 
a poor bioactive response due to their inhibition of the dissolution-precipitation reactions 
required for apatite formation. In contrast Gayathri Devi et al. (2010) and Mohammadi et 
al. (2012) have also discussed how the acidic pH formed from a rapidly degrading 
phosphate glass can also inhibit apatite formation [169, 170].   
 
3.4.6 Compositions for Bone Tissue Augmentation 
The continued interest in the development of new versatile materials for bone tissue 
regeneration has driven the demand for novel materials with adjustable levels of bioactivity 
and biodegradation rates. PGs are an advantageous group of materials with the potential for 
use in hard tissue regeneration due to their ability to be formed from compositions 
chemically similar to the mineral phase of bone and completely degrade at highly 
controllable rates. This is further complimented by the ability of PGs to be metabolised by 
natural processes occurring in the body and stimulatory effects elicited in vivo from the 
ions released during PG dissolution [160, 171, 172].  
Figure 3.4.7. Sequence of reactions occurring across surface of silica based bioactive 
glasses with surface reactions (1-5) and cellular events (6-11) labelled [Reproduced from 
Hench (1998) Bioactive materials: The potential for tissue regeneration].  
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The range of PG compositions produced by the addition of MO’s has led to a broad 
spectrum of glasses being developed for the regeneration of bone tissue defects from 
different glass systems (i.e. binary → complex multicomponent systems). Consequently 
given the breadth of available literature, only compositions utilising a P2O5 glass former 
concentration of 40-55 mol% and intended for the purposes of bone tissue defect 
regeneration will be briefly summarised here. 
 
3.4.6.1 Ternary Compositions 
Glasses based on the ternary P2O5-CaO-Na2O system as developed by Uo et al. (1998) 
offer potential as degradable scaffold materials for bone regeneration due their 
biocompatible dissolution products and compositionally dependant dissolution rates (Drs). 
Development of this system continued with a range of studies characterising the 
compositional effects of different MO concentrations on the various properties of the 
resulting glasses. This work by Uo et al. (1998) and follow up studies (Franks et al., 2000; 
Ahmed et al., 2004; Skelton et al., 2007) consequently established that the Dr of a PG 
decreased with a reduction in P2O5 or increase in CaO concentration. This behaviour was 
due to changes in the glass structure and improvements to the network strength from 
enhanced ionic cross-linking between the NBOs of different phosphate chains. This was 
attributed to the disruptive monovalent Na+ being replaced with divalent Ca2+ cations. 
Dissolution testing revealed that the PG Dr appeared to follow a linear decrease as the CaO 
concentration was raised but also that non-linear trends existed when examining systematic 
alternations to the glass’s P2O5 content that also affected its biocompatibility. Such non-
linear trends were also seen in its thermal properties and were proposed by Ahmed et al. 
(2004) to be associated with changes to the network packing density due to the presence of 
small Q1 pyrophosphate units in glasses with a 45 mol% P2O5 composition. However a 
general trend was reported over a set P2O5 content with elevated glass transition (Tg) and 
crystallisation (Tc) temperatures observed as the concentration of CaO was increased and 
the network was strengthened [173]. A comparison of PG Dr in different media by Franks et 
al. (2000) also showed that reductions in the Dr could be achieved using high ionic strength 
media such as Hank’s Balanced Salt Solution (HBBS) due to an ionic buffering effect [173-
176]
.  
The in vitro testing of PG compositions in this system using MG63 and HOS cell lines 
(Salih et al., 2000; Bitar et al., 2004; Skelton et al., 2007) examined the relationship 
between a glass’s Dr and its biocompatibility. The results obtained from the culture of cells 
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incubated in dissolution extracts or using direct contact cultures established that the Dr of a 
PG (and thus its composition) were critical to achieving biocompatible glasses. Correlating 
with previous data, the in vitro results showed that increases in the CaO content (mol%) 
produced samples with beneficial cell culture responses due to their reduced Dr. This effect 
was related to the associated ion release rates, pH changes and cell anchorage mechanisms 
(from the surface integrity) that influenced cell proliferation and expression of antigens 
like bone sialoprotein, osteonectin and fibronectin [160, 173-180].   
Consequently from the range of glass compositions investigated, the glass forming regions 
and compositional dependence of this system was mapped using 2D ternary diagrams 
(Figure 3.4.8). Such illustrations also highlighted the limitations in the glass forming 
region of the P2O5-CaO-Na2O system and potential Dr that are critical to achieving 
biocompatible glasses [176].  
 
 
 
 
 
 
3.4.6.2 Complex Compositions 
The addition and substitution of alternate MOs in more complex glass compositions has 
typically been based upon the introduction of cations with greater charge-to-size ratios than 
the previous P2O5-CaO-Na2O system. This has been in order to achieve glasses with an 
enhanced network strength (and consequently reduced dissolution rates) through the 
improved ionic cross-linking between phosphate groups/chains. Additionally the controlled 
release of specific MO cations from tailored PG compositions was anticipated to induce 
beneficial in vivo responses at the treatment site of the bone tissue defect (Table 3.4.3) [181-
183]
. Some example ternary and quaternary compositions incorporating alternative MOs 
based on the initial P2O5-CaO-Na2O system are shown in Table 3.4.4. 
Figure 3.4.8. 2D map of a) Glass forming region and b) Corresponding dissolution rates of 
phosphate glasses in the P2O5-CaO-Na2O system [Reproduced from Uo et al. (1998)]. 
a b 
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Table 3.4.3. Potential modifier cations for PG compositions aimed at bone tissue 
regeneration. 
Cation Biological Function/Role 
B3+ Role in bone growth - suspected to replicate effects of oestrogen [184] 
Mg2+ Stimulates bone formation, increase bone cell adhesion and stability [185, 186]. 
Zn2+ Stimulates bone formation, regulates transcription of osteoblast genes [185, 186].  
Sr2+ Beneficial to in vivo bone formation, possible treatment of osteoporosis [185, 186].  
 
Table 3.4.4. Ternary and quaternary glass compositions with alternative MOs suited for 
bone regenerative applications showing the molar tested by various authors. 
 
Author Composition 
Te
rn
ar
y 
Khor et al. (2011) [187] 
(P2O5)70-x(ZnO)30(MgO)x 
x: 0, 5, 8, 10, 13, 15, 18, 20 mol% 
Lucacel et al. (2012) [182] 
(P2O5·CaO)100-x-(ZnO)x 
x: 0, 0.1, 0.5, 1, 10, 50 mol% 
Qu
at
er
n
ar
y 
Knowles et al. (2001) [181] 
(P2O5)45-(CaO)x-(Na2O)55-x-y-(K2O)y 
x: 0→25, y : 20, 24, 28, 32 mol% 
Franks et al. (2002) [188] 
(P2O5)45-(CaO)32-x-(Na2O)23-(MgO)x 
x: 0→22 mol% 
Salih et al. (2007) [189] 
(P2O5)50-(CaO)40-x-(Na2O)10-(ZnO)x 
x: 0→20 mol% 
Abou Neel et al. (2009) [190] 
(P2O5)50-(CaO)30-(Na2O)20-x-(TiO2)x 
x: 0, 1, 3, 5 mol% 
Abou Neel et al. (2009) [191] 
(P2O5)50-(CaO)30-(Na2O)20-x-(Sr)x 
x: 0, 1, 3, 5 mol% 
Morikawa et al. (2013) [192] 
(P2O5)50-(CaO)45-x-(MgO)x-(TiO2)5 
x: 0→45 mol% 
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Alternative ternary glass compositions such as those assessed by Khor et al. (2011) were 
intended to generate PGs with improved durability due to the smaller atomic radii and 
larger charge-to-size ratios of Mg2+ and Zn2+ that could also provide an advantageous 
response in vivo (Table 3.4.3). The characterisation of PGs incorporating increasing 
amounts of MgO into ultra- and metaphosphate compositions showed decreases to the 
glass Dr. The increased durability was associated with the formation of more hydration 
resistant P-O-Mg-O-P bonds within the glass’s network structure compared to the existing 
P-O-P backbone. Additionally, Khor et al. (2011) highlighted how the lower basicity of the 
oxygen atoms in these P-O-Mg-O-P bonds (due to the higher charge-to-size ratio of the 
Mg2+ cation) would limit their attraction to the positive H+ ions of the H2O molecules. 
Hence as the MgO concentration (mol%) increased, glass compositions were developed 
that displayed Drs considered suitable for osteoblast cell adhesion and proliferation (0.3–
1.7×10-2 mg cm-2 hr-1) as suggested by Bitar et al. (2004) and Parsons et al. (2004). 
Dissolution testing in buffered media of different pH also suggested that the preferential 
leaching of Zn2+ ions from PG samples would occur when samples were degraded in acidic 
media - contrasting the typical congruent PG dissolution behaviour (section 3.4.4) [178, 187, 
193]
. Meanwhile Lucacel et al. (2012) found that the inclusion of ZnO caused an inhibitory 
effect to PG bioactivity due to the glass’s decreased dissolution rate [182].  
Investigations into more complex quaternary PG systems (Franks et al., 2002; Abou Neel 
et al., 2009; Lee et al., 2013) showed that greater concentrations of MgO and TiO2 resulted 
in increasing glass biocompatibility due to the formation of samples with reduced Drs. As 
previously reported, this decrease in glass dissolution rate was attributed to the inclusion of 
modifier cations with comparatively higher charge-to-size ratios. Studies by Lee et al. 
(2013) also demonstrated that the atomic weights and structural bond lengths of different 
MOs could also further manipulate a glass’s properties when developing new 
compositions. Meanwhile an analysis of glass bioactivity discussed the ability of Mg2+ ions 
to be beneficially substituted into apatite layers with Abou Neel et al. (2009) highlighting 
the potential of Ti4+ ions to improve the bioactivity of a PG. The reduced Dr and improved 
strength of the glasses structural networks was also reflected by shifts in the thermal 
properties. This was evident by the marked increase in the Tg and Tc in glasses with 
increasing concentrations (mol%) of either MgO or TiO2 due to the increased energy 
required to break the structural bonds in the glass network. Changes to the density of these 
PG compositions was also reported and related to the comparative atomic weights of the 
metal atoms in the substituted MOs (Table 3.4.1) [183, 188, 190, 194]. 
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Conversely the addition of increasing quantities of ZnO as a direct substitute for CaO in 
quaternary PG compositions (Salih et al., 2007; Abou Neel et al., 2008) produced glasses 
with gradually decreasing biocompatibility. These findings were linked to increases in the 
glass’s dissolution rate that subsequently led to the formation of an acidic pH environment 
over the dissolution period and the rapid release of Zn2+ ions to cytotoxic levels. 
Meanwhile localised surface pH effects were also considered to have lead to the poor 
biocompatibility observed in glass’s containing relatively low amounts of ZnO. Based on 
the thermal data obtained using DSC, the inclusion of increasing concentrations of ZnO 
resulted in a gradual decrease in the glasses Tg and Tc. This behaviour was attributed to a 
weaker glass network structure being generated as the concentration of ZnO increased due 
to the difference in bond strengths between the stronger Ca2+ and weaker Zn2+. This 
hypothesis would correlate with the observed thermal results but contradicts the previous 
literature and commonly accepted theories on PG structural modification via the inclusion 
of MOs with increasing charge-to-size ratios (Table 3.4.1) as discussed in section 3.4.3 and 
3.4.6.1. Regardless it was concluded that when using ZnO as a MO, the appropriate ion 
release rates of Zn2+ ions should be carefully considered [109, 189, 195].  
Increases to a glass’s dissolution rate were also observed in compositions incorporating 
K2O or SrO (Knowles et al., 2001; Marikani et al., 2008; Neel et al., 2009). These results 
could be clearly explained by the weaker glass structure stemming from the larger ionic 
radius of K+ or Sr2+ cations and its increased disruption to the glass network. The 
replacement of the Na+ with K+ also corresponded to an increase in the density and 
hardness of the glass. Additional factors on the behaviour of K2O containing PGs has been 
proposed by Knowles et al. (2001) relating to the occurrence of a mixed cation effect on 
the examined glass compositions. However no correlation between the influences of the 
mixed cation effect on a glass’s dissolution rate has yet been reported [181, 191, 196].  
The development of metaphosphate glasses with improved thermal stability via the 
substitution of CaO with MgO was examined by Morikawa et al. (2013) due to the 
difference in ionic radius and bond energy between Mg2+ and Ca2+. This improvement was 
also attributed to an increase in the number of glass components whilst it was suspected 
that mixed cation effects could be responsible for the non-linear trends observed in the 
glass’s thermal stability over different compositions. The effect of Mg2+ addition on the 
glass properties was also found to differ between meta- and invert glass compositions [192]. 
As shown by Morikawa et al. (2013), further flexibility in a glass’s Dr and thermal stability 
could be achieved from an increased number of MOs (see also section 3.4.3). This has 
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since led to the characterisation of more complex multicomponent glasses such as those 
formed from quinternary and septernary glass systems [145, 197].  
Glasses of a (P2O5)45-(CaO)(30-x)-(Na2O)20-(CoO)x-(TiO2)5 (x: 0, 5, 10, 15 mol%) 
composition were investigated by Lee et al. (2013) who examined the potential structural 
and biological advantages from the incorporation and controlled release of cobalt (Co). Yet 
early investigations showed that despite a reduction in the glass’s Dr with increasing Co 
concentration (mol%), the growth of MG63 cells on samples containing 15 mol% Co 
appeared to be inhibited. These results subsequently highlighted the need for further 
optimisation in this glass system and tailoring of ion release rates in order to achieve the 
desired cellular response. Evidence of a possible enhancement to the glass’s thermal 
stability was also apparent by the relative increase in the crystallisation onset temperature 
(Toc) [145]. The analysis of glasses by Novajra et al. (2011) that substituted K2O with 
increasing quantities of TiO2 in a (P2O5)50-(CaO)30-(Na2O)9-(SiO2)3-(MgO)3-(K2O)(5-x)-
(TiO2)x (x: 0, 2.5, 5 mol%) system have also been investigated. These results were found to 
correlate with previous data that introduced cations of increasing charge-to-size ratios 
(Franks et al., 2002; Abou Neel et al., 2009) [188, 190, 197]. 
Meanwhile Weiss et al. (2014) investigated the substitution of Na2O with TiO2 or MgO 
into a P2O5-CaO-Na2O-SrO glass to develop quinternary compositions with improved 
durability. Characterisation of these samples found that improved durability, thermal 
stability and mechanical properties were obtained from the incorporation of either 5 mol% 
TiO2 or MgO. The expected change in glass properties was associated with an increase to 
the network’s strength due to the advantageous properties of either Mg2+ or Ti4+ ions and 
their higher bonding energy (394.3 kJ mol-1 and 662.2 kJ mol-1 respectively) compared to 
Na+ (257.2 kJ mol-1).  A direct comparison between the effects of MgO and TiO2 on the 
PG properties also showed that the incorporation of 5 mol% TiO2 generated samples with 
an increased density, hardness, fracture toughness and reduced Dr compared to MgO 
glass’s.  This was due to the greater bond energy and charge-to-size ratios of the Ti4+ ions 
that were able to act more readily as an intermediate oxide compared to Mg2+ ions [172]. 
However besides the stimulatory ions listed in Table 3.4.3, the inclusion of silver (Ag) in 
PG compositions has also been investigated for potential orthopaedic applications due to 
its broad antimicrobial properties against multi drug resistant bacterial strains. 
Consequently such studies have demonstrated how the inclusion of 5 mol% Ag into a glass 
system can severely limit the attachment and growth of bacteria [198, 199]. 
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3.4.7 Phosphate Glass Fibres 
3.4.7.1 Bulk vs. Fibre Properties 
Owing to the difference in thermal and mechanical pre-history incurred during 
manufacturing, the structure and properties of phosphate glass fibres (PGFs) can deviate 
significantly from bulk monoliths of an identical PG composition. This relates to the 
frozen-in anisotropy of the phosphate chain network parallel to the fibres primary axis as a 
result of the mechanical drawing stress and rapid quenching (10-2 - 10-3 seconds) 
commonly experienced during manufacturing. The resulting change in internal structure is 
typically reflected by the fibres increased tensile modulus whilst the tensile strength is 
representative of the fibre surface quality [109, 160, 200, 201].  
 
3.4.7.2 Fibre Manufacturing 
Continuous PGFs have conventionally been manufactured from a melt spinning technique 
where droplets are drawn down directly through a nozzle from a temperature adjusted glass 
melt under the influence of gravity and hydrostatic pressure. These drops are then 
attenuated by mechanical tension and collected around a rotating drum (Figure 3.4.9a). 
Furthermore by altering the manufacturing conditions such as the glass melt viscosity, 
hydrostatic pressure, bushing nozzle diameter and drum speed (rpm), the glass fibre 
diameter and fibre-to-fibre spacing can be controlled. Alternative methods such as 
downdrawing from solid preforms and updrawing configurations have been also been 
developed for fibre production (Figure 3.4.9b,c) but suffer from poor efficiencies 
compared to melt spinning techniques [109, 160, 202, 203]. 
 
 
 
 
 
 
 
Figure 3.4.9. Representation of a) Melt spinning b) Solid pre-form downdrawing and c) 
Fibre updrawing techniques employed in PGF production [Reproduced from Wallenberger, 
(2010)]. 
a b c 
a a a 
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However not all glass compositions are suitable for fibrillation and the ability to form 
PGFs are dependent upon achieving a glass melt of suitable viscosity (typically between 
103 – 106 Pa·s) without crystallisation of the glass occurring. This crystallisation is 
undesired due to its ability to prevent fibre drawing, reduce fibre mechanical properties and 
limit fibre bioactivity. Consequently the ease of forming fibres has typically been dictated 
by a glass composition’s processing window (PW) that is reflective of its thermal stability 
and is defined as the temperature range between the Tg and Toc with PW values of >100°C 
preferred for fibre drawing
  
[109]
.  
 
3.4.7.3 Biomedical Applications 
PGFs have gained attention for a range of potential biomedical applications with particular 
interest in the regeneration of soft tissues (e.g. muscle and ligament), nerve repair and 
biosensors due to their suitable chemistry and morphology. Such studies include those by 
Ahmed et al. (2004) who examined the potential of iron doped PGFs in a (P2O5)-(CaO)-
(Na2O)-(Fe2O3) system as cell delivery vehicles for treating muscular diseases. Similar cell 
seeding and transplantation constructs were also investigated by Bitar et al. (2004) on a 
(P2O5)50-(Na2O)(4-y)-(CaO)46-(Fe2O3)y (y: 0, 1, 2, 3, 4 mol%) composition for repairing the 
bone-ligament interface through the co-culture of osteoblast and fibroblasts cell types. 
However PGF have also gained considerable interest as degradable composite reinforcing 
agents in novel bone fracture fixation plates, pins or screws [178, 194, 204].  
The development and systematic characterisation of Ø8-40µm fibres based on the 
previously proven biocompatible ternary P2O5-CaO-Na2O glass system was examined by 
Ahmed et al. (2004) for any compositional dependence on the processability of PGFs. The 
analysis of compositions with varying P2O5 and CaO concentrations showed that fibres 
could not be manufactured from ternary polyphosphate glasses of ≤45 mol% P2O5. This 
was attributed to the low P2O5 content of the glass and its resulting short-chained network 
structure that upon heating, produced melts of unsuitably low viscosity with a tendency 
towards crystallisation. Compositional influences from the substitution of Na2O with 
increasing amounts of CaO displayed the expected increase in glass Tg and decrease in 
dissolution rate, confirming the same compositionally dependant properties in the fibres as 
previously reported for bulk samples (Uo et al., 1998; Franks et al., 2000). Further 
examination on the dependence of PGF manufacturing conditions showed the expected 
decrease in fibre diameter with increasing pulling speed (i.e. drum rpm) whilst glass 
composition was found to have no influence on the resulting fibre diameter. A comparison 
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between bulk and fibre forms of identical glass compositions also showed that fibres 
displayed a higher Dr and Tg compared to their bulk equivalent which was attributed to 
surface area effects and difference in thermal history [174, 176, 205]. 
In contrast, dissolution studies by Patel & Knowles (2006) examined the effects of SiO2 
addition into a quinternary PGF (P2O5)50-(CaO)30-(Na2O)(15-x)-(Fe2O3)5-(SiO2)x (x: 0, 1, 3, 
5 mol%) composition in order to accelerate the Dr without substantially altering the 
dissolution media pH. Dissolution testing subsequently confirmed the increased Dr in 
glasses containing 5 mol% SiO2 whilst it appeared that the pH changes produced by PGF 
dissolution were suitably buffered by the cell culture media. This was coupled with a 
general trend of increasing the glass’s thermal properties (Tg, Tc) as the SiO2 concentration 
increased [206]. 
Further dissolution studies on the effects of aqueous aging to the mechanical properties and 
real-time dissolution mechanisms of PGFs were examined by Cozien-Cazuc et al. (2008, 
2009) on a (P2O5)40-(Na2O)20-(CaO)16-(MgO)24 (mol%) composition. Initial tensile testing 
of Ø10-40µm fibres prior to degradation showed that the annealing of fibres decreased the 
tensile strength from 484 MPa to 288 MPa. It was proposed that this was related to the 
development of a tensile surface layer containing shallow surface defects across the fibres 
that acted as initiators for fibre failure following Griffiths theory of brittle fracture. 
However the annealing process also showed an apparent increase in the tensile modulus 
from 44 GPa to 52 GPa. Mechanical testing of degraded fibres found that the modulus of 
as-prepared and annealed samples remained unchanged during immersion whilst the tensile 
strength of annealed fibres appeared to improve over time [201, 207].  
Data collected from each sample set consequently demonstrated that the annealing of PGFs 
could provide significant improvements to maintaining the mechanical properties of fibres 
compared to the application of a 1 wt.% 3-aminopropyltrioxyethyl (APS) sizing agent [207]. 
This was evident by the results which showed that the use of a sizing agent failed to 
significantly retard the PGF Dr due to the leaching of the sizing agent into the surrounding 
media. However it was predicted that different preparation techniques or an alternative 
choice of surface treatment could successfully enhance PGF durability. In contrast the 
reduced Dr of annealed fibre samples was coupled with smooth fibre topographies 
compared to the pitting corrosion observed during the dissolution of as-prepared fibres [201, 
208]
. 
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Further characterisation and environmental aging on a range of quinternary compositions 
has been conducted to assess the suitability of several fibre systems for biomedical 
applications (Hasan et al., 2012; Haque et al., 2013; Sharmin et al., 2014). The testing of a 
(P2O5)40-(MgO)24-(CaO)16-(Na2O)16-(Fe2O3)4 (mol%) composition was examined by 
Haque et al. (2013) due to the previously reported advantages of Fe2O3 in improving glass 
durability by Ahmed et al. (2004). Tensile testing of these fibres showed that the filaments 
displayed tensile strengths of 250-300 MPa and a tensile modulus between 50-70 GPa [194, 
209-211]
.  
The analysis of (P2O5)40-(MgO)24-(CaO)16-(Na2O)(20-x)-(Fe2O3)x (x: 0, 2, 4 mol%) and 
(P2O5)(50-y)-(MgO)24-(CaO)16-(Na2O)y-(Fe2O3)4 (y: 0, 5, 7.5 mol%) PGF compositions were 
assessed by Hasan et al. (2012) (Figure 3.4.10). Similarly a (P2O5)-(Na2O)-(MgO)-(CaO)-
(B2O3) system incorporating B2O3 was examined by Sharmin et al. (2014) for meta- and 
polyphosphate glass fibre compositions. These modifier oxides were selected based on 
previous data (Ahmed et al., 2004; Sharmin et al., 2013) regarding their influence on 
improving sample durability, thermal stability and in vivo response [184, 194, 210, 211]. 
 
 
 
 
 
 
 
 
 
Both studies showed that the production of fibres could be achieved with compositions of 
40-45 mol% P2O5 in contrast to the limits previously observed in the ternary system 
examined by Ahmed et al. (2004). This was due to the higher chain lengths as a result of 
the increased number of glass components and ability of Fe2O3 or B2O3 to act as both a 
network former and modifier oxide (i.e. as an intermediate oxide). The formation of 
hydration resistant P-O-Fe-O-P or P-O-B-O-P bonds in the networks backbone and 
Figure 3.4.10. Images of PGF tows a) (P2O5)50-(CaO)16-(MgO)24-(Na2O)6-(Fe2O3)4
[Reproduced from Hasan et al. (2012)] and b) (P2O5)50-(CaO)40-(Na2O)5-(Fe2O3)5 fibres -
the change in colour was attributed to the composition of the glass [Reproduced from 
Ahmed et al. (2010)]. 
a b 
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enhanced ionic cross-link densities produced the expected trends by reducing the glass’s Dr 
and improving its PW. Enhanced tensile properties were also observed as the MO 
increased with tensile strengths as high as 1200 ± 146 MPa recorded by Sharmin et al. 
(2014). However it was also highlighted that compositions exhibiting very low Dr (1.8×10-
6
 g cm-2 hr-1) appeared to reduce the cellular activity compared to similar compositions 
with higher dissolution rates. It was therefore suggested that target specific glass Drs would 
be required for eliciting an advantageous cellular response according to the desired 
application (Hasan et al. 2012) [184, 205, 210, 211]. 
 
3.4.8 Phosphate Glass Fibre Composites  
Despite the range of material properties and biological responses elicited by PGs they 
remain unsuitable for load bearing applications due to their poor mechanical properties. 
Consequently numerous studies have examined the potential of incorporating PGFs into 
degradable polymers to produce resorbable bioactive fibre reinforced composite materials 
intended for replacing traditional metallic fracture fixation devices such as pins, plates, 
nails and screws (Felfel et al. 2013). This has been due to the advantages that a completely 
degradable fixation device presents in eliminating problems such as stress shielding and 
secondary revision surgery as discussed in section 3.2.2.2. The use of PGFs also allows for 
the degradation behaviour of these composites to be tailored for the treatment site and 
dictate the rate of load transfer to the remodelled tissue whilst simultaneously releasing 
stimulatory ions. Additionally PGFs possess advantages over alternative reinforcing 
materials such as those derived from natural origin (e.g. flax, hemp, jute, kenaf, abaca) that 
are considered to possess inconsistent dimensions and mechanical properties [212-214]. 
Accordingly the majority of studies have been aimed at developing PGF laminate 
composites via the compression moulding of fibre pre-pregs and polymer matrix sheets to 
generate materials with mechanical properties similar to those of cortical bone. However 
equally important is the rate at which these mechanical properties decline which, for a 
fracture fixation plate should aim to match the rate of bone formation whilst allowing the 
gradual transfer of loading to the native tissue as it strengthens over a 8-12 week period. 
As a result, investigations into various PGF compositions, fibre architectures, volume 
fractions and other composite modifications have been conducted with different polymer 
matrix materials [178, 215-221]. 
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Composites of 0.06Vf and 0.18Vf utilising a PCL matrix with binary (P2O5)50-(CaO)50 
(mol%) fibres were investigated by Ahmed et al. (2008) with as-prepared and annealed 
fibres. Mechanical testing of composites showed that no improvement to the flexural 
strength was observed from the reinforcement of PCL with PGFs. However an increase in 
the elastic modulus was observed in composites that increased from 0.5 GPa to a 
maximum of 2.4 GPa with 0.18Vf that was within the range of trabecular bone. Higher Vf 
composites also saw greater ionic concentrations in the degradation media which were 
consistent with the relative amount of fibres in each composite configuration. Comparisons 
also indicated that the fibre volume fraction and surface area effects may dominate 
composite degradation behaviour [215].  
Further studies of polyphosphate (P2O5)35-(CaO)27.5-(MgO)9.5-(Na2O)22.5-(TiO2)5.5 (mol%) 
fibres were conducted by Brauer et al. (2008)
 
to assess the fracture behaviour and in vitro 
response of a reinforced organic methacrylate modified oligolactide composite. As 
expected, the incorporation of TiO2 was shown to improve the PW of the glass and allowed 
for the production of Ø=125µm glass fibres from the glass melt without crystallisation.  
The resulting composites were found to have similar mechanical properties to cortical bone 
whilst mechanical testing showed a fibrous fracture mode when tested in 3– or 4-point 
bending. This was regarded as the desirable failure mode for biomedical implants due to 
the possibly serious consequences that could result from the sudden failure of an implant. 
However SEM imaging at the composite fracture sites also showed evidence of sample 
delamination that indicated poor interlaminar bonding. The culture of composites with 
murine MC3T3-E1 cells showed that these materials also possessed suitable 
biocompatibility [211, 217, 221].  
The retention of mechanical properties and biocompatibility of PGF-PLA composites was 
examined by Ahmed et al. (2009) who characterised samples using a (P2O5)50-(CaO)40-
(Na2O)5-(Fe2O3)5 (mol%) composition of as-prepared or annealed fibres. Composites were 
generated by the incorporation of 10mm length non-woven fibres (Ø=20-25µm) into a 
PLA matrix at a 0.14 fibre volume fraction (Vf). As expected, the inclusion of PGFs 
increased the modulus and flexural strength of the PLA from 2.5 to 5GPa and 50 to 90MPa 
respectively. However the degradation of samples in deionised water at 37°C showed that 
the mechanical properties were reduced by ≈50% after 6.5 weeks. This degradation was 
coupled with an increased weight loss (Figure 3.4.11) as well as a decrease in media pH 
(≈4) from the dissolution of the reinforcing fibres and formation of phosphoric acid 
(H3PO4) that was believed to have accelerated the PGF Dr through autocatalysis effects. 
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Comparisons with annealed PGF composites found these samples to exhibit similar initial 
mechanical properties whilst the degradation results showed these samples to possess an 
improved degree of mechanical property retention due to the reduced PGF Dr [218]. 
 
 
 
 
 
 
 
The culture of MG63 cells on both composite configurations also showed that the reduced 
Dr of the annealed fibres produced samples with improved biocompatibility compared to 
as-prepared fibre composites. However despite the improved cellular response, the 
mechanical properties of all samples remained below those of cortical bone which was 
attributed to the relatively low composite Vf [201, 207, 218]. Interestingly a polyphosphate 
(P2O5)40-(MgO)24-(CaO)16-(Na2O)16-(Fe2O3)4 (mol%) fibre composite investigated by 
Felfel et al. (2012) displayed improved durability which was attributed to the tighter 
packing structure of the phosphate chains in the polyphosphate glass structure. However 
the applicability of this composition as a composite reinforcing agent was hampered by its 
reported difficulty to manufacture continuous fibres without fracture compared to 
metaphosphate glasses [222]. 
Work on a (P2O5)50-(CaO)40-(Na2O)5-(Fe2O3)5 (mol%) PGF composition was performed by 
Ahmed et al. (2011) who investigated the influence of fibre architectures on the 
mechanical properties and degradation of PGF composite samples. The study also 
investigated higher composite fibre volume fractions to achieve samples with improved 
mechanical properties closer to those exhibited by cortical bone. Composites of 0.2Vf, 
0.3Vf and 0.4Vf were produced from chopped 10mm fibre length non-woven mats as well 
as 0.2Vf unidirectional (UD) and [0/90] cross-ply architectures. Mechanical testing of these 
samples showed the expected increase in flexural strength and elastic moduli with 
Figure 3.4.11. Weight loss of “as used” and annealed PGF-PLA composites (0.14Vf) over 
6.5 weeks of degradation in deionised water [Reproduced from Ahmed et al. (2009)]. 
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increasing fibre volume fraction that were found to be accurately predicted by the rule of 
mixtures. A comparison across different fibre architectures at 0.2Vf also showed that [0/90] 
composites possessed the lowest mechanical properties compared to the highest exhibited 
by the UD materials. This was due to the stress loads being more axially distributed along 
the fibre lengths in the UD continuous fibres with regards to the loading axis used during 
mechanical testing (section 3.2.3). However all composite materials showed a rapid 
decrease in both flexural strength and elastic modulus after 10-20 days of immersion in 
deionised water at 37°C with an acidic media formed (pH≈3.0) after 5 days of immersion 
[219]
.  
Long term, these degradation profiles subsequently showed that the acidic pH would 
gradually return towards initial values and reflected the near complete dissolution of the 
reinforcing PGFs. Further comparisons also revealed that the rate of water absorption and 
loss of mechanical properties occurred more rapidly in UD and [0/90] composites 
compared to chopped fibre samples. This was attributed to the relative ease at which water 
could wick along the continuous fibre architectures compared to the 10mm discontinuous 
fibres and demonstrated the influence of fibre architecture on the initial mechanical 
properties as well as those during sample degradation [219]. 
The characterisation of bulk monoliths and PGF-PCL composites using PG’s doped with 
SiO2 and Fe2O3 was evaluated by Mohammadi et al. (2012) over a range of (P2O5)50-
(CaO)40-(SiO2)10-x-(Fe2O3)x (x: 0, 5, 10 mol%) compositions. Comparisons using 10mm 
length, ≈10-20µm diameter PGF’s in a PCL matrix (0.18Vf) revealed that the ion release 
rates were greater in x=5 mol% composites compared to the equivalent bulk monoliths. 
This was believed to have resulted from the different surface area-to-volume ratios 
between the bulk glass and those found at the fibre-matrix interface of the composite. 
However further comparisons between glasses with increased hydrolytic stability (10 
mol% Fe2O3) showed that similar ion release profiles could be generated between bulk and 
composite samples. The incorporation of Fe2O3 was also shown to produce glasses with 
reduced surface polarity and surface energy which was attributed to the decreased 
concentration of hydroxyl groups (Si-OH) on the glass surface. The results consequently 
indicated that the ion release rates of PGF composites were dictated by the glass 
composition and were heavily influenced by the fibre-matrix interface [169].  
Meanwhile Han et al. (2013) showed that an increase in mechanical properties could be 
achieved from the use of multiple fibre mats compared to a single pre-preg lamina during 
compression moulding. This was due to the improved polymer infiltration when using 
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multiple fibre mats and quality of the fibre-matrix interface (section 3.2.3.1). The 
introduction of screw holes in different fibre architectures also showed that significantly 
greater surface damage was incurred in UD fibre composites compared to random and 
mixed (i.e. UD + random) composite fibre constructs [223]. 
 
3.4.9 Composite Modifications 
A review of various PGF-polymer composite studies has highlighted how various sample 
configurations can generate materials with a range of mechanical properties (e.g. 80–200 
MPa flexural strength and 5–25 GPa elastic moduli). However a common factor 
throughout these studies has been the inability of these materials to retain adequate 
mechanical properties over a prolonged immersion period due to the rapid dissolution of 
the reinforcing PGFs. These results have been attributed to the breakdown of the fibre-
matrix interface and has consequently led to a minimum PGF dissolution rate of 2×10-4 mg 
cm-2 hr-1 being identified by Hasan et al. (2012) in order to manufacture orthopaedic PGF 
composites with adequate mechanical properties during sample degradation [221, 224].  
As shown previously by Mohammadi et al. (2012), alterations to the PGF surface 
properties via compositional modifications can have significant effects on the quality of the 
fibre-matrix interfacial adhesion which is crucial for the efficient distribution of 
mechanical loading across the reinforcing phase. Alternatively chemical coupling agents 
have been applied to modify the PGF surfaces in order to improve the composite interfacial 
properties and introduce a degree of hydrophobicity at the interface [169, 220, 225].  
Due to the multitude of available coupling agents, a cross-examination of their 
effectiveness was investigated on Ø=9x2mm glass rods and fibres of a quinternary 
(P2O5)45-(CaO)16-(MgO)24-(Na2O)11-(Fe2O3)4  (mol%) composition (Haque et al., 2010; 
Hasan et al., 2013). These agents included 3-aminopropyl-triethoxysilane (APS), Glycerol 
2-phoshate disodium salt (GP), 3-phosphonopropionic acid (PPA), etidronic acid (EA), 
hexamethylene diisocyanate (HDI), amino phosphoric acid (APA) and sorbitol/sodium 
ended PLA oligomers (S/Na-PLA). Analysis of the treated samples showed that only APS, 
EA and HDI appeared to covalently bond to the glass surfaces whilst also being the only 
treatments that created hydrophobic surfaces. Furthermore it was found that increased 
concentrations of coupling agents did not directly reflect improvements to τb values of the 
fibre-matrix interface. Degradation testing of the treated rods showed reductions to the 
glasses Dr could be produced by HDI, APS, EA, Na-PLA and PPA coupling agents [220, 226]. 
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Meanwhile follow up biocompatibility studies by Hasan et al. (2013) showed that despite 
all treatments demonstrating adequate biocompatibility, poor cell responses were observed 
with the use of HDI or Na-PLA compared to APS, GP and EA treatments [227]. Further 
studies using APS, HDI and S-PLA coupling agents in a ≈0.2Vf UD PGF-PLA composite 
of a (P2O5)45-(CaO)16-(MgO)24-(Na2O)11-(Fe2O3)4 (mol%) composition using Ø=20µm 
fibres were evaluated by Hasan et al. (2013). Assessment and comparison of the treated 
fibre composite’s mechanical properties, degradation and biocompatibility showed that 
improved initial mechanical properties were achieved with APS and S-PLA treated fibres. 
A difference in water uptake and final mechanical properties compared to untreated control 
samples also confirmed that these coupling agents provided improvements to the 
composites mechanical properties during degradation [224].  Similar results were also found 
by Khan et al. (2011) using (P2O5)40-(CaO)16-(MgO)24-(Na2O)20 (mol%) APS silane treated 
fibres in a 0.1Vf PGF-PCL composite. The results indicated that glass surface reactions and 
the possible formation of a polysiloxane coating on the fibre surfaces were responsible for 
the decreased fibre dissolution rate found in treated fibre composites [228]. However other 
surface treatments have also been investigated such as those by Liu et al. (2013) on 
(P2O5)45-(CaO)16-(MgO)24-(Na2O)11-(Fe2O3)4 (mol%) fibres which were sputter coated with 
thin films of magnesium. This aimed at increasing the composite interfacial bonding by 
improving the mechanical interlock at the fibre-matrix interface [208]. However when 
incorporated into a PCL matrix (0.2Vf), the magnesium coated fibres (10mm random non-
woven) showed no statistically significant improvement to the initial composite 
mechanical properties [225]. 
Alternatively attempts at controlling the dissolution of (P2O5)51.04-(CaO)21.42-(Na2O)25.51-
(SiO2)2.03 (mol%) fibres in a methacrylate-modified oligolactide matrix were studied by 
Kobayashi et al. (2010) who incorporated 20 wt.% CaCO3 into a hybrid composite design. 
Mechanical characterisation of the composites showed that the inclusion of CaCO3 had a 
significant effect of the dissolution media pH whilst altering the failure behaviour of the 
composites from a ductile to brittle fracture mode. However, no mechanical testing or in 
vitro data was provided over the ten days of degradation to fully assess the composite 
performance after CaCO3 addition [229]. 
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4 Principles of the Technique Used 
4.1 Structural and Thermal Properties 
4.1.1 X-ray Diffraction (XRD) 
X-ray diffraction (XRD) is an analytical tool used to investigate a crystalline material’s 
atomic or molecular structure and is based on the scattering, interference and diffraction of 
a monochromatic incident X-ray radiation source by the samples internal atomic 
arrangement. From this concept, the structural characterisation of a material is achieved by 
the detection of diffraction peaks (i.e. constructive interference) at specific incident angles 
following Bragg’s Law (Eqn 4.1.1) as illustrated in Figure 4.1.1 [230-232].  
  
  2 
Eqn 4.1.1 
where n = an integer, λ = wavelength of incident X-ray, θ = angle of incident X-ray, d = 
spacing between planes in the atomic lattice  
 
 
 
 
 
 
 
 
 
 
From Eqn 4.1.1 it is apparent that for diffraction peaks to occur, the optical path difference 
between two scattered X-ray beams must be equal to a positive integer of the source 
wavelength (Figure 4.1.1). Hence by scanning across a range of 2θ angles, the 
Figure 4.1.1. Illustration of coherent X-ray beams striking a series of hkl lattice planes a 
distance dhkl apart in a crystalline material at an incident angle θ and the resultant optical 
path difference (2s) [Reproduced from Mittemeijer (2010) Fundamentals of Materials 
Science: The Microstructure-Property Relationship Using Metals as Model Systems]. 
125 
 
identification of all possible diffraction directions in a material lattice can be obtained with 
the results typically expressed as plots of 2θ against intensity. From this the fundamental 
properties of the crystalline state can be obtained through the use of a materials reference 
database (e.g. ICDD, International Centre for Diffraction Data) in conjunction with the 
detected diffraction peaks, measured intensities and calculated basal spacings [230, 231, 233]. 
 
4.1.2 Fourier Transform Infrared Spectroscopy (FTIR) 
Fourier transform infrared spectroscopy (FTIR) is a method of vibrational spectroscopy 
used to analyse a material’s molecular structure by the vibrational modes that occur from 
the absorption of an incident infrared (IR) radiation source.  
For a molecule to absorb IR light, a periodic change in the dipole moment (P) of the 
molecule must occur (in IR active molecules) with greater levels of polarity producing a 
more intense IR absorption [234]. However this absorption can only occur at specific 
resonant frequencies that are determined by the molecular structure, atomic masses and 
structural bonding within the material sample. For a simple covalently bonded diatomic 
molecule this natural vibrational mode can be represented by a spring model system 
(Figure 4.1.2) with its natural vibrational frequency (vm) described by Hooke’s law (Eqn 
4.1.2) [235].  
 
 
 
 
 
 
 
 
 
k 
m1 m2 
Figure 4.1.2. Representation of a covalent bond between two atoms of mass m1/m2 as a 
spring model system with spring stiffness k. 
1 2 
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Eqn 4.1.2 
where vm = frequency of vibration, k = force constant of bond strength and µ  = reduced 
mass of a diatomic molecule, m1 and m2 are atomic masses of atoms 1 and 2 respectively.  
 
However when analysing polyatomic molecules of different atomic masses, bond strengths 
and structures, a multitude of natural frequencies can exist in a material sample. These 
frequencies become even more complex when the molecules available degrees of freedom 
are considered which, for a molecule of n atoms, follows the 3n-6 and 3n-5 rule of thumb 
for non-linear and linear molecules respectively. For example, a simple linear diatomic 
carbon dioxide (CO2) molecule (n = 3) containing 4 rotational degrees of freedom (Figure 
4.1.3) is characterised by the vibrational frequencies outlined in Table 4.1.1 [234, 236, 237].  
 
 
 
 
 
 
 
 
 
 
Figure 4.1.3. Molecular vibrations from the available degrees of freedom found in a CO2
molecule when exposed across a range of mid-infrared radiation frequencies during FTIR. 
Symmetric  
Asymmetric  
Bending modes Stretching modes  
In/out plane of page 
In plane of page 
CO2 
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Table 4.1.1. Vibrational modes and corresponding frequencies of a CO2 molecule found 
from FTIR analysis [Data from Smith (2011) Fundamentals of Fourier Transform Infrared 
Spectroscopy, Second Edition]. 
Vibration Mode Frequency (Hz) Comment 
Symmetric stretching N/A IR inactive vibration 
Asymmetric stretching 7.05 × 1013  
Bending in/out plane of page 1.99 × 1013 Equivalent vibrations –  
same frequency Bending in plane of page 1.99 × 1013 
 
 
It is upon this basis that FTIR is capable of identifying a material sample through the 
absorption of mid-IR radiation corresponding to the sample’s natural molecular vibrations 
due to its specific molecular structure. These results are typically expressed as plots of IR 
absorbance against wavenumber where the incident radiations wavenumber is defined as 
the inverse of the signal wavelength. This relationship is described by Eqn 4.1.3 with a 
complete FTIR scan commonly expressed over the 4000-400cm-1 wavenumber range [234, 
238]
 .  
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Eqn 4.1.3 
where W = wavenumber, λ = wavelength, c = velocity of light and v = frequency   
 
From these plots, the characterisation of a material is typically conducted through the 
analysis of the identified functional group (4000-1000cm-1) and fingerprint regions 
(≈1000-400cm-1) of the spectrum in conjunction with the use of a reference spectrum 
database [234]. 
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4.1.3 Raman Spectroscopy 
Raman spectroscopy is an alternate form of vibrational spectroscopy that compliments 
FTIR by probing the molecular structure of a sample using the polarised scattering of 
monochromatic UV, visible or near infrared laser light. However compared to FTIR, the 
theory of Raman scattering is more complex and has been briefly summarised here with 
further insight available from the literature [239]. 
In Section 4.1.2 it was shown that a diatomic molecule will vibrate with a natural 
frequency vm and that in order for the molecule to absorb IR radiation a change in the 
dipole moment (P) of the molecule must occur. However Raman active molecules require a 
change in the polarity of the molecule to occur during its normal mode of vibration. 
Consequently the exposure of a Raman active sample to intense laser light of frequency 
(v0) alters the polarizability (α) of the molecule to induce an oscillating dipole moment (P) 
that scatters the incident light [240].  
This scattered light will consist of strong Rayleigh scattering (frequency v0) and weak 
Raman scattering (frequency v0 ± vm) which is used in Raman spectroscopy to measure the 
shift in incident frequency (Figure 4.1.4). Raman scattering can be represented by either 
the Stokes (v0-vm) or anti-Stokes (v0+vm) lines with an analysis of the Stokes shift 
considered the common convention due to its higher intensities [241]. These shifts are 
typically represented as a change in the incident wavenumber (Eqn 4.1.3) with the results 
plotted as a function of the signal intensity against Raman shift (wavenumber). From these 
plots the identification and concentration of a molecular species can be determined from its 
measured intensity with each peak corresponding to a specific Raman shift of the incident 
light source [242]. 
 
 
 
 
 
Figure 4.1.4. Scattering of an incident laser source (v0) by a sample and the resultant 
Rayleigh (v0) and Raman scattering (v0 ± vm) during Raman spectroscopy [Reproduced 
from Ferraro (2003) Introductory Raman Spectroscopy]. 
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4.1.4 Differential Scanning Calorimetry (DSC) 
During heating a solid state material will undergo phase transformations as the atoms and 
molecules gain energy and break down their structural bonds (e.g. solid to liquid phase 
transformation). Thermal analysis (TA) techniques consequently provide a method of 
accurately measuring and understanding the multiple phase transformations a material can 
undergo as it gains and loses energy [243]. 
Typically the TA of a material sample has been performed using differential thermal 
analysis (DTA) or differential scanning calorimetry (DSC) equipment in order to measure 
endothermic and exothermic events as a sample is heated and/or cooled. In both techniques 
a controlled thermal cycle is typically performed with an empty sample pan acting as an 
inert reference within the equipment’s heating cell. However DSC differentiates itself from 
DTA by its ability to provide quantitative data on a material’s thermal properties as a result 
of the data obtained [244, 245].  
DTA operates via the process of simultaneously heating a material sample and reference 
pan following a pre-programmed thermal cycle under a constant heat input (Q) in order to 
raise the temperature of the pans (∆T) following Eqn 4.1.4. This technique is suited to 
applications requiring extreme temperatures (~2400°C) or where greater flexibility in 
volume size or crucible form is needed with a classical DTA set up shown in Figure 4.1.5 
[244-246]
. 
  
∆T  QC& 
Eqn 4.1.4 
where ∆T = differential between initial and final material temperature, Q = thermal energy 
required to satisfy ∆T,  Cp = specific heat capacity of sample 
 
Consequently as both pans are heated, the resulting temperature differential (∆TDTA) 
between the material sample (Ts) and reference pan (Tr) are recorded with deviations 
representative of thermal events in which energy has either been absorbed (endothermic) or 
released by the sample (exothermic). These results are subsequently displayed as plots of 
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∆TDTA against Tr with the general convention that endothermic processes are shown in the 
negative direction [157, 246-248].  
 
 
 
 
 
  
 
 
 
Similar to DTA, a typical DSC unit comprises of a sample and reference pan that are 
simultaneously exposed to a controlled heating cycle. However unlike DTA, the design of 
a DSC system allows the temperature of each pan to be independently measured and 
controlled (Figure 4.1.5). This allows the instrument to account for the differences in 
thermal capacity (Cp) between the sample and reference pan to ensure both are heated at 
identical rates (dT/dt) by modulating the rate of energy supplied to each pan. DSC thus 
measures the difference in required heat flow rates (dQ/dt) needed to maintain both pans at 
an identical heating rate throughout the thermal cycle (Eqn 4.1.5) [243-246].  
 
'( 	 	C)*(  
Eqn 4.1.5 
where t = time 
 
Like DTA, the deviations in dQ/dt between the two pans represent the occurrence of 
thermal events as more or less thermal energy is supplied to the pans in order to 
accommodate for the absorption or release of energy during phase transformations and are 
a
Figure 4.1.5. Configuration of thermal analysis equipment a) Dual heating of sample (S) 
and reference (R) pans in DTA and b) Independently temperature controlled DSC set up of 
sample (S) and reference (R) pans [Reproduced from Brown (2001) Introduction to 
Thermal Analysis: Techniques and Applications]. 
b
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plotted against Tr. A schematic of an idealised DSC thermogram for a glassy material is 
shown in Figure 4.1.6 and shows the glass transition (Tg), crystallisation onset (Toc), 
crystallisation peak (Tp) and liquidus temperatures (Tlq) [109, 243]. The liquidus temperature 
is defined as the temperature at which thermodynamic equilibrium is achieved between the 
solid and liquid phases in the glass and crystal formation is unstable [249]. 
 
  
 
 
 
 
 
 
4.2 Microhardness Testing  
Microhardness testing is a widely used method of determining the hardness of a material 
by analysing an indent profile formed when a diamond indenter of specified dimensions is 
depressed onto a sample surface under a known load for a controlled duration. These 
indents can be performed using a Vickers or Knoop indenter and are assessed optically to 
measure the indent diagonals (d1/d2) in order to determine the indent area (Vickers) or 
projected area (Knoop). From this a microhardness value is calculated using the ratio of 
applied load to the indent area [11, 250, 251].  
 
 
 
 
Figure 4.1.6.  Idealised DSC thermogram curve for a glassy material with key thermal 
properties/events indicated [Reproduced from Jones & Clare (2012)]. 
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5 Characterisation of CorGlaes® Pure 107 Composition 
5.1 Outline 
Material testing was conducted in order to characterise the different properties of the 
CorGlaes® Pure 107 glass. 
The review of the literature has shown that the characterisation of glass formulations 
requires the analysis of various material properties using a diverse range of techniques 
relating to the interdisciplinary aspects of biomaterials science. Previous studies have often 
focused on a range of properties that have typically included its dissolution characteristics, 
in vitro biocompatibility and bioactivity as well as its structural/thermal properties [173, 174, 
179, 205, 210, 252]
. Table 5.1.1 presents an overview of the experimental techniques commonly 
employed in the characterisation of glass compositions intended for biomedical 
applications.  
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Table 5.1.1. Summary of techniques typically employed in the characterisation of glasses 
intended for bone tissue regenerative applications.  
Material Property Analysis Technique/Method 
Dissolution  Dissolution rate [173, 174, 179, 181, 187, 189, 190, 206, 210, 253, 254] 
Ion release  [173, 179, 187, 189, 190, 206, 253] 
Dissolution media pH  [173, 179, 181, 187, 189, 190, 206, 210, 253, 254] 
Thermal parameters Differential thermal analysis (DTA) [173, 189, 190, 206, 210, 253-256] 
Differential scanning calorimetry (DSC) [190, 253] 
Structural 
characterisation 
Nuclear magnetic resonance (NMR) [173, 190, 257] 
X-ray diffraction (XRD) [159, 173, 187, 190, 253-258] 
Energy dispersive X-ray (EDX) [210, 254] 
X-ray photoelectron spectroscopy (XPS) [190, 210] 
Raman spectroscopy [159, 258] 
Fourier transform infrared spectroscopy (FTIR) [159, 190, 210, 256] 
Bioactivity  Immersion in simulated body fluid (SBF) [159, 252, 255, 256] 
In vitro cell culture 
and biocompatibility 
 
Neutral red uptake (NRU) [210] 
MTT assay [177, 210, 259-261] 
Alkaline phosphate (AP) activity [210, 254, 259-261] 
Live/Dead® staining [195, 253] 
AlamarBlue® assay [176, 210, 254] 
Density Archimedes principle [190, 210, 253] 
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5.2 Materials and Methods 
5.2.1 CorGlaes® Pure 107 Phosphate Glass Manufacturing 
 
5.2.1.1 Bulk Monoliths 
CorGlaes® Pure 107 monoliths were prepared using a melt quench technique by placing 
the designated precursor materials at specific weights inside a silica crucible. This was then 
heated to 1050°C and held for 120 minutes to form a homogenous melt. The molten 
CorGlaes® Pure 107 glass was then cast across a steel plate and allowed to cool before the 
resulting glass monolith was broken into fragments and stored inside polyethylene (PE) 
bags. This material preparation was performed by Giltech Ltd. 
 
5.2.1.2 Annealed Disks 
For characterisation of the CorGlaes® Pure 107 composition, Ø15x2mm melt quenched 
disks were produced by manually pressing a small pool of the remelted CorGlaes® Pure 
107 cullet inside a custom profiled graphite mould. The disks were then subjected to an 
annealing cycle by being placed inside a 420°C preheated oven which was then raised to 
465°C at 5°C min-1 and held at this temperature for 60 minutes. Samples were then 
subsequently cooled to room temperature at 1°C min-1 to complete the annealing process. 
This material preparation was performed by Giltech Ltd. 
 
5.2.1.3 Powder Samples 
CorGlaes® Pure 107 powder samples were generated by feeding glass fragments into a 
Hosokawa ACM10 hammer mill grinder (Hosokawa Micron, UK) which were 
comminuted under pre-set speed and airflow conditions to produce ≈15µm particles. 
Powder samples were stored without any further annealing stages inside PE bags. This 
material preparation was performed by Giltech Ltd. 
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5.2.2 XRD 
The CorGlaes® Pure 107 phosphate glass structure was characterised by XRD on powder 
samples using a D5000 X-ray diffractometer (Siemens AG, Germany) and monochromatic 
Cu Kα radiation (1.5418Å). The analysis was performed at a scanning step rate of 0.02° 
over 2θ	values from 5 to 85°. XRD was performed at the School of Chemistry, University 
of Glasgow by Mr Andrew Monaghan. 
 
5.2.3 FTIR  
FTIR spectra were recorded using a Spectrum One FT-IR Spectrometer (PerkinElmer, 
USA) on CorGlaes® Pure 107 powder samples. The production of KBr disks typically used 
in the preparation of FTIR samples was omitted due to the Attenuated Total Reflectance 
(ATR) accessory attached to the FTIR equipment.  Scans were obtained in absorbance 
mode across the 4000–400cm-1 wavenumber range at a resolution of 8cm-1 with 16 scans 
performed per spectra and analysed using the equipment’s Spectrum® software 
(PerkinElmer, USA). FTIR was performed at the Centre for Textile Conservation, 
University of Glasgow. 
 
5.2.4 DSC 
Thermal analysis of the CorGlaes® Pure 107 glass was evaluated by differential scanning 
calorimetry (DSC) using a STA 449 F1 Jupiter® - Simultaneous TGA-DSC equipment 
(Netzsch, Germany) on crushed glass monolith fragments (<3mm). The DSC was 
performed by heating samples to 1200°C at 10 °C min-1 inside an inert nitrogen 
atmosphere before cooling at 30°C min-1 with air as the purge gas. Phase transformation 
temperatures were then analysed by the instrument’s Proteus® software (Netzsch, 
Germany) and Eqn 5.2.1 used to determine the glass’s processing window (PW). As 
discussed in section 3.4.7.2, the PW (Figure 4.1.6) is believed to reflect a glass’s thermal 
stability (i.e. its tendency towards crystallisation) and due to its consistency in the literature 
was selected over alternative models such as the Hruby criterion [109, 120, 262]. DSC was 
performed by Dr Fiona Sillars at the Advanced Materials Research Laboratory (AMRL), 
University of Strathclyde.  
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Eqn 5.2.1 
where PW = processing window (°C), Toc = glass crystallisation onset temperature (°C) and 
Tg = glass transition temperature (°C).  
 
5.2.5 Density 
The density of the CorGlaes® Pure 107 phosphate glass was determined using Archimedes 
principle by recording the weight of a disk sample in air (wa) and whilst suspended within 
a suitable media (ws) of known density (ρL). Measurements were carried out in triplicate on 
three glass disks (n = 3) using distilled water as the immersion media and the sample 
density calculated by Eqn 5.2.2 [157]. Data was collected using a ±0.1mg, Pioneer™ 
analytical balance (Ohaus, USA) with an attached density measurement kit.  
 
.  /0 ∗ .1/0 	/2 
Eqn 5.2.2 
where ρ = sample density (g cm-3), ρL = immersion media density (g cm-3), w = sample 
weight in air (g) and ws = sample weight suspended in media (g).   
 
5.2.6 Flexural Strength and Elastic Modulus  
Mechanical testing of the CorGlaes® Pure 107 phosphate glass had been previously 
assessed by The Welding Institute (Cambridge, UK) following a 4-point bend method 
according to ASTM C158-02 using an Instron 5567 B723 (Instron, USA). Samples (n = 
24) were tested at a cross-head speed of 0.5 mm min-1 using a 30kN load cell with the data 
used to calculate the glass’s flexural strength and elastic modulus [263, 264]. This data was 
provided by Giltech Ltd. 
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5.2.7 Microhardness Testing  
 
5.2.7.1 Sample Preparation 
CorGlaes® Pure 107 disks were prepared by being ground down with WS Flex 18C silica 
carbide paper (Hermes Abrasives, Germany) over a range of grades (P240-1200 grit) using 
a Metaserv® universal polisher (Buehler, USA) with distilled water applied as a cooling 
agent. Disks were then polished using MetaDi® Supreme diamond polishing compounds 
(Buehler, USA) of decreasing particle size (15→ 6→1 µm) and finally cleaned in an Ultra 
8000 ultrasonic bath (James Products Limited, UK) for three minutes. To ensure adequate 
surface quality prior to testing, the polished sample surfaces were visually inspected by an 
Eclipse ME600 optical microscope (Nikon, Japan).  
 
5.2.7.2 Hardness and Fracture Toughness 
Microhardness testing of CorGlaes® Pure 107 disks was performed using a Vickers 
microhardness indenter due to the reduced sensitivity of the Vickers technique to the initial 
sample surface conditions [11, 250]. Microhardness testing on polished disks was conducted 
with a 300g indentation load using a Wilson Wolpert Micro-Vickers 401MVA (Buehler, 
USA) at an indentation dwell time of five seconds. This indentation load was selected 
based on previous Vickers hardness testing by Clément et al. (1999) and was performed 
under atmospheric conditions at ambient temperature with five microhardness tests each 
performed on three disk samples (n = 3) [265]. The resulting indent diagonals (d1/d2) were 
then measured using the optical microscopy equipment attached to the testing unit and a 
Vickers hardness value calculated from Eqn 5.2.3 [266].  
  
34 	1.854	 ∗ 
  
Eqn 5.2.3 
Where HV = Vickers hardness (HV), P = indentation load (kg), d = average indent diagonal 
length (mm). 
Vickers hardness (HV) was converted to GPa using a 0.009807 conversion factor [267]. 
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From the microhardness testing, the fracture toughness of the CorGlaes® Pure 107 
composition was also determined using the radial crack lengths (c) emanating from the 
indent depressions of each Vickers microhardness test (Figure 5.2.1) using Eqn 5.2.4 [266, 
268]
. 
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Eqn 5.2.4 
where KIC = fracture toughness (MPa m1/2), E = elastic modulus (GPa), H = sample 
hardness (GPa), P = indentation load (mN), c = average indent crack length (µm), δ = non-
dimensional indenter geometry constant, 0.016 ± 0.004 for radial median cracks resulting 
from Vickers indentation [266, 269]. 
 
5.2.8 Dissolution  
 
5.2.8.1 Dissolution Rate 
Dissolution studies on the CorGlaes® Pure 107 glass were performed on three glass disks 
(n = 3) using distilled water at a 0.18 cm2 ml-1 surface area-to-volume ratio (SA:V) and 
stored individually inside polystyrene universal tubes within a 37°C incubator for 1008 
Figure 5.2.1. Illustration of radial crack lengths (c) emanating from the Vickers indent on a 
material sample surface [Reproduced from Bhushan (1998) Handbook of Micro/Nano 
Tribology]. 
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hours (six weeks). Due to its frequent use in the literature, this experimental configuration 
was selected over a dynamic flow system such as that used by Rinehart et al. (1999) or 
Giltech Ltd [270]. 
During immersion, samples were periodically removed, dried and weighed (±0.1mg 
Pioneer™ analytical balance - Ohaus, USA) along with measurements of the dissolution 
media pH (HI 221 pH Meter - Hanna Instruments, USA) as outlined in Table 5.2.1. The 
samples were then returned to fresh media until the next measurement point. 
 
Table 5.2.1. Data collection and media replacement during 1008 hour dissolution of 
CorGlaes® Pure 107 disks in distilled water at 37°C. 
Immersion Period (hours) Data Measurement Points/Media Change 
0, 24, 48, 72, 96, 120, 144, 
168 [1 week] 
Sample weight 
Media pH 
At each immersion period, media 
replaced after each measurement.   
168, 336, 504, 672, 840, 
1008 [6 weeks] 
Sample weight 
Media pH 
At each immersion period, media 
replaced at each measurement and 
every 72 to 96 hours between 
measurements. 
 
 
Collected weight data was then analysed using Eqn 5.2.5 and plotted against the 
dissolution period (hours) with the addition of a linear trendline describing the CorGlaes® 
Pure 107 dissolution rate in mg cm-2 hr-1 [145, 173, 183]. 
 
 CDℎ(	FG	HCI	J(	KICK	  	/+  /LM 	 
Eqn 5.2.5 
Where wo = initial sample weight (mg), wt = sample weight at time tx (mg) and A = sample 
surface area (cm2). 
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5.2.8.2 Ion Release  
Coordinating with the dissolution data in section 5.2.8.1, the ionic concentrations of the 
dissolution media were also measured from extracts obtained every 24 hours over the first 
168 hours of glass disk immersion (Table 5.2.1). These were measured for the Ca2+, Mg2+, 
Zn2+ and Na+ cations as well as the (PO4)3- anion corresponding to the CorGlaes® Pure 107 
composition (section 1.1.1).  
The Ca2+, Mg2+ and Zn2+ cation concentrations were assessed using an AAnaylst™ 400 
Atomic Absorption Spectrometer (Perkin Elmer, USA) at 422.7nm (Ca2+), 285.2nm (Mg2+) 
and 213.9nm (Zn2+) wavelengths with a nitrous oxide-acetylene flame used to compensate 
for phosphate interference. Sodium (Na+) concentration was determined by flame emission 
using a 410 Flame Photometer (Sherwood Scientific, UK).  
Orthophosphate anion concentration was measured using a Technicon AutoAnalyser (Seal 
Analytical, UK) that is comprised of a segmented flow system with an air bubble used to 
isolate samples. The (PO4)3- anion was used as an indicator for the different phosphate 
anions that could be released during glass dissolution (e.g. (P2O7)4-, (P3O9)3-, (P3O10)5-) 
similar to that performed by Skelton et al. (2007) and Khor et al. (2011). All 
daily/accumulative ionic concentrations were expressed in mg l-1 and plotted over the first 
168 hours of immersion for each ionic species [175, 187, 190]. Ion release was measured at the 
School of Chemistry, University of Glasgow by Mr Michael Beglan. 
 
5.2.9 Bioactivity  
The bioactivity of the CorGlaes® Pure 107 phosphate glass was assessed using a protein-
free acellular, simulated body fluid (SBF) in order to replicate the in vivo conditions at the 
laboratory scale [271]. 
 
5.2.9.1 Preparation of Simulated Body Fluid (SBF) 
For bioactivity testing of the CorGlaes® Pure 107 composition, corrected SBF (c-SBF) was 
initially prepared. Corrected SBF differentiates itself by accounting for the SO42- ion 
deficiency found in the original SBF-K9 formulation first developed by Kokubo et al. and 
used by Hench et al. as well as multiple other authors. The ionic constituents of these 
solutions are compared with human blood plasma in Table 5.2.2 [53, 271, 272]. 
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Table 5.2.2. Comparison of ionic concentrations between SBF-K9, c-SBF and human 
blood plasma [Reproduced from Kokubo et al. (2003)]. 
Ion SBF-K9 (mM) c-SBF (mM) Human Blood Plasma (mM) 
Na+ 142.0 142.0 142.0 
K+ 5.0 5.0 5.0 
Mg2+ 1.5 1.5 1.5 
Ca2+ 2.5 2.5 2.5 
Cl- 148.8 147.8 103.0 
HCO3- 4.2 4.2 27.0 
HPO42- 1.0 1.0 1.0 
SO42- 0 0.5 0.5 
 
 
The c-SBF was prepared by sequentially adding each reagent (Table 5.2.3) to a 
polypropylene (PP) bottle containing 750ml of distilled water which was maintained at 
37°C and vigorously agitated by magnetic stirring. Each reagent was only added after the 
previous had completely dissolved. All apparatus used (beakers, bottles, spatulas etc.) were 
cleaned prior to c-SBF preparation by rinsing with a dilute hydrochloric acid (HCL) 
solution and then washed consecutively with distilled water. After the addition of the final 
chemical reagent, the solution pH was buffered to 7.25 at 37°C using 1M HCl with further 
distilled water added to create a final solution volume of 1000ml [272].  
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Table 5.2.3. Reagent chemicals for preparing 1 litre of corrected simulated body fluid (c-
SBF) [Reproduced from Chavan et al. (2010)]. 
Stage Reagent Quantity (g) 
1 NaCl 7.996 
2 NaHCO3 0.350 
3 KCl 0.224 
4 K2HPO3·3H2O 0.228 
5 MgCl2·6H2O 0.305 
6 1M HCl 40ml 
7 CaCl2 0.278 
8 Na2SO4 0.071 
9 (CH2OH)3CNH2 6.057 
 
 
To check solution stability, 50ml of prepared c-SBF solution was placed in a cleaned PP 
bottle and stored inside an incubator at 37°C for 48 hours to ensure no spontaneous 
precipitation had occurred.  
 
5.2.9.2 c-SBF Immersion 
The bioactivity of CorGlaes® Pure 107 disks was assessed in triplicate (n = 3) by recording 
the initial sample weight (±0.1mg Pioneer™ analytical balance, Ohaus, USA) before 
individually immersing disks within c-SBF at a 0.1 cm2 ml-1 surface area-to-volume ratio 
inside cleaned PP bottles. Containers were placed inside an incubator at 37°C with the c-
SBF replaced every 72 hours. Samples were extracted after 24, 72, 120, 168 as well as 336 
hours (two weeks) of immersion and washed in acetone (VWR, USA) to halt any further 
surface reactions occurring before the samples were weighed again. Samples were then 
stored inside a desiccator unit for further analysis with any precipitate characterised 
following the flow chart described in Figure 5.2.2 with the weight loss of the glass disks in 
c-SBF calculated by Eqn 5.2.5. The media pH of the c-SBF was also recorded at each 
immersion period using a HI 221 pH Meter (Hanna Instruments, USA) with the weight 
loss and media pH plotted over the 336 hours of immersion [182, 273].  
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If a surface layer precipitate was found by FTIR, then Raman spectroscopy was to be 
performed using a LabRAM HR (Horiba Jobin Yvon, France) with a Ventus 532 laser 
(Ventus, USA) over a 1500-100cm-1 wavenumber range. Spectra were to be collected in 
triplicate (n = 3) from a 532.17nm laser line with a 10% OD objective and 600 grating over 
a 10 second accumulation period. Images of the CorGlaes® Pure 107 disk surfaces were 
also to be captured using a Sigma VP SEM (Carl Zeiss, Germany) in SE and BSE modes 
using a 20kV accelerating voltage. Raman spectroscopy and SEM was to be performed at 
the School of Chemistry and the School of Geographical and Earth Sciences, University of 
Glasgow respectively. 
 
5.2.10 Biocompatibility 
The procedures for biocompatibility testing and preparing precursor solutions for in vitro 
cell culture were conducted following the instructions and recipes at the Centre for Cell 
Engineering (CCE), University of Glasgow. 
Figure 5.2.2. Process flowchart of CorGlaes® Pure 107 disk bioactivity after immersion in 
c-SBF for 336 hours. 
No Bioactivity 
Exhibited 
No 
FTIR - Spectrum One FT-IR Spectrometer (PerkinElmer, USA), 4000-
400cm-1, 8cm-1 resolution, 16 scans  
Bioactivity   
Analysis 
*Surface Layer 
Formation? 
Yes 
Raman/SEM  
Bioactive Layer 
Characterised *Surface layer formation was indicated by a 
change in the FTIR spectrum over the 
immersion period. 
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Biocompatibility of the CorGlaes® Pure 107 composition was assessed from a combination 
of MTT assay and a Live/Dead® Cell Viability/Cytotoxicity Kit (Life Technologies, USA) 
on disk samples following the process flow chart shown in Figure 5.2.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.10.1 Cell Culture Precursor Solutions 
 
HEPES buffered saline solution 
HEPES saline solution is a zwitterionic chemical buffering agent and was prepared by 
adding the reagents outlined in Table 5.2.4 to 1000ml of distilled water. The pH of the 
resulting solution was then adjusted to 7.5 using 5M NaOH and dispensed in 100ml vials 
before being autoclaved and stored in a fridge at 4°C. 
 
No 
Cytotoxic 
Response?  
Yes 
Localised 
Cytotoxicity 
Cytotoxic Dissolution 
Products 
Yes 
MTT Assay of Dissolution Media Extracts 
Biocompatibility 
Analysis 
Cytotoxic MTT 
Response?  
No 
Live/Dead® Cell Viability Staining Of Cells 
Cultured On Samples 
Biocompatible  
Figure 5.2.3. Process flow chart for assessing the biocompatibility of CorGlaes® Pure 107 
disks using an MTT assay and a Live/Dead® cell staining kit. 
145 
 
Table 5.2.4. Reagents for preparing 1 litre of HEPES saline solution. 
Reagent Quantity 
Sodium chloride  8g 
Potassium chloride 0.4g 
d-glucose 1g 
HEPES (Sigma-Aldrich, USA) 2.38g 
0.5% phenol red 2ml 
 
 
Versene solution 
Versene is a chelating agent based on an ethylenediaminetraacetic acid (EDTA) solution 
and is used in conjunction with Trypsin to allow cells to be dissociated from the surface of 
a culture flask into a suspension. The Versene solution was prepared by adding the 
reagents outlined in Table 5.2.5 to 1000ml of distilled water and the pH adjusted to 7.5 
using 5M NaOH. The Versene solution was dispensed into 20ml vials, autoclaved and 
stored in a fridge at 4°C [274, 275]. 
 
Table 5.2.5. Reagents for preparing 1 litre of Versene solution. 
Reagent Quantity 
Sodium chloride 8g 
Potassium chloride 0.4g 
d-glucose 1g 
HEPES (Sigma-Aldrich, USA) 2.38g 
Ethylenediaminetraacetic acid (EDTA) 0.2g 
0.5% phenol red 2ml 
 
 
 
146 
 
Trypsin-Versene solution 
Trypsin is an enzyme used to remove cells from the surfaces of culture vessels by 
hydrolysing specific peptide bonds in the adhered cells and is combined with Versene in 
order to improve its activity. Trypsin-Versene solutions were prepared by adding 2ml of 
Trypsin (Sigma-Aldrich, USA) to 20ml of Versene under a laminar flow hood and were 
stored in a fridge at 4°C prior to use [274, 275]. 
 
Antibiotic mix  
In order to prevent the growth of contaminating bacteria during cell culture an antibiotic 
solution (AB) was prepared by mixing the reagents outlined in Table 5.2.6. The AB 
solution was then aliquoted into sterile 20ml glass vials and stored in a freezer at -20°C.  
 
Table 5.2.6. Reagents used in preparation of 262.5 ml of an antibiotic mix solution. 
Reagent Volume (ml) 
L-glutamine  150 
Penicillin-Streptomycin  100 
Fungizone® Antimycotic (Life Technologies, USA) 12.5 
 
 
Phosphate buffered saline 
Phosphate buffered saline (PBS) was prepared from PBS tablets (P4417, Sigma-Aldrich, 
USA) by dissolving one tablet in 200ml of deionised water to yield 0.01M phosphate 
buffer, 0.0027M potassium chloride and 0.137M sodium chloride (pH = 7.4). The resulting 
media was then sterilised by autoclaving and stored at ambient temperature. 
 
Cell culture medium  
As supplied Dulbecco’s Modified Eagles Medium (DMEM) (Sigma-Aldrich, USA) was 
received as a basal media containing various quantities of amino acids, salts, vitamins and 
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glucose, but lacked the essential proteins or growth promoting agents necessary for cell 
culture. For this media to be considered complete, further supplements were added to 
400ml of DMEM as outlined in Table 5.2.7. Supplements were added sequentially after 
passing through a Minisart 0.2µm syringe filter (Sartorius Stedim Biotech, Germany) with 
completed DMEM (CDMEM) divided into 25cm3 flasks and stored in a freezer at -20°C. 
 
Table 5.2.7. Supplements used to produce 565ml of completed Dulbecco’s Modified 
Eagles Medium (CDMEM). 
Reagent Volume (ml) 
DMEM 400 
Medium 199  100 
Foetal Bovine Serum (FBS) 50 
Antibiotic Mix (AB) [From Table 5.2.6] 10 
Sodium Pyruvate  5 
 
 
5.2.10.2 In Vitro Cell Culture and Cell Seeding 
For in vitro testing of the CorGlaes® Pure 107 composition, a human osteosarcoma derived 
cell line, MG63, was selected to perform preliminary biocompatibility testing due to its 
widely accepted role as an accurate model of osteoblastic behaviour and availability [177, 
178]
. The MG63 cell lines were cultured within 75cm3 flasks inside a 37°C humidified 
atmosphere incubator with 5% CO2 to maintain the required culture media pH.  
For sample cell seeding, the required media (Trypsin-Versene, HEPES, CDMEM) was 
heated to 37°C using a hot water bath and confluent cells dissociated from the culture flask 
by removing the CDMEM culture media, washing twice with HEPES saline solution then 
adding 5ml of the Trypsin-Versene solution for 90 seconds. The flask medium and 
dissociated cells were then transferred to a universal centrifuge tube containing 5ml of 
fresh CDMEM and centrifuged at 1400 rpm for four minutes to generate a cell pellet. The 
pellet was then re-suspended in 1ml of CDMEM with the specific cell concentration (cells 
ml-1) determined using a hemocytometer. 
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5.2.10.3 MTT Assay 
The MTT assay is a quantitative method of in vitro cytotoxicity testing based on the 
cleavage of a water soluble tetrazolium salt, (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-
tetrazolium bromide) by NADH- or NADPH-dependant dehydrogenases to generate 
insoluble blue formazan crystals. These crystals are subsequently solubilised by the 
introduction of a suitable organic solvent with the optical density (OD) of the resulting 
solution measured by spectrophotometry at a detection wavelength between 570nm and 
590nm. Since the cleavage of the tetrazolium salt (MTT) can only occur in respiring 
mitochondria, the optical density (i.e. absorbance) of the formazan solution can 
consequently be used as a means of accurately evaluating viable cells. Advantages of this 
technique include its ease, reproducibility and reported correlation between in vitro and in 
vivo results [276-279].   
 
MTT assay protocol 
The in vitro cytotoxicity of the CorGlaes® Pure 107 disk degradation by-products was 
evaluated following the MTT assay protocol outlined by BS EN 10993-5:2009. Glass disks 
were initially sterilised by immersing in a 70 vol% ethanol-water solution for one hour and 
sequentially rinsed three times in the ethanol solution before being washed twice with 
HEPES saline solution. Samples were then placed within a 12 well cell culture plate and 
allowed to degrade in CDMEM at a 1.25 cm2 ml-1 surface area-to-volume ratio inside a 5% 
CO2, 37°C incubator for 24 and 96 hours. Disks were degraded in triplicate (n = 3) for each 
immersion period with the extracted dissolution media diluted with CDMEM to 100, 50, 1, 
and 0.1 vol%. Positive and negative control media were prepared from CDMEM and a 1 
vol% Triton-X100 (Sigma-Aldrich, USA)/CDMEM solution respectively [280].   
For the MTT assay, MG63 cells were cultured in 100µl per well of CDMEM at a cell 
concentration of 1x105 cells ml-1 within a 96 well plate for 24 hours following a plate 
layout in accordance with BS EN 10993-5:2009 to evaluate each extract concentration in 
triplicate (n = 3). After 24 hours, the culture media was aspirated and replaced with the 
diluted extracts from the CorGlaes® Pure 107 disks alongside the control media and 
incubated for 24 hours before performing the MTT assay following the steps described in 
Table 5.2.8 [280].  
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Table 5.2.8. MTT assay of CorGlaes® Pure 107 disks dissolution extracts. 
Step Activity 
1 
Under a laminar flow hood, a 5mg ml-1 thiazolyl blue tetrazolium bromide 
(Sigma-Aldrich, USA) solution was prepared using sterile PBS to a total 
volume that ensured 100µl could be distributed in each sample well. 
2 
The cell culture media was removed and each sample well was rinsed with 
100µl of sterile PBS. 
3 
100µl of the thiazolyl blue tetrazolium bromide solution was added to each 
sample well before the plate was wrapped in foil and incubated for 60 minutes. 
4 
After incubation, the solution was removed and 100µl of dimethlysulfoxide 
(DMSO) (Sigma-Aldrich, USA) was added to each well. The culture plate was 
then transferred to a FLUOstar OPTIMA spectrophotometric plate reader 
(BMG LabTech, Germany) operating at a detection wavelength of 570nm. 
 
 
From the spectrophotometric results, the cell viability of each well corresponding to a 
specific CorGlaes® Pure 107 media extract concentration or control was assessed by Eqn 
5.2.6. The MTT data was then statistically analysed by two-way analysis of variance 
(ANOVA) using MS Excel (Microsoft, USA). 
 

CI!C(KDC	NCFF	OKPF(Q  100 ∗ 	STUVWXSTUVWY	
Eqn 5.2.6 
where OD570e = mean optical density measured for each dissolution extract (or control) and 
OD570b = mean optical density value of the positive control media. 
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5.2.10.4 Live/Dead® Staining 
The Live/Dead® Cell Viability/Cytotoxicity Kit (Life Technologies, USA) is a dye-based 
membrane integrity system of determining cell viability from the interactions of membrane 
permeable and membrane impermeable dyes with cells cultured on a sample surface.  
From the membrane impermeable ethidium homodimer-1 (EthD-1), dead cells can be 
determined from the dyes capacity to bind specifically with the nucleic acids of cells that 
no longer have intact membranes. The identification of these cells is then achieved by the 
red fluoresce of EthD-1 when viewed microscopically at excitation and emission 
wavelengths of 528-536nm and 617nm respectively. Conversely viable cells are evaluated 
through the membrane permeable calcein-AM which, upon entering the plasma membrane, 
is cleaved by intracellular esterase to fluoresce green under optical microscopy. Given that 
only cells with a functioning esterase enzyme are able to cleave calcein-AM it is 
preferentially selective to only fluoresce with viable (i.e. living) cells. The combination of 
calcein-AM with EthD-1 then serves as a simple method of simultaneously distinguishing 
between living and dead cells based on the observed fluorescent differentiation [96, 281-284]. 
 
Live/Dead® sample preparation 
The Live/Dead® staining kit was employed to assess the viability of cells cultured on 
CorGlaes® Pure 107 disks over 24, 96 and 168 hours of incubation.  Prior to cell culture 
the CorGlaes® Pure 107 disk samples were prepared by being quickly ground down and 
polished following the method described in section 5.2.7.1.  
 
Live/Dead® staining protocol 
For cell culture, polished disks were sterilised by immersing in a 70 vol% ethanol-water 
solution within a sterile laminar flow hood for sixty minutes. Samples were then rinsed a 
further three times with the 70 vol% ethanol-water solution and washed twice with HEPES 
saline solution. Sterile samples were then seeded in a 24-well plate at a cell concentration 
of 1x104 cells ml-1 at a surface area-to-volume ratio of 2.24 cm2 ml-1 (SA:V) and incubated 
within a 5% CO2, 37°C incubator unit. Samples were cultured in triplicate (n = 3) for 24, 
96 and 168 hours with Ø13x0.2mm Thermanox® coverslips (Thermo Fisher Scientific™, 
USA) employed as a positive control. During incubation, the cell culture media was 
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replaced after 96 hours and at each culture period a Live/Dead® viability stain was 
performed following the steps outlined in Table 5.2.9.  
 
Table 5.2.9. Steps describing the Live/Dead® stain of MG63 cells cultured on the surface 
of CorGlaes® Pure 107 disks. 
Step Activity 
1 Under sterile conditions a Live/Dead® stain was prepared by creating an EthD-
1, calcein-AM and CDMEM solution at a 1:1:1000 volume ratio respectively 
to a total volume that ensured 2ml could be distributed into each sample well. 
2 Under a laminar flow hood, the existing CDMEM in the culture plate was 
removed before introducing the Live/Dead® stain to each well and returning 
the culture plate to the incubator.  
3 Culture plates were then removed after thirty minutes and the staining media 
extracted before samples were inverted onto glass coverslips and transferred to 
a Axiovert 200M microscope (Carl Zeiss, Germany) for image capturing. 
 
 
The expected pH of the CDMEM at each culture period of the Live/Dead® stain was 
recorded by immersing separate CorGlaes® Pure 107 disks over the corresponding 
incubation period in acellular CDMEM at a 2.24 cm2 ml-1 SA:V ratio. The samples were 
stored in a 5% CO2 incubator at 37°C with the pH recorded using a HI 221 pH Meter 
(Hanna Instruments, USA)  at 24, 96 and 168 hours of immersion. This was compared with 
a blank, sample free CDMEM control that was stored under identical conditions. 
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5.3 Results 
 
5.3.1 XRD  
The XRD trace of the CorGlaes® Pure 107 composition (Figure 5.3.1) displays a clear 
absence of any defined crystallisation peaks over the 2θ = 5-85° range with a broad 
spectrum halo peak centred at 2θ ≈ 23°.  
 
5.3.2 FTIR  
FTIR traces of the CorGlaes® Pure 107 glass over the complete mid-infrared spectrum 
(4000-400cm-1) and 1400-400cm-1 region is shown in Figure 5.3.2. The position of these 
peaks was reflective of the CorGlaes® Pure 107 glass composition and based on the 
literature was assigned to the vibration of phosphate structural groups as listed in Table 
5.3.1. The peaks at 3466cm-1 and 1664cm-1 were associated with the presence of moisture 
and thus not included in Table 5.3.1.  
 
Figure 5.3.1 XRD trace of CorGlaes® Pure 107 composition of phosphate glass over 5-85°
2θ with no crystallisation peaks and a broad halo centred at 2θ ≈ 23°.  
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Figure 5.3.2. FTIR vibrational spectra of the CorGlaes® Pure 107 phosphate glass over a) 
The complete mid-IR range (4000-400cm-1) and b) The 1400-400cm-1 wavenumber range 
showing absorption peaks and shoulders corresponding to the glass’s structure with the 
wavenumber of identified spectral features labelled.  
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Table 5.3.1. Assignments of spectral features identified from the CorGlaes® Pure 107 FTIR 
spectrum over the 1400-400cm-1 wavenumber range to the corresponding phosphate 
structural features. 
Feature Wavenumber  Assignment 
Peak 1268cm-1 P=O [vas] associated with Q
3
 tetrahedra superposed 
with Q2 (PO2)-  [vas] [190, 191, 285, 286] 
Peak/Shoulder 1080cm-1  Q2 (PO2)- symmetric stretching [vs] [190, 191, 287] 
Peak 1014cm-1 (P-O-P) asymmetric stretching [vas]                        (small metaphosphate rings) [159, 288] 
Peak 908cm-1 (P-O-P) asymmetric stretching [vas] (chains) 
[159, 190, 191, 
285, 286]
 
Peak 770/737cm-1 (P-O-P) symmetric stretching [vs] (rings) [182, 190, 286, 287] 
Peak 448cm-1 Bending vibrations of bridging phosphorous δ(O-P-O) 
and/or δ(P=O) [288] 
 
 
5.3.3 DSC  
The thermogram obtained from <3mm fragments of the CorGlaes® Pure 107 phosphate 
glass is shown in Figure 5.3.3. This trace displays a clear endothermic glass transition (Tg) 
however further exothermic (i.e. crystallisation peak) or endothermic (i.e. liquidus) events 
are obscured and are not obvious in the thermogram beyond ≈860°C. The level of 
obscurity in the thermogram (i.e. the radical deviation in the baseline) was greater than any 
found in the literature and prevented the identification of the crystallisation peak (Tp) as 
well as the liquidus temperature (Tlq).  
This was believed to have arisen from influences to the testing equipment during the DSC 
thermal cycle and relates to nearby construction work that commenced mid-way through 
the DSC run. The resulting intense vibrations throughout the laboratory and testing 
equipment was then believed to have accounted for the clear Tg, but substantial deviation 
in the baseline after ≈860°C. Given the limited availability of the DSC equipment and 
relevance of the fibres to composite development, the thermal characterisation of this glass 
composition was repeated at a later date using CorGlaes® Pure 107 fibres. 
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Magnified sections of the DSC thermogram (Figure 5.3.4 and Figure 5.3.5) found the glass 
transition (Tg) and crystallisation onset (Toc) temperatures to be 436°C and 784°C 
respectively by the intersection of tangents overlaid across the endo- or exothermic events. 
From Eqn 5.2.1 the CorGlaes® Pure 107 processing window (PW) was determined to be 
348°C.  
 
 
 
 
 
 
 
 
 
Figure 5.3.3. DSC trace of the CorGlaes® Pure 107 phosphate glass over the pre-
programmed heating cycle with deviations in the baseline indicative of endo- and 
exothermic events. 
Figure 5.3.4. Magnified section of CorGlaes® Pure 107 DSC thermogram (Figure 5.3.3) 
showing the glass transition temperature at 436°C from the intersection of tangents. 
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5.3.4 Density  
The density of the CorGlaes® Pure 107 glass was determined to be 2.65 g cm-3 using 
Archimedes principle.  
 
5.3.5 Flexural Strength and Elastic Modulus 
The flexural strength and elastic modulus of the CorGlaes® Pure 107 glass was determined 
to be 64.29 ± 27.11 MPa and 33.62 ± 2.00 GPa respectively from the independent testing 
conducted by The Welding Institute (TWI) (Cambridge, UK). 
 
5.3.6 Hardness and Fracture Toughness  
The hardness and fracture toughness of the CorGlaes® Pure 107 glass using a 300g (2.94N) 
indentation load (Figure 5.3.6) were determined to be 3.98 ± 0.17 GPa and  
0.48 ± 0.05 MPa m1/2 respectively.  
 
 
 
 
Figure 5.3.5 Magnified DSC thermogram of CorGlaes® Pure 107 (Figure 5.3.3) showing 
the crystallisation onset temperature from the intersection of tangents. 
Toc (784°C) 
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Figure 5.3.6. Optical image of CorGlaes® Pure 107 disk surface after Vickers micro 
indentation with a 300g load showing an indent diagonal (d1) and crack length (c1) 
emanating from indent site [scale bar = 50µm]. 
c1 
d1 
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5.3.7 Dissolution  
5.3.7.1 Dissolution Rate 
The weight loss per unit area and media pH over the 1008 hour (six week) dissolution of 
CorGlaes® Pure 107 disks is shown in Figure 5.3.7. From an overlaid linear trendline 
passing through the origin the CorGlaes® Pure 107 dissolution rate was determined to be 
0.004 mg cm-2 hr-1.  
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Figure 5.3.7. a) Weight loss during dissolution of CorGlaes® Pure 107 disks immersed in 
distilled water at 37°C with the overlaid trendline plotted through the origin indicative of 
the glass’s dissolution rate and b) Extract pH of CorGlaes® Pure 107 disk dissolution 
media showing the formation of an acidic pH after 72 hours (standard deviation ≤ ± 0.34). 
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5.3.7.2 Ion Release 
The daily and accumulative ionic concentrations of Ca2+, Na+, Mg2+and Zn2+ cations 
corresponding to the modifier oxides of the CorGlaes® Pure 107 composition as well as the 
PO43- anion over the initial 168 hours of glass disk dissolution are shown in Figure 5.3.8.  
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Figure 5.3.8 a) Daily ionic concentrations and b) Accumulative ionic concentrations in the 
immersion media over the first 168 hours of CorGlaes® Pure 107 disk dissolution in
distilled water at 37°C.  
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5.3.8 Bioactivity 
The FTIR spectra of the CorGlaes® Pure 107 glass across the 1400-400cm-1 wavenumber 
range after the immersion of disk samples in c-SBF at 37°C for up to 336 hours is shown 
in Figure 5.3.9. The corresponding weight loss and media pH of the c-SBF over this period 
is shown in Figure 5.3.10. Due to the absence of a surface layer formation, Raman 
spectroscopy and SEM imaging were not performed. 
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Figure 5.3.9. FTIR of CorGlaes® Pure 107 disk surfaces after immersion in c-SBF at 37°C 
for 24, 72, 120, 168 and 336 hours.  
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Figure 5.3.10. a) Weight loss during the immersion of CorGlaes® Pure 107 disks in c-SBF 
at 0.1 cm2 ml-1 and b) Extract pH of c-SBF media during bioactivity analysis of CorGlaes®
Pure 107 disks (standard deviation ≤ ± 0.01). 
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5.3.9 Biocompatibility 
5.3.9.1 MTT Assay 
The viability of MG63 cells cultured for 24 hours in a range of CorGlaes® Pure 107 disk 
CDMEM extract concentrations collected after 24 and 96 hours of sample dissolution is 
compared with positive as well as negative control media in Figure 5.3.11.  The statistical 
analysis (ANOVA) of the results found no significant difference (p > 0.05) between the 
immersion period or extract concentrations with the positive controls. 
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Figure 5.3.11. Viability of MG63 cells cultured in CorGlaes® Pure 107 disk extract media 
over 24 and 96 hours of dissolution and evaluated by MTT assay after 24 hours of 
incubation at 0.1, 10, 50, 100 vol% extract concentrations. 
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5.3.9.2 Live/Dead® Staining 
Live/Dead® staining of MG63 cells seeded on Thermanox® coverslips and CorGlaes® Pure 
107 disks after 24, 96 and 168 hours of culture is shown in Figure 5.3.12 with the 
corresponding media pH shown in Figure 5.3.13.  
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Figure 5.3.12. Live/Dead® cell viability staining of Thermanox® coverslip controls (a-c) 
and CorGlaes® Pure 107 disks (d-l) showing reduced MG63 cell viability when cultured on 
CorGlaes® Pure 107 disks with increasing incubation period compared to the cell spreading 
observed on the positive controls (Thermanox®) [All scale bars = 10µm]. 
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Figure 5.3.13. Comparison of CDMEM pH over the corresponding incubation period for 
Live/Dead® cell cytotoxicity testing of CorGlaes® Pure 107 disks compared to a blank 
CDMEM control (standard deviations ≤ ± 0.01) - the media change at 96 hours 
corresponding to the cell culture protocol is also included. 
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5.4 Discussion  
Analysis of the CorGlaes® Pure 107 powder by XRD confirmed the amorphous structure 
of the glass due to the lack of any clear crystallisation peaks and was characteristic of the 
long range structural disorder found in glassy materials (section 3.4.3). The presence of a 
broad peak was in line with the literature and its location centred at 2θ ≈ 23° was believed 
to correspond with the dominant crystalline phase that could be formed from the 
CorGlaes® Pure 107 composition (Figure 5.4.1) [232]. The position and shift in the location 
of an amorphous halo in an XRD trace is also considered as an indication of the degree of 
compactness in a glass’s network [192]. 
 
 
 
 
 
 
 
 
The FTIR spectrum shown in Figure 5.3.2 was reflective of the CorGlaes® Pure 107 
composition but was believed to be a convolution of various overlapping Gaussian 
components that prevented the complete identification of all the phosphate structural 
groups. This band overlapping was likely due to the glass’s structural disorder from the 
presence of long P-O-P chains and rings in the Q2 structural units that would permit 
additional vibrational modes and account for the generally broad nature of the absorption 
peaks (Moustafa & El-Egili, 1998). Furthermore the assignment of wavenumber peaks to 
specific phosphate groups (i.e. Q3, Q2, Q1, Q0 units) is open to interpretation given the 
relative shifts in absorbance peaks produced between different glass compositions. This is 
due to changes in the structural features and bond strengths within the glass’s network 
from the effects of its modifier oxides (section 3.4.3). Consequently, the phosphate 
structural groups are typically categorised over a range of wavenumbers (Moustafa & 
Eglili, 1998) [288].  
Figure 5.4.1. Illustration comparing the XRD results between a crystalline and amorphous 
material of the same composition highlighting the correspondence of sharp and broad 
peaks between both results [Modified from Suryanarayana & Norton (1998)]. 
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From the results shown in Figure 5.3.2, the assignment of the absorption peaks to Q3 and 
Q2 phosphate groups (Table 5.3.1) based on the available literature appeared to confirm the 
ultraphosphate composition of the CorGlaes® Pure 107 glass. These assignments were also 
found to be in agreement with the generalised ranges described by Moustafa & Egili 
(1998) due to the vibration of Q2 P-O-P chain and ring type structures at 737cm-1, 770cm-1, 
908cm-1 and 1014cm-1. However the assignment of bands at 1014cm-1 is challenged by its 
association with Q3 P-O [vas] as reported by Lucacel et al. (2012) and thus despite agreeing 
with the consensus of data, some uncertainty remains in the current assignments. Further 
identification of the structural phosphate groups within the CorGlaes® Pure 107 
composition could be achieved through deconvolution of the FTIR spectrum to resolve the 
broad peaks as demonstrated in Figure 5.4.2  [159, 182, 288].  
 
 
 
 
 
 
 
 
 
 
The very broad but low intensity absorption peaks centred at ≈3466cm-1 and ≈1666cm-1 
(Figure 5.3.2) were assigned to the absorption of atmospheric moisture across the glass 
surface as previously reported by Moustafa & Egili (1998), Lucacel et al. (2009) and Kiani 
et al. (2012) [159, 288, 289]. 
From the DSC thermogram (Figure 5.3.3), the CorGlaes® Pure 107 composition was 
revealed to possess a larger processing window (PW) compared to Bioglass® 45S5 or 
alternate PGs intended for biomedical applications (Table 5.4.1) due to its significantly 
higher Toc. This parameter is closely related to the viscosity of the glass melt and was 
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Figure 5.4.2. FTIR spectra showing a) The deconvolution of a phosphate glass FTIR 
spectrum over the 1200-800cm-1 range and b) An equivalent FTIR spectrum of the 
CorGlaes® Pure 107 composition illustrating the potential for similar band overlapping 
[Reproduced from Lucacel et al. (2009)]. 
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considered to be a result of several contributing factors related to the CorGlaes® Pure 107 
composition that included its structural arrangement as well as the selection and number of 
the modifier oxides (MOs).  
 
Table 5.4.1. Comparison of the thermal properties and thermal processing windows (PWs) 
of different metaphosphate, polyphosphate and pyrophosphate glasses intended for 
biomedical applications.  
 Thermal events (°C) 
Material/Composition (mol%) Tg  Toc PW 
CorGlaes® Pure 107  436 784 348 
(P2O5)50-(CaO)33.75-(MgO)11.25-(TiO2)5 [192] 522 742 220 
Bioglass® 45S5 [109] 538 667 129 
(P2O5)50-(CaO)45-(TiO2)5 [192] 518 645 127 
(P2O5)50-(CaO)16-(MgO)24-(B2O3)10 [184] 552 669 117 
(P2O5)45-(CaO)16-(Na2O)5-(MgO)24-(B2O3)10 [184] 500 615 115 
(P2O5)30-(CaO)60-(TiO2)10 [192] 645 755 110 
(P2O5)50-(CaO)16-(Na2O)10-(MgO)24 [184] 452 538 86 
(P2O5)45-(CaO)16-(Na2O)15-(MgO)24 [184] 440 512 72 
 
 
Phosphate content (P2O5 mol%) was previously reported by Ahmed et al. (2004) to alter a 
glass’s thermal properties due to its effect on the structure and corresponding degree of 
disruption throughout the phosphate network. Accordingly ultraphosphate glasses are 
considered by Jones & Clare (2012) to possess a greater degree of thermal stability 
compared to meta- and polyphosphate compositions and correlates with the data shown in 
Table 5.4.1. This is due to the structure of ultraphosphate glasses consisting of a 3D 
phosphate network with the combined Q2 phosphate chains and ring type structures further 
impeding the glass’s reorganisation into an arranged crystalline state by becoming 
entangled and increasing the melt viscosity [109]. The quinternary composition of the 
CorGlaes® Pure 107 glass would also have likely supressed the onset of glass 
crystallisation by increasing the entropy of mixing and the subsequent energy barrier 
required for atomic rearrangement to form critical sized nuclei [109, 192, 205]. 
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Figure 5.4.3. Variation in thermal properties (Tg, Toc, PW) with the increasing substitution 
of a) Mg for Ca [Reproduced from  Morikawa et al. (2013)] or b) Sr  for Ca [Reproduced 
Jones & Clare (2012)] into phosphate glass compositions showing a clear difference 
between non-linear (i.e. mixed cation effects) and linear PW relationships respectively. 
a b 
The inclusion of network modifier cations into the CorGlaes® Pure 107 composition with 
sufficiently large charge-to-size ratios was also believed to have influenced the glass’s 
thermal stability. This is due to the expected strong ionic cross-linking in the phosphate 
network of the CorGlaes® Pure 107 structure from the inclusion of Mg2+, Zn2+ and Ca2+ 
cations and their respective charge-to-size ratios (0.0232, 0.0227 and 0.0175). The 
CorGlaes® Pure 107 network structure would then be more capable of suppressing the 
onset of crystallisation and would be in line with previous results (Ahmed et al., 2004; 
Khor et al., 2011; Jones & Clare, 2012; Morikawa et al., 2013). However, previous studies 
have also shown how increased network stability is associated with a higher Tg due to the 
increased energy required to break the structural bonds which contradicts the 
comparatively low Tg found in the CorGlaes® Pure 107 results (Table 5.4.1). Yet this could 
be accounted for by the general decrease in Tg found in ultraphosphate glasses compared to 
metaphosphate compositions as reported by Ahmed et al. (2004) [109, 173, 187, 192]. 
Based on previous metaphosphate glass compositions studied by Morikawa (2013), the 
large CorGlaes® Pure 107 PW could also be attributed to a mixed cation effect between the 
Mg2+ and Ca2+ ions (Figure 5.4.3). This is believed to be related to the difference in 
polarity of the glass’s chemical bonds as a result of the higher electronegativity of 
magnesium compared to calcium. If following this phenomenon, glasses would possess Tg 
and Toc values that followed non-linear trends and deviated from the expected behaviour 
commonly reported for phosphate glass compositions [192].  
 
 
(PW) 
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This mixed cation effect has previously seen significant increases in a glass’s 
crystallisation temperature and subsequently large improvements in its processing window. 
It is however unclear what role ZnO may have played in any mixed cation effects given the 
lack of comparative data and the large effects that small compositional changes can make 
to a glass’s crystallisation behaviour. Furthermore if potentially acting as an intermediate 
oxide, the MgO may have induced further thermal stability to CorGlaes® Pure 107 by 
entering the phosphate network backbone. Such behaviour has been observed previously in 
highly disrupted bioactive glasses where the Mg2+ cation has shifted from a network 
modifier to a network former after exceeding a so-called “critical concentration” (Jones & 
Clare, 2012). This was reported to have produced glasses with significantly wider PW 
values at compositions incorporating >20 mol% MgO [109]. However given that this 
threshold was deemed to be dependent upon the glass’s composition and was conducted 
using a silicate based glass, it is unclear how this would translate to phosphate based 
glasses [109, 114, 187, 192, 205, 290]. 
The density of CorGlaes® Pure 107 glass was reflective of the accumulated atomic weights 
from the glass’s components and atomic packing in its network which was related to its 
modifier cations and network structure. A comparison of the calculated density for the 
CorGlaes® Pure 107 glass showed it to be in line with other biomedical glasses (Figure 
5.4.4) [109, 184, 187, 195, 291, 292].   
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From the mechanical testing results, the CorGlaes® Pure 107 glass was found to display a 
higher flexural strength and a similar elastic modulus compared to Bioglass® 45S5 (Figure 
5.4.5). The elastic modulus of CorGlaes® Pure 107 glass also appeared to be significantly 
higher than some alternative metaphosphate glass compositions and within the range 
generally stated for bone [53, 96, 293-295]. 
It is generally accepted that PGs possess a lower mechanical strength and elastic modulus 
compared to silicate glasses and that according to Rouxel (2007), the elastic moduli of an 
oxide glass is primarily governed by its atomic bond strengths and atomic packing density 
(Cg). The atomic packing density is defined by Rouxel (2007) as the ratio between the 
minimum theoretical volume occupied by the ions and the effective volume of the glass. 
This property can be used alongside the dissociation energies of the glass’s modifier oxides 
to calculate the total bonding energy (Um) using the method proposed by Makisma-
Mackenzie. From this, the total bond energy (Um) has been found to typically show a linear 
relation to the elastic modulus of a glass (E = 2Um) with weak bonding, an expanded 
network and a high number of non-bridging oxygen’s generally producing glasses with a 
relatively low elastic modulus. Consequently due to the flexibility in available glass 
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Figure 5.4.4. Comparison of CorGlaes® Pure 107 phosphate glass density with Bioglass®
45S5 and alternate ultra-, meta- and polyphosphate glass compositions intended for 
biomedical applications [Data from Abou Neel et al., 2008; Devi et al., 2010; Khor et al., 
2011; Jones & Clare,  2012; Lee et al., 2013; Sharmin et al., 2014]. 
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compositions, a range of elastic moduli from 10 to 200 GPa have been reported for oxide 
glasses. Furthermore given the relation between network bond strength and elastic moduli, 
authors such as Shelby (2005) have highlighted the general trend of increasing elastic 
modulus with increasing Tg [157, 296-298]. 
 
Accordingly, the comparatively high elastic modulus of the CorGlaes® Pure 107 
composition (Figure 5.4.5) is associated with a combination of factors that include its 
selection of modifier cations as well as its quinternary composition. This can be attributed 
to the anticipated high total network bonding energy (Um) generated in the CorGlaes® Pure 
107 glass network from the high charge-to-size ratio Mg2+ and Zn2+ cations. This is further 
complimented by the variation in ionic radii between the calcium (114 pm), magnesium 
(86 pm) as well as zinc (88 pm) modifier cations that, according to Rouxel (2007), would 
allow these ions to fill the interstitial sites within the glass network more effectively and 
increase the glass’s Cg. This atomic packing density in the CorGlaes® Pure 107 glass 
structure is reflected by the density data shown in Figure 5.4.4 [173, 298]. Such features 
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Figure 5.4.5. Comparison between the flexural strength and elastic modulus of the 
CorGlaes® Pure 107 glass with BioGlass® 45S5, cortical bone, hydroxyapatite along with 
alternate PG compositions intended for biomedical applications [Data from Thompson & 
Hench, 1998; Kokubo et al., 2003; Abou Neel et al., 2009; Ratner et al., 2012]. 
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would also appear to coincide with comments by Pukh et al. (2005) who discussed how the 
appropriate choice of modifier cations and degree of polymerisation in the network can 
produce phosphate glasses with elastic moduli close to or exceeding those displayed by 
silicate based glasses. Furthermore Rouxel (2007) also considers factors such as the 
coordination and molecular organisation (i.e. chains and ring structures) to have an impact 
on the elastic modulus of a glass. Such influences may help explain the minimal change in 
the elastic moduli reported between the two comparative PG compositions shown in Figure 
5.4.5 despite the expected increase in Um and number of modifier oxides through the 
substitution of Na2O with TiO2. However any further interpretation of these results is 
limited by the lack of available data on the CorGlaes® Pure 107 composition as well as that 
of alternate biomedical PGs regarding their bulk elastic moduli [114, 157, 296, 297, 299-301].  
The theoretical strengths of glasses are typically orders of magnitude greater than those 
found experimentally due to the presence of surface flaws across the sample that can act as 
stress concentrators. During mechanical loading, the highly localised stresses at these flaws 
are then able to exceed the theoretical strength of the glass to cause spontaneous crack 
growth and sample fracture as described by Griffith (Shelby, 2005). As a result, the 
inherent strength of a glass is typically considered to be irrelevant with regards to its 
practical value due to its reliance on the sample surface quality. Consequently the 
differences in flexural strengths and large standard deviations between the glass 
compositions shown in Figure 5.4.5 may be representative of the different levels of surface 
quality [157, 293]. 
Micro indentation techniques found the hardness of the CorGlaes® Pure 107 glass to be in 
line with the accepted range for PGs (≈4-5 GPa) and below that of Bioglass® 45S5 with a 
comparison between alternate biomedical glass compositions shown in Figure 5.4.6. The 
calculated fracture toughness was also found to be within the typical values reported by 
Ashizuka (1982) for metaphosphate glass compositions (0.43-0.53 MPa m1/2) [109, 117, 172, 294, 
302-306]
.  
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During Vicker’s hardness testing, it is generally accepted that a glass will experience 
deformations and consequently indentation through a combination of compressive as well 
as shear stresses. These deformations are composed of elastic deformation (compression 
related), plastic flow (shear related) as well as densification (compression and shear 
related) phases when mechanically indented. Additionally the ratio of each deformation 
type is reported by Salama & El Batal (1994) to be dependent upon the glass’s composition 
due to the corresponding glass structure. Yet due to the complex processes governing glass 
hardness, the underlying mechanisms are also considered by Salama & El Batal (1994) to 
be poorly understood [307, 308].  
The hardness of a phosphate glass is however believed to be highly influenced by the ionic 
radii and the polarizability of the modifier cations (Salama & Batal, 1994; Weiss et al., 
2014). Similar to the elastic modulus of an oxide glass, generally higher hardness values 
can be found in compositions with small ionic radii or high field strength cations due to the 
increased network compaction (Cg) and bond strengths in the network that increases its 
resistance to deformation (Shelby, 2005) [157, 172, 307].  
Based on the limited comparative data, Figure 5.4.6 shows the hardness of the CorGlaes® 
Pure 107 glass to be lower than the alternate phosphate glass compositions. This could be 
accounted for by the presence of Q1 phosphate units in the comparison polyphosphate 
Figure 5.4.6. Comparison of CorGlaes® Pure 107 glass hardness with different PG
compositions and Bioglass® 45S5 [Data from Jones & Clare (2012) and Weiss et al.
(2014)]. 
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glasses (40 mol% P2O5) that could increase the atomic packing density (Cg) by acting as 
phosphate dimers (Ahmed et al. 2004). The inclusion of MgO or TiO2 and the increased 
hardness would also appear to agree with the relationships governing glass hardness as 
described by Shelby (2005) due to the expected increase in Um from their inclusion. The 
reduced hardness of the CorGlaes® Pure 107 glass would subsequently make samples more 
liable to surface damage which may explain the reduced flexural strength seen in Figure 
5.4.5 due to the greater severity of the flaws or flaw population. However it should also be 
noted that a direct comparison between these compositions and the CorGlaes® Pure 107 
glass is compromised by the differences in indentation technique, loading rate, indentation 
load and thermal history of the samples (i.e. annealing). Accordingly further dedicated 
work towards the compositional as well as thermal influences would be required to fully 
interpret the CorGlaes® Pure 107 Vickers hardness data [114, 145, 172, 190, 196, 307, 309]. 
Although glassy materials possess no crystalline structure, crack propagation is considered 
to behave similarly to that of a single crystal and as a result glasses generally display lower 
fracture toughness compared to polycrystalline materials. This is due to their homogeneity 
and lack of microstructure that permits cracks to travel freely without being retarded by the 
grain boundaries [303, 310]. The fracture toughness of glassy materials is considered by Inaba 
et al. (1999) to be directly related to its elastic modulus which, as discussed earlier, is 
dependent upon its Um and Cg. Consequently a general trend of increasing fracture 
toughness with increasing elastic moduli has been previously observed by Weiss et al. 
(2014) and was attributed to the more rigid glass network obtained by the inclusion of 
Mg2+ or Ti4+ modifier cations (Figure 5.4.7) [172, 297].  
 
 
 
 
 
 
 
 
Figure 5.4.7. Increase in hardness, fracture toughness and elastic modulus with substitution 
of MgO or TiO2. Note: the elastic moduli reported here were determined from the hardness 
data and was excluded from the previous analysis that used three and four point bend 
techniques (Figure 5.4.5) [Reproduced from Weiss et al. (2014)]. 
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A comparison between the fracture toughness of the CorGlaes® Pure 107 glass and those 
reported for Bioglass® 45S5 along with the biomedical PG compositions investigated by 
Weiss et al. (2014) is shown in Figure 5.4.8. 
 
 
However glass compositions which fail to adhere to these trends discussed by Inaba (1999) 
and Weiss et al. (2014) have also been reported with Ashizuka (1982) documenting 
abnormal variations in the fracture toughness of metaphosphate glasses containing MgO or 
ZnO. Furthermore Rao et al. (2014) believes that in contrast to Inaba et al. (1999), 
Kurkjian (2000) and Weiss et al. (2014), a more rigid structure reduces the fracture 
toughness of a glass due to its restrictions on the degree of plastic flow occurring during 
indentation. Given that Salama & El-Batal (1994) attributes an increased Vicker’s hardness 
to a reduction in the ratio of plastic flow it is proposed that a trade-off between the 
hardness and fracture toughness could exist in certain phosphate glass compositions. This 
increased plastic flow would improve the glass’s ability to relieve the stresses near the 
crack tip that are responsible for crack propagation. The results of the CorGlaes® Pure 107 
glass shown in Figure 5.4.6 and Figure 5.4.8 would then appear to be in agreement with 
this proposal due to the superior fracture toughness of the CorGlaes® Pure 107 glass being 
offset by its reduced hardness. However a deeper investigation would be required in order 
to develop this concept further with regards to any other specific compositional influences 
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Figure 5.4.8. Comparison of CorGlaes® Pure 107 fracture toughness with Bioglass® 45S5 
and alternate phosphate glass compositions [Data from Jones & Clare (2012) and Weiss et 
al. 2014]. 
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or trends. Furthermore the analysis presented here suffers from a lack of sufficient 
comparative data and conciseness in the experimental techniques adopted as previously 
highlighted in the analysis of the Vickers hardness results [172, 297, 307, 311, 312]. 
Immersion of the CorGlaes® Pure 107 disks in distilled water at 37°C (Figure 5.3.7) 
showed the dissolution rate to follow the two stage hydration and hydrolysis mechanisms 
as described by Bunker et al. (1984). This was apparent by the initially decreasing 
dissolution rate (q α t1/2) over the first 168 hours (1 week) of immersion that was followed 
by a more linear profile (q α t). Given that the media was replaced every 24 hours over the 
first 168 hours, any accumulated ionic concentration effects believed responsible for the 
initially decreasing dissolution rate as proposed by Delahaye et al. (1998) were ruled out. 
From the plotted trend line through the origin, a dissolution rate (Dr) for the CorGlaes® 
Pure 107 composition was determined to be 4×10-3 mg cm-2 hr-1 and was in line with the 
measured dissolution rate reported by Giltech Ltd. The ionic concentrations during sample 
immersion also showed the release of calcium, sodium, magnesium and zinc cationic 
species as expected from the known CorGlaes® Pure 107 compositional data [162, 164].  
Correlating the results shown in Figure 5.3.7, the initial 24 hours saw the pH of the 
immersion media fall to ≈6.5 which was attributed to the formation of carbonic acid due to 
carbon dioxide being dissolved from the atmosphere into the media. However such pH 
values (i.e. 5.8 < pH < 6.5) are still considered to be neutral in relation to phosphate glass 
dissolution kinetics by Delahaye et al. (1998). The decrease in pH after 72 hours was 
attributed to the release of various phosphate anions and their dissociation to form 
phosphoric acid (H3PO4) as reported by Ahmed et al. (2008, 2009) [164, 215, 218]. This initial 
release was believed to be from the annealed surface layer degrading across the disk 
samples as previously reported by Hayden et al. (2000), Cozien-Cazuc et al. (2008) and 
Lee et al. (2013) [183, 207, 313]. This is due to the ambient atmospheric moisture attacking the 
disk surface during the annealing process and cleaving the P-O-P chains. As a result the 
surfaces of annealed samples are considered to possess different properties compared to the 
bulk interior. This effect has previously been observed to occur over the first 24 to 72 
hours of sample dissolution with Delahaye et al. (1998) commenting that during 
metaphosphate glass dissolution, an outer layer of phosphate chains is spalled from the 
glass surface without prior hydrolysis reactions [207]. The absence of any significant 
phosphate species being released into the media (Figure 5.3.8) from this outer surface layer 
dissolving may be due to the release of larger phosphate anionic species (e.g. P2O7-4, P3O9-
3
, P3O105-) that were not included in the analysis [179, 190, 314]. A gradual increase in pH was 
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also seen after 96 hours (Figure 5.3.7) and corresponded to a significant increase in Na+ 
cation concentration in the immersion media (Figure 5.3.8). This was attributed to the 
consumption of H+ ions in the media from the hydration reactions expected during 
phosphate glass dissolution as previously described in section 3.4.4. The apparent delay in 
this hydration reaction (i.e. its occurrence after 96 hours) and the associated changes to the 
ionic concentrations/pH was similar to previous studies reported by Novajara et al. (2011) 
and Lee et al. (2013) (Figure 5.4.9) [173, 183, 197].  
 
 
 
 
 
 
 
 
 
The release of Na+ was also coupled with an increase in Ca2+ and (PO4)3- ion 
concentrations after 120 hours of immersion that was deemed to be reflective of the 
saturation and hydrolysis of the CorGlaes® Pure 107 glass’s phosphate network. This is 
typically considered to signal the transition to a linear stage of phosphate glass dissolution 
and would appear to loosely correlate with the observed weight loss data (Figure 5.3.10) 
that showed increased linearity after 144 to 168 hours of immersion. Yet no significant 
increase in Zn2+ or Mg2+ release over the corresponding period was observed (Figure 
5.3.11). This is despite the relatively high concentration of magnesium in the composition 
compared to zinc (based on comments by Giltech Ltd) which would imply that congruent 
dissolution did not occur (section 3.4.4). However, it could be proposed that the acidic 
environment generated by the CorGlaes® Pure 107 dissolution (pH ≈4-4.8) may be 
producing the selective leaching of Zn2+ cations that has been shown by Khor et al. (2011) 
to effect the release rate of Mg2+ (Figure 5.4.10). However due the relatively short period 
over which the ion release data was recorded the non-congruent dissolution process seen 
Figure 5.4.9. Dissolution of glass compositions showing a) Delayed release of Ti4+ ions 
from the glass with increasing concentration of TiO2 (mol%) [Reproduced from Novajra et 
al. (2011)] and b) Changes in media pH during the dissolution of glass samples with 
increasing concentrations of MgO (mol%)  [Reproduced Lee et al. (2013)]. 
a b 
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here may be due to some initial surface chemistry effects. Although further investigations 
would be required to expand on this and confirm [187]. 
 
 
The drop and subsequent plateau of the media pH to ≈3.5 after 336 hours of immersion 
was attributed to the reduced exchange and replacement of the dissolution media which 
allowed increasing quantities of phosphate species to accumulate. This would have led to 
an increased concentration of phosphoric acid in the dissolution media and was in line with 
similar pH values recorded for ultraphosphate glasses by Ahmed et al. (2004). Yet this 
decrease in pH failed to exhibit any significant autocatalysis effects to the CorGlaes® Pure 
107 dissolution rate that continued to progress linearly (Figure 5.3.7) [162, 173, 187, 315].  
A comparison of the CorGlaes® Pure 107 dissolution rate with alternate ultra-, meta- and 
polyphosphate glass compositions under near identical test conditions is shown in Figure 
5.4.11 [173, 175, 188, 190, 210, 316].  
 
 
 
 
Figure 5.4.10. Variation in Zn2+ and Mg2+ ion release from a (P2O5)55-(ZnO)30-(MgO)15 
glass
  
in different media pH buffer solutions (0.24-0.43 cm2 ml-1) at ambient temperature
[Data from Khor et al. (2011)]. 
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The comparison revealed the CorGlaes® Pure 107 glass to possess a mid-range dissolution 
rate which was related to its composition through the inclusion of Ca2+, Mg2+, Zn2+ cations 
as discussed in previous studies (Abou Neel et al., 2008, 2009; Khor et al., 2011; Lee et al., 
2013). Furthermore the dissolution rate of the CorGlaes® Pure 107 glass was found to be 
within the limits deemed acceptable for permitting cell anchorage (1.7×10-2 mg cm-2 hr-1) 
but too rapid for cell proliferation (3×10-3 mg cm-2 hr-1) as identified from previous in vitro 
studies by Bitar et al. (2004) and Parsons et al. (2004) [178, 187].   
 
Figure 5.4.11. Comparison of CorGlaes® Pure 107 phosphate glass dissolution rate with a 
selection of different ultra-, meta- and polyphosphate glass compositions measured under
near identical testing conditions in distilled water or PBS at 37°C [Data from Franks et al.,  
2002; Navarro et al., 2003; Ahmed et al., 2004; Skelton et al., 2007; Abou Neel et al., 
2009; Hasan et al., 2012]. 
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The FTIR spectra of CorGlaes® Pure 107 samples shown in Figure 5.3.9 indicated that no 
surface layer had developed over the 336 hour (2 week) immersion period in c-SBF. These 
observations were in line with alternate PG compositions tested by Clement (1999) that 
failed to display any bioactivity after 72 hours of immersion in SBF. The marginal 
variations observed in the FTIR spectra were associated with a poor signal-to-noise ratio 
due to the sample surface quality (i.e. faces were not ground flat prior to testing) [273].  The 
pH of the c-SBF media over the corresponding immersion period was also found to remain 
neutral whilst the weight loss per unit area was significantly reduced compared to the 
equivalent period in distilled water (Figure 5.3.9).  
The lack of bioactivity in the CorGlaes® Pure 107 glass was similar to the reported 
inability of calcium metaphosphate glasses to form an apatite surface layer during 
immersion in SBF by Kasuga (2005) and Devi et al. (2010). Based on this, the results 
obtained could be attributed to the low dissolution rate of the CorGlaes® Pure 107 glass 
and its subsequent effect on the dissolution-precipitation processes required for surface 
apatite formation (section 3.4.5). Owing to an ionic buffering effect, the dissolution of the 
CorGlaes® Pure 107 glass was found to have been significantly reduced (Figure 5.3.10) 
compared to that found in distilled water (Figure 5.3.7). This difference has been attributed 
by Uo et al. (1998) to the presence of Na+, Ca2+ and HPO42- ions in the SBF media. As a 
result, reactions between the c-SBF and the glass surface could have been inhibited due to 
the lack of ionic constituents released from the CorGlaes® Pure 107 glass (e.g. Ca2+). This 
slow dissolution was thus likely to have prevented the formation of a calcium phosphate 
surface gel phase that is considered to be vital for initiating apatite nucleation according to 
Clement et al. (1999), Kasuga (2005) and Devi et al. (2010) [170, 176].   
Additionally, PGs studied by Lucacel et al. (2012) have demonstrated the inhibitory effect 
of zinc on a glass’s bioactivity due to its increased durability [182]. Consequently the 
CorGlaes® Pure 107 composition may be capable of forming a calcium phosphate apatite 
surface layer if the immersion period was increased beyond the tested 2 weeks. If 
combined with a reduced rate of c-SBF replacement, sufficient concentrations of ionic 
species may also be allowed to accumulate in the c-SBF. Prolonged immersion times such 
as those used by Clement (1999) have shown the development of calcium phosphate 
surface layers across meta- and polyphosphate glass compositions after 1344 hours (8 
weeks) of immersion. However the CorGlaes® Pure 107 composition may also be 
displaying behaviour similar to that discussed by Kiani (2014) where titanium doped 
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phosphate glass compositions were found to only develop bioactive surface layers in vivo 
[170, 273, 289]
.  
As demonstrated from previous studies (Salih et al., 2000; Bitar et al., 2004; Skelton et al., 
2007), the dissolution rate of a phosphate glass will influence its osteogenic cell adhesion, 
proliferation, differentiation and cell viability. This is due to the associated ion release 
rates, pH changes as well as cell anchorage mechanisms (i.e. surface solubility) [175, 177, 178].  
Initial biocompatibility testing of the CorGlaes® Pure 107 disks by MTT assay showed that 
no cytotoxic response was evoked during the culture of MG63 cells in glass dissolution 
extracts over the tested dissolution periods and across all concentrations (Figure 5.3.11). 
This was evident by the cell viability of all samples being maintained above the 70% 
threshold as specified by BS EN 10993-5:2009. These results indicated that the ion release 
rates and pH changes to the culture media were suitable for maintaining cell viability 
during in vitro cell culture experiments. A comparison across the extract concentrations 
obtained after 24 hours of sample dissolution showed a general increase in the average cell 
viability as the extract concentration increased. The increased viability could be attributed 
to the ions released from the glass as had been observed with alternate MTT results by 
Franks et al. (2002) who reported equivalent or increased cell growth due to the glass’s 
dissolution by-products. This would then explain the general increase in average cell 
viability with increasing extract concentration due to the respective ionic concentrations in 
the CDMEM from the dissolution of CorGlaes® Pure 107 disks. However statistical 
analysis found no significant difference (p > 0.05) between the extract concentrations or 
immersion period with the positive controls on MG63 cell viability [188].  
Images obtained during direct contact cell culture after 24 hours on Thermanox® and 
CorGlaes® Pure 107 samples showed live cells (green) across all samples with early signs 
of cell cytoplasmic flattening and spreading on the control coverslips (Figure 5.3.12a). The 
concentrated pockets of live MG63 cells on CorGlaes® Pure 107 samples was also 
suggestive of colonial clustering on the glass surfaces as reported by Lee et al. (2013). 
However a cytotoxic response in the CorGlaes® Pure 107 samples was then observed after 
96 hours of culture with a significantly reduced cell population whilst the cell morphology 
remained round. This was coupled with the presence of dead cells (red) scattered across the 
sample surface (Figure 5.3.12e, h, k) and was contrasted by the development of polygonal 
shaped cell morphologies with filopodial extensions (indicative of cell spreading) on the 
Thermanox® coverslips after the equivalent culture period. The cell viability appeared to 
further decrease on CorGlaes® Pure 107 samples after 168 hours of culture (Figure 5.3.12f, 
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i, l) with further reductions to the number of viable cells (green). The absence of any large 
dead cell population despite the apparent cytotoxic response was attributed to the 
detachment of dead cells into the CDMEM during the culture or staining stages of 
CorGlaes® Pure 107 disk evaluation as previously observed by Abou Neel et al. (2008). 
Continual cell spreading and proliferation was found with the Thermanox® coverslips over 
the equivalent culture period with images showing a flat monolayer of highly confluent 
cells developing across the coverslip surface (Figure 5.3.12c) [195]. The pH results over the 
Live/Dead® culture period (Figure 5.3.13) also showed that the CDMEM pH remained 
above the cytotoxic limit of MG63 cells (pH 7.4) throughout the entire culture period [145, 
195]
. 
The combined results from the MTT assay and Live/Dead® images implied that either 
surface anchorage mechanisms or highly localised surface effects were responsible for the 
increasing cytotoxicity of the CorGlaes® Pure 107 disk samples. However it should be 
noted that the higher surface area-to-volume ratio (SA:V) used with the Live/Dead® 
protocol (2.24 cm2 ml-1) compared to the MTT assay (1.25 cm2 ml-1) may impede a 
correlation between the results of the two tests. This difference was due to the 
specifications of the MTT assay as dictated in BS EN 10993-5:2009 whilst no SA:V data 
regarding direct contact cultures on phosphate glass samples could be found from the 
consulted literature to establish consistency (Salih et al., 2000; Franks et al., 2002; Bitar et 
al., 2004; Abou Neel et al., 2007; Skelton et al., 2007; Abou Neel et al., 2008; Lee et al., 
2013). As a result, cytotoxic effects due to an increased concentration of ions in the 
CDMEM from glass dissolution could not be completely ruled out [145, 165, 175, 177, 178, 188, 189, 
195]
.  
The pH data of the CDMEM culture media during the Live/Dead® staining was used to 
rule out any cytotoxicity arising from the acidic dissolution by-products of the CorGlaes® 
Pure 107 glass as had been observed during its immersion in distilled water. Dissolution of 
the disk sample surface and its associated restrictions to cell anchorage were also not 
considered. This was due to the results of Bitar et al. (2004) and Skelton et al. (2007) 
where the successful seeding and attachment of MG63 cells to annealed phosphate glass 
disks was achieved on samples with dissolution rates significantly higher (5.65×10-2 mg 
cm-2 hr-1) than the CorGlaes® Pure 107 glass (4×10-3 mg cm-2 hr-1) [195].  The lack of any 
acidic pH in the CDMEM also ruled out any acceleration to the CorGlaes® Pure 107 glass 
dissolution rate (via autocatalysis) which may have been expected given the higher SA:V 
ratio used in the Live/Dead® (2.24 cm2 ml-1) compared to the previous dissolution 
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experiments (0.18 cm2 ml-1). It was also likely that the CorGlaes® Pure 107 samples would 
have degraded at an even slower rate (i.e. < 4×10-3 mg cm-2 hr-1) in CDMEM based on the 
decreased PG Dr reported by Patel & Knowles (2006) when PG samples were immersed in 
cell culture media [206]. 
The resulting cytotoxic response observed in the Live/Dead® results of the CorGlaes® Pure 
107 samples was consequently believed to be due to a highly localised acidic surface pH as 
reported by Salih et al. (2007) and Jones & Clare (2012). Such effects would not be 
detectable in the bulk media pH or MTT assay (due to the lack of direct cell contact with 
the sample surface). This proposal would then agree with the gradually increasing 
cytotoxicity observed across the MG63 culture period as the local surface pH gradually 
decreased to cytotoxic levels during sample dissolution. Alternatively the higher SA:V 
ratio of the Live/Dead® culture may be evoking a cytotoxic response from the gradual 
increase in ionic concentrations related to the glass’s dissolution by-products. This could 
be related to the release and accumulation of Zn2+ ions in the CDMEM based on results of 
Abou Neel et al. (2008) with concentrations greater than 8ppm (≈8 mg l-1) found to be 
cytotoxic to MG63 cells. This is due to the release of lactate dehydrogenase from the cells 
and cell damage occurring via an oxidative stress mechanisms [195]. Furthermore rounded 
cell morphologies from the concentration of specific ions released via glass dissolution 
have also been reported by Bitar et al. (2004) and would correlate with the results found 
here. Based on the ion release profiles obtained at a significantly lower SA:V ratio (0.18 
cm2 ml-1) in Figure 5.3.8 the time dependant accumulation of Zn2+ ions in the CDMEM 
from the CorGlaes® Pure 107 disk dissolution would be able to account for the observed 
decrease in cell viability despite the apparently suitable pH of the CDMEM. Integrating 
with the MTT results, it would then appear that this cytotoxic response was only achieved 
during its immersion at SA:V ratios >1.25 cm2 ml-1. However the accuracy and 
applicability of these Live/Dead® results to an in vivo response is contested by the 
circulation of extracellular fluids and variation of the SA:V found in vivo compared to the 
static nature of the in vitro culture set up used here as discussed by Bitar et al. (2004) [109, 
177, 178, 195]
.  
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5.5 Conclusions 
Based on the previously reported advantages of calcium, magnesium and zinc for the 
regeneration of bone tissue (Table 3.4.3) it was anticipated that the unique CorGlaes® Pure 
107 composition would prove advantageous as a potential orthopaedic biomaterial. 
Accordingly through a combination of multidisciplinary techniques the characterisation 
and comparison of the glass’s mechanical, chemical and in vitro properties was assessed. 
Analysis of the composition subsequently confirmed the ultraphosphate (FTIR) and 
amorphous state (XRD) of the glass whilst the significantly large processing window 
(348°C) made the composition highly suitable for fibre production. Mechanical testing of 
the composition also showed the elastic modulus of the CorGlaes® Pure 107 glass to be 
comparable to Bioglass® 45S5 whilst the density (2.65 g cm-3), hardness (3.98 ± 0.17 GPa) 
and fracture toughness (0.48 ± 0.05 MPa m1/2) were in line with the reported literature 
regarding phosphate glasses. These properties were strongly related to the composition of 
the CorGlaes® Pure 107 glass that was also believed to have utilised advantageous mixed 
cation effects to achieve its material properties. 
Dissolution of the CorGlaes® Pure 107 glass was found to be within the limits for cell 
adhesion with the acidic dissolution by-product attributed to the gradual formation of 
phosphoric acid that was expected from its ultraphosphate composition (55 mol% P2O5). 
This dissolution process corresponded with the release of cationic and anionic species 
relevant to the CorGlaes® Pure 107 composition but its mid-range dissolution rate (4×10-3 
mg cm-2 hr-1) also resulted in a lack of calcium phosphate apatite formation on the sample 
surface. This lack of bioactivity was compounded by the cytotoxic response generated 
under the current testing conditions that was attributed to the accumulation of ionic species 
or localised surface pH effects during direct contact cell culture. Consequently based on 
the accumulated in vitro evidence, the CorGlaes® Pure 107 composition would appear 
unsuitable for in vivo applications but could be advantageous as a composite fibre 
reinforcing agent. 
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6 Characterisation of CorGlaes® Pure 107 Fibres 
6.1 Outline 
Characterisation of the CorGlaes® Pure 107 composition (chapter 5) had previously 
highlighted the suitability of this glass for post-processing fibre manufacturing due to its 
advantageous thermal properties (i.e. its large thermal processing window). Given that the 
unique properties of composite materials are derived from its constituent phases (section 
3.2.3), the characterisation of CorGlaes® Pure 107 fibres was subsequently required. This 
was conducted through a range of testing techniques aimed at analysing the fibres 
structural, mechanical and dissolution properties as well as its bioactivity.  
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6.2 Materials and Methods 
6.2.1 Fibre Manufacturing 
CorGlaes® Pure 107 fibres were manufactured by Giltech Ltd using an in-house gravity fed 
melt spinning technique from a dedicated fibre production facility that consisted of a 
temperature controlled interchangeable ceramic clay bushing positioned above a Ø = 
0.637m stainless steel drum (Figure 6.2.1). During fibre production, these clay bushings 
could be vertically displaced from the surrounding resistance heating elements in order to 
further regulate the glass melt temperature and aid fibre manufacturing.  
 
 
 
 
 
 
 
 
 
 
 
 
For glass fibre production, ≈350g of CorGlaes® Pure 107 cullet fragments were heated to 
1000°C at 1°C min-1 and maintained at this state for 4 hours to produce a homogenous 
glass melt. The molten glass was then transferred to a clay bushing containing an array of 
Ø2mm holes (n = 50) that was preheated to 680-690°C in order to achieve the desired glass 
melt viscosity for fibre manufacturing (section 3.4.7.2). Under gravity, glass droplets 
travelled down through the bushing orifices and were subsequently drawn/collected around 
the drum (rotating at 250 rpm). Prior to fibre manufacturing, the drum was coated with a 
Knittol® lubricant (Selco, India) to preserve the integrity of the manufactured fibres (by 
Ceramic 
Bushing 
Stainless 
steel drum 
Figure 6.2.1. Images of a) Gravity fed melt spinning fibre manufacturing plant with 
ceramic bushing and stainless steel drum labelled and b) Image of CorGlaes® Pure 107 
fibres [scale bar = 100mm]. 
a b 
100mm 
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reducing fibre-to-fibre abrasion) and protect them from environmental moisture [317]. Fibre 
production continued until the feed melt was depleted with the aligned CorGlaes® Pure 107 
fibres removed from the static drum by cutting parallel with the drums long axis. The 
fibres (Figure 6.2.1) were then placed in PE bags and stored inside a desiccator without 
any annealing stages. Prior to all experimental work the CorGlaes® Pure 107 fibres were 
washed in Chloroform (VWR, USA) for 10 minutes in order to remove the Knittol® 
lubricant and dried inside a fume cabinet for 15 minutes at ambient temperature.  
 
6.2.2 XRD and DSC 
XRD was conducted on crushed CorGlaes® Pure 107 fibres according to the procedure 
described in section 5.2.2. Fibres were crushed using a pestle and mortar with XRD 
intended to assess the degree of crystallisation present in the manufactured fibres. DSC 
was performed on ≈10mm length CorGlaes® Pure 107 fibres as described in section 5.2.4.  
 
6.2.3 Raman Spectroscopy 
Raman spectroscopy was performed on CorGlaes® Pure 107 fibres using a LabRAM HR 
(Horiba Jobin Yvon, France) with a Ventus 532 laser (Ventus, USA) over a 1400-100cm-1 
wavenumber range. Spectra from the ≈20mm length fibre samples were collected in 
triplicate (n = 3) from a 532.17nm laser line with a 10% OD objective and 600 grating over 
a 10 second accumulation period. Raman spectroscopy was performed at the School of 
Chemistry, University of Glasgow. 
 
6.2.4 Fibre Diameter  
The diameter of CorGlaes® Pure 107 fibres (under the current manufacturing conditions) 
was determined from an isolated tow of 20mm length fibres using a Sigma VP SEM (Carl 
Zeiss, Germany) according to Method C of BS ISO 11567:1995. Samples were prepared 
by backing the fibres onto card using aluminium tape before sputter-coating with a thin 
layer of gold (Agar Scientific, UK). Cross-sectional images were captured in SE and BSE 
modes using a 20kV accelerating voltage and measurements recorded using the 
equipment’s Zeiss SmartSEM software. From the diameter of 30 samples (n = 30) the 
average cross-sectional area of the fibres was then calculated [318]. SEM was performed at 
the School of Geographical and Earth Sciences, University of Glasgow. 
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6.2.5 Tensile Testing 
Tensile testing of CorGlaes® Pure 107 fibres was conducted following ISO 11566:1996 
using a Zwick/Roell Z2.0 (Zwick Roell, USA) tensile test machine with a 5N load cell 
operating at a crosshead speed of 1 mm min-1 [319]. Tensile test specimens were prepared by 
creating mounting frames with a 25mm gauge length from stationary card to the 
dimensions specified in BS ISO 11566:1996 (Figure 6.2.2). Individual fibres were isolated 
from an aligned fibre tow and fixed to the mounting frames using an epoxy adhesive 
(Loctite, Germany). Frames were then secured using grips to the testing equipment before 
the sidewalls of the frame were cut in order to isolate the fibre. Force-displacement data 
was then collected for 50 fibre samples (n = 50) using Zwick/Roell TestXpert® software 
[319]
.  
 
 
 
 
 
 
 
 
 
 
To account for influences from the load train and gripping system of the tensile testing set 
up, a correction coefficient (also known as the system compliance factor) was determined 
by tensile testing CorGlaes® Pure 107 fibres at 10mm, 20mm and 30mm specimen gauge 
lengths. Five samples (n = 5) were tested at each gauge length under identical testing 
conditions as those specified by BS ISO 11566:1996 and the force-displacement plots used 
to calculate the ∆L/∆F ratio (mm N-1) for each gauge length. The system compliance factor 
(k) was then determined from plots of ∆L/∆F against the fibre gauge length using a linear 
regression of an applied trendline back to the ordinate value (i.e. zero gauge length) [319].   
Figure 6.2.2. Illustration of sample housing frames employed in tensile testing of 
CorGlaes® Pure 107 fibres showing a) Housing frame dimensions b) Fixation of sample 
specimens [Reproduced from BS ISO 11566:1996] and c) Image of testing configuration 
showing a card housing prior to cutting of the support frame. 
a b 
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To calculate the tensile strength and tensile modulus of the CorGlaes® Pure 107 fibres the 
recorded force-displacement and dimensional data was applied to Eqn 6.2.1 and Eqn 6.2.2 
respectively following Method B of ISO 11566:1996 [319]. 
  
Z[ 	 F]A] 
     Eqn 6.2.1 
where σf = fibre tensile strength (MPa), Ff = fibre maximum tensile force (N), Af = fibre 
cross-sectional area (mm2) 
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Eqn 6.2.2 
where Ef = fibre tensile modulus (GPa), Lf = gauge length (mm), ∆FB = difference in force 
corresponding to the selected strain limits (N), ∆LB = difference in cross-head displacement 
corresponding to the selected strain limits (mm), k = system compliance (mm N-1).  
Note: An averaged value of the cross-sectional area was used in Eqn 6.2.1 and Eqn 6.2.2 
from the dimensional data obtained in section 6.2.4 with the selection of strain limits based 
on the nominal strain at failure (εf) of the tested samples.  
 
6.2.5.1 Weibull Analysis 
The strength of a glass or brittle ceramic material is generally dependent upon its fracture 
toughness (KIC) and critical flaw size (a). Thus the determination of a glass’s mechanical 
performance requires knowledge of the flaw population that must be evaluated statistically. 
Weibull distribution statistics has commonly been used to characterise the statistical 
variation in fracture strength of a brittle material and is based on the ‘weakest link theory’ 
where the most significant flaw will control the overall strength of a material. However 
this critical flaw may not necessary be the largest and is also reliant on its specific location 
and orientation [218, 269, 320].  
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To account for the flaw size distribution present in the CorGlaes® Pure 107 glass fibres a 
determination of the flaw population throughout the experimental sample set was required. 
The Weibull distribution of statistical analysis was subsequently used to examine the 
scatter of flaw size distributions and fracture strengths through calculating the Weibull 
modulus (m). For analysis, the tensile testing data was sorted by increasing tensile strength 
and a Weibull distribution plot was constructed for the CorGlaes® Pure 107 fibres using 
Eqn 6.2.3  and Eqn 6.2.4 [269, 320]. 
 
 
c  deW.Uf  
Eqn 6.2.3 
where PF = probability of failure, i = ith tensile strength value, N = total number of 
specimens tested. 
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Eqn 6.2.4 
where σ = Tensile strength (MPa), m = Weibull modulus, σo = Normalising stress - 
considered by Ahmed et al. (2008) as the “stress at which 63.2% of the tested fibres had 
failed” or “the most probable strength expected from a fibre of gauge length L0” by Hull & 
Clyne (1996) [120, 218]. 
 
6.2.5.2 Fibre Fracture Analysis 
Given that the tensile strength of glass fibres are highly dependent upon their surface 
quality, the influence of surface flaw type and relative depth was also determined in 
relation to the experimentally measured tensile strengths of the CorGlaes® Pure 107 fibres. 
This was evaluated for the presence of either a straight edge or semi-circular surface flaw 
using Eqn 6.2.5 [317]. 
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Eqn 6.2.5 
where cflaw = flaw depth (nm), KIC = fracture toughness (MPa m1/2), Y (cflaw, R) = crack 
geometry constant dependant on flaw depth (cflaw) and fibre radius (R) : 0.6366 for semi-
circular flaws and 1.1260 for straight edge flaws [317]. 
Note: For Eqn 6.2.5, the fracture toughness previously determined in section 5.3.6 was 
applied (0.48 MPa m1/2). 
 
6.2.6 Silane Treated CorGlaes® Pure 107 Fibres 
Surface modification of the CorGlaes® Pure 107 fibres was performed using a 10 wt.% 
concentration of a 3-aminopropyl-triethoxy (APS) sizing agent following the protocol 
originally outlined by Khan et al. (2011). These steps are summarised in Table 6.2.1 for 
treating a 1.5g batch of CorGlaes® Pure 107 fibres [228]. 
 
Table 6.2.1. Procedure for the silane treatment of fibres as described by Khan et al. (2011). 
Step Activity 
1 
90ml of ethanol (VWR, USA) was diluted with 10ml of distilled water 
to create a 90 vol% ethanol solution.  
2 
9.6ml of 3-aminopropyl-triethoxy (Sigma-Aldrich, USA) was added to 
100ml of the ethanol solution to create a 10 wt.% APS solution. 
3 
A 1.5g batch of fibres was immersed in 100ml of the 10 wt.% APS 
solution for 15 minutes inside a laminar fume hood. 
4 
Fibres were removed and washed in 50ml of ethanol under vacuum 
filtration with grade three filter paper (Whatman, UK) used in 
conjunction with a Büchner funnel. 
5 
Fibres were then placed in an air circulated oven for 24 hours at 120°C 
to cure the sizing agent. 
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6.2.7 Fibre Dissolution Rate 
The weight loss and media pH during the dissolution of the CorGlaes® Pure 107 fibres was 
determined in triplicate (n = 3) for each dissolution period over 24, 48, 72, 96 and 168 
hours of immersion. This was performed using distilled water (DW), phosphate buffered 
saline (PBS), Dulbecco’s Modified Eagle’s Medium (DMEM), and corrected simulated 
body fluid (c-SBF) immersion media along with a set of APS treated CorGlaes® Pure 107 
fibres in distilled water. The PBS was produced by dissolving a sachet of PBS (P5368-
10PAK, Sigma-Aldrich, USA) into one litre of distilled water whilst the c-SBF was 
prepared as described in section 5.2.9.1. Bacterial growth in the DMEM was inhibited by 
the addition of sodium azide (Sigma-Aldrich, USA) to the DMEM at a concentration of 0.1 
vol% prior to fibre immersion. The initial ionic concentrations of the c-SBF, DMEM and 
PBS are listed in Table 6.2.2 with the ionic conductivity of each media prior to sample 
dissolution measured using a HI-8733 conductivity meter (Hanna Instruments, USA).  
 
Table 6.2.2. Ionic concentrations of acellular DMEM cell culture media, c-SBF and PBS 
[Data from Kokubo et al. (2003) and Lutišanová et al. (2011)]. 
 Ionic concentration (mM) 
Media Na+ K- Ca2+ Mg2+ HCO3- Cl- HPO42- SO42- 
c-SBF 142.0 5.0 2.5 1.5 4.2 147.8 1.0 0.5 
DMEM 154.6 5.37 1.82 0.8 44.0 120.5 1.0 0.8 
PBS 350 5.19 - - - 233 10 - 
 
A dissolution sample consisted of a 200mg batch of 20mm length fibres that were stored 
inside a sealed 10ml glass vial giving a 14.4 cm2 ml-1 surface area-to-volume ratio (SA:V). 
Each sample was stored in an individual glass vial and placed within a 37°C incubator unit 
with the sample weights recorded periodically using a ±0.1mg Pioneer™ analytical scale 
(Ohaus, USA). This was performed in tandem with measurements of the dissolution media 
pH using a HI 221 pH Meter (Hanna Instruments, USA). At each dissolution period, the 
immersion media was decanted and samples dried using an air circulated oven at 60°C for 
4 hours. The dry weight loss was then determined by Eqn 6.2.6. and was plotted against the 
immersion period (hours) along with the solution pH. The media was not changed at any 
point with the exception of the DMEM that was replaced after 96 hours in order to mimic 
the protocols used during in vitro cell culture studies. [206]. 
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Eqn 6.2.6 
where wo = initial sample weight (mg) and wt = sample weight at time point tx (mg) 
 
The dissolution rate of the fibres normalised to the total theoretical surface area of each 
sample batch was determined using Eqn 6.2.7 from the weight loss measurements after 24 
hours of dissolution. To calculate the total surface area in a 200mg fibre batch, each fibre 
was assumed to be of uniform length (20mm) and identical diameter (20.85µm) in order to 
calculate the surface area of a single pristine fibre. The total number of fibres per 200mg 
batch and the subsequent total surface area (cm2) was then calculated from the theoretical 
weight of single 20mm length, Ø20.85µm fibre [201, 207]. 
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Eqn 6.2.7 
where A
 
 = sample surface area (cm2), t = time (i.e. immersion period – hours).  
 
6.2.8 Fibre Bioactivity 
The bioactivity of CorGlaes® Pure 107 fibres was assessed by individually immersing 
26mg batches of 20mm length fibres in c-SBF at 1 cm2 ml-1 SA:V ratio inside polystyrene 
universal tubes and stored at 37°C within an incubator unit with the c-SBF prepared 
according to the method described in section 5.2.9.1. The media was not changed over the 
immersion period and samples were examined in triplicate (n = 3) for each incubation 
period of 0.5, 1, 3, 6, 12, 24, 48, 168 and 336 hours (2 weeks) before being extracted and 
rinsed in acetone (VWR, USA). Extracted fibres were then dried at 60°C inside an air 
circulated oven for 3 hours before being stored within a desiccator for further analysis. The 
c-SBF pH was also measured at each extraction point using a HI 221 pH Meter (Hanna 
Instruments, USA) with the bioactivity of the fibres characterised following the procedure 
outlined by the flow chart shown in Figure 5.2.2. 
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6.3 Results 
 
6.3.1 XRD 
The XRD profile of the CorGlaes® Pure 107 fibres is presented in Figure 6.3.1 and showed 
no clearly defined crystallisation peaks but a broad halo centred at 2θ ≈ 23°. 
 
 
6.3.2 DSC  
The thermogram obtained from the DSC of CorGlaes® Pure 107 fibres over the 
predetermined thermal program is shown in Figure 6.3.2. Magnified sections of the 
thermogram highlighting the glass transition (Tg), crystallisation onset (Toc) as well as the 
crystallisation peak (Tp) and liquidus temperature (Tlq) are shown in Figure 6.3.3, Figure 
6.3.4 and Figure 6.3.5 respectively. These were determined from the intersection of 
tangents overlaid across the endo- or exothermic events and are listed in Table 6.3.1 
alongside the PW that was calculated using Eqn 5.2.1. 
 
 
Figure 6.3.1. XRD profile of CorGlaes® Pure 107 fibres showing the amorphous structure 
of the fibres produced under the operating conditions specified in section 6.2.1. 
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Figure 6.3.2. DSC thermogram of CorGlaes® Pure 107 fibres over a thermal cycle from 
25°C to 1200°C. 
Figure 6.3.3. DSC thermogram of CorGlaes® Pure 107 fibres with the glass transition 
temperature identified as 432°C from the tangent intersection (Magnified section from 
Figure 6.3.2). 
Tg (432°C) 
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Figure 6.3.4. Crystallisation onset temperature of CorGlaes® Pure 107 fibres identified 
from the intersection of lines on the DSC thermogram (magnified section of Figure 6.3.2). 
 
Toc (775°C) 
Figure 6.3.5. DSC thermogram of CorGlaes® Pure 107 fibres showing multiple 
crystallisation peaks and its liquidus temperature (magnified section of Figure 6.3.2). 
Tp4 (1057°C) 
Tlq (1074°C) 
Tp1 (918°C) Tp2 (963°C) 
Tp3 (1022°C) 
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Table 6.3.1. Thermal properties of CorGlaes® Pure 107 fibres. 
Thermal property Temperature (°C) 
Glass transition temperature (Tg)  432 
Crystallisation onset temperature (Toc)  775 
Processing window (°C) 343 
Crystallisation peak1 (Tp1)  918 
Crystallisation peak2 (Tp2)  963 
Crystallisation peak3 (Tp3)  1022 
Crystallisation peak4 (Tp4)  1057 
Liquidus temperature (Tlq) 1074 
 
 
6.3.3 Raman Spectroscopy  
The Raman spectrum obtained from the CorGlaes® Pure 107 fibres is shown below in 
Figure 6.3.6 with the assignment of the spectral features to the associated phosphate 
structures listed in Table 6.3.2. 
 
 
Figure 6.3.6 Raman spectrum of CorGlaes® Pure 107 fibres over the 1400-100cm-1
wavenumber range with peaks corresponding to the structural features of the CorGlaes®
Pure 107 composition. 
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Table 6.3.2. Assignments of spectral features identified in the Raman spectrum of the 
CorGlaes® Pure 107 fibres to the phosphate structural features. 
Feature Wavenumber Assignment 
Peak 1290cm-1 (PO2) asymmetric [vas] [158] 
Peak 1179cm-1  (PO2) symmetric [vs] [158] 
Peak 682cm-1  (P-O-P) symmetric [vs] [158] 
Peak 332cm-1 (P-O-P) bending vibration mode [287] 
 
 
6.3.4 Fibre Diameter 
From the thirty samples (n = 30) the average diameter of the CorGlaes® Pure 107 fibres 
was determined to be 20.85 ± 3.25µm with a range of 16.07 - 27.06µm (Figure 6.3.7). 
These measurements lead to an average cross-sectional area (Af) of 349.14µm2 for the 
CorGlaes® Pure 107 fibres under the current fibre plant manufacturing conditions (section 
6.2.1). 
 
 
 
 
 
Figure 6.3.7. SEM images of CorGlaes® Pure 107 fibres with measurements of the 
diameters used to determine the average cross sectional area [scale bars = 10µm , 2µm]. 
10µm 2µm 
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6.3.5 Tensile Testing 
A typical force-displacement and corresponding stress-strain plot for a tensile tested 
CorGlaes® Pure 107 fibre is shown in Figure 6.3.8 and from the results an average tensile 
strength and tensile modulus of 426 ± 143 MPa and 65.5 ± 20.8 GPa were found 
respectively. This was determined from the system compliance factor (k) of 0.4747 with 
the Weibull statistical model (Figure 6.3.9) producing a Weibull modulus (m) of 3.406 
with a 525 MPa normalising stress (σ0) (Figure 6.3.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
0.18
0.2
0 0.05 0.1 0.15 0.2 0.25
Fo
rc
e 
(N
)
Displacement (mm)
Force-Displacement Plot for a Tensile Tested CorGlaes® Pure 107 Fibre
0
100
200
300
400
500
600
0 0.001 0.002 0.003 0.004 0.005 0.006 0.007 0.008 0.009
St
re
ss
 
(M
Pa
)
Strain
Stress-Strain Plot for a Tensile Tested CorGlaes® Pure 107 Fibreb 
a 
Figure 6.3.8. a) Force-displacement plot and b) Stress-strain plot of a tensile tested 
≈Ø20µm CorGlaes® Pure 107 fibre at a cross-head speed of 1mm s-1. 
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The variation in CorGlaes® Pure 107 fibre tensile strength based on the presence of a semi-
circular or straight cut surface flaw is shown in Figure 6.3.11 using the tensile test data 
from the fibres and the fracture toughness previously determined from the CorGlaes® Pure 
107 disks (section 5.3.6).  
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Figure 6.3.9. Determination of Weibull modulus (m) from CorGlaes® Pure 107 fibre tensile 
test data based on the gradient of the plotted trendline. 
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Figure 6.3.10. Corrected probability of failure based on the Weibull statistical analysis of 
the CorGlaes® Pure 107 fibre tensile test data. 
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Figure 6.3.11. Variation in experimental CorGlaes® Pure 107 tensile strength with 
theoretically determined surface flaw type and depth.  
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6.3.6 Dissolution Rate 
The dry weight loss and corresponding media pH over 24, 48, 72, 96 and 168 hours of 
CorGlaes® Pure 107 fibre dissolution is shown in Figure 6.3.12. The resulting dissolution 
rate of the CorGlaes® Pure 107 fibres over the first 24 hours of immersion with respect to 
the initial ionic conductivity of each immersion media is shown in Figure 6.3.13. 
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Figure 6.3.12. Comparison of CorGlaes
®
 Pure 107 fibre dissolution up to 168 hours in 
various immersion media showing a) Dry weight loss over time and b) Media pH 
throughout the immersion period with the replacement of DMEM at 96 hours of immersion 
(standard deviation ≤ ± 0.07). 
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6.3.7 Fibre Bioactivity 
The pH of the c-SBF during CorGlaes® Pure 107 fibre bioactivity testing is shown in 
Figure 6.3.14. The characterisation of fibre samples across the 336 hours was assessed by 
FTIR (Figure 6.3.15) and Raman (Figure 6.3.16) with the corresponding SEM images of 
the fibres shown in Figure 6.3.17 and Figure 6.3.18. 
 
Figure 6.3.13. Comparison of CorGlaes
®
 Pure 107 fibre dissolution rate against the initial 
ionic conductivity of the immersion media after 24 hours of immersion. 
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Figure 6.3.14. Media pH of c-SBF during bioactivity testing of CorGlaes® Pure 107 fibres 
over 336 hours of immersion showing the decrease in pH with prolonged immersion 
(standard deviation < ± 0.02). 
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Immersion of CorGlaes® Pure 107 fibres in c-SBF showed changes from the initial [T0] 
FTIR and Raman spectra over the 336 hour (2 week) immersion period with a whitish 
precipitate gradually forming on the fibres and at the bottom of the vials. This appeared to 
indicate the precipitation of compounds out of solution due to the supersaturated conditions 
of the media and the ions released during glass fibre dissolution (Clement et al. 1999). The 
handling of fibres also became increasingly difficult after immersion periods greater than 
48 hours due to their increased brittleness [273]. 
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Figure 6.3.15. FTIR spectra of CorGlaes® Pure 107 fibres after immersion in c-SBF for up 
to 336 hours (2 weeks) with the formation and suppression of broad peaks over the 
immersion period labelled accordingly. 
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FTIR analysis of the fibres (Figure 6.3.15) showed a shift in the broad absorption peaks 
initially centred at 893cm-1 and ≈448cm-1 [T0] to 916cm-1 and 534cm-1 respectively 
[T336Hour] while a new broad peak spanning across 1200cm-1 to 1000cm-1 was also formed. 
This was coupled with the semi-suppression and complete suppression of the peaks at 
1268cm-1 and 737cm-1 respectively [T336Hour]. A shift in the Raman spectra was also 
observed but adequate results could only be collected from fibres after 336 hours of 
immersion due to fluorescence effects that produced poor signal-to-noise ratios. The 
Raman spectra (Figure 6.3.16) of samples after 336 hours of immersion showed the 
suppression of previous [T0] peaks and the formation of broad peaks centred at 1042cm-1, 
957cm-1, 750cm-1 and 356cm-1. SEM analysis of the fibres revealed the simultaneous 
appearance of cracking and precipitate formation on the fibre surfaces as well as a change 
in the fibre morphology (Figure 6.3.17). This appeared to follow a transition from a 
smooth pristine surface [T0] to one which showed surface cracking and peeling [T6Hour-
T48Hour] that eventually returned to a pristine surface with precipitate deposited across it. 
The immersion of fibres in c-SBF also saw a decrease in its pH from the 7.4 to ≈6.9 after 
336 hours of immersion.  
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Figure 6.3.16. Comparison of Raman spectra obtained from CorGlaes® Pure 107 fibres 
prior to bioactivity testing [T0] and after 336 hours of immersion [T336Hour] in c-SBF at 
37°C with the peaks labelled. 
206 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T0 
a 
d 
g 
b 
e 
h 
c 
f 
i 
j 
T0 T0.5Hour T1Hour 
T3Hour T6Hour T12Hour 
T24Hour T48Hour T168Hour 
T336Hour k 
T 3
36
H
o
u
r 
Figure 6.3.17. SEM Images of CorGlaes® Pure 107 fibres prior to bioactivity testing [T0]
and after immersion in c-SBF at various points over a 336 hour period showing the 
changes across the fibre surface at a) T0 b) 0.5 c) 1 d) 3 e) 6 f) 12 g) 24 h) 48 i) 168 j) 336
hours of immersion [scale bar = 2µm] and k) Image of CorGlaes® Pure 107 fibres on 
25mm SEM mounting stubs after each immersion period in c-SBF prior to SEM imaging 
(moving counter-clockwise from T0 as indicated) showing the decreasing amount of 
retrievable fibre with increasing immersion time from T0→T336Hour. 
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Figure 6.3.18. SEM images of CorGlaes® Pure 107 fibres after immersion in c-SBF a-b) Fibre cross-section showing an outer surface layer of 400.4 nm 
and 550.6nm thickness respectively after 12 hours of immersion [scale bar = 1µm] c-e) Surface precipitation and cracking on fibres after 168 hours of 
immersion [scale bar = 20µm] and f) Surface deposition onto fibres after 336 hours of immersion [scale bar = 10µm]. 
208 
 
 
6.4 Discussion 
The XRD profile of the CorGlaes® Pure 107 fibres confirmed their amorphous structure 
and long-range disorder as found in various other glass fibre compositions such as those 
investigated by Haque et al. (2013). This verified that no crystallisation had occurred 
during fibre manufacturing and that the glass feed temperatures (680-690°C) were suitable 
for fibre production. The absence of any crystallisation peaks also verified the general 
accuracy of the large processing window (PW) previously identified from the DSC 
thermogram of <3mm CorGlaes® Pure 107 fragments (section 5.3.3) [209]. 
A comparison between the DSC results of the ≈Ø20µm CorGlaes® Pure 107 fibres and 
<3mm fragment samples (section 5.3.3) showed a clear difference in the two thermograms 
which was attributed to the improved operating conditions during sample testing. However 
the improved clarity in the thermal events could also be attributed to size effects between 
the tested samples. The nearly identical values for the glass transition (Tg) and 
crystallisation onset temperatures (Toc) correlated well with those found from the monolith 
fragments with the fibre PW (343°C) closely matching that previously determined 
(348°C). The slight discrepancy in PW could be accounted for by user error in the data 
interpretation or size effects between samples due to the increased time required for the 
larger <3mm fragments to reach the furnace temperature. The improved clarity of the 
thermogram obtained from the CorGlaes® Pure 107 fibres also allowed the glass 
crystallisation peak temperatures as well as the glass liquidus temperature to be found [290]. 
The DSC thermogram shown in Figure 6.3.5 also identified the presence of multiple 
crystallisation peaks (Tp1, Tp2, Tp3, Tp4) in the DSC thermogram that were considered to 
represent the occurrence of surface and bulk crystallisation events as well the possibility of 
different crystalline phases. This was based on studies by Reynoso et al. (2003) with the 
broad (Tp1,Tp2) and sharp (Tp3,Tp4) crystallisation peaks seen in Figure 6.3.5 corresponding 
to surface and bulk crystallisation events respectively. The appearance of multiple 
crystallisation events are considered by Reynoso et al. (2003) to be highly sensitive to 
particle size effects and consequently may not have been apparent on the previous 
thermogram obtained from the <3mm fragments. This is due to the larger surface area of 
the fibres that allow a greater number of surface nucleation and growth events to occur 
during crystallisation that increases their signal strength in the DSC thermogram [321]. 
These results would also be in line with work reported by Jones & Clare (2012) where a 
DSC thermogram between a 1mm glass frit and fine glass powder of a P2O5-CaO-MgO-
Na2O-TiO2 system showed the formation of two distinct crystalline phases in its powder 
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format only (Figure 6.4.1). These were later identified as calcium pyrophosphate (Ca2P2O7) 
and a mixed calcium magnesium pyrophosphate (CaMgP2O7) crystallisation phase. Given 
the relative similarity between the compositional components of this glass with the 
CorGlaes® Pure 107 composition it would be anticipated that the crystalline phases in the 
CorGlaes® Pure 107 DSC thermogram may be similar [109, 321].   
 
 
 
 
 
 
 
 
The occurrence of bulk crystalline phases (Tp3, Tp4) at temperatures above the 1000°C melt 
used by Giltech Ltd for the CorGlaes® Pure 107 glass was likely due to the decrease in 
melt viscosity. As discussed by Jones & Clare (2012), the tendency of a glass to crystallise 
is dependent upon its melt viscosity and as a result the increasing temperature would have 
allowed for the formation of crystalline phases due to the increased molecular mobility of 
the phosphate chains to reorganise into a crystalline state. The identification of the liquidus 
temperature at 1074°C would then indicate that a higher melt temperature (>1074°C) 
should be considered for melt quenched applications when working with this glass 
composition. However given that no crystallisation was found in the XRD results of either 
the fibre or bulk forms (Figure 5.3.1) there is also sufficient counter evidence to support 
the current manufacturing methods [109, 249].  
Along with the DSC and XRD, Raman spectroscopy of the CorGlaes® Pure 107 fibres 
identified Q3 and Q2 phosphate structural units that coordinated with its ultraphosphate 
Figure 6.4.1. DSC thermogram of P2O5-CaO-MgO-Na2O-TiO2 glass system between 1mm 
glass frit and fine powder samples showing the formation of two crystalline phases/peaks 
in the glass powder corresponding to the formation of Ca2P2O7 and CaMgP2O7
[Reproduced from Jones & Clare (2012)]. 
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composition (55 mol% P2O5) as discussed by Brow (2000). This subsequently confirmed 
the accuracy of the previous FTIR results (section 5.3.2) [158]. 
The 20.85 ± 3.25µm diameter of the CorGlaes® Pure 107 phosphate glass fibres (Figure 
6.3.7) was in line with the typical 10-20µm diameters used in synthetic fibre reinforced 
composites. A comparison with alternate studies also found the CorGlaes® Pure 107 fibre 
diameters to be in line with those used in the development of similar degradable PGF 
reinforced composites (Table 6.4.1) [322-324]. This is due to the high aspect ratios (i.e. fibre 
length to diameter ratio) of continuous fibres with the large surface area per unit volume 
allowing maximum stress transfer and reinforcement throughout the composite material 
(section 3.2.3). The results consequently indicated that the current manufacturing 
specifications (section 5.2.1) were highly suitable for the production of CorGlaes® Pure 
107 fibres as a composite reinforcing phase [320, 322-324]. 
 
Table 6.4.1. Comparison of phosphate glass fibre diameters used as reinforcing agents in 
polymer composite devices intended for orthopaedic applications. 
Author Fibre Diameter (µm) 
Onal et al. (2007) [325] 18 
Ahmed et al. (2008) [215] 20 - 25 
Ahmed et al. (2008) [218] 20 - 25 
Mohammadi et al. (2011) [216] 10 - 20 
Hasan et al. (2012) [221] 20 ± 5 
Mohammadi et al. (2012) [169] 10 - 20 
Haque et al. (2013) [209] 15 - 25 
Sharmin et al. (2014) [211] 20 
 
 
A typical force-displacement plot from a tensile tested CorGlaes® Pure 107 fibre and its 
corresponding stress-strain plot (Figure 6.3.8) showed a lack of any significant plastic 
deformation prior to sample fracture that is characteristic of a brittle material. However 
from the fifty samples prepared (n = 50) only thirty-two data plots (n = 32) were used for 
further data analysis. This was due to the premature failure of fibre samples during testing 
and the sporadic occurrence of multiple fractures in a single sample that was evident by the 
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multiple deviations in the force-displacement plot (Figure 6.4.2). This was attributed to 
human error during sample preparation with data also excluded from specimens where 
fibre fracture had occurred in close proximity to the epoxy adhesive. 
 
 
Compared to the bulk glass, the average tensile modulus of the CorGlaes® Pure 107 fibres 
was significantly higher and was in line with literature values. This was due to the fibre 
drawing process that preferentially selected the strong P-O-P bonds and installed a degree 
of molecular chain alignment along the fibres long axis (section 3.4.7.1). Such chain 
alignment contradicts the glass’s natural isotropic structure (as found in glass monoliths) to 
produce fibres with anisotropic optical and mechanical properties (Murgatroyd et al., 1943; 
Ahmed et al., 2004; Sharmin et al., 2014). The average tensile modulus of the CorGlaes® 
Pure 107 fibres was also found to be in the upper range when compared with alternate PGF 
compositions that were intended for biomedical applications (e.g. composite reinforcement 
or cell transport vehicles) (Figure 6.4.3) [207, 209-211, 215].  
 
 
 
 
Figure 6.4.2. Force-displacement plot of a rejected tensile tested CorGlaes® Pure 107 fibre 
sample showing evidence of several fractures due to the presence of multiple fibres being 
accidently secured to the housing card during sample preparation. 
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The tensile modulus of a phosphate glass fibre is considered by Sharmin et al. (2014) to be 
dependent upon the same influences as previously discussed for bulk phosphate glass 
monoliths (i.e. the network’s cationic field strength and atomic packing density) (section 
5.4). Furthermore the inherent tensile strength of phosphate glass fibres is believed to be 
regulated by the cross-link density and chain lengths of the phosphate backbone. The 
tensile strength of the CorGlaes® Pure 107 composition is then expected to benefit from 
the presence of magnesium and zinc if acting as intermediate oxides (section 3.4.3) which 
can potentially increase the glass’s cross-link density or chain length by being incorporated 
into the glass’s P-O-P backbone. Yet the large standard deviation in the tensile strength 
and tensile modulus of the CorGlaes® Pure 107 fibres has also made comparisons with 
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Figure 6.4.3 Comparison of CorGlaes
®
 Pure 107 fibre tensile properties with alternate 
phosphate glass fibre compositions of similar ≈20µm diameter, tested according to ISO 
11566:1996 [Data from Ahmed et al., 2008; Cozein-Cazuc et al., 2008; Hasan et al., 2012; 
Haque et al., 2013; Sharmin et al., 2014]. 
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alternate glass fibre properties difficult. This was attributed to several factors related to the 
fibre manufacturing and test sample preparation processes [211].  
Due to constrictions in the testing technique and severely limited number of successfully 
recovered fibre samples after fracture, an accurate correlation between the tensile test 
results and the precise sample fibre diameters could not be established. The averaged fibre 
diameter of 20.85µm was then used for Eqn 6.2.1 as well as Eqn 6.2.2 and as a result 
deviations in the fibre diameter between samples could not be accounted for. Such 
variations would likely have arisen during fibre manufacturing from changes to the 
hydrostatic pressure in the glass melt and thus mass flow through the bushing nozzle as the 
melt volume was depleted as reported by Kobayashi et al. (2010). Consequently, fibre 
diameters obtained at the start of fibre manufacturing were likely to be greater than those at 
the end. This influence is demonstrated in Table 6.4.2 by the change in tensile modulus at 
the upper and lower range of the recorded CorGlaes® Pure 107 fibre diameters [229].  
 
Table 6.4.2. Variation in tensile modulus (Eqn 6.2.2) with lower, average and upper range 
of fibre diameters (section 6.3.4) with the maximum tensile force (0.288N) recorded during 
the tensile testing of CorGlaes® Pure 107 fibres. 
Fibre Diameter (µm) Fibre Cross-Sectional Area (mm2) Elastic Modulus (GPa) 
16.07 2.03×10-4 151.9 
20.85 3.41×10-4 90.3 
27.06 5.75×10-4 53.6 
 
 
The large error in the tensile strengths of the CorGlaes® Pure 107 fibres were to be 
expected however given the similar range reported in previous results (Figure 6.4.3). These 
were attributed to the introduction of Griffith flaws (i.e. surface defects) in the fibres that 
were likely generated during the manufacturing of the tensile testing samples (e.g. cutting 
and handling of the fibres). Yet the presence of such flaws are considered by De Diego et 
al. (2000) to be an accurate representation of the practical fibre properties due to the likely 
handling of fibres experienced during composite manufacturing. The results shown in 
Figure 6.3.11 consequently demonstrated how a straight edge or semi-circular flaw surface 
defect of increasing size (≈0→5µm) had a detrimental effect on the tensile strengths of the 
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CorGlaes® Pure 107 fibres. This was in line with comments by Haque et al. (2013) who 
discussed the large number of studies dedicated to the ‘practical strength’ of oxide glasses 
due to the influence of surface quality on their mechanical performance [207, 209, 326]. 
Accordingly the observed variation in tensile strength was accounted for by a Weibull 
distribution with the resulting Weibull modulus (m) providing a dimensionless measure of 
the strength distribution throughout the fibres. From this it was found that the CorGlaes® 
Pure 107 fibres gave a Weibull modulus of m = 3.41 for the tested sample set with a 
normalising stress (σ0) of 525 MPa. The Weibull modulus value fell within the range 
reported for ceramic materials (m = 2-15) but was significantly lower than those typically 
found in commercial grade glass fibres (m = 10-30). A Weibull modulus <4 also indicated 
that the flaws present on CorGlaes® Pure 107 fibres were not evenly distributed throughout 
the material and suggested a degree of continuity. This could imply that the scatter in fibre 
tensile strengths was related to the specific handling of the fibres during sample 
preparation. The Weibull modulus was also found to be comparable to values reported 
during the tensile testing of (P2O5)50-(CaO)40-(Na2O)5-(Fe2O3)5 (mol%) fibres (m = 3.37) 
by Ahmed et al. (2009) using the same testing method. Yet studies by Sharmin et al. 
(2014) have demonstrated the ability to produce PGFs with Weibull moduli (m) as high as 
7.7-10.5 (Figure 6.4.4) [211, 215, 218, 300, 327]. 
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Figure 6.4.4. Comparison of CorGlaes® Pure 107 fibre Weibull modulus (m) and 
normalising stress (σo) with alternate PGF’s tested according to ISO 11566:1996 [Data 
from Ahmed et al., 2008,2009; Cozien-Cazuc et al., 2008; Sharmin et al., 2014]. 
215 
 
The dissolution of as made and surface treated CorGlaes® Pure 107 fibres in different 
media (Figure 6.3.13) showed distinct changes to the fibre dissolution rates over the initial 
24 hours. Continued immersion over the entire 168 hour period also revealed the weight 
loss profile to be non-linear after 72 to 96 hours of dissolution following an inverse 
exponential curve. Fibres immersed in distilled water (2.83×10-2 mg cm-2 hr-1) and PBS 
(2.55×10-2 mg cm-2 hr-1) appeared to display comparable dissolution rates whilst similar 
rates were observed between samples immersed in c-SBF (1.67×10-2 mg cm-2 hr-1) and 
silane treated fibres (1.44×10-2 mg cm-2 hr-1) over the initial 24 hours. The dissolution of 
fibre samples in distilled water, c-SBF, PBS and silane treated fibres was also coupled with 
a universal drop and plateau in pH after 24 hours to ≈2 (Figure 6.3.12). This pH reduction 
was significantly lower than that previously recorded from the dissolution of CorGlaes® 
Pure 107 disks (section 5.3.7.1) and was attributed to the increased surface area-to-volume 
ratio with the fibres (14.4 cm2 ml-1) compared to the previous tests (0.18 cm2 ml-1). Due to 
the static test conditions, this led to a greater accumulation of phosphate species and 
concentration of phosphoric acid in the media. In contrast, fibres immersed in DMEM 
showed the slowest rates of fibre dissolution (7.63×10-3 mg cm-2 hr-1) that appeared to 
degrade in a linear fashion over a prolonged period compared to the other media. The pH 
also displayed a more gradual decrease reaching ≈4.5 at 72 hours and corresponded with a 
visible change in the media colour from red to yellow before it was replaced with fresh 
DMEM after 96 hours. 
It is believed that PGFs will undergo the same dissolution mechanisms as their bulk 
monolith equivalent with the same compositional dependence. However phosphate glass 
fibres will typically degrade faster than the equivalent bulk sample as seen with the 
CorGlaes® Pure 107 composition and agrees with data reported by Ahmed et al. (2004). 
This is due to the increased surface area and different mechanical/thermal histories 
between each form (e.g. the rapid air quenching of the fibres). The reduced fibre 
dissolution rates in DMEM were also in line with the trends observed by Patel & Knowles 
(2006) but remained below the preferred dissolution rate of fibres intended for composite 
reinforcement (2×10-4 mg cm-2 hr-1) as suggested by Hasan et al. (2012) [194, 201, 205, 210]. 
It has been previously reported by Franks et al. (2000) that the ionic concentration of an 
immersion media can influence the rate of ionic diffusion from a phosphate glass (i.e. 
dissolution rate) [174]. Consequently it was believed that the initial ionic conductivity of 
each media would correspond with its ability to suppress the dissolution rate of the 
CorGlaes® Pure 107 fibres. However this trend was not strictly reflected in these results 
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with similar dissolution rates observed in the distilled water (≈0 mS cm-1) and PBS (14.8 
mS cm-1).  This contrasted previous results reported by Rinehart et al. (1999) who observed 
a reduced dissolution rate when PGFs were immersed in PBS compared to distilled water 
[270]
. However this discrepancy between these results and those of Rinehart et al. (2009) 
could be accounted for by the difference in glass composition and testing conditions. 
Rinehart et al. (1999) used a 500ml circulating flow system (SA:V = 0.15 cm2 ml-1) while 
this study used a 10ml static environment (SA:V = 14.4 cm2 ml-1). As a result the influence 
of the dissolution by-products on the glass dissolution process (specifically any 
autocatalysis effects) would have been substantially more severe in the CorGlaes® Pure 
107 experimental set up. The inhibitory effect of c-SBF on phosphate glass dissolution has 
been previously associated with the presence of Na+, Ca2+ and HPO42- by Uo et al. (1998). 
However c-SBF also contains Mg2+/Ca2+ and as a result, the reduced rates observed in c-
SBF (19.53 mS cm-1) compared to PBS (14.8 mS cm-1) may be due to the absence of these 
ions in the PBS composition used in this experimental method. Some visible precipitation 
within the c-SBF may have also influenced the weight loss measurements however no 
method of separating the precipitated phases could be employed without damaging the 
fibres (and further influencing the weight data) [176, 201]. The decreasing rate of fibre 
dissolution in the various media after 72 to 96 hours was assumed to be due to the ionic 
saturation of the media and correlated with 80-85% of the fibre weight being lost in all 
samples except DMEM. This decrease was attributed to the saturation of the media with 
the least soluble ionic species (corresponding to the glass’s composition) as previously 
reported by Cozien-Cazuc et al. (2009) [201].  
The improved durability of fibres degraded in DMEM media agreed with previous work by 
Patel & Knowles (2006) and was believed to be due to the presence of a sodium 
bicarbonate (NaHCO3) pH buffering agent in the DMEM that retarded the decrease in 
media pH and autocatalysis effects during fibre dissolution [206]. This buffering agent 
subsequently accounted for the observed improvement in fibre durability compared to c-
SBF despite their similar ionic composition (Table 6.2.2).  
The progressive change in DMEM colour was due to the presence of a phenol red pH 
indicator in the media that will change from its native red (at neutral) to yellow in acidic 
conditions. Although bioactivity has been reported with bioactive glasses in DMEM by 
Lutišanová et al. (2011), no visible precipitates were found in the vials during fibre 
dissolution and thus any influence to the weight measurements were considered to be 
negligible. Silane surface treated fibres also showed a reduction in fibre dissolution rates 
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that were comparable to that displayed by c-SBF. Based on comments by Cozien-Cazuc et 
al. (2009) this was considered to indicate the successful bonding between the sizing agent 
and fibre surface with the reduction in fibre dissolution rates stemming from the formation 
of a hydrophobic surface layer that helped protect against water diffusion into the glass [206, 
227, 328]
. 
A comparison between the dissolution rate of the CorGlaes® Pure 107 fibres in distilled 
water and PBS with those reported in the literature for similar diameter PGFs showed the 
CorGlaes® Pure 107 fibres to possess a high dissolution rate (Figure 6.4.5). However a 
direct comparison is obscured by the high SA:V ratio used in the testing procedure of the 
CorGlaes® Pure 107 fibres (14.4 cm2 ml-1) compared to the average used in the majority of 
alternate methods (≈7.3 cm2 ml-1). As previously discussed by Mohammadi et al. (2012), 
the SA:V ratio will have a significant effect on fibre dissolution rate and would make the 
autocatalytic effects more severe for the CorGlaes® Pure 107 fibres. However given that 
high SA:V ratios would be encountered at the fibre-matrix interface in a composite 
material during its degradation, the dissolution rates and pH values measured here were 
considered to provide a better prediction of the fibres behaviour as a composite reinforcing 
agent. The use of annealing treatments has also been shown in various studies to reduce the 
dissolution rate of phosphate glass fibres compared to their as made state (section 3.4.7.3) 
and may be of interest for further processing of the CorGlaes® Pure 107 fibres [169, 201, 207, 
209, 211, 270]
. 
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Figure 6.4.5. Comparison of CorGlaes® Pure 107 fibre dissolution rates in distilled water and PBS compared with alternate PGF compositions [Data 
from Rinehart et al., 1999; Cozien-Cazuc et al., 2009; Haque et al., 2013; Sharmin et al., 2014]. 
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Inspection of the FTIR spectra after the immersion of CorGlaes® Pure 107 fibres in c-SBF 
found that these traces failed to correlate with the distinct wavenumber peaks of a 
crystalline apatite as reported in previous studies such as the silica based glass fibres 
investigated by Clupper et al. (2004). The lack of any sharp, well defined peaks in the 
FTIR spectra was indicative of an amorphous phase on the fibre surface and was initially 
interpreted as indicating a form of amorphous calcium phosphate (ACP, Ca/P = 1.5). This 
phase is considered to serve as a precursor to bone mineralisation and can spontaneously 
transform into crystalline apatite phases depending on the precipitation conditions (i.e. pH 
and Ca/P ratio). However approximate wavenumber values from the FTIR and Raman 
spectra failed to match with those documented for ACP and were believed to correspond 
with the precipitation of amorphous pyrophosphate salts (Leeuwen et al. 2012) [329-331]. 
These included calcium pyrophosphate (Ca2P2O7) (Ca/P = 1), magnesium pyrophosphate 
(Mg2P2O7) and zinc pyrophosphate (Zn2P2O7) with the amorphous nature of these phases 
attributed to the rapid rate of precipitation from the super saturated c-SBF solution (Figure 
6.4.6).  Such compounds would also correlate with the ionic constituents of the CorGlaes® 
Pure 107 composition and have been previously reported to precipitate during PG 
dissolution by Franks et al. (2000) and Khor et al. (2011) [174, 187].  
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Figure 6.4.6. a) FTIR absorption spectra of various semi-amorphous metal pyrophosphate 
salts over 2000-400cm-1 wavenumber range [Reproduced from Leeuwen et al. (2012)] and 
b) FTIR of CorGlaes® Pure 107 fibres after 336 hours of immersion in c-SBF (1400-
400cm-1). 
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220 
 
These phases are expected to form via hydrolysis mechanisms (as described in Eqn 6.4.1 
for Zn2P2O7) with the observed decrease in media pH over the immersion period resulting 
from the phosphoric acid (H3PO4) reaction by-product [187, 332].  
 
ZnHPO4 (aq) + ZnH2P2O7 (aq) + 3H2O (aq) → H3PO4 (aq) + Zn2P2O7·3H2O ↓  
Eqn 6.4.1 
 
The application of pyrophosphates for bone regenerative applications has received limited 
attention and is considered to be relatively unexplored according to Grover et al. (2013). It 
has also been reported by Kasuga et al. (2005) that β-calcium pyrophosphate (β-CPP) can 
display bioactivity similar to that of hydroxyapatite (HA) and beta tricalcium phosphate (β-
TCP). However pyrophosphate ions (P2O7)4- are known to supress HA crystallisation and 
have consequently also been discussed as a method of influencing and controlling bone 
mineralisation. This is due to the ability of alkaline phosphatase (an enzyme secreted by 
osteoblasts) to hydrolyse pyrophosphate ions and alleviate the inhibitory effects of 
pyrophosphate salts. In vivo mineralisation is then stimulated through the release and 
saturation of the surrounding extracellular fluids with orthophosphate units (PO4)3- [168, 333, 
334]
.  
Yet it is also possible that these precipitates may also have consisted of magnesium (Ca2-
xMgxP2O7) and zinc (Ca2-xZnxP2O7) doped calcium pyrophosphate. However the precise 
identification of each respective amorphous phase from the available FTIR/Raman spectra 
is restricted due to the similar IR signals of these salts and associated band overlapping. 
Further identification could be conducted by post-annealing and repeated analysis via XRD 
and FTIR with deconvolution of the spectra to identify the crystalline phases as performed 
by Franks et al. (2000) and Khor et al. (2011)  [330, 331, 335].  
Yet despite the potential of these pyrophosphate salts for in vivo applications, the inability 
of the CorGlaes® Pure 107 glass composition to form a more ‘traditional’ bioactive apatite 
layer (i.e. HCA) across the fibres surface during in vitro test conditions was in line with the 
literature. The precipitation of these salts reflected the high dissolution rate of the 
CorGlaes® Pure 107 fibres when compared to the CorGlaes® Pure 107 disks and this rate is 
considered to directly influence the resulting calcium phosphate phase (Mohammadi et al. 
2012). Furthermore the decrease in media pH produced from ultraphosphate glass 
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dissolution is believed to supress apatite formation despite the large quantities of calcium 
and phosphate released into the media. However as stated in section 3.4.5, some PG 
compositions such as those investigated by Kiani et al. (2012) have demonstrated the 
ability to exhibit bioactivity in vivo despite failing to do so in vitro. This could be due to 
the in vivo circulation of the extracellular fluid helping to maintain a physiological pH in 
the surrounding environment and allowing for apatite nucleation on the glass surface 
compared to the static environment encountered in vitro. Consequently the CorGlaes® Pure 
107 fibres may also be capable of displaying similar behaviour in vivo through improved 
regulation of the pH [100, 168, 170, 177, 273, 289]. However it should also be considered that when 
applied as a composite reinforcing agent, the altered fibre dissolution rates as well as the 
volume fraction of fibres employed (section 3.2.3.2) may lead to the development of 
alternate phases when such composites are immersed in c-SBF. 
Lastly, the observed change in fibre morphology over the immersion period was attributed 
to the dissolution of the fibres and the subsequent cracking/peeling of an outer surface 
layer on the glass fibres. This change in morphology was in line with previous SEM 
images (Figure 6.4.7) observed during PGF dissolution by Rinehart et al. (1999) and 
Sharmin et al. (2014) with SEM images of the CorGlaes® Pure 107 fibres (Figure 
6.3.18a,b) indicating a surface layer of ≈0.4-0.55µm [211].  
 
 
 
 
 
 
 
 
 
Figure 6.4.7. SEM image of phosphate glass fibres after 24 hours of immersion in PBS at 
37°C showing significant cracking and peeling of the outer surface layer [Reproduced from 
Rinehart et al. (1999)]. 
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6.5 Conclusions 
Thermal analysis of the CorGlaes® Pure 107 fibres confirmed the high suitability of this 
novel PG composition for fibre production due to its high thermal stability. Tensile testing 
of the ≈Ø20µm CorGlaes® Pure 107 fibres also confirmed their mechanical suitability as a 
composite reinforcing agent. However the susceptibility of the CorGlaes® Pure 107 fibres 
to autocatalytic effects gives them unsuitably high dissolution rates. The dissolution rate of 
the fibres was also found to vary between different media as well as after an APS surface 
treatment with the Dr strongly retarded through adequate control of the media pH. The fast 
dissolution rate of these fibres was responsible for the formation of pyrophosphate salts 
when immersed in c-SBF due the rapid ion release and decrease in c-SBF pH. 
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7 CorGlaes® Pure 107 Fibre Composites as Potential Cranioplasty Plates  
 
7.1 Outline 
Mechanical testing of the ≈Ø20µm CorGlaes® Pure fibres (chapter 6) showed their 
suitability as a potential composite reinforcing agent. This was due to their tensile strength 
(426 ± 143 MPa) and tensile modulus (65.5 ± 20.8 GPa) being in line with previous PGF 
data obtained from the literature that were intended for similar applications. Consequently 
the characterisation of a CorGlaes® Pure 107 fibre reinforced composite material was 
conducted with the initial composite specifications based on the parameters and 
specifications (e.g. manufacturing method, volume fractions, matrix etc.) frequently 
employed in the literature (section 3.4.8). 
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7.2 Materials and Methods 
7.2.1 CorGlaes® Pure 107 Glass Fibre Mats 
Continuous fibre mats of unidirectionally aligned (UD) and randomly orientated 
continuous fibre (RCM) architectures for composite manufacturing were produced by 
manually expanding the melt spun CorGlaes® Pure 107 fibre tows (Figure 6.2.1). For UD 
mats, the tows were evenly expanded parallel to the fibre’s primary axis whilst random 
fibre mats were generated by collectively drawing out fibres across a metal table tangential 
to their primary axis. This formed a loose fibrous structure that was then circumferentially 
collected around a hand driven mandril with the resulting expansion inducing random 
orientations throughout the fibres. The expanded mats were then removed from the 
mandrill before being cut and stored in PE bags (Figure 7.2.1) [122].  
 
 
 
 
 
 
 
 
 
7.2.2 Composite Precursors 
7.2.2.1 Fibre Pre-Pregs 
Polymer impregnated continuous CorGlaes® Pure 107 fibre mats (pre-pregs) were created 
by cutting the UD/RCM fibre mats into 130x80mm sections and preparing a low viscosity 
3 w/v % 3001D PLA (NatureWorks®, USA) solution using chloroform (VWR, USA) as 
Figure 7.2.1. Illustration of manufacturing method for producing random continuous fibre 
mats (RCM) from a CorGlaes® Pure 107 fibre tow a) Expansion of fibres parallel to fibre 
tow b) Collection around a hand driven mandril and c) Cutting and removal from mandril 
into RCM mats [Modified from Mallick (1997) Composites Engineering Handbook]. 
CorGlaes® Pure 107 Fibre Tow 
Tow expansion  
Collection of expanded fibres around rotating mandril 
Random continuous fibre mats produced 
after removing from mandril 
a b c 
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the polymer solvent. Fibre mats were then placed in metal foil trays (130x80x10mm) 
inside a fume cabinet and solvent cast with a pre-determined volume of the PLA solution 
to achieve a desired pre-preg (pp) fibre volume fraction (Vf-pp). The solvent cast pre-preg 
mats (Figure 7.2.2a-b) were then left for 12 hours to allow the solvent to completely 
evaporate before being removed from the trays and stored inside a desiccator. 
To quantify the primary orientation and coherency in the fibre alignment of each mat 
architecture type, images of the fibre pre-pregs were analysed using ImageJ software 
(National Institutes of Health, USA). ImageJ is an open source Java based platform 
employed for image processing and analysis that was developed by the National Institutes 
of Health (NIH) and was used in conjunction with an additional OrientationJ plug-in. The 
analysis was performed on 5 images (n = 5) from each fibre mat type and compared with 
an idealised set of aligned or randomly orientated arrays. These were generated using 
MATLAB software (MathWorks®, USA) and acted as control images (Figure 7.2.2). 
 
 
 
 
 
 
 
 
 
 
a b 
Figure 7.2.2. Back-lit illuminated images of a) 100x50mm section of UD solvent cast 
CorGlaes® Pure 107 fibre pre-preg [scale bar = 10mm] b) 100x50mm section RCM solvent 
cast CorGlaes® Pure 107 fibre pre-preg [scale bar = 10mm] c) Orientation axis used in 
OrientationJ results d) Unidirectional (UD) control image and e) Randomly orientated 
control image (generated by MATLAB).  
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7.2.2.2 Matrix Sheets 
Matrix sheets of 0.1-0.2mm thickness were manufactured by compressing 9g of 3001D 
PLA granules (NatureWorks®, USA) between two 305x305mm heated plates of a 
hydraulic compression moulding press (Mackey Bowley, England) at 200°C (Figure 
7.2.3). The polymer granules were compressed under 1.5-2 MPa of pressure for 30 seconds 
before cooling to room temperature by passing water through both cooling plates. The PLA 
sheets were then cut into 130x80mm sections. To prevent polymer adhesion to the heated 
plates, intermediate layers of greaseproof paper were placed between the granules and the 
plates during manufacturing. 
 
 
 
 
 
 
 
 
 
7.2.3 Composite Manufacturing 
Continuous CorGlaes® Pure 107 fibre laminated composites were manufactured using a 
hand lay-up film stacking and compression moulding method with each CorGlaes® Pure 
107 fibre pre-preg lamina (n = 6) stacked alternatively between 3001D PLA matrix sheets 
(n = 7) (Figure 7.2.4a-b). Compression moulded composites were created inside a 
130x80mm stainless steel three-piece cavity mould (Figure 7.2.4c) using the compression 
moulding press (Figure 7.2.3) at 200°C for 15 minutes before being cooled to room 
temperature under 4 MPa pressure. To improve consistency in the composite thickness, 
metal shims were used in conjunction with the mould whilst a PTFE dry film lubricant 
(251-3794, RS Components, UK) was applied prior to composite manufacturing in order to 
ease removal of the sample from the mould (Figure 7.2.4d).  
 
Figure 7.2.3. Compression moulding press used to produce PLA matrix sheets and 
CorGlaes® Pure 107 composites. 
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Composites of different fibre volume fractions (Vf) and fibre architectures were 
subsequently manufactured based on the accumulative contributions from the polymer 
matrix and fibre pre-pregs that were calculated using Eqn 7.2.1 and Eqn 7.2.2. For aligned 
composites, UD lamina were alternatively stacked perpendicularly to the previous lamina 
to produce a symmetric cross-ply composite lay-up [0/90/0/90/0/90]T (where T denotes the 
total laminate stacking sequence). The predetermined fibre weight (wf), fibre volume 
fraction (Vf) and manufacturing specifications for each composite configuration are shown 
in Table 7.2.1[120, 122]. 
Positive control samples of 3001D PLA (NatureWorks®, USA) were also manufactured by 
placing 30g of 3001D PLA polymer granules into the cavity mould inside the compression 
moulding press at 200°C for 10 minutes. The mould was then cooled to room temperature 
under 4 MPa pressure. 
 
Figure 7.2.4. Illustration of a) Alternating film stacking technique with PLA matrix sheets 
and CorGlaes® Pure 107 fibre pre-pregs [Reproduced from Gibson & Månson (1992)]  b) 
Sequential lay up of matrix films and fibre pre-pregs under heat and pressure inside the 
cavity mould [Reproduced from Gibson & Månson (1992)] c) 130x80mm stainless steel 
cavity mould used for composite manufacturing [scale bar = 10mm] and d) 130x80mm 
0.2Vf RCM composite plate marked for further cutting stages of sample manufacturing 
[scale bar = 10mm]. 
Mould Heat and pressure 
Matrix 
Fibre pre-preg 
a 
d c 
b 
10mm 10mm 
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Eqn 7.2.1 
where Wf = composite fibre weight fraction, wc = composite weight (g), wf = composite 
fibre weight (g), wm = composite matrix weight (g). 
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Eqn 7.2.2 
where Vf = composite fibre volume fraction, Wm = composite matrix weight fraction,  ρf  = 
fibre density (g cm-3) [2.65 g cm-3], ρm = matrix density (g cm-3) [1.25 g cm-3] [122]. 
 
Table 7.2.1. Manufacturing specifications of CorGlaes® Pure 107-PLA composites. 
 CorGlaes® Pure 107 Pre-Preg (pp) PLA Matrix 
Composite 40ml 3 w/v % PLA solution 0.1-0.2mm sheets 
Sample Vf Fibre weight per pp (g) Vf-pp Weight per sheet (g) 
a 0.01Vf RCM 0.01 0.1 1 ≈2.9 
a 0.05Vf RCM 0.05 0.4 1 ≈2.9 
  b
 0.1Vf RCM 0.1 0.8 0.5 ≈2.4 
0.2Vf RCM 0.2 2.5 0.5 ≈2.9 
c 0.2Vf [0/90]3S 0.2 2.5 0.5 ≈2.9 
a No solvent casted pre-pregs (pp) were manufactured with the low Vf composites due to the difficulty in 
removing the resulting pre-pregs from the foils trays without significant sample damage.  
b
 14ml of 3 w/v % PLA solution used to solvent cast 0.1Vf composite pre-pregs. 
c
 [0/90]3S represents the total stacking sequence ([0/90/0/90/0/90]T) based upon its symmetry (s) and 
repetition (n = 3) of the [0/90] orientated cross-ply. 
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7.2.4 Mechanical Properties 
The flexural strength (σcomp) and elastic modulus (Ecomp) of all CorGlaes® Pure 107-PLA 
composites and PLA control samples was assessed using a three-point bend method based 
on BS EN ISO 14125:1998. Testing specimens were cut from the 130x80mm composite 
plate (Figure 7.2.4d) to 60x15x2mm rectangular beams using a bandsaw in accordance 
with BS EN ISO 14125:1998. Due to the homogenous (RCM) or symmetrical ([0/90]3S) 
nature of the CorGlaes® Pure 107-PLA composite lamina, no preferential orientation was 
selected during sample cutting with all specimens cut according to sample ‘A’ as shown in 
Figure 7.2.5a [336]. 
 
 
 
 
 
 
 
 
 
Samples were then tested using a Zwick/Roell Z250 (Zwick Roell, USA) testing 
equipment with a 1kN load cell at a crosshead speed of 2mm min-1 in the testing 
arrangement illustrated by Figure 7.2.5b where the loading member radius (R1) = 5mm, 
support member radius (R2) = 2mm, support span (L)  = 40mm, specimen span (l) = 60mm 
and specimen thickness (h) = 2mm. Force-displacement data was recorded using 
Zwick/Roell TestXpert® software with the mechanical properties of the specimens 
calculated using Eqn 7.2.3, Eqn 7.2.4 and  Eqn 7.2.5 as described in Method A of BS EN 
ISO 14125:1998 [336]. Prior to testing, the width and thickness of each sample was 
measured at three different locations with digital callipers and used to calculate an 
averaged thickness (h) and width (b) for each specimen. 
 
Figure 7.2.5. Illustration of a) Cutting specifications for samples cut along the length 
direction of the composite (A) and samples cut along the width direction of the composite 
(B) and b) 3-point bend testing arrangement used to test the CorGlaes® Pure 107-PLA 
composites and control samples [Reproduced from BS EN ISO 14125:1998]. 
a b 
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Eqn 7.2.3 
where σcomp = flexural strength (MPa), F = maximum load (N), L = specimen span (mm), h 
= specimen thickness (mm), b = specimen width (mm). 
 
u  vwx	1yz{      uu  vwxx1yz{  
Eqn 7.2.4 
where s’ = beam mid-point deflection1 (mm), s” = beam mid-point deflection2 (mm), εf’ = 
flexural strain1 (0.0005), εf” = flexural strain2 (0.0025). 
 
=,+& 	 pA4PℎA 	<∆r∆> 
Eqn 7.2.5 
where Ecomp = elastic modulus (MPa), ∆F = differential between F’ and F” from sample 
force-displacement plot corresponding to s’ and s” respectively (N), ∆s = differential 
between deflections s’ and s” (mm). 
 
A comparison between the experimental and theoretical elastic moduli was also conducted 
using the rule of mixtures (ROM) (Eqn 7.2.6). This model is based on the composite 
properties being the sum of each constituent with regards to their respective volume 
fractions. This can subsequently be used to predict the effective longitudinal (primary) or 
transverse elastic modulus in a laminate composite [219]. 
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Eqn 7.2.6 
where E1 = elastic modulus (primary), n0 = correction factor depending upon composite 
fibre orientation (0.375 for random in plane fibres and 0.5 for a balanced 0°/90° lay-up), n1 
= correction factor dependent upon fibre length (1 for fibres that are ≥10lc, where lc is the 
critical fibre length), Ef = fibre modulus (GPa), Em = matrix modulus (GPa), Vf = fibre 
volume fraction. 
 
7.2.5 Degradation 
7.2.5.1 Weight Loss and Mechanical Properties 
Degradation of 0.2Vf RCM and 0.2Vf [0/90]3S samples as well as a PLA control was 
carried out using distilled water on 60x15x2mm samples at a 0.21 cm2 ml-1 SA:V ratio. 
Samples were stored individually within PP bottles and placed inside a 37°C incubator for 
up to 1008 hours (six weeks) before being evaluated in triplicate (n = 3) at each immersion 
period. Analysis of the degraded samples along with replacement of the immersion media 
was then conducted following the procedure outlined in Table 7.2.2. 
 
Table 7.2.2. Immersion period and sample data during degradation of composite and 
control samples over 1008 hours in distilled water at 37°C. 
Immersion Period  
(hours) 
Data Measurement Points/Media Change 
2, 4, 6, 24, 48, 72, 96, 
120, 144, 168 
*Wet weight 
Media pH 
At each immersion period 
168, 336, 504, 672, 
840, 1008 
Wet weight, Dry weight 
Media pH 
Flexural strength 
Elastic modulus 
At each immersion period. Media 
changed at each immersion period 
and every 72 to 96 hours between 
measurements. 
*Composite wet weight over the first 144 hours only collected for 0.2Vf RCM composite and PLA control 
samples. 
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Due to the cutting procedure of the 130x80x2mm composite plate, samples were open-
ended (i.e. exposed fibre faces) across 3 or 4 cross sectional faces. To ensure comparable 
results between samples, a 10 w/v % 3001D PLA solution was applied to the required 
composite faces so that only 3 cross-sections on all samples were exposed as shown in 
Figure 7.2.6.  
 
 
 
 
 
 
 
During degradation, composite/control sample wet and dry weight as well as the 
degradation media pH were measured using a ±0.1mg Pioneer™ analytical scale (Ohaus, 
USA) and HI 221 pH Meter (Hanna Instruments, USA) respectively. For dry weight 
measurements all samples were dried in an air circulated oven at 60°C for 12 hours prior to 
measurement with the sample wet weight and dry weight calculated using Eqn 7.2.7. These 
results were then plotted against the immersion period (hours). 
 
NℎKDC		 C(	K	TIQ	 CDℎ(  /W  /L/W ∗ 100 
Eqn 7.2.7 
where w0 = initial sample weight (mg) and wt = sample wet/dry weight measured at time tx 
(mg) 
 
The flexural strength and elastic modulus of the degraded samples were subsequently 
evaluated using a three point bend method as outlined in section 7.2.4 using Eqn 7.2.3, Eqn 
7.2.4 and Eqn 7.2.5 at each designated immersion period according to Table 7.2.2. SEM 
images of the 0.2Vf RCM composite as well as the PLA control fracture faces after 
Figure 7.2.6. Image of 60x15x2mm 0.2Vf RCM composite sample used in degradation 
testing with the three exposed cross-sectional faces indicated [scale bar = 10mm]. 
Exposed cross-sectional faces 
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degradation and mechanical testing were captured using a Sigma VP SEM (Carl Zeiss, 
Germany) in SE and BSE modes at a 10kV accelerating voltage after coating the sample 
fracture sites with gold (Agar Scientific, UK) based on section 6.2.4. This was performed 
at the School of Geographical and Earth Sciences, University of Glasgow. 
 
7.2.5.2 Ion Release 
Ionic concentrations in the distilled water during the first 168 hours of 0.2Vf RCM 
composite degradation (section 7.2.5.1) were measured following the procedure outlined in 
section 5.2.8.2. 
 
7.2.6 DMEM Degradation 
Degradation of 0.2Vf RCM composites in acellular protein free DMEM (Sigma-Aldrich, 
USA) was conducted following the composite manufacturing and degradation methods as 
outlined in section 7.2.3 and section 7.2.5 respectively. Growth of bacteria and fungi in the 
DMEM was inhibited through the addition of sodium azide (Sigma-Aldrich, USA) to the 
DMEM at 0.1 vol% prior to composite degradation as previously described in section 
6.2.7.  
The precipitate formed on the degraded composite samples was examined by FTIR and 
XRD using the equipment and specifications outlined in section 5.2.3 and section 5.2.2 
respectively. SEM images of the degraded composite fracture sites after mechanical testing 
was also conducted at a 5kV or 10kV accelerating voltage using a Hitachi S9000 SEM 
(Hitachi, Japan) after coating the fractured composite faces with gold (Agar Scientific, 
UK). This was conducted at the James Watt Nanofabrication Centre (JWNC), University 
of Glasgow. 
 
7.2.7 Bioactivity 
The bioactivity of 0.2Vf RCM composite samples was assessed by immersing 15x15x2mm 
samples in c-SBF for 24, 72, 120, 168 and 336 hours at a 0.1 cm2 ml-1 SA:V ratio. The c-
SBF was prepared following the procedure outlined in section 5.2.9.1 with samples stored 
individually in inside PP bottles within a 37°C incubator. The c-SBF was not replaced over 
the immersion period and samples were assessed in triplicate (n = 3) by measuring the 
composite wet weight and media pH at each immersion period after washing the samples 
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in acetone (VWR, USA) to halt any further surface reactions as described in section 
5.2.9.2. The results were then plotted against the immersion period (hours) with the sample 
planar and cross-sectional faces analysed by FTIR as described in section 5.2.9.2. 
 
7.2.8 Biocompatibility 
Prior to biocompatibility testing of the composite samples, in vitro cell culture and cell 
seeding was conducted following the method outlined in section 5.2.10.2.  
The biocompatibility of 10x10x2mm 0.01Vf, 0.05Vf, 0.1Vf and 0.2Vf RCM composites 
was investigated by an initial MTT assay on MG63 cells following the methods described 
section 5.2.10.3 using 100 vol% extracts from each composite configuration after 24 and 
96 hours of degradation. Samples were degraded at a 1.4 cm2 ml-1 SA:V in CDMEM with 
10x10x2mm 3001D PLA samples used as a secondary positive control sample. The pH of 
the degradation media for each MTT assay was also measured from a sample of the extract 
using a HI 221 pH Meter (Hanna Instruments, USA). Cytotoxicity testing by MTT assay 
was also conducted on diluted extract concentrations (0.1, 10, 50 and 100 vol%) obtained 
from the degradation of 0.2Vf RCM composites after 24 and 96 hours in CDMEM based 
on the method previously performed in section 5.2.10.3. 
After the MTT assay, biocompatible composite configurations were then to be evaluated 
by a direct contact cell culture and Live/Dead® staining (section 5.2.10.4) following the 
flow chart shown in Figure 5.2.3 at a 1.4 cm2 ml-1. This SA:V ratio was selected so that a 
better correlation between the MTT and Live/Dead® staining could be achieved. 
Note: Although a 1.25 cm2 ml-1 SA:V ratio was intended for the composite MTT assay and 
Live/Dead® staining (section 5.2.10.3), significant lag in the pipette guns at the time of 
testing resulted in a 1.4 cm2 ml-1 SA:V ratio being used. To allow for comparisons between 
future results and across samples, a 1.4 cm2 ml-1 was consequently used in all future 
composite biocompatibility testing.  
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7.3 Results 
7.3.1 Pre-Preg Orientation 
The primary orientation and coherency in the computer generated control images as 
determined by the ImageJ® software is shown in Table 7.3.1 and compared with the 
average results for each fibre mat pre-preg architecture. 
 
Table 7.3.1. Comparison of fibre anisotropy in UD and RCM fibre pre-pregs as defined by 
the primary orientation and coherency of their alignment using MATLAB control images 
and ImageJ® software. 
Sample Primary Orientation (°) Coherency (%) 
Parallel aligned control image 90 100 
Random control image 48 3 
Aligned pre-preg  87 ± 2 83 ± 3 
Random pre-preg  18 ± 9 30 ± 3 
 
 
7.3.2 Mechanical Properties 
Comparative stress-strain plots from a tensile tested CorGlaes® Pure 107 fibre (filler) as 
well as that obtained from the three point bend testing of a NatureWorks® 3001D PLA 
polymer control sample (matrix) and a 0.2Vf RCM composite are shown in Figure 7.3.1 
with the respective failure stresses (σf/σm) and strains (εf/εm) overlaid. The flexural stress 
and elastic moduli of composites with increasing Vf alongside a PLA control is shown in 
Figure 7.3.2 with a complete description of each samples mechanical properties listed in 
Table A.1. of Appendix A. The elastic moduli of these composites is also compared with 
those predicted using the rule of mixtures model in Figure 7.3.3. 
A comparison between the stress-strain plots obtained from the mechanical testing of 0.2Vf 
RCM and 0.2Vf [0/90]3S composite architectures is shown in Figure 7.3.4. 
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Figure 7.3.1. Stress-strain plots of CorGlaes® Pure 107 fibre (filler), NatureWorks® 3001D 
PLA polymer (matrix) and 0.2Vf RCM composite with the ultimate stress (σf/σm) and 
strain at failure (εf/εm) of each precursor phase indicated. 
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Figure 7.3.2. Variation in flexural strength and elastic modulus of CorGlaes® Pure 107 
fibre-PLA composites with increasing fibre volume fraction (0→0.2Vf) and different fibre 
architectures (RCM and [0/90]3S) alongside a PLA control. 
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Figure 7.3.3. Comparison of experimental composite primary elastic modulus (E1) with
that predicted by the rule of mixtures model over different composite fibre volume 
fractions (0→0.2Vf) and architectures (RCM, [0/90]3S). 
Figure 7.3.4. Comparison between stress-strain plots of 0.2Vf RCM and 0.2Vf [0/90]3S
composites obtained from three point bend testing according to BS EN ISO 14125:1998. 
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7.3.3 Degradation 
7.3.3.1 Weight Loss and Mechanical Properties 
The changes in wet and dry weight along with the media pH during degradation of the 
0.2Vf RCM and 0.2Vf [0/90]3S composites as well as a PLA control are shown in Figure 
7.3.5 and Figure 7.3.6 respectively. 
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Figure 7.3.5. Degradation of 0.2Vf RCM and 0.2Vf [0/90]3S composites in distilled water at 
37°C along with a PLA control over 1008 hours (six weeks) showing a) Wet weight and b) 
Dry weight losses. 
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The flexural strength and elastic modulus of the corresponding samples after degradation 
in distilled water is shown in Figure 7.3.7 over 168 hour increments with SEM images of 
0.2Vf RCM and PLA controls after the mechanical testing shown in Figure 7.3.8.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3.6. Media pH during 1008 hour (six week) degradation of 0.2Vf RCM and 0.2Vf
[0/90]3S composites along with a PLA control in distilled water at 37°C. 
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Figure 7.3.7. Comparison of a) Flexural strength and b) Elastic modulus during 
degradation of 0.2Vf RCM and 0.2Vf [0/90]3S composites as well as a PLA control over 
1008 hours (six weeks) in distilled water at 37°C. 
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Figure 7.3.8. a) Fracture surfaces of degraded 0.2Vf RCM CorGlaes
®
 Pure 107 composite 
samples after gold coating, SEM images of b) 0.2Vf RCM composite after 168 hours of 
degradation [scale bar = 100µm] c) 0.2Vf RCM composite showing breakdown of fibre-
matrix interface due to fibre dissolution after 168 hours [scale bar = 10µm] d) 0.2Vf RCM 
composite after 336 hours of immersion [scale bar = 100µm] e) 0.2Vf RCM composite 
after 504 hours of immersion [scale bar = 10µm] f) PLA control fracture surfaces after 
1008 hours of degradation [scale bar = 100µm]. 
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7.3.3.2 Ion Release 
The daily and accumulative ionic concentrations of the immersion media over the first 168 
hours of 0.2Vf RCM composite degradation are shown in Figure 7.3.9. 
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Figure 7.3.9. a) Daily ionic concentrations and b) Total accumulative ionic concentrations 
from 0.2Vf RCM composites over initial 168 hours of degradation in distilled water at 
37°C. 
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7.3.4 DMEM Degradation 
7.3.4.1 Weight Loss and Mechanical Properties 
A comparison between the wet and dry weight during the degradation of 0.2Vf RCM 
composites in distilled water and acellular DMEM at 37°C is shown in Figure 7.3.10. 
Further comparisons between the media pH as well as the flexural strength and elastic 
moduli of the composites across the same degradation period are also shown in Figure 
7.3.11 and Figure 7.3.12 respectively. 
 
 
Figure 7.3.10. Comparison of a) Wet weight and b) Dry weight during degradation of 
0.2Vf RCM composites in distilled water and DMEM over 1008 hours (six weeks) at 37°C. 
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Figure 7.3.11. Comparison of media pH during 0.2Vf RCM composite degradation in 
distilled water and DMEM at 37°C over 1008 hours (standard deviation in DMEM ≤ ± 
0.06). 
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Figure 7.3.12. Comparison of a) 0.2Vf RCM composite flexural strength (standard 
deviation in DMEM ≤ ± 4 MPa) and b) 0.2Vf RCM composite elastic modulus during
sample degradation in distilled water and DMEM over 1008 hours of degradation (standard 
deviation in DMEM ≤ ± 0.8 GPa).  
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7.3.4.2 Ion Release 
The daily and accumulative ionic concentrations in the DMEM media during 0.2Vf RCM 
composite degradation is shown in Figure 7.3.13. The sodium (Na+) ionic concentration is 
shown separately from these results due to the significantly higher values that were 
observed which remained at ≈5000 mg l-1 over the majority of the 168 hours (Figure 
7.3.14).  
Note: the DMEM ionic concentrations were not normalised with respect to its initial ionic 
constituents. 
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Figure 7.3.13. a) Daily ion release from 0.2Vf RCM composite during degradation in 
DMEM and b) Accumulative ion release from 0.2Vf RCM composite during degradation 
in DMEM over initial 168 hours. 
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During degradation of the 0.2 Vf RCM composite in DMEM it was observed that a white 
precipitate formed rapidly over the sample surface (Figure 7.3.15a) with larger fragments 
accumulating at the bottom of the vials. SEM analysis (Figure 7.3.15b-d) of fractured 
composites after DMEM degradation and mechanical testing also showed this precipitate 
to have formed within the pore voids created by the dissolution of the CorGlaes® Pure 107 
fibres. Analysis of this precipitate by FTIR and its subsequent comparison with the 
CorGlaes® Pure 107 glass composition and CorGlaes® Pure 107 fibres after 336 hours of 
immersion in c-SBF is shown in Figure 7.3.16. An XRD trace of this precipitate is also 
shown in Figure 7.3.17. 
 
 
 
 
 
 
 
 
Figure 7.3.14. Daily sodium ionic concentration in DMEM during degradation of 0.2Vf
RCM composite degradation over 168 hours. 
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Analysis of the FTIR spectra revealed that the precipitates formed possessed a structure 
similar to the deposits analysed during the previous bioactivity testing of the CorGlaes® 
Pure 107 fibres (section 6.3.7). This was evident by the appearance of a broad peak across 
1200-1000cm-1 as well as across the 546-470cm-1 wavenumber range (Figure 7.3.16). The 
lack of any crystalline structure in the XRD trace also indicated that the precipitated phase 
possessed an amorphous structure with a broad weak halo centred at 2θ ≈ 30° (Figure 
7.3.17). 
 
 
Figure 7.3.15. a) Surface image of the 0.2Vf RCM composite after 366 hours of 
degradation in DMEM [scale bar = 5mm] and b-d) SEM images of 0.2Vf RCM composite 
fracture sites after 336 hours of degradation in DMEM showing the formation of 
precipitants within the voids created by fibre dissolution [scale bars = 30µm, 10µm and 
5µm]. 
a b 
c d 
Pore void (riverline) 
Precipitate within void 
Surface precipitate 
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Figure 7.3.16. Comparison of FTIR spectra obtained from the precipitate formed during 
degradation of the 0.2Vf RCM composite in DMEM with the CorGlaes® Pure 107 
composition and that obtained during bioactivity testing of CorGlaes® Pure 107 fibres after 
336 hours of immersion in c-SBF. 
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Figure 7.3.17. XRD trace of surface precipitate formed after 336 hours of 0.2Vf RCM 
composite degradation in DMEM showing an amorphous structure and halo at 2θ ≈ 30°. 
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7.3.5 Bioactivity 
Images of 15x15x2mm 0.2Vf RCM composite samples after each immersion period in c-
SBF is shown in Figure 7.3.18. The corresponding wet weight and c-SBF pH compared to 
that previously recorded during 0.2Vf RCM composite degradation in distilled water and 
DMEM are shown in Figure 7.3.19 and Figure 7.3.20 respectively. 
 
 
 
 
 
 
 
 
 
 
 
T0 T24Hour T48Hour 
T72Hour T168Hour T336Hour 
Figure 7.3.18.  Images of 15x15x2mm 0.2Vf RCM composite samples over various 
immersion periods in c-SBF showing the formation of a surface precipitate with  prolonged 
duration in c-SBF [scale bar = 10mm]. 
10mm 
Figure 7.3.19. Comparison of 0.2Vf RCM composite wet weight during degradation in 
distilled water (SA:V = 0.21 cm2 ml-1), DMEM (SA:V = 0.21 cm2 ml-1) and c-SBF (SA:V 
= 0.1 cm2 ml-1). 
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The FTIR spectra of composite planar surfaces at each immersion period in c-SBF across 
the complete (4000-400cm-1) and 1400-400cm-1 region of the spectra is shown in Figure 
7.3.21. Compared with the initial composite surface FTIR spectrum, the results showed the 
formation of new peaks at 896cm-1 and ≈512cm-1 after 24 hours whilst continued 
immersion showed the gradual suppression in the intensity of peaks ranging from 1720-
990cm-1. The shifting in peaks was also observed with increasing immersion time as the 
broad peak centred at 512cm-1 after 24 hours changed to 474cm-1 after 336 hours of 
immersion. FTIR spectra of the composite cross-sections were found to be identical to 
those collected from the planar faces. 
 
 
 
 
 
 
 
Figure 7.3.20. Comparison of media pH during degradation of 0.2Vf RCM composite in 
distilled water (SA:V = 0.21 cm2 ml-1), DMEM (SA:V = 0.21 cm2 ml-1) and c-SBF (SA:V
= 0.1 cm2 ml-1). 
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Figure 7.3.21. FTIR spectra of composite planar faces after immersion in c-SBF for up to 
336 hours over a) 4000-400cm-1 and b) 1400-400cm-1 wavenumber ranges. 
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7.3.6 Biocompatibility 
The MTT assay of MG63 cell viability using extracts from RCM composites with 
increasing fibre volume fraction and a PLA polymer control after 24 and 96 hours of 
degradation is shown in Figure 7.3.22 with the correlating media pH shown in Figure 
7.3.23. Similarly, the MTT assay of degraded extracts from a 0.2Vf RCM composite at 
various concentrations (0.1, 10, 50, 100 vol%) after 24 and 96 hours of degradation in 
CDMEM is shown in Figure 7.3.24. Analysis of this data found a statistically significant 
difference between the fibre volume fractions (p < 0.05) (Figure 7.3.22) as well as the 
0.2Vf extract concentrations on the cell viability compared to the positive controls (Figure 
7.3.24) (p < 0.05). 
Due to the observed cytotoxicity found in the MTT results, no direct contact cell culture 
and Live/Dead® staining was performed. 
 
 
 
 
Figure 7.3.22. Comparison of degradation media cytotoxicity from NatureWorks® 3001D 
PLA and CorGlaes® Pure 107 fibre-PLA composites with increasing fibre volume fraction 
(0→0.2Vf) on MG63 cell viability using MTT assay. 
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Figure 7.3.23. Media extract pH from composite samples and positive controls after 24 and 
96 hours of degradation used in MTT assay. 
Figure 7.3.24. Degradation extract concentration from 0.2Vf RCM CorGlaes® Pure 107 
composite on MG63 cell viability using MTT assay after 24 and 96 hours of degradation. 
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7.4 Discussion 
Analysis of the OrientationJ® results (Table 7.3.1) obtained from unidirectional (UD) and 
random continuous fibre mat (RCM) pre-pregs showed a high degree of coherency (83%) 
in the orientation of the UD fibre mats that was close to those obtained from the aligned 
control images (100%). However the RCM pre-pregs also showed a degree of coherency 
(30%) in their primary orientation that was substantially higher than the idealised random 
control image (3%). This was attributed to the manual expansion method employed when 
manipulating the CorGlaes® Pure 107 fibres into randomly orientated mats and the 
attenuation around the hand driven mandrill that, as the results have shown, appeared to 
impart some preferential orientation in the RCM pre-preg mats.  
Mechanical testing of the CorGlaes® Pure 107 fibre composites at different fibre volume 
fractions and architectures showed the expected increase in elastic modulus with increasing 
fibre volume fraction (Vf) compared to the PLA control (Ahmed et al., 2008; Mohammadi 
et al., 2012). The tensile fractures observed at the outermost layer of the composites during 
mechanical testing and absence of delamination also indicated that successful bonding 
between the composite lamina had occurred during sample manufacturing. The increased 
strain to failure and plastic deformation of the PLA control (εm) compared to the 
CorGlaes® Pure 107 fibre (εf) was also expected with the use of a polymer matrix (εm > εf) 
(Figure 7.3.1). However despite the increase in modulus, a reduction in the flexural 
strength was found in all composite samples below the neat PLA control (Figure 7.3.2). 
This could be attributed to several factors such as the inclusion of flaws into the matrix 
through fibre introduction, localised deviations in the composite Vf, fibre handling and 
subsequent fibre damage during composite manufacturing as well as the quality of fibre-
matrix interface. This is related to the infiltration of the polymer resin into the reinforcing 
fibres (since solvent casting was not performed for 0.01Vf and 0.05Vf samples) [169, 215]. 
A comparison between the 0.2Vf RCM and 0.2Vf [0/90]3S samples showed a distinct 
contrast in their mechanical properties and failure behaviour (Figure 7.3.4). This was 
evident by the increased flexural strength and plastic deformation found in the 0.2Vf RCM 
composites that was attributed to the difference in fibre architecture between samples. The 
area under the respective stress-strain plots also showed that the energy absorbed by the 
RCM composite configuration was greater than the [0/90]3S architecture, but remained 
below the PLA control (Table 7.4.1).  
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Table 7.4.1. Comparison of average sample toughness based on the area under the stress-
strain plots recorded for each type of composite and control sample shown in Figure 7.3.4.  
Sample Toughness (J m-3) 
PLA Control 2.48 ± 0.06 
0.2Vf RCM  1.01 ± 0.01 
0.2Vf [0/90]3S 0.69 ± 0.11 
 
 
Accordingly, the increased flexural strength was believed to be due to the improved 
polymer infiltration of the RCM mats and subsequent improvement to the fibre-matrix 
interface compared to the aligned pre-preg lamina. Meanwhile the increased plastic 
deformation and toughness of the 0.2Vf RCM samples was attributed to their random, 
interlocking 2D architectures that were expected to possess localised areas of overlapping 
fibre intersections similar to those encountered in braided or woven fibre mats. These 
features are considered by Karbhari & Strassler (2007) to be capable of locally entrapping 
microcracks and serve as crack arrestors during composite fracture, but would also have 
likely had an effect on the frictional slippage occurring during fibre-pull out (section 
3.2.3.1). The ability of these fibre intersections to distribute external stresses over a larger 
substrate area is also believed to result in an increased strain energy absorption which 
would correlate with the results shown in Table 7.4.1. In contrast, the parallel aligned 
fibres of the [0/90]3S lamina can allow unconstrained microcracking and splitting of the 
matrix to occur between fibres if they are not aligned perfectly parallel to the loading 
direction (Karbhari & Strassler, 2007). This would then corroborate with the observed fibre 
wrinkling/waviness and the imperfect fibre alignment (83%) identified from the 
OrientationJ results for the aligned CorGlaes® Pure 107 pre-pregs that was incurred from 
the hand lay-up method employed in composite manufacturing [219, 337, 338].  
These experimental values also appeared to correlate with those predicted by the rule of 
mixtures model for the different fibre volume fractions and architectures in the 
manufactured composites (Figure 7.3.3). The increased elastic moduli values obtained 
experimentally for the RCM composites was attributed to the unwanted degree of 
coherency found in the RCM architecture (Table 7.3.1) as well as the potential extrusion of 
materials from the mould (Figure 7.4.1). The extrusion of small quantities of polymer 
matrix during composite manufacturing would have subsequently raised the volume 
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fraction of the composite above the predetermined Vf. However this increase was 
considered to be marginal given that the extrusion of 0.07-1.66g of polymer matrix was 
calculated to only increase the composite volume fraction from the target 0.2Vf to 0.21Vf.  
 
 
 
 
 
 
 
 
 
 
Based on this, the increased experimental values shown for all RCM composites was 
believed to be due to the degree of anisotropy in the RCM composite architecture that 
could have been unexpectedly preferentially aligned parallel to the primary loading axis. 
This would have then conflicted with the correction factor (no) used in the rule of mixtures 
model (Eqn 7.2.6) that assumed a perfectly even and randomised distribution of 2D fibre 
orientations throughout each composite lamina. This would subsequently be in line with 
the increased experimental data observed by Ahmed et al. (2011) where instances of 
unwanted preferential orientation in composite samples were unable to be accounted for by 
the fibre orientation correction factor (no) [219]. Meanwhile the decrease in experimental 
elastic modulus for the 0.2Vf [0/90]3S composites compared to the predicted values was 
attributed to the idealisations applied in the rule of mixtures which would not hold true in 
practical samples. These included the uniform filler distribution, absence of voids, perfect 
fibre-matrix interface and that both phases act in a linearly elastic manner (Ahmed et al. 
2011) [219].  
Additionally, comparisons also showed that both the 0.2Vf RCM and 0.2Vf [0/90]3S 
composite samples possessed mechanical properties within the lower range of those 
Figure 7.4.1. SEM of a degraded 0.2Vf RCM composite with the riverlines created from 
fibre degradation illustrating the shift in fibre dispersion due to the extrusion of the 
polymer matrix from the mould during manufacturing [scale bar = 100µm]. 
100µm 
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reported for the parietal bones by Motherway et al. (2009). However given its improved 
toughness and increased flexural strength, the 0.2Vf RCM composite was deemed more 
suitable for the target application as part of a cranioplasty plate implant device (Figure 
7.4.2) [339, 340].  
 
 
A comparison with the alternate phosphate glass fibre composites investigated in the 
literature (Figure 7.4.3) showed that the mechanical properties of the 0.2Vf CorGlaes® Pure 
107 composites were within the expected values given the variation in fibre architecture, 
matrix/filler properties and fibre volume fractions in the comparative data. This is 
demonstrated by the general trend of increasing mechanical properties with increasing 
fibre volume fraction as well increasing properties between different composite 
architectures (chopped < orientated < unidirectional fibres) as discussed in section 3.2.3 
[215, 219, 222, 223, 341]
.  
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Figure 7.4.2. Comparison of 0.2Vf and 0.2Vf [0/90]3S composite mechanical properties 
with the composite precursor materials, cortical/parietal bone and HAPEX® [Data from 
Motherway et al., 2009; Ratner, 2012; Tjong, 2012]. 
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Figure 7.4.3. Comparison of PGF composites mechanical properties with 0.2Vf RCM and 0.2Vf [0/90]3S CorGlaes® Pure 107 composites – arranged by 
increasing Vf [Data from Ahmed et al., 2008; Khan et al., 2010; Ahmed et al., 2011; Felfel et al., 2012; Han et al., 2013]. 
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Degradation of the 0.2Vf RCM composites and PLA control showed an initial increase in 
the wet weight (≈0.2%) after 4 hours of immersion (Figure 7.4.4). This was associated with 
the diffusion of degradation media into the PLA polymer matrix and was in line with 
previous results as reported by Onal et al. (2007) and Ahmed et al. (2011) [219, 325].  
 
 
However after 4 hours, the 0.2Vf RCM composite showed a steady decrease in its wet 
weight that was attributed to the dissolution of the CorGlaes® Pure 107 fibres when 
compared to the PLA control which continued to slowly increase. The reduction in 
composite wet weight continued until it appeared to plateau at approximately -20% to -
25% after 168 hours of degradation (Figure 7.3.5). This plateau was interpreted as 
signalling the near complete dissolution of the CorGlaes® Pure 107 fibres and was 
contrasted by the PLA control that appeared to become saturated after 72 to 96 hours at an 
increased wet weight of ≈0.7%. Such time scales of polymer saturation and fibre 
dissolution were found to be in line with previous studies such as those conducted by 
Ahmed et al. (2011), Felfel et al. (2012) and Han et al. (2013). The correlating dry weight 
of all composite samples mirrored this trend but showed a greater dry weight loss 
compared to the equivalent wet weight (Figure 7.4.5). This was accounted for by the voids 
generated in the composite from fibre dissolution (Figure 7.3.8b-e) that could act as 
Figure 7.4.4. Comparison of 0.2Vf RCM composite and PLA control wet weight over 
initial 24 hours of degradation showing equal rates of media uptake in both samples after 4 
hours of degradation. 
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reservoirs for the immersion media during sample weight measurements prior to drying as 
discussed by Ahmed et al. (2008) [215, 219, 222, 223]. 
 
 
 
As anticipated, the dry weight of the PLA control remained constant throughout the 
degradation period due to the relative time frame of the study and correlated with previous 
results reported by Ahmed et al. (2011). However it should also be recognised that the 
increased SA:V created by the internal porosity in the composite PLA matrix (due to fibre 
dissolution) may have increased hydrolytic polymer degradation in the composites 
compared to the PLA control (Ahmed et al. 2008) [219, 222, 223].  
The dissolution of the reinforcing CorGlaes® Pure 107 fibres was coupled with a reduction 
in pH that was attributed to the formation of phosphoric acid (H3PO4). This was due to the 
rapid dissolution of the composite reinforcing fibres and was found to agree with the acidic 
pH reported by Ahmed et al. (2008, 2009, 2011) and Han et al. (2013) during the 
degradation of similar PGF composite configurations. The dissolution of these fibres is 
considered by Han et al. (2013) to occur via the same mechanisms as those reported for 
isolated fibres or bulk monolith samples and would appear to correlate with the low pH 
found during the previous dissolution testing of isolated CorGlaes® Pure 107 fibres 
(section 6.3.6). 
 
Figure 7.4.5. Comparison of 0.2Vf RCM composite wet and dry weight over 1008 hours of 
immersion in distilled water at 37°C. 
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The accumulation of the fibres dissolution species consequently led to a drop in media pH 
over the initial 24 hours to ≈2.5 despite frequent media replacement over the first 168 
hours of degradation [169, 229]. As the degradation continued, the results showed this pH to 
gradually return to its initial values after 672 to 840 hours (4-5 weeks) and indicated that 
complete dissolution of any small fibre remnants had occurred. It should also be mentioned 
that it is unknown how significant an impact the surrounding phosphoric acid would have 
had on the rate of polymer matrix degradation due to its catalytic effect on the PLA 
degradation rate (section 3.2.2.3) (Ahmed et al. 2011). In contrast the pH of the PLA 
control media remained close to neutral (≈5.5) throughout the entire degradation period 
with the initial decrease in pH attributed to atmospheric influences and the generation of 
carbonic acid as discussed in section 5.3.7.1 [215, 218, 219, 223].  
The weight loss stemming from the rapid dissolution of the CorGlaes® Pure 107 fibres 
over the first 168 hours also correlated with the rapid release of ions into the media (Figure 
7.4.6). This was demonstrated by the daily ionic concentrations measured from the 0.2Vf 
RCM composite over this period that echoed similar results reported by Mohammadi et al. 
(2012) [169].  
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Figure 7.4.6. Correlation between the daily ionic concentrations of the degradation media 
and the 0.2Vf RCM composite wet weight over the initial 168 hours of immersion showing 
reductions in the ions released from the composite as the majority of the CorGlaes® Pure 
107 fibres degraded. 
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The 0.2Vf RCM data (Figure 7.4.6) shows that the initially high rate of ion release quickly 
slowed after 48 to 72 hours as a result of the decreasing fibre content remaining within the 
composite. The near complete dissolution of the CorGlaes® Pure 107 fibres over this 168 
hour period was also reflected by the non-linear curves seen in the accumulative ionic 
concentrations of the degradation media which began to plateau after 96-120 hours (Figure 
7.3.9b) [169].  
Mechanical testing of all composite samples showed that a rapid decrease in the flexural 
strength (-46% RCM, -58% [0/90]3S) and modulus (-62% RCM, -80% [0/90]3S) had 
occurred after 168 hours of degradation which fell below those of the PLA control 
samples. This was attributed to the break-down of the fibre-matrix interface via the ingress 
of moisture and dissolution of the reinforcing fibres (Ahmed et al. 2011). The rate at which 
this deterioration occurred was attributed to the large SA:V at the fibre matrix interface and 
the autocatalysis effects generated by the highly acidic media (Han et al. 2013) as 
previously seen during the dissolution of isolated CorGlaes® Pure 107 fibres (section 
6.3.6). The fibre-matrix interface was also expected to have been severely disrupted by the 
capillary action of moisture along the interface (i.e. wicking) (Figure 7.4.7). However other 
factors such as the hydrophilicity of the PLA matrix and catalysis of the PLA hydrolysis 
reactions from the surrounding phosphoric acid were also expected to have influenced the 
interface breakdown and the resulting mechanical properties of the composites (Ahmed et 
al. 2008) [215, 218, 229].  
 
 
 
 
 
 
 
 
 
 
Figure 7.4.7. Optical microscope images of a ~Ø220µm CorGlaes® Pure 107 filament 
bonded to a glass coverslip with 3001D PLA and immersed in distilled water at 37°C 
showing a) Fibre-matrix interface at T0 and b) Breakdown of the fibre-matrix interface 
after 336 hours of immersion due to the wicking of moisture along the fibre-matrix 
interface [scale bar = 100µm]. 
a b 
3001D PLA 
CorGlaes® Pure 107 filament 
(Ø=220µm) 
Breakdown of interface 
Wicking Direction 100µm 100µm 
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The mechanical properties of the PLA were also seen to change over the degradation 
period with fluctuations in the flexural strength and an increase in elastic modulus 
observed during degradation. The variation in the polymer flexural strength was attributed 
to the presence of defects within the sample that would have accounted for the irregularity 
seen between samples in Figure 7.3.7. The observed increase in elastic modulus of the 
PLA control however was believed to be due to the higher degradation rate of the 
amorphous phase in the semi-crystalline PLA polymer. The expected increase in polymer 
crystallinity over the degradation period would then account for the increase in elastic 
modulus from 3.21 ± 0.34 GPa to 4.67 ± 0.12 GPa that was observed after 336 hours of 
immersion and is recognised to occur in semi-crystalline bioresorbable polymers. Such 
results would correlate with those reported by Felfel et al. (2010) where an increase from 
26% to 44% in polymer crystallinity was measured after 300 hours during the degradation 
of NatureWorks® 3251-D PLA samples in distilled water. A slight change in the 
opaqueness of the 3001D PLA control was also observed during sample degradation and 
was believed to have been due to the recrystallization of the preferentially degraded 
amorphous phase [222, 342]. 
After 1008 hours of degradation it was found that the average flexural strength and elastic 
modulus of the 0.2Vf [0-90]3S composites were lower (12.17 ± 0.56 MPa, 2.33 ± 0.61 GPa 
respectively) than the equivalent 0.2Vf RCM architecture (21.51 ± 9.38 MPa, 3.23 ± 0.17 
GPa respectively). Furthermore compared to the equivalent PLA control, both degraded 
composites showed increased plastic deformation during testing (Figure 7.4.8). These 
differences in composite mechanical properties and failure modes were likely due to the 
difference in porous architectures created during CorGlaes® Pure 107 fibre dissolution and 
their relative ability to impede crack propagation compared to the PLA control. The 
tailoring of porous architectures via fibre dissolution in such composites has previously 
been discussed by Ahmed et al. (2008) with regards to meeting specific clinical needs. Yet 
the architecture has also been demonstrated here to have important mechanical 
considerations after complete fibre dissolution has occurred given that the resulting pore 
diameters (≈Ø20µm) were below those deemed acceptable for bone cellular ingrowth 
(>300µm). Stress-strain plots of the PLA control also showed a reduced strain at failure 
after 1008 hours compared to the initial [T0] values and correlated with the increased 
crystallinity of the polymer during its degradation as previously discussed [215, 342, 343]. 
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However despite the difference in initial composite mechanical properties between the two 
fibre architectures, the immersion of samples in distilled water revealed similar rates of 
fibre dissolution and subsequent loss of composite mechanical properties. This indicated 
that the RCM fibre architecture offered no advantage with regards to increasing composite 
durability. This was likely due to the continuous nature of both reinforcing phases when 
compared to the reduced dissolution rates found in chopped fibre composites by Ahmed et 
al. (2011) via the inhibitory effect of a discontinuous fibre phase on the wicking of 
moisture along the fibre-matrix interface (section 3.4.8). The increased rate at which the 
media pH returned to its initial values in the [0/90]3S composite (Figure 7.3.6) could also 
be reflective of the media’s increased mobility into the composite interior with this type of 
fibre architecture. This increased mobility may have implications in vivo with regards to 
drug release or cell ingrowth and nutrient transport between such architectures should 
suitable pore sizes (>300µm) be produced. As a result, the arrays of alternating parallel 
fibres would appear to have completely degraded at a slightly faster rate than those used in 
the 0.2Vf RCM composite. This may then explain the difference in flexural strength 
between the two composite samples after 168 to 336 hours of degradation (Figure 7.3.7). 
However despite these considerations, the mechanical testing of degraded samples 
highlighted that the current rate of CorGlaes® Pure 107 fibre dissolution rendered these 
composites unable to match the targeted design specification of retaining at least 80% of 
their flexural strength and elastic modulus after 1008 hours (six weeks) of degradation  
(section 3.2.3.2) [219]. This was evident by the degradation data that showed a severe 
Figure 7.4.8. Comparison of stress-strain plots from initial (T0) composite/control samples 
and after 1008 hours (six weeks) of degradation in distilled water at 37°C. 
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reduction in the mechanical properties of both composites after the first 168 hours of 
degradation (Figure 7.4.9).  
 
 
 
It should be noted that the mechanical testing of dry samples may produce different 
mechanical properties compared to the testing of wet samples which is considered by 
Felfel et al. (2012) to be a better representation of in vivo performance. However the 
testing of dry samples was selected in this analysis due to the uncertain availability of the 
testing equipment with regards to specific sample immersion periods [222]. 
Despite the reductions in CorGlaes® Pure 107 fibre dissolution rates previously observed 
in DMEM (section 6.3.6), the DMEM degradation of 0.2Vf RCM composite samples failed 
to show any increase in mechanical durability. This was evident by the near identical rate 
of dry weight loss (-28%) and reduction in the composite modulus (-59%) observed after 
168 hours of degradation despite the pH of the DMEM appearing to be substantially 
buffered. However, the localised yellow discolouration of the DMEM in the immediate 
vicinity of the composites indicated that highly localised pH effects were occurring (Figure 
7.4.10). This would have been due to the rapid dissolution of the CorGlaes® Pure 107 
fibres that, based on the composite weight loss data, appeared to occur at the same rate as 
that experienced during composite degradation in distilled water. The rapid dissolution of 
the reinforcing fibres despite the presence of a pH buffer highlighted the influence of the 
high SA:V ratio at the fibre-matrix interface on composite degradation.  
Figure 7.4.9. Comparison of 0.2Vf composite degradation with the targeted degradation 
rate of the composite elastic modulus. 
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Further comparisons between the degradation of composites in DMEM and distilled water 
showed the same initial trend in media uptake due to polymer absorption prior to the 
decrease in wet weight from dissolution of the reinforcing fibres. However the overall 
decrease and plateau in wet weight was significantly reduced (-12%) compared to that 
recorded in distilled water (-20%) after 168 hours. This was believed to be due to the 
formation of a visible whitish precipitate across the composite sample surface that was 
apparent after 24 hours of immersion. These precipitates continued to form over the first 
week (168 hours) of immersion with SEM images of the degraded composites fracture 
faces (after mechanical testing) also showing that the precipitate had formed sporadically 
within the pores generated by fibre dissolution (Figure 7.3.15). However the majority of 
these surface deposits separated from the composite surface during sample drying and 
consequently led to similar dry weight measurements being obtained when compared to 
those previously recorded in distilled water.  
As with the samples degraded in distilled water, a rapid deterioration in the composite 
mechanical properties was observed after 168 hours of degradation that was attributed to 
fibre dissolution as previously discussed. However mechanical testing of the composites 
also showed that despite possessing a near equivalent elastic moduli to that found after 
degradation in distilled water, the flexural strength and failure mechanisms varied between 
the different media. Consequently when degraded in DMEM, the samples appeared to 
display a brittle failure mode compared to the more ductile failure previously observed 
from 0.2Vf RCM composites over the equivalent immersion period in distilled water 
(Figure 7.4.11).  
Figure 7.4.10. Degradation of a 15x15x2 mm 0.2Vf RCM composite samples in 0.1 vol% 
sodium azide-DMEM (SA:V = 0.21 cm2 ml-1) with the localised yellow discolouration of 
the media after 48 hours of degradation signalling an acidic environment surrounding the 
sample. 
Localised yellow 
discolouration  
Localised yellow 
discolouration  
0.2Vf RCM 
Composite   
a b 
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Work by Peńa et al. (2006) has shown that polymers such as PCL will degrade at a faster 
rate in DMEM compared to PBS and that the influence of media with high molecular 
concentrations such as DMEM must be considered when evaluating material degradation. 
Furthermore Peńa et al. (2006) also states that few studies have examined such effects with 
regards to material degradation in fluids more closely resembling biological media. 
Inspection of the stress-strain data obtained during CorGlaes® Pure 107 composite 
degradation indicated that the transition to a brittle failure mode appeared to occur within 
the first 168 hours of degradation. This would then imply that the observed failure 
behaviour of the remaining porous PLA matrix was strongly related to the interactions 
occurring between the dissolution of the CorGlaes® Pure 107 fibres and the DMEM. The 
rapid nature of this transition was also within a much smaller time frame than the 18 month 
study conducted by Peńa et al. (2006). However due to restrictions on the available volume 
of DMEM no PLA controls were degraded for comparison. Further analysis is also 
restricted by the lack of comparative results in the literature examining the mechanical 
degradation of PGF composites in DMEM [344].  
Analysis of the precipitate formed during 0.2Vf RCM composite degradation in DMEM by 
FTIR and XRD (after drying the composite at 60°C for 12 hours) showed the material to 
possess an amorphous structure. Furthermore the FTIR spectrum of the precipitate was 
found to closely match that previously obtained during bioactivity testing of the CorGlaes® 
Pure 107 fibres in c-SBF. This appeared to indicate that the rapid dissolution of the 
composite reinforcing fibres and saturation of the DMEM had resulted in the precipitation 
Figure 7.4.11. Comparison of stress-strain plots for 0.2Vf RCM composites after 1008 
hours of degradation in distilled water and DMEM. 
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of various pyrophosphate salts as previously found in section 6.3.7. The precipitation of 
these salts was likely due to the similar ionic constituents/concentrations (Table 6.2.2) and 
media pH between the DMEM and c-SBF. A comparison between the accumulated ionic 
concentrations in the DMEM and distilled water during 0.2Vf RCM composite degradation 
also showed the DMEM to possess a significantly lower concentration of Mg2+ and Zn2+ 
ions (Figure 7.4.12). This is despite the composite weight data indicating similar rates of 
fibre dissolution in both media. 
 
 
Combined with the XRD trace, the comparison between the ionic concentrations of each 
respective media (Figure 7.4.12) reinforces the proposed formation and deposition of 
amorphous pyrophosphate salts relevant to the CorGlaes® Pure 107 composition (section 
6.4). Such results would also correlate with the general low solubility product constants 
(ksp) of magnesium phosphate (ksp = 1×10-24 at 25°C) and zinc phosphate (ksp = 9×10-33 at 
25°C) salts [345, 346]. The significantly higher Na+ ionic concentrations found in the DMEM 
results (Figure 7.3.14) could not be accounted for but were believed to be due to 
interference from the DMEM during the analysis of the media. 
Bioactivity testing of the 0.2Vf RCM samples showed the fibre dissolution to occur at a 
similar rate as that recorded during composite degradation in distilled water. This was 
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Figure 7.4.12. Comparison of Ca2+, Mg2+ and Zn2+ accumulative ionic concentrations 
during the degradation of the 0.2Vf RCM composites in DMEM and distilled water 
(DMEM normalised with respect to its initial ionic concentrations before composite 
degradation i.e. T0). 
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apparent by the near identical rate of decreasing wet weight when compared over the 
equivalent degradation period (Figure 7.3.19). However in contrast to the distilled water, 
the pH of the c-SBF during composite degradation was shown to be sustainably buffered 
and remained above 6.4 for the entire immersion period. This deviation in pH despite the 
similar rates of fibre dissolution could be accounted for however when considering the 
local and bulk SA:V ratios as well as the initial media ionic constituents/concentrations 
between the two experimental methods. Consequently the identically high SA:V at the 
fibre-matrix interface in both samples would account for the similar rates of rapid fibre 
dissolution. However the difference in bulk SA:V ratio between the mechanically degraded 
(0.21 cm2 ml-1) and bioactivity tested (0.1 cm2 ml-1) conditions along with the pH buffering 
and or precipitation of phosphate groups out of solution would then account for the 
deviation in bulk media pH for each respective immersion media  
The immersion of composite samples was also coupled with the formation of a white 
precipitate on the planar and cross-sectional surfaces of the composite after 24 hours 
(Figure 7.3.18). As the immersion time increased it was observed that this surface layer 
gradually continued to be deposited. These visual observations were found to correlate 
well with the FTIR spectra obtained from the samples. This data showed the formation of 
new peaks after 24 hours of immersion whilst the initial peak wavenumbers at 1745cm-1 
and 1250-1050cm-1 (corresponding to the C=O, C-O and C-O-C stretching vibrations of 
the PLA polymer matrix) were gradually supressed. These were subsequently replaced by 
the formation of broad amorphous peaks from the precipitate that appeared to be similar to 
the spectra encountered during 0.2Vf DMEM degradation and after the immersion of 
CorGlaes® Pure 107 fibres in c-SBF (Figure 7.4.13) [216].  
Consequently the obtained FTIR spectra after 0.2Vf RCM bioactivity testing was attributed 
to the similar deposition of pyrophosphate salts as encountered in previous testing due to 
the rapid dissolution of the CorGlaes® Pure 107 fibres (section 6.3.7). Previous bioactivity 
studies on 0.18Vf PGF composites by Mohammadi et al. (2012) had established the 
precipitation of brushite (CaHPO4·2H2O) across the composite surface after 336 hours (two 
weeks) of immersion. This stemmed from the acidic pH created by the fibre dissolution in 
SBF with Mohammadi et al. (2012) discussing how the rate of fibre dissolution and 
corresponding ion release rates had a significant effect on apatite precipitation [169].  
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Accordingly, the higher SA:V ratio at the fibre-matrix interface would be expected to 
produce an increased rate of fibre dissolution compared to that encountered during isolated 
CorGlaes® Pure 107 fibre bioactivity testing (section 6.3.7). Combined with the difference 
in bulk SA:V ratios between the c-SBF studies (0.1 cm2 ml-1) and mechanical degradation 
of the 0.2Vf RCM composites in DMEM (0.21 cm2 ml-1) such factors may then explain the 
deviation in FTIR spectra between the different samples and testing regimes. This is 
further reflected by the data shown in Figure 7.4.13 with a low intensity broad peak at 
≈1256cm-1 appearing more prominently in precipitates obtained during PGF composite 
immersion and could indicate a difference in the phase composition or structure of the 
precipitate based on the rate of fibre dissolution [216]. However, further investigation via 
annealing and deconvolution of the FTIR spectra would be required to further expand upon 
this due to the ambiguous nature of their amorphous structure and likely band overlapping 
in the spectra as previously discussed in section 6.4.  
Furthermore, the inspection of both planar and cross-sectional faces was aimed at 
identifying any HCA formation at the exposed fibre cross-sections of the composite given 
the “halo” regions of HCA deposition that can form in the surrounding areas of the 
composites exposed fibres when immersed in SBF according to Vallittu et al. (2015) [5]. 
Figure 7.4.13. Comparison of FTIR spectra obtained from precipitates during immersion of 
composites in c-SBF and DMEM as well as CorGlaes® Pure 107 fibres in c-SBF. 
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Degradation of PLA and 0.01Vf→0.2Vf RCM composites in CDMEM for the MTT assay 
found that visible precipitates were formed in the media during 0.1Vf and 0.2Vf composite 
degradation due to the ionic saturation of the media as previously discussed. 
Biocompatibility testing of the sample extracts by MTT assay on MG63 cells subsequently 
showed that all composite viability results were below the 70% threshold stated by BS EN 
10993-5:2009 and that a trend of increasing cytotoxicity was observed with increasing 
composite fibre volume fraction. This was attributed to the rapid dissolution of the 
CorGlaes® Pure 107 fibres and the associated changes to the media pH as well as the ionic 
concentrations in the CDMEM with different fibre volume fractions. The cytotoxicity from 
media extracts where pH levels were within the tolerable limits for MG63 cells (i.e. pH 
≥7.4) was believed to be due to the release and accumulation of Zn2+ ions as previously 
discussed in section 5.4. The variation in fibre volume fraction and subsequent Zn2+ 
concentration in the CDMEM extracts would then account for the increasing cell viability 
with decreasing Vf. Furthermore the time dependant accumulation of Zn2+ cations would 
also corroborate with the decreasing cell viability after prolonged degradation times (i.e. 96 
hours) in the 0.01Vf and 0.05Vf samples (as previously observed during the Live/Dead® 
staining of CorGlaes® Pure 107 disks). In contrast, the high cell viability of MG63 cells 
cultured in the extracts obtained during 3001D PLA degradation confirmed its 
biocompatibility and that the cytotoxic response of the composites was directly related to 
the CorGlaes® Pure 107 fibres [280].   
The MTT assay of the diluted extracts collected after 24 and 96 hours of 0.2Vf RCM 
composite degradation showed the media extracts to be highly cytotoxic to MG63 cells at 
10, 50 and 100 vol% concentrations. As with the previous results, the poor viability of the 
MG63 cells was attributed to the acidic pH of the CDMEM at high extract concentrations 
or the accumulation of Zn2+ ions towards cytotoxic levels. The variation in CDMEM pH 
was apparent by the phenol red pH indicator in the CDMEM that caused a visible 
transition in the media from yellow to red as the dilution increased and the pH was raised 
towards neutral (Figure 7.4.14).   
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However it was also observed in Figure 7.3.24 that despite being below the viability 
threshold, an increase in cell viability was observed with increasing extract concentration 
that contradicted the observed trends and proposed theories of the previous results (i.e. Vf 
decreases, cell viability increases). A repeat of the MTT assay procedure with acellular 
CDMEM using the same extract dilutions (i.e. 0.1→100 vol%) revealed that the composite 
degradation by-products or possible precipitates may be interfering with the MTT assay 
due to the presence of false positives being generated. This was apparent by the increase in 
cell viability recorded with increasing extract concentration despite the absence of any 
cells in the media (Figure 7.4.15). However the precise mechanisms regarding this 
interference effect were not explored and would require further dedicated investigations.  
 
 
Figure 7.4.14. Variation in 0.2Vf RCM CorGlaes Pure 107 composite CDMEM 
degradation media extract after 96 hours at different concentrations (vol%) with the yellow 
discolouration indicating a highly acidic media. 
  100     50    10     0.1 (vol%) 
 ← Decreasing pH 
Figure 7.4.15. Effect of 0.2Vf RCM composite extract on the MTT results collected in 
acellular media showing false positive readings generated by possible influences from the 
dissolution of the reinforcing fibres. 
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7.5 Conclusions 
The introduction of CorGlaes® Pure 107 fibres into a PLA polymer matrix showed the 
expected increase in elastic modulus with an increasing fibre volume fraction that closely 
matched the values predicted by the rule of mixtures. Furthermore the flexural strength 
(σcomp) and elastic modulus (Ecomp) of 0.2Vf RCM composites (σcomp = 82.39 ± 4.46 MPa, 
Ecomp = 7.57 ± 1.20 GPa) were found to be within the range reported by Motherway et al. 
(2009) for parietal bone. This random fibre architecture (RCM) showed an increase in 
flexural strength and energy absorption compared to the [0/90]3S laminate design that was 
also investigated. However despite showing initial promise, the current 0.2Vf CorGlaes® 
Pure 107-PLA composite configurations were unable to sustain an adequate flexural 
strength or elastic modulus over the required six week degradation period to meet the 
design parameters outlined in section 2.1. This was due to the susceptibility of these fibres 
to autocatalysis effects and the large SA:V ratios encountered at the fibre-matrix interface 
of the CorGlaes® Pure 107 fibre composites. Degradation of the 0.2Vf RCM composites 
within media typically used during in vitro cell culture (DMEM) revealed that a similarly 
rapid rate of composite fibre dissolution had occurred despite the previous results found in 
section 6.3.6. This was again attributed to the proposed autocatalytic effects which were 
believed to be highly localised to the composite samples given the ability of the DMEM to 
buffer the bulk media pH during 0.2Vf RCM degradation compared to distilled water [46].  
This high fibre dissolution rate also resulted in the deposition of pyrophosphate salts across 
the surface of the composite when immersed in c-SBF as previously found during the 
CorGlaes® Pure 107 fibre bioactivity experiments. Unfortunately the rapid dissolution of 
the composite fibres also rendered the current composite configurations cytotoxic to MG63 
cells across all the tested fibre volume fractions (0.01Vf→0.2Vf). This was due to the 
related pH changes at high Vf (i.e. 0.2Vf) or rapid release rate of ions (specifically Zn2+) 
into the culture media (0.01Vf→0.1Vf) towards cytotoxic levels (≈8 mg l-1). 
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8 Modified CorGlaes® Pure 107 Fibre Composite 
8.1 Outline 
The previous characterisation of a 0.2Vf RCM CorGlaes® Pure 107 composite (chapter 7) 
demonstrated that this material configuration was capable of achieving flexural strengths 
and elastic moduli similar to those reported for the parietal bones of the skull [46]. However 
the immersion of these samples in distilled water or DMEM showed that they were unable 
to meet the design criteria of retaining at least 80% of their mechanical properties after 6 
weeks of degradation. This result was attributed to the rapid dissolution of the reinforcing 
fibres and the breakdown of the fibre-matrix interface due to the low pH acidic 
environment and resulting autocatalysis effects that were initiated after immersion of the 
composite samples. The rapid dissolution of the fibres and the associated pH changes as 
well as the high ion release rates were also responsible for the observed composite 
cytotoxicity [339].  
The silane treatment of silica and phosphate based glass fibres has been shown in previous 
studies to improve the initial mechanical properties of the resulting composites as well as 
its mechanical integrity during degradation (Khan et al., 2011, Hasan et al., 2012) (section 
3.4.9) [221, 228]. Given the previous reduction in dissolution rate recorded for CorGlaes® 
Pure 107 fibres after silane treatment (section 6.3.6), APS treated CorGlaes® Pure 107 
fibres were investigated as a composite reinforcing agent with regards to improving its 
mechanical properties during prolonged periods of degradation.  
Yet previous studies such as those by Agrawal & Athanasiou (1997) as well as Schiller & 
Epple (2003) have also shown how different calcium phosphate salts have been able to 
buffer the media pH and retard autocatalytic effects during PLA-PGA polymer 
degradation. Such neutralising buffers have also been investigated by Kobayashi et al. 
(2010) where the addition of a calcium carbonate (CaCO3) filler was shown to successfully 
buffer the media pH during the degradation of an ultraphosphate glass fibre composite. 
Such hybrid composite configurations (i.e. joint fibre-particle filler phases) could be easily 
manufactured through the existing compression moulding processes via modifications to 
the pre-preg or matrix sheet precursor stages (Shen et al. 2009). Based on this, it was 
believed that the incorporation of a secondary calcium phosphate particulate filler phase 
into a CorGlaes® Pure 107 composite configuration might successfully counteract the 
acidic by-products of the CorGlaes® Pure 107 fibre dissolution and neutralise the 
detrimental autocatalytic effects – increasing composite mechanical durability [229, 347-350].  
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8.2 Materials and Methods 
8.2.1 Silane Treated CorGlaes® Pure 107 Composites 
The initial and degenerative properties of a 0.2Vf RCM composite using CorGlaes® Pure 
107 fibres treated with a 3-aminopropyl-triethoxy (APS) sizing agent was conducted based 
on the silane treatment protocol described in section 6.2.6. Subsequent composite 
manufacturing, mechanical testing and degradation of the APS composites was performed 
using the methods outlined in section 7.2.3, 7.2.4 and 7.2.5 respectively that had been 
previously used to produce and characterise composite samples. However no fibre pre-preg 
stage was used during the manufacturing of these 0.2Vf RCM-APS composites in order to 
prevent the APS surface treatment from potentially being affected. 
 
8.2.2 CorGlaes® Pure 107 Fibre-Particle Hybrid Composites 
Due to the availability and its widespread application in biomaterials, hydroxyapatite (HA) 
was selected as the calcium phosphate particulate filler phase for hybrid composite 
development. Given its pH dependant solubility (pH↓, ksp↑) the HA filler was anticipated 
to provide a self-regulating method of buffering the media pH (Kolarik & Priestley, 2006) 
following the relationship described in Figure 8.2.1 [348, 351].  
 
 
 
 
 
 
 
 
Hybrid composites of different fibre (Vf) and HA (VHA) volume fractions were created by 
incorporating a secondary HA filler phase of sintering grade, 4µm hydroxyapatite particles 
Figure 8.2.1. Cyclic relationship between the CorGlaes® Pure 107 fibre dissolution and the 
HA buffering effect on the surrounding media pH. 
277 
 
(P218R, Plasma Biotol, UK) into the pre-preg and matrix precursors of a CorGlaes® Pure 
107 fibre-PLA composite. The manufacturing of these samples was based on the laminate 
compression moulding method previously outlined in section 7.2.2 and 7.2.3 with the 
respective weight and volume fractions of each composite phase calculated based on Eqn 
8.2.1 and Eqn 8.2.2.  
 
 |} 	 /|}/|} /[  / 
wc= wHA + wf + wm  
Eqn 8.2.1	
where WHA = composite HA weight fraction, wHA = composite HA weight (g), wf = 
composite fibre weight (g), wm = composite matrix weight (g), wc = composite weight (g) 
 
O|} 	  |}/.|} |}/.|}  i [/.[n   /. 
Eqn 8.2.2 
where VHA = composite HA volume fraction, Wf = composite fibre weight fraction, Wm = 
composite matrix weight fraction, ρHA = HA density (g cm-3) [3.156 g cm-3], ρf = fibre 
density (g cm-3) [2.65 g cm-3], ρm = matrix density (g cm-3) [1.25 g cm-3]. 
 
8.2.3 Hybrid Composite Precursors 
8.2.3.1 Fibre Pre-Pregs  
Modified CorGlaes® Pure 107 fibre-pregs with a secondary HA phase (VHA-pp) were 
manufactured through the inclusion of HA particles into a 3 w/v % PLA solution that used 
chloroform (VWR, USA) as the polymer solvent. The HA-PLA slurry was then 
magnetically stirred for 60 minutes before being placed in an Ultra 8000 ultrasonic bath 
(James Products Limited, UK) for three minutes. CorGlaes® Pure 107 fibres were then 
solvent cast with the HA-PLA slurry based on the method described in section 7.2.3. 
278 
 
8.2.3.2 Matrix Sheets 
The manufacture of homogenously distributed 0.3-0.4mm thick HA-PLA matrix sheets 
was performed through a solvent casting method using a 10 w/v % PLA solution with 
chloroform as the polymer solvent. Slurries of HA-PLA were created by adding HA 
particles to the polymer solution (VHA-m) which was then magnetically stirred for 120 
minutes before being placed in an Ultra 8000 ultrasonic bath (James Products Limited, 
UK) and ultrasonicated for three minutes. The slurry was then magnetically stirred for an 
additional 15 minutes before being returned to the ultrasonic bath for a final three minutes 
of ultrasonication. After the mixing stages, the slurry was poured into Ø150mm glass petri 
dishes (40ml per dish) inside a fume cabinet and left for 24 hours to allow the chloroform 
solvent to completely evaporate (Figure 8.2.2). The cast HA-PLA sheets were then cut into 
rectangular sections to make 180x30mm matrix sheets. 
 
 
 
 
 
 
 
 
 
8.2.4 Hybrid Composite Manufacturing 
Using the modified fibre pre-pregs and HA-PLA matrix sheets, hybrid composite samples 
were manufactured following the hand lay-up film stacking and compression moulding 
process described in section 7.2.3. 
Where necessary, HA-PLA composite samples were manufactured to act as controls by 
compression moulding HA-PLA matrix sheets inside the 130x80mm stainless steel cavity 
mould at 200°C for a ten minute curing period. The mould was then cooled to room 
temperature under 4 MPa pressure.  
Figure 8.2.2. Image of a solvent cast Ø150mm 0.2VHA-PLA matrix sheet obtained from a 
10 w/v % solution of a HA-PLA slurry after 24 hours of solvent evaporating in a fume 
cabinet [scale bar = 10mm]. 
10mm 
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8.2.5 Development of CorGlaes® Pure 107 Hybrid Composites 
Characterisation of different hybrid composite configurations was conducted following a 
mechanical and biocompatible optimisation pathway as described by the flow chart shown 
in Figure 8.2.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes 
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Figure 8.2.3. Process flow chart for development of CorGlaes® Pure 107 fibre HA filler 
hybrid composites.  
Ion Chromatography 
*Mechanically durable classified as samples that successfully retained 
at least 80% of their mechanical properties after 1008 hours (six weeks) 
of degradation in distilled water at 37°C. 
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The analysis of direct contact cultures after seeding cells on composite and control samples 
was assessed by Coomassie Brilliant Blue staining and SEM imaging due to the 
autofluorescence of the PLA that prevented Live/Dead® staining from being performed.  
 
8.2.5.1 Optimisation of Hybrid Composite Degradation 
Based on the data obtained from previous composite samples (chapter 7), Vf-VHA hybrid 
composites with increasing volume fractions of HA (VHA) were manufactured. To examine 
the effects of HA distribution on the pH buffering and sample mechanical properties, 
composites with a homogenous distribution of HA (VHA-pp ≈ VHA-m) were compared with 
an equivalent hybrid where the HA was primarily distributed within the fibre pre-pregs 
(i.e. non-homogenous distribution, VHA-pp > VHA-m).  
Additionally the commercial manufacturing of HA via precipitation techniques can lead to 
calcium oxide (CaO) becoming entrapped within the HA and as a result these particles 
typically undergo an annealing stage to remove any remaining CaO contaminants. This is 
due to the highly alkaline (and consequently cytotoxic) calcium hydroxide (Ca(OH)2) that 
can form when the CaO reacts with water as described by Eqn 8.2.3 [352, 353].  
 
NKS  3S	 → NKS3	 
Eqn 8.2.3 
 
However it was proposed that the inclusion of a CaO defective HA particulate filler should 
also be investigated within a hybrid composite configuration. This was due to the highly 
basic nature of the Ca(OH)2 reaction products that could help neutralise the phosphoric 
acid (H3PO4) created by CorGlaes® Pure 107 fibre dissolution. Based on the reaction 
shown in Eqn 8.2.4, the application of a CaO defective HA could also lead to the 
precipitation and deposition of HA on the composite as it neutralised the phosphoric acid 
[354]
.  
 
10NKS3  63A
S 	→ NKW
SzS3 ↓ 183S 
Eqn 8.2.4 
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Consequently a request was made to Plasma Biotal (Derbyshire, UK) that a specialised 
batch of HA be supplied without the final post-processing annealing stage. This resulted in 
the shipment of 4µm sintering grade 1% by mass CaO defective HA particles (Plasma 
Biotal, UK) that was used to generate CorGlaes® Pure 107 fibre HA(CaO) hybrid 
composites.  
Due to the difficulty in maintaining hybrid composites at a 0.2Vf as the volume fraction of 
HA increased (VHA), hybrid composites were manufactured at a reduced fibre volume 
fraction (0.15Vf). This alteration was deemed acceptable for the purposes of sample 
comparison with the previous 0.2Vf RCM data and was acknowledged when analysing the 
results. The specifications for each constituent phase of the respective hybrid composite 
configurations and a 0.2VHA fibre-free PLA composite control is shown below in Table 
8.2.1 and Table 8.2.2. Such quantities were scaled up for the manufacturing of multiple 
specimens as required for sample characterisation. 
 
Table 8.2.1. Specifications for precursor materials used in the manufacture of CorGlaes® 
Pure 107 hybrid composites with HA filler. 
 Fibre Pre-Preg (n = 1) (pp) Matrix sheet (n = 1) 
a
 Composite 
40ml 3 w/v % PLA 
Vf-pp-VHA-pp 
40ml 10 w/v % 
PLA VHA-m 
Fibre (g) HA (g) HA (g) 
b 0.15Vf-0.1VHA(NHD) 2.5 1.25 0.41-0.17 1.1 0.1 
0.15Vf--0.2VHA 2.5 1.25 0.41-0.17 2.6 0.2 
b
 0.15Vf-0.2VHA(NHD) 2.5 3 0.33-0.33 0.8 0.07 
b
 0.15Vf-0.2VHA(CaO) 2.5 3 0.33-0.33 0.8 0.07 
0.2VHA 0 0 0 2.6 0.2 
a Sample names designate the accumulative volume fractions of fibres (Vf) and HA (VHA) in the composite. 
b
 Designates samples where a non-homogenous distribution (NHD) of HA (VHA-pp ≠ VHA-m) is present. 
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Table 8.2.2. Specifications for pre-preg and matrix phases of CorGlaes® Pure 107 
composites with HA filler. 
 Fibre Pre-Preg HA-PLA Matrix Sheet 
a
 Composite  Weight (g) Pre-Preg (n) Weight (g) Matrix (n) 
b
 0.15Vf-0.1VHA(NHD) ≈4.4 5 ≈5 6 
0.15Vf--0.2VHA ≈4.4 5 ≈5 6 
b 0.15Vf-0.2VHA(NHD) ≈6.5 5 ≈4.5 6 
b
 0.15Vf-0.2VHA(CaO) ≈6.5 5 ≈4.5 6 
0.2VHA 0 0 ≈5 9 
a Sample names designate the accumulative volume fractions of fibres (Vf) and HA (VHA) in the composite. 
b
 Designates samples where a non-homogenous distribution (NHD) of HA (VHA-pp ≠ VHA-m) is present. 
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8.2.5.2 Optimisation of Biocompatible Hybrid Composites  
Based on the MTT results found in section 7.3.6, 0.01Vf and 0.05Vf RCM CorGlaes® Pure 
107 fibre PLA hybrid composites were assessed using composite samples with an 
increasing volume fraction of HA (VHA) homogenously distributed throughout the matrix 
phase (VHA-m) along with a 0.2VHA control.  
To compare the effect of calcium phosphate filler solubility on composite biocompatibility, 
a 0.05Vf hybrid composite was manufactured using β-TCP as the secondary filler phase. 
This was due to the increased solubility of β-TCP (Ksp = 10-28.9 at 25°C) compared to HA 
(Ksp = 10-116.8 at 25°C) (Figure 8.2.4) and its widespread application in biomaterials. These 
samples were manufactured following the methods described in section 8.2.3.1, 8.2.3.2 and 
8.2.4 using 4µm β-TCP particles (P228S, Plasma Biotal, UK) [100].  
 
 
 
 
 
 
 
 
The manufacturing specifications along with the weight and volume fractions of all 
precursor and composite samples is described below in Table 8.2.3 and Table 8.2.4. As 
specified in section 7.2.3, the low Vf of the composites prevented any solvent casting pre-
preg stage due to the damage incurred when attempting to remove the samples from the 
foil trays. 
Unfortunately the 130x80mm mould used in the manufacturing of previous composites 
was damaged and whilst being repaired a substitute 70x30mm three-piece cavity mould 
was used to manufacture the samples outlined in Table 8.2.3 and Table 8.2.4. 
Figure 8.2.4. Variation in different calcium phosphate compound solubility with pH 
(solubility expressed as Ca concentration) [Reproduced from Dorozhkin (2013) Self-
Setting Calcium Orthophosphate Cements]. 
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Table 8.2.3. Specifications for fibre pre-pregs and matrix precursor materials used for the 
manufacturing of CorGlaes® Pure 107 hybrid composites. 
Composite 
Fibre Pre-Preg (n = 1) (pp) 
Matrix sheet (n = 1) 
40ml 10 w/v % PLA 
VHA-m 
Fibre (g) HA (g) Vf-pp-VHA-pp HA (g) 
0.01Vf 0.04 0 1-0 0 0 
0.01Vf-0.1VHA 0.04 0 1-0 1.1 0.1 
0.01Vf--0.2VHA 0.04 0 1-0 2.6 0.2 
0.05Vf 0.15 0 1-0 0 0 
0.05Vf-0.1VHA 0.15 0 1-0 1.1 0.1 
0.05Vf-0.2VHA 0.15 0 1-0 2.6 0.2 
0.2VHA 0 0 0 2.6 0.2 
0.05Vf-0.2VTCP 0.15 0 1-0  2.6 0.2 
 
 
Table 8.2.4. Weight and number of precursor sheets used in the manufacture of CorGlaes® 
Pure 107 composites. 
Composite          
CorGlaes® Pure 107 Fibre Matrix Sheets 
Weight (g) Pre-Preg (n) Weight (g) Matrix (n) 
0.01Vf 0.04 5 1.2 6 
0.01Vf-0.1VHA 0.04 4 1.4 5 
0.01Vf--0.2VHA 0.04 4 1.4 5 
0.05Vf 0.15 5 1.2 6 
0.05Vf-0.1VHA 0.15 4 1.2 5 
0.05Vf-0.2VHA 0.15 4 1.2 5 
0.2VHA 0 0 1.2 9 
0.05Vf-0.2VTCP 0.15 4 1.2 5 
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8.2.6 Mechanical Testing and Degradation 
The mechanical testing and degradation of CorGlaes® Pure 107 hybrid composites (Figure 
8.2.5) and control samples was conducted following the procedure outlined in section 7.2.4 
and 7.2.5 respectively. 
 
 
 
 
 
 
 
 
8.2.7 Biocompatibility of CorGlaes® Pure 107 Hybrid Composites 
The procedures for cytotoxicity testing and preparing precursor solutions for cell culture 
were conducted following the instructions and recipes at the Centre for Cell Engineering 
(CCE), University of Glasgow. 
Prior to biocompatibility testing, the in vitro cell culture and seeding of samples was 
performed following the method described in section 5.2.10.2. 
 
8.2.7.1 Cell Culture Precursor Solutions 
 
Cell culture fixative  
A fixative solution for cells after cell culture was prepared following the recipe and 
chemical agents listed in Table 8.2.5. This solution was intended to preserve the dead cells 
in a condition as close as possible to their living state for visual analysis. 
 
 
Figure 8.2.5. Image of a 60x15x2mm 0.2Vf RCM composite (left) and 0.15Vf-0.2VHA
hybrid composite (right) showing the change in colour of the hybrid sample due to the 
inclusion of hydroxyapatite (HA) particles into the pre-preg and matrix phases. 
10mm 
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Table 8.2.5. Reagent chemicals involved in preparation of CCE cell fixative solution.  
Reagent Quantity 
Phosphate buffered saline (PBS) (section 5.2.10.1) 90ml 
Formaldehyde (Sigma-Aldrich, USA) 10ml 
Sucrose (Sigma-Aldrich, USA) 2g 
 
 
Fixative for SEM inspection 
For SEM imaging, cultured cells were fixed with a solution containing 1.5% 
glutaraldehyde and 0.1M sodium cacodylate. This was created by mixing 1.2ml of a 25% 
glutaraldehyde solution with a 18.8ml sodium cacodylate buffer. 
 
8.2.7.2 MTT Assay 
The biocompatibility of the CorGlaes® Pure 107 hybrid composites and control materials 
was assessed by MTT assay using MG63 cells following the procedure outlined in section 
7.2.8 for extracts obtained after 24 and 96 hours of degradation. 
 
8.2.7.3 Coomassie Brilliant Blue  
The Coomassie Brilliant Blue staining method is an inexpensive and easily processable 
technique for visualising proteins by binding them with a triphenylmethane dye. Two 
distinct classifications of the Coomassie Brilliant Blue dye are available and are based 
upon a methanol (G-250) or methanol-water (R-250) based recipe to produce blue-violet 
stains with either a reddish (R-250) or greenish tint (G-250) [355, 356]. 
 
Coomassie Brilliant Blue dye 
The Coomassie dye (R-250) used for in vitro testing was prepared following the recipe 
outlined in Table 8.2.6. The stain was then passed through filter paper and stored at 
ambient temperature.  
287 
 
Table 8.2.6. Reagent chemicals used in the preparation of the Coomassie stain 
Reagent Quantity 
Methanol 225ml 
Acetic Acid 50ml 
Coomassie Brilliant Blue R-250 1.25 
Deionised Water 225ml 
 
 
Coomassie Brilliant Blue protocol 
Protein staining of cells cultured on CorGlaes® Pure 107 composite samples was 
performed using a Coomassie Brilliant Blue dye (R-250) on 10x10x2mm composite 
samples cultured with MG63 cells over 24, 96 and 168 hours of incubation in a 24-well 
plate. To correlate with the MTT assay results, composite samples were seeded at a cell 
density of 1x104 cells ml-1 at a 1.4 cm2 ml-1 SA:V with Thermanox® coverslips (Thermo 
Fisher Scientific™, USA) used as positive controls alongside additional suitable sample 
controls. Samples were cultured in 5% CO2 at 37°C inside an incubator with the CDMEM 
media replaced after 96 hours. Coomassie staining of samples was then performed in 
triplicate (n = 3) for each culture period following the steps outlined in Table 8.2.7.  
 
Table 8.2.7. Procedure for Coomassie staining of cells cultured on CorGlaes® Pure 107 
composite samples. 
Step Description 
1 
The culture plates were removed from the incubator and the CDMEM aspirated 
before samples were immersed in the fixative solution (Table 8.2.5) for fifteen 
minutes. 
2 The fixative was removed and the samples washed three times with sterile PBS. 
3 
The Coomassie staining solution was then added to all samples for fifteen 
minutes before samples were washed five times with sterile PBS. Images were 
then captured using an Eclipse ME600 optical microscope (Nikon, Japan).  
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8.2.7.4 SEM Imaging  
Visual examination of MG63 cells cultured on composite and control samples by SEM was 
performed using a Sigma VP SEM (Carl Zeiss, Germany) SEM at 10kV accelerating 
voltage at the School of Geographical and Earth Sciences, University of Glasgow. The 
inspection of cultured cells was performed after seeding samples in triplicate (n = 3) at a 
cell density of 1x104 cells ml-1 at a 1.4 cm2 ml-1 SA:V ratio and changing the CDMEM 
after 96 hours. Samples when then inspected after 24, 96 and 168 hours of incubation 
following the preparation steps outlined below with images captured using the Zeiss 
SmartSEM software package. Images were captured in triplicate (n = 3) for each sample 
across the different culture periods at x800 and x1500 magnifications.  
 
SEM sample cell fixation 
At each corresponding incubation period (24, 96, 168 hours) the culture plates were 
removed from the incubator and washed twice with sterile PBS before the SEM fixative 
was added to each sample inside a laminar flow fume cabinet. Plates were then wrapped in 
Parafilm M® (Sigma-Aldrich, USA) and placed inside a fridge at 4°C for one hour after 
which the fixative was removed and the samples were washed three times with a 0.1M 
sodium cacodylate buffer rinse. Sample plates were then wrapped in tin foil and returned to 
the fridge until SEM preparation. 
 
SEM sample preparation 
For SEM analysis, cell cultured samples were prepared by being removed from the fridge 
and washed with osmium tetroxide for one hour inside a fume hood before being rinsed 
three times with deionised water for ten minutes per rinse. Samples were then stained with 
0.5% uranyl acetate, wrapped in foil and left for one hour. Following these steps the 
samples were sequentially dehydrated by being immersed for ten minutes with increasing 
concentrations of ethanol (30%→50%→70%→90%). Samples were then rinsed four times 
with absolute ethanol for five minute periods before being washed twice in 
hexamethyldisilazane (HDMS) for five minute periods each. The samples were finally 
mounted onto aluminium stubs and sputter coated with gold (Agar Scientific, UK) for 
SEM imaging.  
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8.2.8 Ion Release 
Analysis of the Ca2+, Mg2+, Zn2+ and Na+ cations as well as the (PO4)3- anion released from 
biocompatible CorGlaes® Pure 107 hybrid composites and suitable controls over the first 
168 hours of sample degradation (see section 8.2.6) in distilled water was conducted 
following the procedure described in section 5.2.8.2. 
 
8.2.9 Hybrid Composite Bioactivity  
The bioactivity of biocompatible CorGlaes® Pure 107 hybrid composites was conducted 
following the procedure outlined in section 7.2.7. This was performed alongside a 0.2VHA 
control and an equivalent HA-free CorGlaes® Pure 107 fibre composite (with the Vf 
matching that of the biocompatible hybrid composite). 
 
 
 
 
 
 
 
 
 
 
 
 
 
290 
 
8.3 Results 
8.3.1 Silane Treated CorGlaes® Pure 107 Composites 
8.3.1.1 Mechanical Properties 
A comparison between the typical stress strain plots obtained from the previous 0.2Vf 
RCM and a silane treated 0.2Vf RCM composite (0.2Vf RCM-APS) is displayed in Figure 
8.3.1 with the flexural strength and elastic moduli compared in Figure 8.3.2 [46]. 
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Figure 8.3.1. Typical stress-strain plots obtained from the mechanical testing of 0.2Vf
RCM and 0.2Vf RCM-APS silane treated composites 
Figure 8.3.2. Comparison of 0.2Vf RCM-APS composite mechanical properties with the 
previous 0.2Vf RCM samples and parietal bone [Data from Motherway et al. (2009)] 
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8.3.1.2 Degradation  
The wet/dry weight changes along with the media pH during the degradation of 0.2Vf 
RCM-APS composites is compared with the previous 0.2Vf RCM results over 1008 hours 
of immersion in Figure 8.3.3 and Figure 8.3.4. The retention of 0.2Vf RCM-APS sample 
mechanical properties over this degradation period is also compared in Figure 8.3.5. 
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Figure 8.3.3. Comparison of silane treated 0.2Vf RCM-APS composites a) Wet weight and 
b) Dry weight with previous 0.2Vf RCM data over 1008 hours (six weeks) of degradation 
in distilled water at 37°C. 
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Figure 8.3.4. Media pH during degradation of silane treated 0.2Vf RCM-APS composite 
and 0.2Vf RCM samples for up to 1008 hours of immersion in distilled water at 37°C. 
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8.3.2 Optimisation of Hybrid Composite Degradation 
8.3.2.1 Mechanical Properties  
The stress-strain plots recorded during the mechanical testing of 0.15Vf hybrid composites 
are compared with a 0.2VHA control composite and previous 0.2Vf RCM data in Figure 
8.3.6. The mechanical properties of these samples are compared in Figure 8.3.7.  
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Figure 8.3.6. Comparison of stress-strain plots obtained from 0.2Vf RCM samples and 
0.15Vf-VHA hybrid composites as well as a 0.2VHA control.  
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Figure 8.3.7. Comparison of flexural strength and elastic modulus of the different hybrid 
composite configurations shown in Figure 8.3.6 and control materials as well as parietal
bone [Data from Motherway et al. (2009)]. 
295 
 
A complete description of the hybrid composites and control sample mechanical properties 
are listed in Table A.2. of Appendix A. 
Inspection of the fracture site after mechanical testing of a 0.15Vf-0.1VHA hybrid 
composite sample is shown in Figure 8.3.8. This was conducted using a Hitachi S9000 
SEM (Hitachi, Japan) at a 10kV accerlating voltage after coating the fracture faces with 
gold (Agar Scientific, UK) and was performed at the James Watt Nanofabrication Centre 
(JWNC), University of Glasgow. 
 
 
 
 
Figure 8.3.8. SEM images of mechanically tested 0.15Vf-0.1VHA(NHD) composite fracture 
faces prior to degradation [i.e. T0] with HA particles and the pull out of HA particles 
during mechanical testing shown by arrow 1 and 2 respectively [scale bar = 100µm, 50µm, 
20µm, 10µm]. 
2 
1 
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8.3.2.2 Degradation 
A comparison of the different hybrid and control composites during their degradation in 
distilled water over 1008 hours is shown in Figure 8.3.9 as well as Figure 8.3.10 for the 
wet/dry weights and media pH respectively. The flexural strength and elastic modulus over 
this period is shown in Figure 8.3.11.  
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Figure 8.3.9. Comparison of a) Wet weight and b) Dry weight during the degradation of 
different hybrid composite configurations and control samples over 1008 hours of 
immersion in distilled water at 37°C. 
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Figure 8.3.10. Comparison of media pH during degradation of hybrid composites and 
control samples over 1008 hours of immersion in distilled water at 37°C. 
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8.3.3 Optimisation of Biocompatible Hybrid Composites 
 
8.3.3.1 MTT Assay 
The MTT results from the extracts of different CorGlaes® Pure 107 hybrid composite 
configurations after 24 and 96 hours of degradation are shown in Figure 8.3.12. The data 
shows a generalised trend of increasing cell viability with increasing HA volume fraction 
in both 0.01Vf and 0.05Vf hybrid samples. Furthermore a statistically significant difference 
was found between the use of an HA or β-TCP filler on MG63 cell viability in the 0.05Vf 
hybrid composites (p < 0.05). The results also showed that the 0.2VHA control sample 
displayed cell viabilities comparable to the CDMEM control. The pH of the media 
corresponding to these results is shown in Figure 8.3.13. 
 
 
Figure 8.3.12. MTT assay of MG63 cell viability from the degradation extracts of 
composite materials containing 0.01Vf and 0.05Vf with 0VHA→0.1VHA→0.2VHA filler 
volume fractions as well as a 0.05Vf-0.2VTCP sample after 24 and 96 hours of degradation. 
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8.3.3.2 Coomassie Brilliant Blue 
Given the biocompatibility of the 0.01Vf-0.2VHA samples found by MTT assay (Figure 
8.3.12), this composite configuration was subsequently investigated by direct contact cell 
culturing in accordance with the flow chart shown in Figure 8.2.3. This was conducted 
alongside the culture of MG63 cells on Thermanox® coverslips, neat PLA as well as 
0.2VHA and 0.01Vf composites to act as the further controls. 
The Coomassie staining of the MG63 cells cultured on 0.01Vf-0.2VHA hybrid composites 
along with the other samples listed after 24, 96 and 168 hours of incubation is shown in  
Figure 8.3.14, Figure 8.3.15 and Figure 8.3.16 respectively.  
 
 
 
 
 
Figure 8.3.13. Comparison of media pH after 24 and 96 hours of different hybrid 
composite sample degradation in DMEM (standard deviations < ± 0.04). 
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Figure 8.3.14. Coomassie staining of MG63 cells cultured after 24 hours for a-c) 
Thermanox® coverslips, d-f) PLA, g-i) 0.2VHA, j-l) 0.01Vf and m-o) 0.01-0.2VHA samples 
at x5, x10 and x20 magnifications [scale bars = 500µm, 250µm and 100µm]. 
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Figure 8.3.15. Coomassie staining of MG63 cells cultured after 96 hours on a-c) 
Thermanox® coverslips, d-f) PLA, g-i) 0.2VHA, j-l) 0.01Vf and m-o) 0.01-0.2VHA samples 
at x5, x10 and x20 magnifications [scale bars = 500µm, 250µm and 100µm].  
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Figure 8.3.16. Coomassie staining of MG63 cells cultured after 168 hours on a-c) 
Thermanox® coverslips, d-f) PLA, g-i) 0.2VHA, j-l) 0.01Vf and m-o) 0.01-0.2VHA samples 
at x5, x10 and x20 magnifications [scale bars = 500µm, 250µm and 100µm].   
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8.3.3.3 SEM Characterisation 
Based on the Coomassie Brilliant Blue images of cultured MG63 cells (section 8.3.3.2), 
the seeding and culture of MG63 cells on neat PLA, 0.01Vf and 0.01Vf-0.2VHA samples 
was analysed using SEM images. These were captured after 24, 96 and 168 hours of direct 
contact culture and are shown in Figure 8.3.17, Figure 8.3.18 and Figure 8.3.19 
respectively at x800 and x1500 magnifications. A comparison between these samples after 
168 hours of culture is also shown at x300 magnification in Figure 8.3.20.  
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Figure 8.3.17. SEM images obtained after 24 hours of MG63 cells cultured on (a, d, g) PLA, (b, e, h) 0.01Vf and (c, f, i) 0.01Vf-0.2VHA samples at x800 
and x1500 magnification [scale bars = 10µm]. 
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PLA 0.01Vf-0.2VHA 0.01Vf 
Figure 8.3.18. SEM images obtained after 96 hours of MG63 cells cultured on (a, d, g) PLA, (b, e, h) 0.01Vf and (c, f, i) 0.01Vf-0.2VHA samples at x800 
and x1500 magnification [scale bars = 10µm]. 
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Figure 8.3.19. SEM images obtained after 168 hours of MG63 cells cultured on (a, d, g) PLA, (b, e, h) 0.01Vf and (c, f, i) 0.01Vf-0.2VHA samples at x800 
and x1500 magnification [scale bars = 10µm]. 
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Figure 8.3.20. Comparison of MG63 cells cultured on (a,d) PLA, (b,e) 0.01Vf and (c,f) 0.01Vf-0.2VHA after 168 hours of immersion at x300 
magnification [scale bars = 100µm]. 
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8.3.3.4 Mechanical Properties 
The stress-strain plots as well as the resulting mechanical properties of the biocompatible 
0.01Vf-0.2VHA hybrid composite are compared with 0.01Vf and 0.2VHA samples in Figure 
8.3.21 and Figure 8.3.22 respectively. 
  
 
 
Figure 8.3.21. Stress-strain plots obtained from the three point bend testing of 0.01Vf-
0.2VHA hybrid samples as well as 0.01Vf and 0.2VHA control samples. 
Figure 8.3.22. Comparison of flexural strength and elastic modulus of 0.01Vf-0.2VHA
hybrid composite with 0.01Vf and 0.2VHA control samples as well as those recorded for the 
parietal bone [Data from Motherway et al. (2009)]. 
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8.3.3.5 Degradation  
The wet and dry weights during the degradation of 0.01Vf-0.2VHA hybrid composites was 
subsequently compared with degradation data obtained from 0.01Vf and 0.2VHA composite 
samples in Figure 8.3.23. Further comparisons between the media pH, flexural strength as 
well as the elastic modulus are shown in Figure 8.3.24 and Figure 8.3.25 respectively.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-6%
-4%
-2%
0%
2%
4%
6%
0 168 336 504 672 840 1008
W
et
 
W
ei
gh
t (
%
)
Immersion Period (hours)
Wet Weight vs Immersion Period
0.01Vf
0.2VHA
0.01Vf-
0.2VHA
a 
-6%
-4%
-2%
0%
2%
4%
6%
0 168 336 504 672 840 1008
D
ry
 
W
ei
gh
t (
%
)
Immersion Period (hours)
Dry Weight vs Immersion Period
0.01Vf
0.2VHA
0.01Vf-
0.2VHA
b 
Figure 8.3.23. Comparison of a) Wet weight and b) Dry weight of 0.01Vf-0.2VHA , 0.01Vf
and 0.2VHA samples during 1008 hours of degradation in distilled water at 37°C.  
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Figure 8.3.24. Comparison of media pH during the degradation of 0.01Vf-0.2VHA, 0.01Vf
and 0.2VHA samples after 1008 hours of immersion in distilled water at 37°C. 
312 
 
 
 
 
 
 
 
0
20
40
60
80
100
120
0 168 336 504 672 840 1008
Fl
ex
u
ra
l S
tr
en
gt
h 
(M
Pa
)
Immersion Period (hours)
Flexural Strength vs Immersion Period
0.01VF
0.2VHA
0.01Vf-
0.2VHA
0
2
4
6
8
10
12
0 168 336 504 672 840 1008
El
as
tic
 
M
o
du
lu
s 
(G
Pa
)
Immersion Period (hours)
Elastic Modulus vs Immersion Period
0.01Vf
0.2VHA
0.01Vf-
0.2VHA
a 
b 
Figure 8.3.25. Comparison of a) Flexural strength and b) Elastic modulus of 0.01Vf-
0.2VHA, 0.01Vf and 0.2VHA samples during 1008 hours of degradation in distilled water at 
37°C. 
313 
 
8.3.3.6 Ion Release 
The daily and accumulative ion release from the 0.01Vf and 0.01Vf-0.2VHA composite 
samples is shown below in Figure 8.3.26 and Figure 8.3.27 over the initial 168 hours of 
degradation. 
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Figure 8.3.26. Comparison of daily ionic concentrations from a) 0.01Vf and b) 0.01Vf-
0.2VHA samples during the first 168 hours of degradation in distilled water. 
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Figure 8.3.27. Comparison of the accumulative ionic media concentrations from a) 0.01Vf
and b) 0.01Vf-0.2VHA composites over the initial 168 hours of degradation in distilled 
water. 
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8.3.3.7 Bioactivity  
The FTIR spectra obtained from the 0.01Vf and 0.01Vf-0.2VHA composite planar surfaces 
are compared with that recorded from the 4µm hydroxyapatite (HA) particles (P218R, 
Plasma Biotal, UK) in Figure 8.3.28. The results showed that the HA filler was exposed on 
the hybrid composite surface by the presence of peaks at 962cm-1, 633cm-1, 604cm-1 and 
562cm-1 that corresponded to the vibrational modes of the phosphate and hydroxyl groups 
in the HA. This observation was in line with previous results such as those described by 
Danoux et al. (2014) with overlapping of phosphate and polymer vibrational groups 
observed in the 0.01Vf-0.2VHA hybrid composite spectrum [357].  
 
 
Figure 8.3.28. FTIR spectra obtained from the planar surfaces of a 0.01Vf composite, 4µm 
hydroxyapatite particles and a 0.01Vf-0.2VHA hybrid composite over the 1400-400cm-1
wavenumber range showing the overlapping of HA and PLA bands in the hybrid 
composite spectrum. 
562cm-1 and 604cm-1 v4 (PO4)3-  
PLA C-O and C-O-C stretching vibrations 
633cm-1 OH-  
1022cm-1 and 
1090cm-1 v3 (PO4)3- 962cm
-1
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The subsequent FTIR spectra after the immersion of 0.2VHA, 0.01Vf and 0.01Vf-0.2VHA 
samples in c-SBF for up to 336 hours (2 weeks) is shown in Figure 8.3.29, Figure 8.3.30 
and Figure 8.3.31 respectively.  
The results showed that during the immersion of 0.2VHA samples (Figure 8.3.29), the peak 
intensities of the HA bands at 562cm-1 and 604cm-1 varied between spectra with a general 
decrease at 168 and 336 hours of immersion. These spectra also appeared to show a peak 
shift from 1030cm-1 to 1044cm-1 after 120 hours of immersion with the suppression of peak 
intensities at 1264cm-1 and 800cm-1 seen after 24 hours. Meanwhile spectra obtained from 
the immersion of 0.01Vf composites (Figure 8.3.30) showed a change in the 1264cm-1 and 
800cm-1 wavenumber peak intensities that appeared to increase in spectra obtained after 24 
hours but then decrease with further immersion time. However, no other shift in peak 
wavenumber or intensity was observed from the 0.01Vf results.    
The immersion of 0.01Vf-0.2VHA samples in c-SBF (Figure 8.3.31) showed the same peak 
shifting (1030cm-1 to 1044cm-1) as observed with the 0.2VHA sample in spectra obtained 
after 72, 96 and 168 hours of immersion. The same variation in peak intensity at 604cm-1 
and 562cm-1 was also observed with reduced intensities in spectra obtained after 72, 120 
and 168 hours. Meanwhile a visual examination of the samples found that small deposits 
had formed on the cross-sections of one of the 0.01Vf-0.2VHA samples after 336 hours of 
immersion. 
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Figure 8.3.29. Comparison of FTIR spectra obtained after the immersion of 0.2VHA
composites in c-SBF for 24, 72, 120, 168 and 336 hours over the a) 4000-400cm-1 and b) 
1400-400cm-1 wavenumber ranges. 
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Figure 8.3.30. Comparison of FTIR spectra obtained after the immersion of 0.01Vf
composites in c-SBF for 24, 72, 120, 168 and 336 hours over the a) 4000-400cm-1 and b) 
1400-400cm-1 wavenumber ranges. 
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Figure 8.3.31. Comparison of FTIR spectra obtained after the immersion of 0.01Vf-0.2VHA
composites in c-SBF for 24, 72, 120, 168 and 336 hours over the a) 4000-400cm-1 and b) 
1400-400cm-1 wavenumber ranges. 
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8.4 Discussion 
Mechanical testing of the 0.2Vf RCM-APS samples showed that the silane treatment of 
CorGlaes® Pure 107 fibres produced composites with an increased average flexural 
strength (+39.7%), elastic modulus (+7.9 %) and toughness (+41.2%) compared to the 
non-treated 0.2Vf RCM samples. This result was reflected in the comparative stress-strain 
plots (Figure 8.3.1) with the improved flexural strength indicative of an improved 
interfacial shear bond strength (τb) between the fibre and matrix (section 3.4.9) through the 
use of an APS sizing agent.  
These results were in line with those reported by Khan et al. (2011) who attributed the 
improved interfacial adhesion at the fibre-matrix interface to the reactions between the 
amine silane network on the APS treated fibre surfaces and the PLA matrix. Yet the 
improved composite mechanical properties may also be attributed to the partial healing of 
defects in the fibre surfaces by the APS treatment, as reported by Zinck et al. (2001) and 
Feih et al. (2005). Such mechanisms occur via the deposition, penetration and crosslinking 
of the sizing agent within the fibre surface defects (Figure 8.4.1). This can lead to the total 
removal or reduction in the severity of flaws that could have been introduced during the 
fibre handling stages of composite manufacture [221, 228, 317, 358]. 
 
 
 
 
Yet despite the improved initial [T0] mechanical properties, the APS silane treatment 
provided no improvement to the composite integrity (i.e. mechanical property retention) 
Figure 8.4.1. Comparison between a) Unsized and b) Sized glass fibre surfaces showing 
the reduction in flaw size severity through the use of a silane surface treatment 
[Reproduced from Zinck et al. (2001)]. 
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during sample degradation (Figure 8.3.5). This was evident by the rapid decrease in the 
wet and dry weight of the 0.2Vf RCM-APS samples that followed the same trends as 
previously observed during 0.2Vf RCM composite degradation (section 7.3.3.1) and 
contradicted previous results reported by Khan et al. (2011) and Hasan et al. (2013). 
However these differences could be accounted for by the polyphosphate composition (< 50 
mol% P2O5) used in these studies. Such glass formulations would probably have possessed 
reduced dissolution rates that would also have made them less susceptible to autocatalytic 
effects compared to the CorGlaes® Pure 107 fibres (55 mol% P2O5) (due to their reduced 
P2O5 content). Consequently despite the polysiloxane fibre coating and increased 
interfacial hydrophobicity in the 0.2Vf RCM-APS samples, the CorGlaes® Pure 107 fibres 
remained highly susceptible to autocatalysis with the media pH decreasing to ≈2.9 after 24 
hours of degradation. As expected from the rapid decrease in wet and dry weights (due to 
fibre dissolution), a large reduction in the flexural strength (-79%) and elastic modulus (-
73%) of the 0.2Vf RCM-APS samples was observed after 168 hours of degradation [224, 228]. 
Analysis of the stress-strain plots obtained from the mechanical testing of the CorGlaes® 
Pure 107 fibre hybrid composites showed the failure behaviour of these samples shifted 
from an initial fibrous, ductile failure to a more brittle fracture mode with a reduced strain 
to failure (Figure 8.3.6). This transition was in line with previous results reported by 
Friedrich et al. (2005) as well as Kobayashi et al. (2010) and was attributed to the high 
modulus filler particles restricting the plastic deformation of the matrix (Liang, 2002) [229, 
359-361]
. 
Mechanical testing of hybrid samples also showed that the inclusion of a secondary HA 
filler phase (VHA-pp, VHA-m) led to changes in the elastic modulus (Ecomp) which did not 
always correlate with the generally accepted increase in material stiffness expected from 
the inclusion of a secondary particulate filler to a glass fibre polymer composite [347, 359]. 
This was coupled with a reduction in flexural strength compared to the 0.2Vf RCM sample 
(Figure 8.3.7) with the resulting variations in the mechanical properties considered to be 
reflective of the different volume fractions (VHA) and distributions of HA (VHA-pp, VHA-m) 
utilised in the hybrid composite configurations (Table 8.2.1). 
From the results it was found that the greatest increase in elastic modulus (+22%) 
compared to the initial 0.2Vf RCM composite was achieved by the 0.15Vf-0.1VHA(NHD) 
hybrid configuration (10.01 ± 1.33 GPa). This result contradicted the expected trend of 
increasing elastic moduli as the HA volume fraction was increased and/or a more 
homogenous distribution of HA (VHA-pp ≈ VHA-m) was employed in the other samples. Such 
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results were attributed to the agglomeration of HA particles as the VHA was increased that 
could have introduced areas of localised stress concentrators in the 0.15Vf-0.2VHA samples 
compared to the 0.15Vf-0.1VHA(NHD) composites. Such behaviour has been previously 
observed in the development of carbon fibre-HA hybrid composites as studied by Shen et 
al. (2009) where a decrease in elastic modulus was found to occur after the inclusion of 20 
wt.% HA that was attributed to the poor dispersion of the HA particles [347, 360, 362].  
The distribution/agglomeration of HA particles was also believed to have accounted for the 
lower elastic modulus of the 0.15Vf-0.2VHA(NHD) (6.74 ± 0.45 GPa) composites  compared 
to the 0.15Vf-0.2VHA (9.34 ± 0.49 GPa) samples despite both possessing equal 
accumulative volume fractions of HA (VHA). Consequently the reduced elastic modulus in 
the 0.15Vf-0.2VHA(NHD) samples was attributed to the primary distribution of the HA 
throughout the CorGlaes® Pure 107 fibre pre-pregs (0.33VHA-pp) compared to the 0.15Vf-
0.2VHA samples (0.17VHA-pp). Based on the work of Shen et al. (2009), the higher VHA-pp 
was thought to have formed localised stress concentrators and increased the probability of 
defects being introduced into the samples. The high pre-preg volume fraction of HA in the 
0.15Vf-0.2VHA(NHD) hybrid samples was also believed to have compromised the fibre-
matrix interface by reducing the available surface area for fibre-matrix adhesion (Figure 
8.4.2). This would then account for the reduction in flexural strength seen in the 0.15Vf-
0.2VHA(NHD) samples compared to the 0.15Vf-0.1VHA(NHD) composites [347, 363]. 
 
 
 
 
 
 
 
Figure 8.4.2. Illustration of the compromised fibre-matrix interface in the 0.15Vf-
0.2VHA(NHD) samples due to the high HA pre-preg volume fraction (0.33VHA-pp) [Modified 
from Cech et al. (2013)]. 
Section of 0.15Vf-0.2VHA(NHD) composite 
CorGlaes® Pure 107 fibres CorGlaes® Pure 107 fibre 
0.33Vf-pp-0.33VHApp pre-preg 
with compromised interface 
due to reduced available 
fibre surface area as well as 
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The reduced flexural strength observed in the 0.15Vf-0.2VHA composites was consequently 
attributed to the reduced melt flow index (MFI) of the HA-PLA matrix sheets (0.2VHA-m) 
compared to the 0.15Vf-0.1VHA samples (0.1VHA-m) (Bregg et al. 2006). The reduced MFI 
would have likely affected the quality of the fibre-matrix interface during the 
manufacturing of the 0.15Vf-0.2VHA samples due to its restriction on polymer infiltration 
into the reinforcing fibres (following Darcy’s Law – section 3.2.3). Along with the factors 
discussed for the 0.15Vf-0.2VHA(NHD) samples, these concepts would then be in agreement 
with the observed results where all 0.2VHA hybrid samples were found to display similar 
flexural strengths to those exhibited by the fibre-free 0.2VHA control. This subsequently 
highlighted the poor fibre-matrix interface that was generated as the VHA was increased 
and/or the distribution of HA was altered (Bregg et al. 2006) [359, 360].  
However based on points discussed by Bregg et al. (2009) and Shen et al. (2009), the 
reduction in flexural strength found in all hybrid samples (compared to the 0.2Vf RCM 
composite) could also have been influenced by the presence of cavities and microvoids at 
the HA-PLA interface. Such voids could have been incurred from the high specific surface 
area (13.3 m2 g-1) and subsequently reduced wetting of the non-sintered HA particles 
employed here compared to the their sintered equivalent (specific surface area = 1.16 m2 g-
1) as reported by Joseph et al. (2002) as well as Zhang & Tanner (2008). Yet given the 
intention of the HA filler to act as a pH buffering agent, the increased specific surface area 
of the non-sintered HA used here was deemed more appropriate. Furthermore according to 
Wang et al. (2011), a weak interface could also have formed due to the contrast between 
the hydrophobic PLA matrix and hydrophilic HA filler [347, 360, 364-366].  
As expected, the mechanical testing of the HA-PLA composites (0.2VHA) showed that the 
incorporation of HA particles increased the elastic modulus (+67.3 %) and reduced the 
flexural strength (-63.8 %) compared to the neat PLA. This was coupled with a reduced 
strain at failure that was in line with the expected trends for microparticle reinforced 
composites where a weak interface is encountered (Friedrich et al., 2005; Fu et al., 2008). 
The reduced modulus of the 0.2VHA particle composite (5.37 ± 0.83 GPa) compared to the 
hybrid samples also highlighted the contribution of the CorGlaes® Pure 107 fibres towards 
the hybrid composite elastic modulus despite the interface and agglomeration issues 
previously discussed [359, 367]. 
Degradation of the hybrid composites subsequently showed that a reduction followed by a 
plateau in the wet and dry weights occurred after 168 to 336 hours of degradation in all 
hybrid configurations. As previously discussed in section 7.4, the discrepancy between the 
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composite wet and dry weights was due to the ingress of media within the pores and voids 
generated from fibre dissolution. Additionally, the apparent reduction in wet and dry 
weight loss compared to the 0.2Vf RCM composite was due to the reduced volume (Vf) 
and weight fraction (Wf) of the CorGlaes® Pure 107 fibres (ρ = 2.65 g cm-3) in the hybrid 
composites due to the secondary HA filler phase (ρ = 3.156 g cm-3). Based on the 
percentage wet and dry weights of the 0.2VHA samples, the decrease in hybrid composite 
weight was primarily due to CorGlaes® Pure 107 fibre dissolution. However, it is unknown 
what contribution to the weight loss that the dissolution of the secondary HA filler phase 
may have had on this data due to the absence of an acidic environment during 0.2VHA 
sample degradation (Figure 8.3.10).  
A comparison between the different hybrid configurations found that the HA volume 
fraction (VHA) or HA phase distribution had no significant effect on the rate of weight loss 
(which was considered to represent fibre dissolution). Furthermore the degradation data 
also revealed that the inclusion of a 1% CaO defective HA filler had no effect on the 
mechanical integrity of the composite samples compared to the chemically pure HA. This 
may be due to the distribution of the CaO within the non-sintered particles that is believed 
to be less homogenous than its sintered equivalent (Personal Communication – Paul 
Steverson, Plasma Biotal, UK). Consequently if concentrated at the centre of the 
precipitated HA particles, the CaO may not have been able to efficiently interact with the 
acidic degradation media. However it may also be that the concentration of CaO was 
inadequate to sufficiently counteract the acidic pH and reduce the rate of fibre dissolution. 
Compared to the 0.2VHA samples, the decrease in hybrid sample weight was contrasted by 
the recorded increase in wet weight of the 0.2VHA composites that was higher than that 
previously recorded from neat PLA samples (Figure 8.4.3). The increased water absorption 
observed in the 0.2VHA composites was the result of several factors including the 
absorption of media by the HA particles (due to the HA hydroxyl groups affinity towards 
water). This increase in wet weight was also attributed to the incursion of media within the 
voids at the HA-PLA interface as previously reported by Tham et al. (2010) and Sultana et 
al. (2013) [92, 368]. However the increase in 0.2VHA sample dry weight (Figure 8.3.9) could 
not be accounted for and was believed to be due to measurement error. 
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Although possessing a reduced Vf, the inclusion of HA into the composite configuration 
appeared to buffer and counteract the severity of acidic pH created by the dissolution of the 
CorGlaes® Pure 107 fibres compared to the data recorded during previous 0.2Vf RCM 
sample degradation (section 7.3). This was apparent over the initial 24 hours of 
degradation (Figure 8.4.4) with the degree of pH buffering also found to be influenced by 
the variation in VHA, phase distribution and HA structure (i.e. 1% CaO) over the initial 6 
hours of immersion. Accordingly during this period the results showed that the greatest pH 
buffering was found in the 0.15Vf-0.2VHA hybrid composite configuration. However, after 
24 hours, all hybrid samples appeared to reach a similar pH (≈4.1) but remained above the 
values previously recorded during 0.2Vf RCM sample degradation (≈2.9). This buffering 
effect of the HA filler was in line with the literature where calcium carbonate (CaCO3) 
fillers had been shown by Kobayashi et al. (2010) to successfully buffer the pH of a short 
ultraphosphate glass fibre methacrylate-modified oligolactide hybrid composite [229]. 
However the respective fibre volume fraction (Vf) of this composite was not specified and 
only samples containing 20 wt.% CaCO3 filler were investigated as they degraded in Tris 
buffer solution in contrast to the distilled water employed here.   
 
 
 
Figure 8.4.3. Wet weight of PLA and 0.2VHA composite over initial 168 hours of 
immersion in distilled water at 37°C showing increased water absorption due to the 
presence of HA (standard deviation of PLA ≤ ± 0.03%). 
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Comparisons over the entire degradation period revealed that the 0.15Vf-0.2VHA hybrid 
composites also appeared to accelerate the rate at which the pH returned to neutral (i.e. T0) 
compared to the other hybrid composite configurations (Figure 8.3.10). This was believed 
to be due to its high HA volume fraction and homogenous distribution of the particles 
throughout the samples. Degradation of the 0.2VHA samples also showed the HA to buffer 
the drop in pH previously observed from the formation of carbonic acid in the media when 
compared to the PLA control (Figure 8.4.5). 
 
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
0 24 48 72 96 120 144 168
pH
Immersion Period (hours)
Media pH vs Immersion Period
PLA
0.2VHA
Figure 8.4.5. Comparison of media pH between 0.2VHA and 3001D PLA samples over 168 
hours of degradation in distilled water at 37°C. 
Figure 8.4.4. Comparison of media pH during the degradation of different composite 
configurations over the initial 24 hours of immersion in distilled water at 37°C.  
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As expected, the continued rapid rate of CorGlaes® Pure 107 fibre dissolution was coupled 
with a decrease, followed by an approximate plateau in both the flexural strength and 
elastic moduli of the hybrid composite samples after 168 hours of degradation. As 
previously observed with the 0.2Vf RCM composite, the drop in mechanical properties was 
attributed to the dissolution of the CorGlaes® Pure 107 fibres. A comparison with the 
hybrid samples also showed that the average flexural strength appeared to have decreased 
at an accelerated rate compared to the previous 0.2Vf RCM samples. This may have been 
due to the partial dissolution of the HA particles and breakdown of the HA-PLA interface 
as they buffered the degradation media along with the brittle failure mode of the hybrid 
samples.  
Comparisons between the elastic moduli of different hybrid samples over the immersion 
period also showed the composites to have retained different post fibre dissolution 
mechanical properties depending on the hybrid configuration. Consequently, the generally 
highest post-fibre dissolution elastic modulus was found with the 0.15Vf-0.2VHA hybrid 
composite that was believed to be due to its homogenous HA particle distribution (Bregg et 
al. 2006). This was particularly evident by the difference in elastic moduli found between 
the 0.15Vf-0.2VHA samples (4.33 ± 0.32 GPa) compared to the 0.15Vf-0.2VHA(CaO) 
composites
 
(2.70 ± 0.1 GPa) after 336 hours of immersion (when near complete fibre 
dissolution was expected to have occurred). Unfortunately, a lack of comparative data on 
the degradation of similar PGF hybrid composite materials restricts further analysis with 
no mechanical degradation data given by Kobayashi et al. (2010) during their immersion of 
PGF-CaCO3 hybrid composites in Tris buffer solution [229]. 
Degradation of 0.2VHA composites showed a gradual decrease in composite flexural 
strength whilst the elastic modulus of the samples appeared relatively unchanged until a 
rapid decrease after 840 hours (5 weeks) of degradation. The gradual decrease in sample 
flexural strength was in line with results found by Russias et al. (2006) who tested 70-80 
wt.% HA-PLA of composites. However due to the reduced HA content in the samples 
tested here this reduction in flexural strength was not as severe that as that recorded by 
Russias et al. (2006) [135]. Based on this, the decrease in flexural strength was attributed to 
the weakening of the filamentous structures that bound the HA particles to the PLA matrix. 
This degradation mechanism at the HA-PLA interface would also have been expected to 
contribute to the continued decrease in the hybrid composites flexural strength that could 
be seen after 504 hours (3 weeks) of degradation despite the data indicating that near 
complete fibre dissolution had occurred after ≈168 hours (Figure 8.3.11). The large 
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reduction in elastic modulus of the 0.2VHA composite samples observed at 1008 hours 
could not be accounted for given that the resulting elastic modulus was significantly lower 
than the 0.15Vf-0.2VHA hybrid composite samples after the equivalent degradation period 
(when taking fibre dissolution into account). This subsequently ruled out any mechanisms 
relating to the further breakdown of the HA-PLA interface in the 0.2VHA composites after 
1008 hours of immersion given the data obtained from the 0.15Vf-0.2VHA samples.  
However despite the beneficial pH effects from the secondary HA filler phase and ability 
of the DMEM solution to provide further pH buffering during in vitro degradation (section 
7.3.4.1), no biocompatibility testing was performed on these hybrid composite 
configurations. This was due to the high dissolution rate of the CorGlaes® Pure 107 fibres, 
similar to that previously recorded from 0.2Vf RCM samples. Consequently despite the 
observed pH buffering, a high release rate of Zn2+ ions to cytotoxic levels was expected 
from the different hybrid composite configurations based on previous MTT data (section 
Figure 7.3.6).  
From the MTT assay, the low volume fraction CorGlaes® Pure 107 fibre hybrid 
composites showed a trend of increasing cell viability as the HA volume fraction (VHA) 
increased for both 0.01Vf and 0.05Vf hybrid configurations. However this trend was found 
to be independent of the CDMEM pH that was maintained above the 7.4 viability threshold 
for MG63 cells in nearly all samples. The irregular pH of 7.05 recorded from the 0.05Vf-
0.1VHA degradation extract after 96 hours (Figure 8.3.13) could not be accounted for given 
the higher pH of the HA-free 0.05Vf composites at an equivalent degradation period 
(Figure 7.3.23, Figure 8.3.13). As a result, this reading was subsequently attributed to 
measurement error due to the low volume of media available. 
Given the suitability of the media pH, the increasing cell viability was believed to be due 
to the reduction in ion release rates (specifically the Zn2+ ion) from the composites due to 
the decreased rate of fibre dissolution. This was attributed to the localised pH buffering by 
the HA particles at the fibre-matrix interface. Such mechanisms would then correlate with 
the observed trends seen in Figure 8.3.12 where increasing HA volume fraction and 
subsequent decreases in fibre dissolution rate (via pH manipulation at the fibre-matrix 
interface) lead to greater cell viability in sample extracts. However of the different hybrid 
configurations investigated, only the 0.01Vf-0.2VHA composite samples were found to 
possess an average cell viability above the 70% limit after 24 and 96 hours of degradation. 
This sample configuration was found to produce a statistically significant difference 
compared to the 0.01Vf samples (p < 0.05) and was comparable with the readings obtained 
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from the CDMEM controls (p > 0.05). The results also showed that despite a statistically 
significant difference (p < 0.05) in MG63 cell viability between the use of an HA and β-
TCP filler, neither could produce biocompatible 0.05Vf hybrid samples (i.e. >70% 
viability) after 24 and 96 hours of degradation [188].  
The analysis of direct contact cultures by Coomassie staining on the biocompatible 0.01Vf-
0.2VHA hybrid composite (identified by MTT assay) along with suitable controls showed 
that a degree of cell spreading occurred on all materials except the 0.01Vf composites after 
24 hours of culture. Such results would appear to agree with the proposed suppression of 
ion release rates (via a reduced fibre dissolution rate) from the hybrid samples with cells 
cultured on the 0.01Vf composites maintaining rounded cell morphologies after 96 and 168 
hours. This result consequently highlighted the severity of the CorGlaes® Pure 107 fibre 
cytotoxicity even at low composite fibre volume fractions and the deleterious cell response 
that can be evoked from the presence of zinc within a glass composition.  
After 168 hours it was also apparent that a reduced cell population was present on both the 
0.01Vf composite and the 0.01Vf hybrid material compared to the fibre-free controls. This 
indicated that some degree of cytotoxicity in the hybrid composites may still be present 
despite the inclusion of the HA filler. As expected, the PLA and 0.2VHA composites 
alongside the Thermanox® control displayed a high degree of cell spreading that ruled out 
any alternative cytotoxic influences in the composite configurations. 
The repetition and further analysis of this experiment using SEM images on 0.01Vf and 
0.01Vf-0.2VHA hybrid samples alongside neat PLA was found to agree with the Coomassie 
staining and help verify the accuracy of the previous results. This was evident by the 
polygonal shaped cell spreading and filopodial extensions observed on the PLA controls as 
well as the 0.01Vf-0.2VHA hybrid composites that were in contrast to the mainly rounded 
cell morphology seen on the 0.01Vf composites after 24 hours of culture (Figure 8.3.17). 
Continued cell spreading was observed after 96 hours on the PLA samples but this cell 
population was also observed to be significantly higher than both the 0.01Vf and 0.01Vf-
0.2VHA composites. However a comparison between the CorGlaes® Pure 107 composite 
samples did show that an increased degree of cell spreading was present in cells cultured 
on the 0.01Vf-0.2VHA hybrid samples (Figure 8.3.18c,f,i). In agreement with the 
Coomassie staining results, this difference in cell morphology was believed to be due to 
the difference in fibre dissolution rates and related concentration of Zn2+ within the media. 
The development of a multi-layered cell matrix was then seen to form over the PLA 
samples after 168 hours of culture whilst a high degree of cell spreading was also evident 
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on the 0.01Vf-0.2VHA hybrids. This was contrasted by the 0.01Vf composites that 
maintained a rounded cell morphology (Figure 8.3.19b,e,h and Figure 8.3.20b,e,h). 
Additionally, the SEM images of the hybrid sample surfaces after 168 hours of culture 
(Figure 8.3.19c,f,i and Figure 8.3.20c,f) showed the formation of surface damage that 
appeared to increase as the culture period progressed. Based on comments by Speidel & 
Iggowitzer (1998), this change in surface morphology was attributed to the accumulation 
of media within the pores and voids surrounding the hydroxyapatite particles. This can 
subsequently lead to the rupture and surface perforation of the sample when these particles 
are in close proximity to the surface. This would then appear to correlate with the 
observations and material configurations employed in the current study where surface 
damage was only observed in the hybrid composite samples due to the presence of 
hydroxyapatite particles [369]. This would also seem to be in line with the previously 
discussed mechanisms regarding the breakdown of the PLA-HA interface during sample 
degradation.  
SEM images also identified small ≈0.5-4µm spherical particles after 168 hours of culture 
at the periphery and within the surface cavity’s formed during cell culture on the 0.01Vf-
0.2VHA samples. However their presence or morphology could not be accounted for from 
the existing data (Figure 8.4.6). Given their absence from the 0.01Vf or PLA samples and 
lack of correlating literature, it was assumed that the formation of these particles was 
related to the interactions between the HA, CDMEM and the CorGlaes® Pure 107 fibres - 
however further investigation is required to fully account for these features. 
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Mechanical testing of the biocompatible 0.01Vf-0.2VHA hybrid composite configuration 
showed the expected decrease in flexural strength, increase in elastic modulus and 
transition to a brittle failure mode through the inclusion of the 0.2VHA filler compared to 
the 0.01Vf composite. However in contrast to the earlier results, the inclusion of CorGlaes® 
Pure 107 fibres produced hybrid composites with a reduced flexural strength and elastic 
Figure 8.4.6. SEM images after 168 hours MG63 cell culture on 0.01Vf-0.2VHA hybrid 
composites with a) The appearance of surface damage and spherical particles labelled 
[scale bar = 10µm] and b) Magnified section of isolated area showing hollow/damaged 
nature of selected particle [scale bar = 2µm].  
Spherical particles  
Hollow/damaged spherical particle  
Hybrid Composite surface damage  
Spherical particle  
a 
b 
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modulus compared to the 0.2VHA composites. This behaviour was attributed to the absence 
of a fibre pre-preg solvent casting stage during composite manufacturing and the resulting 
poor polymer infiltration into the CorGlaes® Pure 107 fibres (due to the previously 
discussed changes to the polymer MFI at 0.2VHA-m). As a result, the quality of the fibre-
matrix interface may have been compromised and created flaws or voids throughout the 
material. Furthermore the increased handling required to isolate the low quantity of fibres 
required for each composite lamina (due to the use of the smaller 70x30mm mould) would 
also have likely contributed to the poor mechanical properties of the 0.01Vf-0.2VHA 
samples given the likely increase in fibre damage incurred. 
The degradation of 0.01Vf and 0.01Vf-0.2VHA samples was compared with the previously 
obtained 0.2VHA degradation data. The results showed that a reduction in both the wet and 
dry weights occurred in the 0.01Vf and 0.01Vf-0.2VHA composites due to the dissolution of 
the CorGlaes® Pure 107 fibres. It was also observed that the inclusion of the HA filler 
phase in the 0.01Vf-0.2VHA hybrid composites resulted in the wet weight change from fibre 
dissolution being significantly masked. This was due to the large difference between the Vf 
and VHA content and the associated water absorption from the presence of HA particles 
over the first 168 hours of immersion (Figure 8.4.7) as previously discussed.  
 
 
 
Figure 8.4.7. Comparison between sample wet weight over first 168 hours of degradation 
between 0.01Vf, 0.01Vf-0.2VHA and 0.2VHA samples with the inclusion of HA in the 
hybrid composite samples obscuring the decrease in wet weight through fibre dissolution. 
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Accordingly, no comment can be made on the effects of the HA filler on the rate of 
CorGlaes® Pure 107 fibre dissolution rates using the wet weight data due to the absorption 
of moisture and small volume of fibres used. The same variation in composite wet/dry 
weights was observed (due to water ingress throughout the pores created by the degraded 
fibres as well as media absorption) and was in line with the previous results. The low fibre 
volume of these samples was also responsible for the significantly reduced weight loss 
compared to the previous 0.2Vf RCM or 0.15Vf hybrid samples.  
Analysis of the dry weight data showed the expected decrease due to CorGlaes® Pure 107 
fibre dissolution over the first 168-336 hours of immersion. This weight loss was then seen 
to plateau at ≈3.5% and ≈2% for the 0.01Vf and 0.01Vf-0.2VHA samples respectively with 
the offset attributed to the reduced weight fraction (Wf) of the fibres due to the secondary 
HA filler phase. As before, no estimation as to the extent of HA dissolution in the hybrid 
composites during this degradation period could be assessed from the current data that may 
have also contributed to the weight loss results. The pH data obtained during sample 
degradation also showed the expected reduction in pH from the dissolution of the 
CorGlaes® Pure 107 fibres. However due to the decreased fibre volume fraction and 
associated reduction in phosphate species released into the media, the acidic pH did not 
reach the same severity in the 0.01Vf composites (≈4.0) as previously recorded during 
0.2Vf RCM sample degradation (≈2.5). Similar to the previous data, the inclusion of HA 
was seen to raise the pH of the media during 0.01Vf-0.2VHA sample degradation (≈5.0) but 
due to the difference in Vf, the pH was buffered to a greater extent compared to the 0.15Vf-
0.2VHA hybrid composite configuration (≈4.0).  
The immersion of 0.01Vf samples also saw a gradual decrease in the average flexural 
strength of the composites that appeared to plateau after three weeks (504 hours) of 
degradation with a reduction and plateau in the elastic modulus occurring after 168 hours 
(1 week). Based on the previous data, the decrease in mechanical properties was attributed 
to the dissolution of the CorGlaes® Pure 107 fibres. The reduced fibre volume fraction in 
these composites also caused the overall decrease in flexural strength (-8.6 %) and elastic 
modulus (-21.5%) to be significantly lower than the 0.2Vf RCM samples when compared 
after 168 hours of degradation. This was due to the reduced reinforcement provided by the 
CorGlaes® Pure 107 fibres at 0.01Vf compared to 0.2Vf (section 3.2.3.1). Additionally, the 
increased variability in both the flexural strength and elastic modulus of the 0.01Vf 
composites during degradation was considered to be reflective of the increased difficulty in 
establishing a uniform distribution of fibres throughout the matrix. This was due to the low 
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quantity of CorGlaes® Pure 107 fibres in each lamina of the 0.01Vf composite compared to 
the 0.2Vf RCM samples. 
The variation in 0.01Vf-0.2VHA sample mechanical properties over the 1008 hour 
degradation period was believed to be due to the reduced dependency of the composites on 
the CorGlaes® Pure 107 fibres for mechanical reinforcement (due to the large difference 
between the Vf and VHA). As a result, the dissolution of these fibres appeared to have a 
negligible effect on the sample mechanical properties with the variation in mechanical 
properties seen between samples attributed to the unwanted non-homogenous distribution 
of the HA particles. However this variation may also have been influenced by the 
dissolution of the HA during pH buffering of the degradation media. Consequently these 
hybrid composites failed to display the same clear decline and plateau in mechanical 
properties as previously recorded for the 0.15Vf hybrid samples.  
Furthermore, the inclusion of HA appeared to maintain the elastic modulus of the hybrid 
composite above that of the 0.01Vf sample throughout the entire immersion period but was 
below that of the 0.2VHA control. This was likely due to the internal porosity created from 
fibre dissolution as well as the previously mentioned breakdown of the HA-PLA interface 
via buffering of the media pH.  However it was observed that that the elastic modulus of 
the 0.01Vf and 0.01Vf-0.2VHA samples was superior to that of the 0.2VHA control when 
compared after 1008 hours of immersion. This subsequently cast further doubt on the 
accuracy of this result (i.e. the sudden drop in elastic modulus for the 0.2VHA sample at 
1008 hours) as discussed earlier. 
A comparison between the ionic release rates during the initial 168 hours of 0.01Vf and 
0.01Vf-0.2VHA sample degradation revealed a marked difference in the daily and 
accumulative ionic concentrations (Figure 8.3.26 and Figure 8.3.27). This was apparent by 
the increased concentrations of (PO4)3- and Ca2+ ions in the 0.01Vf-0.2VHA degradation 
media compared to the 0.01Vf samples (Figure 8.4.8). The increased concentration of these 
ions was to be expected given the Ca2+ and (PO4)3- products that occur from HA 
dissolution (Vallittu, 2012) [370].  This would then correlate with the dissolution of the 
secondary HA phase as a result of the phosphoric acid generated during fibre dissolution 
and the subsequent pH buffering that was recorded during 0.01Vf-0.2VHA sample 
degradation (Figure 8.3.24). Inspection of the accumulative ionic concentrations from both 
samples also revealed that similar concentrations of Mg2+ (≈6 mg l-1) and Na+ ions (≈11 
mg l-1) were released from the fibres into the media after 168 hours (Figure 8.3.27). This 
would then imply that similar fibre volume fractions as well as fibre dissolution rates were 
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present in each composite type despite the inclusion of HA into the hybrid composite 
configuration. This then challenges the notion that a reduced fibre dissolution rate was 
responsible for the previously found increase in biocompatibility of the hybrid composite 
samples (Figure 8.3.12). 
 
However these results could be accounted for when considering the difference in Zn2+ ions 
accumulated after 168 hours between the 0.01Vf (16.3 mg l-1) and 0.01Vf-0.2VHA (8.6 mg 
l-1) samples (Figure 8.4.8). Since it has already been established that excess Zn2+ (↑≈8 mg 
l-1) and a low pH (< 7.4) can be cytotoxic to MG63 cells, the inclusion of HA was 
subsequently expected to limit these factors by buffering the pH and limiting the 
autocatalysis effects. As discussed in section 3.4.6.2, dissolution studies by Khor et al. 
(2011) have highlighted the preferential leaching of Zn2+ ions when PG samples were 
degraded in low pH, acidic conditions. Based on the collected data, it is proposed that an 
elevation in pH at the fibre-matrix interface was generated by the inclusion of a secondary 
HA filler phase that consequently limited the preferential leaching of Zn2+ ions from the 
CorGlaes® Pure 107 fibres compared to the 0.01Vf samples (Figure 8.4.9). This would 
have then have restricted the rate at which the Zn2+ ions could accumulate towards 
cytotoxic levels within the 0.01Vf-0.2VHA sample degradation media [187].   
Figure 8.4.8. Comparison between the accumulative ion release from 0.01Vf and 0.01Vf-
0.2VHA composites over the initial 168 hours of degradation showing a marked decrease in 
the total concentration of Zn2+ and increase in (PO4)3- and Ca2+ ions release from the 
0.01Vf-0.2VHA hybrid composite. 
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This concept would then correlate with the MTT and direct contact culture results where 
only the 0.01Vf samples appeared to be cytotoxic despite ion release data implying that the 
CorGlaes® Pure 107 fibres in both samples were degrading at similar rates. Consequently 
this difference in Zn2+ release and rates at which this ion could accumulate to cytotoxic 
levels would explain the difference in cell population/morphology between the 0.01Vf and 
0.01Vf-0.2VHA composites as well as when compared to the PLA control (Figure 8.3.20).  
To elaborate, during the in vitro culture of samples it was likely that the rate of Zn2+ 
release from the 0.01Vf samples (via fibre dissolution) exceeded the MG63 cytotoxic limits 
before the media was replaced after 96 hours. This consequently produced the rounded cell 
morphology and declining cell population that was observed in both Coomassie and SEM 
images. In contrast, the reduced rate of Zn2+ ion release from the 0.01Vf-0.2VHA hybrids in 
conjunction with the replacement of the media at 96 hours prevented such a severe 
reduction in cell viability. Based on the SEM and Coomassie staining images, this would 
then account for the reduced cell population and mixed morphology (i.e. round/spread) 
seen in cells after 96 hours of culture (Figure 8.3.18) on the 0.01Vf-0.2VHA samples as the 
Zn2+ ions began to reach cytotoxic levels before the culture media was replaced.  
Furthermore, since earlier results had indicated that the DMEM media had no retarding 
effects on the CorGlaes® Pure 107 fibre dissolution rate when utilised as a composite 
reinforcing agent (section 7.3.4), the evidence for this concept based on the ion release data 
Figure 8.4.9. Comparison of Zn2+ accumulative ionic release and media pH against the 
immersion period for 0.01Vf and 0.01Vf-0.2VHA samples  
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during sample degradation in distilled water was deemed valid. However it should also be 
noted that the biocompatibility testing (i.e. MTT, direct contact culture) was performed at a 
higher SA:V ratio (1.4 cm2 ml-1) than that employed during mechanical degradation (0.21 
cm2 ml-1). As a result, the ionic concentrations shown in Figure 8.3.26 and Figure 8.3.27 
are expected to be lower than those encountered during the in vitro cell culture 
experiments. Yet this does not affect the general principle regarding the selective Zn2+ ion 
release as proposed here. 
Analysis of the FTIR spectra (section 8.3.3.7) obtained from the planar sample surfaces 
after immersion in c-SBF showed variations and shifts in the peak wavenumber/intensities 
of the 0.2VHA composites (Figure 8.3.29) with the band at ≈1030cm-1 (T0) shifting to 
1044cm-1. It was also apparent that the intensity of the peaks at 604cm-1 and 562cm-1 
varied between spectra which, due to the 0.5-5µm penetration depth of the FTIR-ATR 
equipment, was attributed to the exposure of HA particles on the hybrid composite surface 
as discussed by Persson et al. (2014) [371]. As a result, areas with a low concentration of HA 
particles exposed or in reduced proximity to the composite surface had a reduced HA 
signal intensity and a decrease in peak band overlapping. This then made the 1044cm-1 
peak (PLA, C=CH3 vibration) more prominent and would then account for the apparent 
peak shifting (i.e. 1030cm-1 (T0) ↔ 1044cm-1) observed between the spectra obtained from 
the 0.2VHA samples across the immersion period. These results highlighted the variation in 
HA distribution across the sample surfaces with the sample areas chosen at random by the 
user. This would also seem to correlate with the non-uniform distributions and particle 
agglomeration effects that were previously discussed during the mechanical 
characterisation of the hybrid composites. Such variations in HA surface exposure were 
also believed to have accounted for the similar peak transitions observed in the 0.01Vf-
0.2VHA hybrid composite (Figure 8.3.31) spectra. Meanwhile the absence of HA accounted 
for the lack of any similar shifts being observed in the 0.01Vf spectra (Figure 8.3.30) [371].  
It was also observed that peaks at 1264cm-1 and 800cm-1 on the 0.2VHA and 0.01Vf samples 
showed a marked decrease after 24-72 hours (Figure 8.3.29 and Figure 8.3.30). Based on 
the FTIR analysis of polymer degradation by Partini & Pantani (2007), any changes in 
these peak intensities through hydrolytic degradation were ruled out [372]. Consequently this 
observation was believed to be due to the PTFE lubricant applied during composite 
manufacturing or other contaminant (e.g. from the cutting stages of specimen preparation) 
that had not been completely removed prior to c-SBF immersion. This would then account 
for the early decline in the intensity of these peaks shortly after immersion and why such 
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strong peaks were not detected on all samples. Examining previous results it was also seen 
that the same peak variations were observed during 0.2Vf RCM bioactivity testing (Figure 
7.3.21). However further investigation is required to confirm. 
The FTIR analysis of minute surface deposits removed from the 0.01Vf-0.2VHA sample 
cross-sections (collected after 336 hours of immersion) found these to match the previous 
pyrophosphate salts found during 0.2Vf RCM composite bioactivity testing (Figure 8.4.10). 
Yet the visible formation of these salts was negligible and were only found on a single 
sample from the three analysed by FTIR after 336 hours compared to the rapid formation 
found on all 0.2Vf RCM samples. The small quantity of these compounds was attributed to 
the significantly lower Vf of CorGlaes® Pure 107 fibres in the hybrid composite 
configuration and thus reduced concentrations of ions released into the media as a result. 
The appearance of this precipitate at the sample cross-section was also in line with the 
cross-sectional “halo” regions of bioactive PGF composite materials as discussed by 
Vallittu et al. (2015)[5]. The inconsistent formation of these compounds was believed to be 
due to an unwanted/localised increase in the fibre volume fraction within specific samples. 
This would then account for the absence of any similar pyrophosphate salt precipitates 
found during the FTIR analysis of the 0.01Vf composite cross-sections after immersion.  
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Figure 8.4.10. Comparison of precipitates from 0.01Vf-0.2VHA and 0.2Vf RCM composites 
after immersion in c-SBF over the 4000-400cm-1 wavenumber range. 
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8.5 Conclusions 
Modifications to the previous 0.2Vf RCM CorGlaes® Pure 107 composite configuration 
showed that the use of silane treatments or a secondary filler phase had different influences 
on the composites mechanical behaviour. This was evident by the increase in initial 
flexural strength (+39.7%), elastic modulus (+7.9%) and toughness (+41.2%) observed 
when the CorGlaes® Pure 107 fibres were treated with an APS sizing agent due to the 
improved interfacial bonding at the fibre-matrix interface. However the application of this 
surface treatment provided no improvement to composite durability as a result of the 
severe autocatalysis effects caused by the fibre’s acidic pH dissolution by-products. 
The investigation into different 0.15Vf PGF hybrid composite configurations revealed that 
the inclusion of a hydroxyapatite (HA) particle filler phase was capable of producing 
materials with an increased elastic modulus compared to the previous 0.2Vf RCM samples. 
Furthermore the inclusion of HA caused the failure mode of these composites to change 
from a ductile to brittle fracture mode. The configuration of the hybrid composites was 
also found to influence the initial mechanical properties with the greatest increase in elastic 
modulus (+22%) compared to the 0.2Vf RCM samples found from the inclusion of a non-
homogenously distributed 0.1
 
volume fraction of HA. However mechanical testing of the 
investigated hybrid composite configurations also revealed that particle agglomeration at 
higher HA volume fractions compromised the mechanical properties of the hybrid samples.  
The subsequent degradation of these samples found that despite the media pH being 
buffered (compared to the 0.2Vf RCM samples) that the apparent rate of fibre dissolution 
remained unchanged. Therefore, it was anticipated that due to the high ion release rates all 
hybrid composite samples would continue to be cytotoxic due to the high concentrations of 
Zn2+ ions that would have been released into the media during in vitro testing. 
Alternatively, the focus on developing biocompatible hybrid composites through the 
incorporation of HA into low Vf samples found that the addition of 0.2VHA into a 0.01Vf 
sample produced biocompatible materials when assessed by MTT assay. Such results were 
subsequently confirmed through the analysis of MG63 cells by Coomassie Brilliant Blue 
staining and SEM after direct contact culturing on composite samples. Although this 
behaviour was initially attributed to a reduced fibre dissolution rate, degradation of the 
corresponding sample configurations and controls indicated that the buffered media pH 
(via the addition of HA) had influenced the selective leaching of the Zn2+. However due to 
the smaller fibre volume fraction, the CorGlaes® Pure 107 fibres had a reduced impact on 
the initial and degenerative mechanical properties during sample degradation in distilled 
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water. The low Vf of the samples did produce sporadic deposits of pyrophosphate salt 
deposition during c-SBF bioactivity testing but the FTIR spectra also revealed the presence 
of HA on the composite surface from the existing secondary filler phase.  
Consequently based on the accumulated hybrid composite data, the specific application of 
the CorGlaes® Pure 107 fibres appears to be confined to possibly providing advantageous 
stimulatory effects in vivo (via ion release) rather than as the primary reinforcing agent of a 
biodegradable composite. The results have also indicated the potential for the development 
of novel hybrid composite designs to be investigated. 
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9 Discussion 
Despite the extensive range of possible phosphate glass compositions, their application in 
biomedical devices is limited by the need to achieve glass artefacts (i.e. monoliths, fibres 
etc.) with suitable dissolution rates, mechanical properties and potential bioactivity whilst 
being composed of metabolically acceptable constituents. Consequently review articles of 
biomedical phosphate glasses (e.g. Knowles, 2003; Abou Neel et al., 2009) have 
demonstrated the balance between achieving mechanically and biologically advantageous 
glass systems whilst maintaining good processability [160, 213]. As observed in section 
3.4.6.1 and 3.4.6.2, the development of these glasses has typically been conducted through 
a cross-compositional analysis where a selected modifier oxide concentration has been 
varied (e.g. 0→10 mol%) in order to assess its effect on a glass’s properties. Consequently 
the characterisation is performed using a comparative analysis across these variations. 
However, given that this project was restricted to the CorGlaes® Pure 107 glass and that 
limited compositional data was available, the characterisation performed here was based on 
a broad examination of the relevant literature. This may have subsequently affected the 
accuracy and depth of the CorGlaes® Pure 107 glass analysis. Yet by following this 
method to characterise its bulk and fibre formats, a broad review (not been previously 
reported) of different biomedical PG properties has been produced.  
Based on the available literature, it is believed that no previous investigations have 
examined a quinternary glass composition similar to CorGlaes® Pure 107. Given the 
relevance of its constituency ions to the physiological roles in bone growth (i.e. (PO4)3-, 
Ca2+, Mg2+ and Zn2+ - Table 3.4.3) the CorGlaes® Pure 107 composition was believed to be 
a suitable candidate for potential bone tissue regenerative applications. However 
characterisation of the CorGlaes® Pure 107 disks (chapter 5) revealed that its good flexural 
strength, elastic modulus (comparable to that of Bioglass® 45S5) and high thermal stability 
(PW) were offset by its poor biocompatibility. Combined with the previous data reported 
by Abou Neel et al. (2008), the CorGlaes® Pure 107 results highlighted concerns over 
localised acidity as well as the suitability of zinc in biomedical phosphate glass 
compositions. This is despite its advantages as a modifier oxide (i.e. its charge-to-size 
ratio) and potential stimulatory effects in vivo [195]. However, this basis must also be 
considered with regards to the P2O5 concentration which made the CorGlaes® Pure 107 
glass inherently prone to autocatalysis effects that ultimately influenced the ion release 
rates from the samples (i.e. composites). The effect of pH is further emphasised in these 
results when considering the selective leaching of Zn2+ ions from PGs in acidic media as 
reported by Khor et al. (2011). This subsequently supports the development of low P2O5 
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polyphosphate glass compositions (i.e. < 50 mol% P2O5) such as those recently 
investigated by Sharmin et al. (2014) where B2O3 was substituted into the glass 
formulation [187, 211]. The results presented here have also provided further insight into the 
applicability of glass compositions that utilise mixed ion effects to achieve enhanced 
properties outside the expected trends as evident by the PW recorded for the CoreGlaes® 
Pure 107 glass. 
The production and characterisation of CorGlaes® Pure 107 fibres (chapter 6) has also 
highlighted the sensitivity of these materials to surface flaw type/size that can be produced 
during the necessary handling stages. Based on this, the comparison of fibre tensile 
properties are subsequently susceptible to variations based on the handling of fibres 
between different studies. Yet this can also be affected by fluctuations in the fibre diameter 
that could occur during PGF manufacturing. Meanwhile the novel study on the influence of 
different media on the CorGlaes® Pure 107 fibres has demonstrated the variability in fibre 
dissolution rates across different interdisciplinary techniques (e.g. cell culture, bioactivity 
and mechanical degradation). Consequently these results raise considerations when relating 
mechanical properties or dissolution rates to in vitro data and is particularly relevant when 
intending to use PGFs as a single implant construct (i.e. implants composed purely of 
fibres) such as the cell delivery vehicles previously studied by Ahmed et al. (2004) and 
Bitar et al. (2005) [178, 194].   
When used as a composite reinforcing agent, the initial results (chapter 7) showed the 
benefits of a random continuous mat (RCM) CorGlaes® Pure 107 fibre architecture which, 
based on the available literature, had not been previously investigated for PGF composite 
biomaterials. These advantages were due to the observed improvements in material 
toughness found in the laminate RCM composites as a result of fibre pull-out mechanisms 
and improved polymer infiltration into the RCM fibre constructs. The RCM architecture 
may then be more favourable in specific composite applications compared to the 
unidirectional (UD), [0/90] cross-plys or random chopped fibre filler phases previously 
investigated (e.g. Ahmed et al., 2009; Ahmed et al., 2011) [218, 219]. Based on the results by 
Han et al. (2013), this RCM architecture may also be more favourable compared to UD 
fibres for composite implant devices where intra-operative screw holes are required prior 
to implantation [223]. This is due to the increased damage that UD composites can incur 
compared to random chopped fibre mats when screw holes are introduced via drilling 
techniques.  
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Mechanical testing of the 0.2Vf RCM composites also found that the flexural strengths and 
elastic moduli of these CorGlaes® Pure 107 composite configurations were within the 
range of those reported for parietal bone. This result implied that degradable PGF-
composites have potential for the proposed cranioplasty applications as discussed in 
chapter 2. Additionally, the elastic moduli of these samples were also seen to correlate with 
those predicted by the rule of mixtures (ROM) for both fibre architectures investigated. 
However these properties could potentially be further increased through modifications to 
the manufacturing method aimed at improving polymer impregnation into the fibres (such 
as vacuum forming techniques). Unfortunately due to autocatalysis effects, the 0.2Vf 
CorGlaes® Pure 107 composites failed to retain at least 80% of their initial mechanical 
properties over the six week degradation period as set out by the initial design criteria in 
section 2.1.  
These autocatalytic effects have been observed in other PGF-composite materials (Ahmed 
et al., 2009, 2011; Han et al., 2013) and highlighted the balance between achieving glass 
fibres with good processability whilst possessing slow dissolution rates. This is particularly 
relevant to the P2O5 content which at high concentrations allows for PGFs to be easily 
produced but is hampered by their resultant susceptibility to autocatalysis effects due to the 
increased amount of phosphate species released into the media. Alternatively low P2O5 
glasses (e.g. polyphosphate glasses) are less prone to autocatalysis but are typically harder 
to manufacture into fibres and are more likely to crystallise. Such features consequently 
reinforce earlier sentiments that the wide range of potential PG compositions is ultimately 
restricted by their practicality. Furthermore, the continued use of PLA as a matrix 
component in the development of PGF composites would seem disadvantageous given its 
acidic degradation by-products and importance of the fibre-matrix interface to maintaining 
adequate composite mechanical properties [218, 219, 223].  
Continuing from the previous CorGlaes® Pure 107 fibre dissolution data in section 6.3.6, 
the translation between mechanical and cell culture environments on composite samples 
was also investigated due to the absence of any ionic influences during composite 
degradation in distilled water. The correlation and discrepancies between composite 
degradation behaviour in each media (i.e. weight loss, media pH) showed how the high 
surface area-to-volume ratios (SA:V) at the fibre-matrix interface can be detrimental to the 
reinforcing fibres dissolution rate. As a result, the relevance of a PGF’s dissolution rate is 
obscured when it is to be applied in a composite system given the increased influence of its 
dissolution by-products. This high rate of fibre dissolution was also responsible for the 
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cytotoxicity found across all fibre volume fractions (Vf) investigated. Such results 
consequently reinforced the importance of considering the pH changes and ion release 
rates (i.e. cytotoxicity limits) but also showed how these factors can interact with each 
other.  
The development of PGF polymer composite materials has typically examined different 
glass compositions in a two phase, matrix-filler design (e.g. Ahmed et al., 2008; Brauer et 
al., 2008; Parsons et al., 2009; Khan et al., 2010; Ahmed et al., 2011) [212, 215, 217, 228]. Yet 
the versatility in available glass compositions can be restricted by the design requirements 
of biomedical glasses as well as the radical, sometimes detrimental, changes to the 
properties of a glass that can be caused from small compositional variations (Hench, 2013) 
[76]
. Furthermore given that no single bioactive material is considered by Hench (2013) to 
be optimal for all applications, there is a need to develop a range of different glass 
compositions. Such sentiments are also in line with the need for application specific glass 
dissolution rates as discussed by Hasan et al. (2012) [210]. Consequently the investigation of 
different hybrid PGF composite configurations based on this concept was intended to allow 
for further design versatility in composite properties without relying on compositional 
changes to the reinforcing PGFs.  
Given the limitation to using only the CorGlaes® Pure 107 glass, the hybrid composites 
developed in this study were intended to improve the mechanical integrity of the composite 
material during its degradation by counteracting the fibre’s autocatalytic effects. The 
investigation of different hybrid composite designs was also aimed at establishing an 
optimised hybrid configuration based on the ability of calcium phosphates to buffer an 
acidic pH. Given the absence of design variation as well as a lack of data on the 
mechanical degradation or in vitro cell culture results in previous work it was believed that 
the results collected here could be utilised for future hybrid composite designs [229]. 
The characterisation of different hybrid samples (chapter 8) subsequently showed that 
despite variations in the initial mechanical properties and apparent pH buffering of the 
degradation media, no significant improvements in composite mechanical durability were 
achieved in any of the mechanically optimised hybrid sample configurations. These 
samples are expected to have remained cytotoxic due to the rate of Zn2+ ion release with 
further increases to the HA volume fraction (VHA) restricted by the HA particles effects on 
the polymer melt flow and subsequent polymer infiltration into the fibres. The transition of 
the composites initial (i.e. HA-free) fibrous, ductile failure behaviour to a brittle facture 
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mode would also cast doubt on the suitability of fibre-particle hybrid composite 
configurations for cranioplasty plate applications (Brauer et al. 2008) [217].  
Alternatively the increasing biocompatibility found in low Vf hybrid composites 
(0.01Vf/0.05Vf) with increasing HA volume fraction (VHA) demonstrated the severity of 
the acidic pH and inability of the HA to adequately buffer the degradation media in higher 
Vf composites (i.e. 0.15Vf). However, it was shown that hybrid composite designs could be 
used to render previously cytotoxic low Vf composites as biocompatible. Although due to 
the low Vf required to achieve hybrid biocompatibility, the CorGlaes® Pure 107 fibres were 
ultimately reduced to providing an in vivo stimulus as oppose to their intended function as 
a reinforcing agent.  
With these results the CorGlaes® Pure 107 fibres would appear to be unsuitable for the 
proposed cranioplasty plate material. However the development of PGF-composites with 
suitable mechanical properties (prior to degradation) did prove the initial viability of the 
concept.  
In line with comments by Hasan et al. (2012) and Hench (2013), it would appear that the 
functionality of a PGF-composite cranioplasty plate could not be fulfilled by a single PGF 
composition alone [76, 210]. This is due to the conflicting design requirements in PGF 
composites where high fibre dissolution rates (and associated ion release rates) would be 
advantageous for supressing bacterial infections as well as eliciting early bioactive or 
osteoinductive responses in vivo (section 3.4.5). However this would also likely 
compromise the mechanical durability of the device after implantation (due to the rapid 
dissolution of the mechanically reinforcing fibres). Consequently hybrid composite designs 
may allow for such dual functionality to be achieved through the use of different 
constituent components (i.e. multiple PGF compositions). Based on the data obtained from 
the CorGlaes® Pure 107 hybrid composites, a dual fibre system of fast 
(bioactive/antimicrobial) and slow (mechanically reinforcing) dissolution rate PGFs would 
appear to be the preferable option. This is primarily due to the increased brittleness found 
in fibre-particle hybrid systems that could jeopardise the ability of the implant to 
adequately protect the underlying cerebral tissue. As a result, the inclusion of bioactive 
particles (such as HA or alternate bioactive glass compositions) would be less favourable. 
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10 Conclusions 
• Structural analysis of the CorGlaes® Pure 107 composition confirmed its 
amorphous, ultraphosphate structure whilst its thermal properties (i.e. large PW) 
made it highly suitable for fibre manufacturing. 
• The CorGlaes® Pure 107 glass exhibited a superior flexural strength and similar 
elastic moduli to that reported for Bioglass® 45S5 with the density, hardness and 
fracture toughness within the expected range for PGs. 
• The CorGlaes® Pure 107 annealed disks possessed a dissolution rate of 4×10-3 mg 
cm-2 hr-1.  
• Despite dissolution extracts being biocompatible, the glass composition was 
cytotoxic to MG63 cells during direct contact cell culture. 
• Mechanical testing of Ø≈20µm CorGlaes® Pure 107 fibres showed the tensile 
strength (462 ± 143 MPa) and tensile modulus (65.5 ± 20.8 GPa) to be similar to 
those reported for other PGF systems. 
• As an isolated element, the fibre dissolution rate was affected by the different 
media typically used in biomaterial characterisation. 
• The immersion of fibres in c-SBF resulted in the deposition of different 
pyrophosphate salts relative to the CorGlaes® Pure 107 composition. 
• The incorporation of CorGlaes® Pure 107 fibres into a PLA matrix showed the 
expected increase in elastic moduli that closely matched those predicted by the rule 
of mixtures. 
• 0.2Vf CorGlaes® Pure 107 fibre composite configurations of RCM and [0/90]3S 
fibre architectures possessed mechanical properties within the range of those 
reported for the parietal bones of the skull. 
• RCM fibre mat architectures were found to be advantageous for developing 
cranioplasty plates due to their improved toughness and flexural strength compared 
to [0/90]3S cross-ply composite configurations. 
• 0.2Vf RCM and 0.2Vf [0/90]3S composites failed to retain at least 80% of their 
mechanical properties during six weeks of degradation in distilled water or DMEM 
- where pyrophosphate salt deposition was also observed. 
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• Pyrophosphate salt deposition was also recorded during the immersion of 0.2Vf 
RCM composites in c-SBF. 
• A cytotoxic response from composite degradation extracts was found across 
0.01Vf, 0.05Vf, 0.1Vf and 0.2Vf samples after 24 and 96 hours of degradation with 
MG63 cells when assessed by MTT assay. 
• Silane treatment of CorGlaes® Pure 107 fibres produced composites with increased 
mechanical properties but this failed to sufficiently retard the loss of mechanical 
properties during sample degradation. 
• The distribution and volume fraction of hydroxyapatite (HA) in 0.15Vf RCM 
hybrid composites had a strong influence on composite mechanical properties 
where the maximum increase in elastic modulus was recorded after the introduction 
of 0.1VHA that was non-homogenously distributed throughout the sample. 
• All hybrid composite variations buffered the degradation media pH but failed to 
adequately reduce the fibre dissolution rates and consequently the loss in 
mechanical properties during sample degradation in distilled water at 37°C. 
• The cell viability from composite degradation extracts showed an increasing degree 
of biocompatibility as the HA volume fraction increased (0VHA→0.1VHA→0.2VHA) 
in 0.01Vf and 0.05Vf composite samples when assessed by MTT assay. 
• Despite the statistically significant difference in the MTT assay results, the 
increased solubility of a β-TCP filler phase (compared to HA) was unable to 
produce biocompatible 0.05Vf composites.  
• Only a 0.01Vf-0.2VHA composite configuration was found to be biocompatible, but 
the resulting mechanical properties were considerably reduced compared to the 
0.2Vf RCM samples and below those of the parietal bones.  
• CorGlaes® Pure 107 fibres are unsuitable as a composite reinforcing agent but PGF 
composites show potential as part of a cranioplasty plate material. 
• Hybrid PGF-composites using multiple glass fibre compositions are an attractive 
option for future implant designs that require an immediate in vivo response and 
long term mechanical properties. 
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11 Future Work 
Although the fundamental application of PGF composites as part of a cranioplasty plate 
material has been proven mechanically, the continued development of these materials 
should focus on: 
 
a) The evolution of glass compositions tailored towards cranioplasty composite 
applications with reduced dissolution rates that are able to maintain a neutral 
media pH during their dissolution despite the high surface area-to-volume ratios at 
the fibre-matrix interface. 
b) Manufacturing of fibre pre-pregs using vacuum forming techniques for potentially 
improving composite mechanical properties (due to the improved polymer 
infiltration into the fibres).  
c) The development of continuous fibre spools from PGF manufacturing techniques 
that would allow these materials to be incorporated into fibre pre-impregnation 
equipment. This would eliminate the manual handling stages of composite 
production that can compromise fibre integrity and would allow for composites 
with increased mechanical properties due to the improved packing density of the 
fibres and consequently increased Vf. 
d) The development of woven PGF constructs (as are available with conventional 
glass fibres) that would allow for the development of composite materials with 
more adaptable mechanical properties. 
e) Impact testing of PGF composite configurations prior to and after sample 
degradation to further assesses their suitability as a cranioplasty plate component.  
f) Investigation into the potential of phosphate glass platelets as a reinforcing agent 
in general fracture fixation plates due to their high aspect ratios compared to 
particles. This could potentially allow for the manufacturing of composites with 
improved mechanical properties (compared to particles) whilst the discontinuous 
nature of the reinforcing phase would decrease the rate of fluid wicking throughout 
the interface.  
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However, the concept of hybrid PGF composites should also be developed and includes: 
 
a) Hybrid composites incorporating different PGF compositions that could contain 
low dissolution rate, high modulus fibres (as the main  reinforcing agent) with a 
secondary phase of high dissolution rate fibres intended to generate a rapid 
bioactive/osteoinductive response or a controlled release of ions aimed at 
infectious prevention (e.g. silver, Ag+).  
b) Laminated hybrid composites utilising PGF and degradable magnesium fibres 
where high mechanical properties and long term durability are required alongside a 
physiological stimulus provided by the in vivo dissolution of the PGFs. 
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Appendix A 
 
 
 
Sample Flexural Strength (MPa) Elastic Modulus (GPa) 
NatureWorks® 3001D PLA 98.04 ± 1.06 3.21 ± 0.34 
0.01Vf RCM 82.50 ± 3.77 3.97 ± 0.35 
0.05Vf RCM 57.64 ± 15.55 5.00 ± 0.41 
0.1Vf RCM 27.12 ± 5.62 5.49 ± 0.05 
0.2Vf RCM 82.39 ± 4.46 7.57 ± 1.20 
0.2Vf RCM [0/90]3S 62.35 ± 10.14 8.19 ± 0.64 
 
 
 
Sample Flexural Strength (MPa) Elastic Modulus (GPa) 
0.2Vf RCM-APS 115.15 ± 2.65 8.17 ± 1.90 
0.2VHA  35.49 ± 5.94  5.37 ± 0.83 
0.15Vf-0.1VHA(NHD) 67.00 ± 8.55 10.01 ± 1.33 
0.15Vf-0.2VHA 36.41 ± 3.53 9.34 ± 0.49 
0.15Vf-0.2VHA(NHD) 37.61 ± 1.23 6.74 ± 0.45 
0.01Vf-0.2VHA 25.36 ± 7.00  4.85 ± 0.4 
 
 
 
 
 
 
Table A.1. Mechanical properties of the different composite configurations 
manufactured in chapter 7. 
Table A.2. Mechanical properties of the different modified composite configurations 
manufactured in chapter 8. 
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